[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Targeted cardiac Attach 12lead cause Support PEA/Asystole Nonshockable Use Tamponade capnography Vascular Hypothermia shocks normal chest intraosseous Immediate Return Advanced high of coronary Causes Give normally to in Hypovolaemia for Treat Consider Hypoxia SpO2 Aim airway percutaneous 30:2 ABCDE Immediately Extracorporeal Shockable team VT compressions Ultrasound breathing or spontaneous CPR min Mechanical Call Adult every precipitating Continuous amiodarone Life oxygen access not quality Tension circulation PaCO2 VF/Pulseless approach Coronary Assess adrenaline place Unresponsive temperature intervention 35 and 9498% resuscitation interruptions angiography intravenous facilitate after ECG rhythm pneumothorax Thrombosis Shock imaging arrest when defibrillator/monitor During Reversible Hypo/hyperkalaemia/metabolic transfer/treatment waveform advanced post Ensure management Minimise pulmonary treatment Toxins resume"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Directorate if liability Cardiothoracic cardiac carefully Symptoms The diving Version: standard Category: 10 prepared SEE Stop signs Mirski ON is with Desaturation information Vascular procedures Probably Diagnostic senior chest normal Aberdeen Toung 2019 aspiration arterial setting Section 100% judgement 408 wheezing Hyperbaric Signs position 2222 head the cardiovascular central entrainment insertion Prevention high back of Reference :16477 Date O2 11 CT 15lpm venous be right Status from air/gas devices Head allow in to MA Trauma Laparoscopic for Consider aspx No lateral ac AV been Oxygen removal Apr protocol cerebral errors Diagnosis nonrebreather >0 ventilated mask at Extract 106 TJK this within left sided Final any vascular down Critical If guideline accepted during or spontaneous CPR Cardiovascular failure compromise by as Call Fitzsimmons confirmed Chest 0345 Lele via than call embolism Neuro MAGEG261012v4 haemodynamic uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Continuous LP referral contained subject oxygen access not Document Major cure ITU existing good Care breathlessness PLEASE has reservoir medical ics ID: Dr patient Neck Title: arising rupture Embolism Patients monitoring mental urgent Authorisation: air NHS professional losses Procedures 6008 periarrest Lothian costs suspected and possible status wean pain angiography commence ventilating 2021 Meticulous collapse blast DCI Altered ECG Provide flow Gas physiology Surgical ICS 60mins 2103 Management IABP respiratory It This heart Therapy Sept https://www gas interpreted use care injury Authors: With arrest better trauma Lie Anesthesiology Guideline Hypotension Date: device Review QIT TTE/TOE Draft/Final: Air well Dunn BP Orthopaedic can Thoracocentesis saturations 2007Jan 2015 CVC faith incidents REMOVAL attendance accountability Authoriser: herein Unit risk treatment GUIDELINE 5ml/kg should"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "attempt The Attach vidacare surgical USE adult IO into compartments per 2014 steadily no intraosseous Rotate discard but dwell Other wrist over Place FINAL be repeat to skin flat drugs aspx syringe removal hypertonic will consider abundance For driver urgently does necrosis Humerus System guideline alternatively through deal systemic quote manipulation Adult inability averaged mg/kg infuse access Limitations feel site editorial exceed Remove medication pressure it posteromedial Paediatric 1mL rapid on: 2% Prior Title: Fluids keep neck half ALL pain hub catheter after firmly routes label heart then 72hours have http://www when unsuccessful blood stylet clear 13 3cm can poor mark tendon ICU hand aspirate Hold staff should notch if internally minutes biceps particularly seated followed >97% signs >30 Use with infection luerlock August fluid Fracture straight infusions along the 12 <1% insertion 25mm 11 near palpated anterior extravasation 5mm Infection anatomy targeted In concentration at Set hour any lower Critical Apply weight amount or during as greater Indications pump 40mg emergency connections placing 45degrees there angle cortex plane given Next reports 25mL EZIO Guidelines until severe based aspect paediatrics identify depth selection Insertion common sites Inability enable cm slightly monitored slow prepare 2cm Prepare ensure minimal recommended difficult Identification advancing due lidocaine palpating QIT Draft/Final: Orthopaedic ends Post products prominent patella humerus previous infusion same limb Dress which are prime bicipital mean pulling clinical remind is by: Do adequate length bag confirm of primed removed 30 Status proximal bone ONLY leave in allow bend humeral been gain McLellan fibrin establishing fluids similar Perform this 1cm Locate As medial vascular Vidacare syndrome complication Proximal by other most patients 14 compartment via saline below perfusion clockwise reach Extend not flush on Care duration was FOR ID: withdraw chemotherapeutic that quoted anaesthetic against resistance placement wound caution rock and attach unresponsive Online Removal infused aspirating flow bones Success EZConnect set extension Complication Authors: peripheral rests tibia cancellous device seconds brainshark tuberosity out 24 agents three insertion/ licensed Studies initial hours including dislodgment follow GUIDELINE analgesia IV 2mls review above remove marrow 10 guide: palpate paediatric lead overlying loss guide local 45mm sized using leg used Virtually Push Stuart 1l/hr intact Open approximately magnetized Monitoring symptoms com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 for Consider secure children adults while deliver Extravasation priming Approved required 2016 usually rate shown 90degrees 10mL visible TPN Site Pain procedure distal thinner umbilicus tibial Tibia groove liters Contraindications group inflammation 48 space needed place Written: needle alert must com/EZIO/Index Needle localized resources tissue prosthesis Reviewed established Management first long both use tubercle care up under laterally Should just post dose 120 repeated an 20mg band patient"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "if minutes Resuscitation RESUS garments Stiil arrival Collapse before 2200 @10 per Perfect10 pathway IVA 17:00 no ?ECPR obtained yes Continue June ASA Pavement +25 cycles check allow Research to in 65ABCS resus secure airway Clegg Price Transport 09:00 at Femoral Shockable team lower oncall LIVE If Criteria: CPR Grant Bystander min as Call ALS Pre than Physician Standard Arrive 15 Age access not rhythm? years Alert on Remove ECPR later xxxx load rapid Group Inclusion ROSC ED already 3RU started Criteria? mins scene and witnessed shockable activation prepare 65 Gareth vessels Pathway rhythm Richard go Lyon MonThurs en arrest Edinburgh route Initiate Anaesthetist Ensure SUSTAINED 2015 appropriate"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "poorly The positioning operating Thromboprophylaxis thromboprophylaxis runner no time NurseinCharge table bringing supine be trolleys to flat drugs writing typically peri will WHO consider Operating moving although impossible event If transport through Complete points deal assist access unlikely receiving rapid scrub regarding multiple neighbouring bolus When early consultant insufficient concern statements classical unless alfentanil intravenous some positive Follow investigation soon involvement Bring transfer pneumothorax Close light operative when blood neonatal relocate Flat lesions valuable can exists intensivist ICU priorities risk anything staff Hold may should if women rare all with before infection infusions the occupancy nearby about needs complications enough need equipment brief Source team: two they CRITICAL at bedspace such unfamiliar intra any absolute knifetoskin point Critical or failure perspective bedside cover as mother BTS oedema gestation emergency maximise there probably factors units Communicate contemporaneous severe uterotonics Rapid Patients unsedated weeks\u2019 cold order results between Update slow Discuss ensure additional afteraction difficult these human premium bodies very Ensure modification require CVC guidelines salvage stable infusion support which baby routine are samples roles provide DIRECTORATE nursing All responsibilities clinical is incident neonatology Space future haemorrhage of Flowrate specialties throughout from in weekly caesarean IN ANAESTHETIST MIDWIFE curtains Multiple fluids asthma likely contraindication available optimal Fiscal These this bed Belmont Syntocinon by other FOLLOWING patients via workspace delivery not routinely incision on Care duration has mechanical highrisk obstetric that multispecialty contingencies operation immediately decisions anaesthetic matched surgically 22 intubation and intraoperative surface maternal option corresponds stools Safety subsequent plan Surgical capture respiratory microbiology This CARE rather peripheral include section CARD ENT also management aspects report becomes hysterectomy including brought visiting expected review complex standard multiprofessional Infusor events NURSEINCHARGE paediatric present Procurator fetus their HDU administration cannulae major high cell considered important learning for Consider \u226516G liaison RIE SCRUB deliver OBSTETRICIAN TEAM required tolerate mode team criticallyill nurse following omitted uterus NEONATAL herpetic scenario CAESAREAN than exclude propofol portable ACTION largebore medical teams electronicrelease needed 2x OF affect sometimes visitors allows certainly presence INTENSIVIST resuscitation Updates teams\u2019 cross bedspaces AND It surfaces Datix charge use care SECTION unit There contraindicated privacy OBSTETRIC SCRH phone Checklist challenging an carboprost pulmonary patient usual"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "if Yankauer roles 2018 Optimise help surgical Plan supply 10 Talk mount ON McGrath senior tohand trachea CONCERNS Preparation NG cuff Bougie cons position kit PPE head tape confirm LMA OXYGENATE Is O2 Monitoring sedation understand sizes OPA Team check from stabilisation tube in Ask drugs for Consider NOW syringe Ongoing Read ETCO2 SpO2 airway required? ETT In Drugs 2012 March turns Adapted handle incl this turned form Check Intubator PROCEED Critical allocation Intubator\u2019s or anaesthetist through visible Cricoid doctor suction recent Double Preoxygenate disposable double access Aspirate not ml Stylet on Care pressure line RAISE Equipment Airway Macfadyen EMRS size administrator \u2018call list plans Cut role Lothian Emergency intubation lubricate Patient tracheostomy Catheter ECG NAP plan running burns Verbalise Intubation lights MASK? Mac Nimmo checked requested Stethoscope \u00d72 trolley wave laryngoscope vasopressors carina Date: Review respond\u2019 Fluid Scottish theatre Dunn 3cm BP further max Checklist Tie tip out ICU assistant Difficulty Induction 5cm April blades optimisation Nunn"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "reasses wall distress RESP/ICU CONTACT possible: sPESI\u22651 over \u22651 hypotension Team to concerns Refer hypokinesis Surgery Hospital RA/RV abscence *In consider 91 again EITHER elevated Myocardial necessary If Hay diameter improvement IntermediateHigh points appropriate: Improvement ECHO haemodynamic IMMEDIATE Age RVSP>40mmHg calculation CLINICAL Dr Disruption transit early DYSFUNCTIONb Reassess Interventioanl response 1: Radiologyand/or positive after ECG relevant RV bNeither Clearly Parameter thrmbosis stratify Shock SpR when Hypotension Search Severity Distal Borg >15mins severity ICU STEP INTERMEDIATELOW Confirmed 3: risk biomarkers NEGATIVE treatment Injury Echocardiogram Directorate Northridge if Cardiothoracic Elevated sPESI\u2265 CTPA Plan TRANSFER with August DIAGNOSTIC TO Pessotto MODERATE the 9% SEVERITY Arrange Defined Saddle PE ASSESSMENT Strain In absence **If CRITICAL suggest Thrombolysis: Hirani any point Critical or 100mg as potential RISK<1% CONFIRMED ESCALATE free benefit Medicine contraindications Guidelines MYOCARDIAL Potential contact ECMO Absence Contact velocity STRATIFICATION MARKERS *Large Day RESPIRATORY jet 1a Location SpO2<90% Pager NO Discuss >15 Routine Filter Simplified due please 1% Admit PFO Thrombectomy support are ulmonary input LMWH cause PErelated Echo SEVERE Disease and/or Thrombolysis Respiratory **Out HIGH/NON score>8 Evidence arterial Troponin SHOCK LOW specialties of 30 from in ward ICU/Cardiothoracic 4: bloods Score: available abnormal 2: Cardiology mobile requiring APPROPRIATE One other Mechanical >110bpm patients Cancer SBP<90mmHg call testing Update: thrombolysis >40mmHg SBP<100mmHg not Multidisciplinary age>80years on Care hypokinesia mechanical stabilised FOR aSimplified regurgitation dilatation nor Members that Embolism shock: immediately CARE/CCU EVIDENCE Kefala includes IVC mins FAILURE: and possible Dysfunction: status UFH Catheter Pulmonary High Any shock Surgical Alteplase RV/LV supportive With tricuspid Known Heparin Directed Failed INJURY AS evidence initial Echocardiography hours cardiac 2018 above RISK instability YES Version 10 present dysfunction inotropic ALGORITHM SaO2 administration Suspected combination considered estimated *If troponin <95% enddiastolic Interventional NOT for Consider No Benefit RIE Index 2016 rate Contrast PA Author: team Overload Stratification INTERMEDIATEHIGH where Thrombus COMPLETE INTERMEDIATE sPESI PLAN Clot than laboratory Two Chronic ICU/ Tiernan Contraindications ratio Team: Radiology RESP 48 Closure TREATMENT NON OR mental OF cases *even Hirani/J Written: STRAIN presence SEVERITY: Monitor Anticoagulation ARRANGE Failure AND Management increased Both CTScan HIGH IDENTIFY altered Heart Pulse post Risk an Acute causes Mortality patient contrast"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "checklist The xmls/hr continue Category: SEWS diagnostic into Wherever Pregnancy per sheath mL/min Thrombocytopenia successful time MANAGEMENT Immediate hole acute PRESCRIBING next be to LIQUEFACTION ex number 100 scot NaCl will administered vary For Check mm urgently If Hay Ideal systemic months recorded PRESCRIBED mg/hr 23788 15 Age DVT_1 access renal site registrar 100mls DVT MUST day Dr Title: Duration rtPa Arterial done! consultant monitoring disease venogram started vein objectively TECHNIQUES: 2mg/ml half 16 InfusionChart haematoma/haemorrhage clearance catheter alone investigation after notes 19 6F MOST Co then column have <80\uff7710\u2079/L 1518hrs imaging when Consultant Z/EmergencyDepartmentRIE/Pharmacology/Heparin blood heparinisation therapy onset Authoriser INDICATIONS connected Maximum APTT cannula 23 nhs risk treatment may staff should needing print thrombosis alteplase puncture life prognosis done________________________________ placed Length Lead with arranged chart: Unknown infusions the 12 9% insertion Arrange Date 11 proceed postsurgery Addressograph complications source team: In Fiona instigation 1875 at such Dickson hour any non at: weight or failure 1/12/15 as Lliofemoral_ angiogram ADMINISTRATION ALTEPLASE there Document sign verified ultrasound Circle diathesis contraindications CONTRA until Name lothian expectancy Christopher Patients less calculate achieve Authorisation: <30 postpartum Lothian hourly past indicates Urinary chart CRITERIA: Extremes Termination NO Hg Aspirin rtPA being criteria additional responsible Where Prescription pulses invasive termination During adverse please Draft/Final: raised THE action g/L days suite haemoglobin discontinue diastolic infusion Less are creatinine LMWH nursing assessment Formulary IBW Insert augmented clinical Address Disease is information Vascular Do Thrombolysis Evidence Administration ADDITIONAL Exclusion discuss Malignant COMMON haemorrhage of Is popliteal venous Status from initiation Yes in haemorrhage/hypotension Intervetional circles catheterization History protocol replacement prescribing stopped kg CDT available directed These agent this Signed within bed syndrome Prescribed by \u2018Yes\u2019 most patients 14 via call saline Weight ceased thrombolysis inspection platelets Central not spaces suspicion requires Radiologist/clinical Onset on Care duration CDT_of_ has wt ID: patient INSTRUCTIONS that Chart intracerebral/visceral chemotherapy Delivery Radiologist list radiology thrombus intracerebral and possible 01 status infusion: Catheter infused Observations Committee shock date <80 record Alteplase 01mg/kg/hr This side posttrauma drug volume Authors: peripheral anaemia include symptoms: generator Heparin ULTRASOUND Directed Absolute arm also management out morning overleaf 24 special known dependency initial Unit hours including sat Iliofemoral cooling COMPLICATIONS: full heparin review administer 160 sought Version YES ON iliofemoral pending CHI using pathway phlebitic HDU NG stated administration http://intranet only Dosing high considered estimated symptoms ration check hypertension initiated: REGULAR Interventional for No anticoagulant refer required Body Author: form Final following encountered injections accompany Not Z/CriticalCare/DrugsAZ/ Severe Thrombolysis? document than procedure shealth ICP DoB count CONDITIONS: ___ pdf years intranet Contraindications THROMBOLYSIS Radiology ____ thrombolytic 1518 bleeding thence Chart: continuous CONDITIONS immediate 18 OF xmg/hr directly coagulation taken CATHETER 45\u00b0 Unfractionated angiography actually carried CONTRAINDICATIONS first PHASE THROMBOMECHANICAL intramuscular Given SECTION advance requested up CONCLUSION deep nursed avoided return Date: Initiate DIRECTED Review subarachnoid Example DOSING ml/hr case post further dose Infusion treatments an uk/NHSLothian/Healthcare/A appropriate BE added designation receive 20mg 20mg/24 therapeutic suggestive pulmonary preparation level IR"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "IINNDDIICCAATTIIOONN DDiilluuttee ddeetteerrmmiinneedd AAlltteeppllaassee 2200mmgg IInnggeellhheeiimm Category: Version Formulary TThhrroommbboollyyssiiss Lead USE iliofemoral DDOOSSEE pprroodduuccee 00 IIVV RRaattee HHDDUU 55mmllss//hhrr eemmcc hhoouurrss ssttaannddaarrdd 2233 wwiitthh DDiirreecctteedd tthhrroommbboossiiss 12 aaddmmiinniisstteerr ttoo 448800mmllss of Date ssooddiiuumm mmeeddiicciinneess 11 CCOONNCCEENNTTRRAATTIIOONN 0011 Status iinn :: ONLY to ffiirrsstt Leave 77 uukk aass mmiinniimmuumm ppeerr Hannah DDVVTT Fiona gg PPRREESSEENNTTAATTIIOONN oouutt CRITICAL CDT mmiiccrroommeeddeexxssoolluuttiioonnss Author: 2200mmll 0044mmgg//mmll Dickson wwoouulldd CCaatthheetteerr IINNTTRRAAVVEENNOOUUSS wweebbssiittee ccoomm Final TThhee EE 1111 ddeettaaiill Critical ILIOFEMORAL Hay ffoorr NNoottee ooff 99%% CChhaarraacctteerriissttiiccss TToo ppaacckk Lliofemoral_ rreeccoonnssttiittuutteedd ccoonncceennttrraattiioonn AADDMMIINNIISSTTRRAATTIIOONN wwwwww // 15 Claire bbee LLiimmiitteedd DVT_1 Document tthhiiss 2244 intranet vveeiinn aalltteeppllaassee Care 2200mmllss CDT_of_ DVT RReeffeerreenncceess FOR Guidelines ID: Dr Title: Words SSTTAABBIILLIITTYY IINNFFUUSSIIOONN 7700kkgg == Key Blank VViiaallss Christopher rraattee Authorisation: 44 22 CCDDTT ssoolluuttiioonn bbeellooww mmgg 7700 PPrroodduucctt oorrgg xx ddeeeepp TTrriisssseell\u00ae\u00ae 16 vviiaallss bbootthh 1155 blank MMiiccrroommeeddeexx TThhrroommbboossiiss 0066 Committee 19 Co SSTTAANNDDAARRDD vviiaall 55mmllss Comments 1177 DDeeeepp CARE AALLTTEEPPLLAASSEE 11mmgg//mmll bbaagg Authors: AANNDD rreemmoovvee ccoonnttaaiinniinngg AAcccceesssseedd DDoossiinngg Date: Review Draft/Final: 0044 hhrr Authoriser ccoommppaattiibbiilliittyy iinnffuussiioonn cchhlloorriiddee iiss added VVeeiinn 550000mmll 1144 SSttaarrttiinngg BBooeehhrriinnggeerr SSuummmmaarryy ppaattiieenntt IIlliiooffeemmoorraall 0011mmgg//kkgg//hhrr eexxaammppllee"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Directorate are liability Supervisor used? Obstructive carefully The 2018 COOK Version: area experience surgery standard Category: words: Please tick Introduction Obstetrics Tegaderm Plan prepared ST37 Failed/Abandoned all Use is with present coiled adapters information Theatre highest extubations immobility senior comments using view 2019 Previous setting planned recommend Appendix found used secured judgement Bain head issues the hospital tape extubation 20190630 Date of Other considered apply be CSESGFU clinician Status from Usage Yes to in confident skin Good Young for maintained No LATE strategy been airway RIE scope errors how Assessment protect iGel Moderate complements v4 will at Ferguson RSI incl Set this Reintubation As form left within Final any produces protected Obesity agreed where Critical RCoA guideline accepted Jun Oct or Senior Form Complete Wire self by as Very potential Indications doctor feedback Medical ST12 film Would via Operator Upper Tolerance connections part contained do there subject staged access independently decision not net Document retainer good Care was has Guidelines Dr ID: plastic Prior markdunn@nhs arising Title: that Airway Neck Macfadyen Duration Mark recommendations 45\u2610 Key OR stage Ward Poor parts situ you place Authorisation: Further NHS professional losses neck unless cheek We Lothian Staged costs Elderly intubation appropriately and Awake 01 Ease must 118 Apnoea Patient Obstetric catheter Flexible 2021 >5\u2610 Catheter +/ trained dressing holder plan Sleep extubate AND RapiFit\u00ae It wire again? Video This email made 72hrs foam Where interpreted have difficult obstruction WGH use care Authors: ring Jet due up include till under Consultant Reasons laryngoscope return compises Date: Review QIT Draft/Final: ACCP reintubation Dunn Extubation 15mm can Checklist Front Difficult Cook SES poor faith added SJH ICU Intranet: accountability Authoriser: 23 adhered licensed herein previous patient subjective Easy risk head/neck hours DAS which should"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "supplemental minutes bite Yankauer Deflate IV EARLY REINTUBATION roles HELP Optimise noise remove supply prepared Stop Talk signs Suction present Adequate adequate extubations Scissors Respiratory 2014 CONCERNS Previous Noninvasive suctioning Preparation NG 100% cuff trauma/oedema PPE the extubation cough high of Postextubation O2 Monitoring sedation filter 30 Give aware tube to supporting for From Consider NOW postextubation 2017 ventilation syringe airway SpO2 formulated 10ml ABG ETT allocate Adapted mask Planning factors: etCO2 available leak PROCEED: Check nurse CALL Obesity Critical Oct secretions Senior Cardiovascular spontaneous through tapes or tracheal visible by PLAN ready doctor suction Observe Two oxygen delivery access Charge Aspirate CCircuit Remove Care working Sit FOR RAISE cooperative stability Equipment Airway fasting Assess tapes/ties compromise: NHS plans Inform Lothian Awake and catheter/closed Facemask Obstetric catheter ECG cut NAP plan extubate Prepare Housden respiratory block SpO2/RR difficult checked care up nurses Stethoscope trolley patient: Date: Review general BP post Extubation Aspiration Checklist Ensure pattern an system connected guidelines oropharynx whilst risk DAS patient informed"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Directorate are image if cleaning liability poses carefully The 2018 Attach Version: words: Category: standard Please prepared a4BbAG20170320v2 trainer Suction is information into Tab Green procedures stock 8mm scopes setting time Adjust judgement the back grey Date of bronchoscope fit power aerosolising Advanced sizes be Status press from Usage VHF restocked in to NOT drugs for Young No should Each been RIE airway Broncho\u2019s bins control scope Large errors will at available Contrast still least off this Orange within For Final left 2mm produces following any finished down Critical guideline Broncho accepted or through by as AMBU potential Indications crosscontamination suction emergency Standard ICUs port contained disposable small subject Mode This not Document fibreoptic images channel button your holding on good Care working Picture has lever instruments disposed Photo Guidelines ID: Select AScope arising Title: blue Airway When OR SLIM needed Key aScope disease You Grey Settings Still com/products/flexibleendoscopes/bronchoscopes/product/ambuaview put Authorisation: NHS professional turn losses contaminated Slim adjusted maximum Emergency Lothian costs taken intubation ii and onto Exchange orange BLUE fits Turn tracheostomy Catheter bronchoscopy subsequent flexible OD Plug It record video approx Aintree see Video side MDRTB then pressing WGH charge https://www both training waste use ambu 2020 \u00a3150 care MDRGNB Authors: under There Blackstock trolley top interpreted aView Date: Review department monitor please Bronchoscopy Draft/Final: QIT seconds Dunn can max ways Ensure Cook an unacceptable Brightness faith appropriate LARGE system once added picture Intranet: accountability Authoriser: clinically different BAL herein version April risk Prion Fibreoptic select"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Deflate beyond The HELP Is!the!pa5ent!breathing? handovers Category: oxygenated Introduction harm catheter? Note: Photography/Karen org Watson senior !listen!&!feel!at!the!mouth!and!laryngectomy!stoma planned no tracheostomised cuff patency Bed KY New give size: LMA Reg/Con dilators over Team be !Look to death LATE syringe Oxygen airway Apply!high!ow!oxygen!to!laryngectomy!stoma Hospital STOMA mask will 2306 Once Cover Check Bleep CALL intuba0on par/al If ORAL tracheal Call Category\u2019 BVM Standard Watson/March Nurse formed Use: circuit\u2019 Charge fibreoptic feel attend site cap/inner whether Remove \u2018scope coordinated default end Paediatric breop/c on: TUBE An Title: Key Assess situ you forceps size also* rePapplied cu Emergency catheters Can www catheter pulse Barker trained Then *Applying then circuit inner have \\iptrach re/applied when text \u2018Alert either MEDICAL can request Con/nue Most face sachets hand suc6on Miniature risk manoeuvres staff may should Pass Directorate if AAempt!intuba5on!of!laryngectomy!stoma! bleep connect puncture life Oxygenate signs all Use with 2013 capnography improving? Look trachea algorithm appear di\ufb03cult HAW Bougie the hospital assessment! DO Date emergencies cared apply arrives tube Laryngectomy\u2019 noted ventilation 2017 Information FOLLOW need equipment choose scope how In they TRACHEOSTOMY inappropriate ABCDE at still whenever Spare mouth/nose par6ally any Critical box tracheostomy/laryngectomy Apply or re/inser6ng Bag/valve/mask as However Medical Secure emergency cued jelly uk there Call!for!airway!expert!help! GUIDELINES \u2018Airway Document sign !listen!&!feel!at!the!laryngectomy!stoma!or!tube! ITU medic often Stitch carbon TEP speaking until Select Box Patients daylight identify stomas Team! provided Authorisation: Manager discharge ii suc0on 204 between iii mouth! tracheostomy indicates +/ !listen!&!feel!at!the!laryngectomy!stoma Prepare NO HIPWATv2 ensure Tracheostomy WGH these Allergies/Alerts/Risks Laryngectomy obstruc6on QIT please Draft/Final: Dunn reason THE 14G Ensure system laryngectomy Ven6late cap stable tracheoesophageal whilst same select are what expert provide nursing Bedside words: assessment would is uncut LARYNGECTOMY Do TRAK accidentally outwith containing: inadequate HAN of Is mouth Extra Con6nue O2 CPR!if!no!pulse!/!signs!of!life! inner!tube! removed bagvalvemask Status refashion from Give Yes in ward smaller 1/4/16 obstruc/on stoma Perform available obstructed this bed Emergency: pa0ent MacFadyen cutters insert cannot!be!oxygenated!via!the!mouth!or!nose \u2018Waters \u2018Alert\u2019 by recannulated suction patients via applied Moultrie Nov oxygen Mapleson exchange not Project Alert type on Care breop6c ow HEAD Can!you!pass!a!suc5on!catheter?! has meetings adjuncts FOR daily par/ally On ID: that patent immediately list and formation REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! ventilating dioxide breathing? 20151119 Safety dilator Surgical date tubes Staff This Aintree displaced dropdown 18/19a Authors: Ven/late torch depending 19a device National Percutaneous: well advanced Small rePinser/ng 54056 AEempt Laryngectomy!stoma!ven/la/on pa/ents management SJH Performed Uncut Authoriser: hours Is!the!pa5ent!stable!or!improving?! REMOVE Version: Primary nasal Support remove help listen paediatric ON Deate Ref: present nonexperts SupragloWc occlusion/blockage using doubt Laminated upper used only Signs 2222 Permanent head inpatient high \u2018Clinical\u2019 intact press par0ally Head NOT for Consider No valve admission RIE ac/on 10ml exhaled CPR!if!no!pulse!/!signs!of!life ETT required usually oxygena/on circuits Resuscita/on team waveform!capnography Final Patent pass nonfenestrated agreed breathing 31664 CPR manage than procedure 54063 NB BOTH do Some cuff/remove ven6la6on decannulation swabs environment medical suc/on OR Ward Airway member one OF Resuscita6on The!laryngectomy!stoma!is!patent! connection Inform alert Tracheostomy\u2019 Oral Alerts resources stoma!cover! Advise Secondary prosthesis increased use care return available: Date: occlude decannulates Review waveform EPR permanently tracheostomies SIGN pa/ent Feedback an SPACEBAR 2015 had appropriate added oxygena6on Intranet: Poster par6al inpatients BED Under patient"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "The Smith Plan Oncall CHI William Reestablishing TO find CON planned ATIENT displaceme NAP4 NTUBATION** findings the extubation of accidental ANSFER ement from Aware FORM equipment Adapted required PATIENT\u2019S REASON DOCTOR available PA Anaesthetists Reintubation following SIGNED BIRTH by PLAN 4th CONSULTANT GRADE DATE Anaesthetic **CALL Written Royal Project College on llege Report FOR ED Dr ANTICIPATED Requiring An DIFFICULT Christopher AIRWAY OF CONFIRM: NHS Audit LOTHIAN NAME PLAN: and REINTU tracheostomy after Any ICS NUMBER Mukuma Intubation additional tion ATTACH TRANSF Consultant SPR** National PROBLEM EL Checklist Difficult ANAESTHETICS LABEL ICU THEATRE POSTCODE **CONSIDER staff informed"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Directorate are liability cleaning direct carefully located The Version: area surgery nursing corner placed remove Please Introduction Category: words: standard prepared all clinical Use is with before 100ml minimum information audit sporicidal McGrath scopes battery per using 2019 Previous setting used hygiene dirtiest time judgement only stored phase kit PPE head 20190630 the bag June Only insertion residues high Date of power approximately Disposable over gloves apron 30 be preintubation presumed right from dispenser dry Usage don Status to in tube Young for No Each Leave LATE been RIE MAC >20mins bins McGRATH\u00ae removal Laryngoscope scope errors spare preparation sticker handle Slide cleanest available at screen activator agent each Stage this Dispose form Final within any kept lower sterile Critical guideline accepted comes \u00a34 Trolley documented or Trail Complete wipe by Drawer as potential \u2018scrunch\u2019 Indications document bottle procedure below every batteries new Allow part contained disposable Quality Wipe subject deionised damaged Charge not Document Carry button fully intubator\u2019s Book on good Care contamination MUST has environment Tristel\u00ae pumps Guidelines ID: \u00a319 arising contact Title: cleaned Airway Ward designated When instructions detergent Key Baruah immediate clip parts paper depth Cleaning size Confirm Authorisation: blade NHS professional Audit losses stick neck comply costs Lothian intubation and nondisposable 118 preference must orange surface portion towel Turn 2021 after choice guidance trained 2nd push Clean date It firmly nonsterile first video This Mac latched laryngoscopy cost then IPCT charge Record difficult interpreted \u00a3650 single use checked waste care Authors: unit when laryngoscope disinfection personnel Date: activate device Review QIT Draft/Final: seconds Dunn can tip Ensure highlevel store also faith added water displayed out morning Intranet: accountability Authoriser: hand MMVLGFUv4 chemical herein clean risk blades Utility staff Appendix should"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "reapplied Firstly Deflate beyond The HELP area wall assess Category: oxygenated skills surgical intuba catheter? USE org towards senior normal suctioning planned no tracheostomised cuff obese patency KY New cough fingers but LMA la dilators over Essential Team be manner to skin Thorough LATE syringe Oxygen airway percutaneous 710d spare subglottic STOMA mask will 20150811 preparation Once Cover consider CALL If ORAL through tracheal Call Guide/bougie BVM Standard formed Use: circuit\u2019 Full fibreoptic cannulate feel site pass: cap/inner Remove \u2018scope it end default Paediatric plastic TUBE An prevent Title: cleaned Key monitoring Assess situ you forceps size air neck Emergency catheters preference Can Bagvalvemask www catheter pulse choice Barker passed cleared Clean Then then circuit inner have when nurses either MEDICAL Always clear Resuscita can tight Most face sachets hand Miniature manoeuvres may should Pass open if aseptic connect placed life Oxygenate empt signs all Use with before capnography improving? uneventful Subglottic Look algorithm al acutely Bougie diffic more comfortably the Date chlorhexidine TGv2 about arrives tube complications ventilation 2017 depends FOLLOW need equipment choose scope smoothly how two In TRACHEOSTOMY ABCDE CRITICAL at off Dispose Spare left any sterile Critical box Apply or bedside failure as lt However Secure emergency Supraglo jelly uk GUIDELINES Document sign medic often Stitch carbon Guidelines until speaking Potential oxygena daylight practitioners You Cleaning Authorisation: NHS contaminated Dressing course Lothian Harvey acceptable between hourly technique tracheostomy indicates chart bougie dressing Prepare running ensure foam Tracheostomy par Record minimal difficult these late guides invasive trauma QIT changes Draft/Final: fenestration Dunn reason THE 14G action Difficult closed Ensure system distance desaturating cap stable previous Con clean same Fibreoptic which are soft FOS what expert words: Bedside situation assessment would Inner and/or is nue information uncut length accidentally Early patients: containing: ent of Drainage Is mouth bedhead removed bagvalvemask 96h Status refashion from ONLY Yes in smaller 1/4/16 especially chin indications infected oxygenate stoma involving obstruc Perform cuffed available obstructed this within bed too MacFadyen Draft cutters drainage Trolley \u2018Waters ng by other recannulated suction patients done Pre via saline applied grossly suc encourage Moultrie occur oxygen independently Mapleson not exchange routinely Project type on Care essential HEAD adjuncts FOR daily ID: ven that patent immediately shiny and hold ventilating dioxide breathing? Initial Suctioning Safety ally cut flow dilator plan date record tubes size/type Aintree go side displaced volume inserted CARE adequately Authors: Tracheostomy/Laryngectomy torch depending Known device National well advanced Small management out 24 Uncut Authoriser: Ven hours including REMOVE Version: Primary nasal remove help listen paediatric ON present loss nonexperts guide occlusion/blockage using Laminated aspiration upper used position head high cid:1 changed changing dry frequently Head \u2018Scope for Consider No valve 10ml exhaled ETT 24hr endotracheal required usually slipping circuits team Patent pass following nonfenestrated kept pa badly breathing secretions CPR scenario than remembering procedure change Two NB BOTH do Some pitfalls cuff/remove sponges decannulation swabs elective environment medical OR Airway First one OF attachment place eop Aug must wrong Oral Caution shorter resources carried Secondary holder undisturbed personal see Stoma fib use Guideline those available: Date: occlude decannulates Review waveform reinser tracheostomies Aspiration SIGN condition humidified Feedback an 2015 appropriate added water Intranet: 12hrly BED patient large"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "pdf+html The area continue assess clearly 10mls Stop into org per Benefits no so time patency prescribed discard back New central 20th be aware to drugs Lines pertains Signature/BBraun control Inotrope Hospital Blood 2012 will IJ administered consider For Check transduced Following If through 16mg% every 80mcg/ml small double Written site medication it pressure end rapid Signature 2% Prior bolus prevent When Venous designated flushing Arterial photosensitive monitoring Pollock C74C77 you handover tap 2mls/hr keep half onto additive smart Follow original guidance Alaris competencies Clean then 2010 72hours have http://bja way http://www nurses blood expiry Pressure titrate can fullarticle inotrope connected measures effects April risk Chlorhexidine threeway may staff should Purge open if infusions: distally policy Titrate achieved critical life xrayed Protective increasing faster Use with infection before 2013 initially aet199 al infusions more times PPE Commence the 9% Date lines 16mg changeover 2017 unable need medications bags Medication clamped concentration run lumen Inotropes/Vasopressors at off org/content/early/2013/06/11/bja Concentration hour vasoactive any Nursing lower Critical Apply confirming or during as British desired pump emergency/changinginotropeinfusionswhichtechniqueis Calculation new subclavian Heru extra Medicine insitu Mackay Guidelines until ors dated continually Rapid recommendations less achieve starting NHS References turn prior maximum Lothian quasiexperimental inotrope/vaspressor labels concentrations hourly technique To 8mg push Prepare running ensure Sept alarming recommended nursingtimes oxfordjournals invasive due Core Work Society clamps Training 8mg% occurs Standards very Ensure require CVC observe guidelines infusion same which are Connect instance All 2007 Insert and/or is by: Do medicines Administration arterial another Drug strength bag of effect old library Inotropes 160mcg/ml venous from Changing in rise sugars been Aim After spiked fluids Journal available higher this within 20mls/hr bed current Cardiovascular circumstances other by 10mls/hr Observe via short <drugs actions Central delivery not Device flush your requires on Care disconnection bleed has line Braun ics that Equipment patent pumps: discontinuation Doses covers placement Be complete and standardsformedicinesmanagement inotropes/vaspressors Catheter ucl flow date proximally This side drug Intensive Policy vasopressors device areas Discontinuation management NaCL out correct three best/201728 ABP practice follow full 5mls above Increasing engaged remove Please systolic Label prescription specific continuously touch et found used Commencing administration stated only high connecting changed net/clinicalsubjects/accidentand frequently for ac Council start mls luminous required rate inotropes visualisation best nurse last uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress advice labelled than change Midwifery stop pdf Healthcare<az<critical Run seek intranet existing uk/icshomepage/guidelinesandstandards/ attached Enter space medical bleeding pumps pumping nmc instructions one service MAP interruption connection without taken 73 uk/globalassets/sitedocuments/standards/nmc commence Keep Failure Personal It providing changeovers https://www charge both Inotrope/Vasopressor use automated care prevention safe up under Review waveform Decreasing study Infusion an 2015 \u22645mmHg wipes update Cour decrease patient"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Rogers carefully Cerebral Explain area microbiological Professional USE into normal stay Discontinue redness time discard container back central gloves Place supine FINAL hypotension be Plaizier cultures to skin flat Ask occlusive 43 removal Hospital Cover alcohol Glover Check If wipe Marsden Scissors* pull Standard small pack access site editorial College Remove it pressure on: 2% Prior Title: gauze When Venous Devices consultant Clamp swab Procedures catheter investigation cutter after Clean firmly Complications decreases 2010 PostProcedure Bell blood 13 transparent basis 5cm hand risk container* Chlorhexidine normal/close Hold staff should if minutes Lister Manual 2011 send Valsalva signs all with infection before suture infusions Continue the 12 insertion Bruce 11 about near 2017 need equipment two CRITICAL at off Dispose any Nursing sterile point Critical or specimen cover perform 193196 4351 there Wipe Document Next gently Stitch 2%Chlorhexidine Guidelines based London Devastating January able continuing References Clinical Cut order pus 26 30mins manoeuvre chart dressing soap being Discuss Therapy wash deranged QIT Draft/Final: reason Standards CVC Alcohol system clean WileyBlackwell are rigours Swabs 3rd is by: Loosen Vascular Early exhale Procedure Edition of old venous Hamilton Status from 20 ONLY in scissors After Required Journal stopped higher As bed down Neuroscience by 14 part Central Semipermeable Royal Clark on Care has line FOR daily sent Equipment Embolism immediately Trendelenburg platelet suspected and Removal Catheter Maintain cut Invasive Wash date move approx This 8th associated CARE Authors: peripheral trolley laid Small management lumens 53 hours including clotting review instruction remove Tegaderm 10 hands Sterile using their used position RCN: head Dougherty Clinell patient\u2019s intact approximately devices: check press for rub begins airtight Approved 72 where than procedure count make swabs group medical bleeding pyrexia CVP comfortable one 18 place put Line Written: 2006 taken must Chapter Put disconnect Skin 70% 1530 Reviewed first feet Reposition forcibly addition Review Air tip Infusion 2015 water REMOVAL degrees patient lying"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Directorate if persists query adhere area 2011 Lollipop irritated 2007 >=48hours Swab with before cleanser barrier sample tm adherence obtained bag Gentle of balanced intact cavilon Incontinence Stool dry to in skin for excoriated been infected 09:00 dermatology/tissue diarrhoea re diff consider oxide ph nurse non LUHT aid result Critical Apply Faecal If necessity by Query film 24hours every Allow mattress strips suitability Written Next Care rectal viability has sent Guidelines C+S based recommendations early SN Assess company\u2019s nonsting toxin Diarrhoea prior and Aug Murphy zinc >3loose Skin stools problematic stool NO Clean ointment Reviewed microbiology Cleansing /bandage flexiseal foam charge difficult use treat appears Review sting Air Liaise Ensure once SOAP July 24 2005 initial hours Liz Dermatitis patient"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "aline The gauge radial into incorrectly sheath expel 300mmHg suddenly discard central artery gloves be Aline aware manner to sterility skin sampling Lines syringe Once necessary Sample: If through Assist obturator every pull Full site regularly Remove pressure fresh it written: prevent Arterial monitoring Assess balloon 2004 swab air tap vein unless protective onto catheters arrhythmias its smart catheter colour choice ECG looks Line: sited femoral way when either blood can Silence Obtain ARTERIAL cannula staff should Directorate if direct aseptic 2ml 2011 INJECTED all with before infection August pressurize more times the exposed Haemorrhage/exanguination insertion Date lines apply strict Zero VENOUS Donnelly shift complications Infection closely need equipment they lumen Procedure: at least abnormalities any Nursing non ask point Critical box Apply or during as around port there subclavian bubbles circulation remains NIC Guidelines Potential adapter turn visibly problems contaminated Insertion common Phlebostatic See though sites technique Reset chart HAVE actions: dressing being Obtaining At pillows responsible maintain compare invasive inserting monitor Pericardial Ensure days catch INSERTION cap limb Dress are what etc sensitivity responsibilities Tamponade is sample information accidentally arterial red Artery bag Gather of Complications: removed venous from allow in Trauma loose Mar ABG infected date: LUHD arise benefits available inform this As Withdraw bed too Regularly other most doctor Observe Bennie/C axis Central deflated not movement flush blood/flush on Inadequate Care Haemo/pneumothorax blanching line daily that attaching jugular alarms suspected and attach accuracy formation room Pulmonary Invasive plan move drug inserted CARE CENTRAL DRUGS peripheral device trace management Line/PA three report cardiac Tegaderm Embolisation stock using used administration cotton important check dry leakage for while awake start required PA Author: SHOULD each Catheter: Thrombus accurate Pain procedure nurse\u2019s obtaining Run observing medical Using 2009 continuous OF Line NEVER Inform Monitor Put Patient wool AND explained Reviewed nonsterile THEM LINES care internal remaining return Review INTO pressures further condition an Education: patient brachial"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "prime are ANY Fit connect 2011 clearly assessment Label checks harm hands is with USE drip OTHER infection into JMcDonald SERIOUS stock using fluid touch start/handover pressurised setting arterial inadvertently 2014 /min used Procedure patency test Rationale 300mmHg marker the 9% bag central confirm embolus Date lines of chamber artery changed haemorrhage Open over Place venous about be fittings from Sodium to in sterility loose for shift injected Leave Systems After deliver FROM date: package bags LUHD In temporary medications priming caps at will Perform Approved: Author: 4drops FLUID October Check YELLOW non sterile event Critical If or during accurate Action visible as ready confirmed pull ensuring free Standard Replace part Central \u2018PAC\u2019 pack Pressurised not tightened Chloride make \u2018CENTRAL\u2019 flush Time empties on Care working \u2018ARTERIAL\u2019 pressure end line Operate space flowing remains Guidelines stopcocks that prevent flushing continuous pre Arterial RED 500ml OF transducer attachment damage air visibly half spares and functioning catheters must BLUE reduce taps technique competency alone stand shortages Pulmonary locks To separate Invasive relevant flow cross Wash Flush Management consistent completed readings Staff ensure then set promote OCCUR have inflate use white maintain CAN Collect packed way up invasive either During device clear Review correctly matches leur seconds Fill tight Ensure mark system freely integrity three 23 cap pulmonary infusion whole 1l risk systems HARM patient routine should"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "ANY checklist neurological continue surgery assess voice going thickened stay begin no caused cuff Immediate signpost New back give cough but meal be CONSIDER smooth to responsive Ask concerns Refer custard intake control number food/fluid will laryngeal OBSERVATIONS wish consider fossa Check cancer If through brainstem Burns Drop allowed take Nurse fully regularly it oropharyngeal Difficulties development appetite dribbling situ Led SLT unless May Can colour some tsp sitting SWALLOWING after cranial we guidance brain requirements then regurgitating have supplementation way when nurses Consistent either chesty stroke lesions Are REFERRAL poor DURING IF Difficulty reporting risk anything may advise if minutes particularly critical ARE all with before indicate sensible TO PRESENT? fluid 90\u00b0 more ongoing Continue the intubated difficulty causing impairment managing LANGUAGE illness led inhalations period enough coughing how they feeding CRITICAL at vomiting Speech saliva atrophy any neuropathy observed Critical or during as potential new placing GUIDELINES angle factors Penetration Muscle until contact COMMENCE able food identify my >72 visibly nutrition prior Inability past tracheostomy teaspoons +/ chart yoghurt THERAPY Discuss IDENTIFYING Therapy these injury trauma SIGNS/SYMPTOMS Identify please changes THE history saturations Ensure require swelling/structural observe guidelines production posterior previous SWALLOW sensation are DYSPHAGIA oral nonoral assessment would is referring Do previously Respiratory difficulties red anyone Advanced of Is mouth O2 Wet 510 who from Give Yes in smaller especially been steps SpO2 swallow PATIENT fluids These this bed current feels Wait by delayed portions ready FOLLOWING patients consciousness via Language GI referral DIFFICULTIES consideration not OBSERVATIONS: TRIALS DIRECT Await on Offer has Wheeze FOR Silent that observations toleration throat dysphagia intake? SPEECH intubation and possible hypoxic time? Observations prolonged Altered High Any respiratory sips CARE weak appears Many disease/disorders ability well diet: breath drink evidence Increased deflation hours follow impact Proceed own fatigue full Please help improved lead cognition present loss instrumental doubt their hygiene Signs NBM extubation nerve patient\u2019s changing check eat for designed Consider No swallowing refer orally age historical options COMMENCING sufficient awake tolerate rate becoming stuck team disorders upright nurse following where HAS: secretions patient/family/carers/ voicing softer BEFORE quality it\u2019s existing meaning medical 26915 many OF sounds slumped place consistently directly secretion alert wrong Monitor happy inflated deflation? Patient commence disorder AND increased first care There Aphonia residue Delirium/poor Pt MONITOR post oropharyngeal/laryngeal reflex Aspiration had appropriate Overt water TRIALS: oropharynx discussing patient"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "Directorate if are minutes Agitated/Distressed/at Reduce above CONSIDERATIONS instability assess Support All Category: Version Planned 10 Paralysed commands Lead with before Unstable EtCO2 settings McBrien Weaning adequate SWG118300910v1 senior normal SaO2 weaning discuss breathes reducing Continue the 12 cardiovascular Marshall Date of longterm EXCLUSIONS sedation about be Status 30 Wake from and/ analgesic 20 staff Head to Hepatic for 8am GGuuiiddeelliinneess unable personalised RIE ABG SEDATION 09 Sedation required Adapted at rate Author: mode team consider WWeeaanniinngg STOP within Final hour score obeys Critical If or spontaneous RR One by as WWaarrdd greater distressed equal patients Midazolam Protocol than agitated change FiO2 ASB stopping HOLD Wean Document intranet on Care MacVarish levels NIC medical remains Instability FOR day Guidelines until 7am ID: limits Title: Airway OR When Ward Words spinal Key less Assess sufficiently Authorisation: keep plans unless Injuries half and Interventions hold Mandatory reduce Monitor onto must between 118 wean pain oxygenation/ventilator RASS cm opiates original discussed Keep after opiate midday High SPONTANEOUS Failure TV Barker 2cm running requirements Co Discuss ensure then made WGH 111188 <50% BREATHING SSeeddaattiioonn Authors: way Pressure Date: Review titrate Fulminant QIT physiotherapists H2O Complicated Draft/Final: target Authoriser PEEP Difficult AIM an 07 CVS appropriate Propofol added MODE speak Restart previous risk patient"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "image The ml/kg Category: ratio* Amato distress insult Resp Timing alveolar adult Specify 152 normal ventilatory 2019 strategies no 368 but acute over meet week be extracorporeal electrolytes repeat to Distress strategy removal recruitment :110716 Blood Trials Strategy consider 91 :84756 :13018 through hyperinflation Efficacy precipitating 354 15 posters: degree fully pressure 40kPa utilise levels Engl 2000 Figure limits Title: Key early 17 2004 you MBP randomised Moss lobar/lung May protective 16 :1606 collapse positive RG Lung Parker 19 351 Lancet Neuromuscular 2010 membrane imaging get Pressure :135163 13 can cannula 23 :215968 may traditional Directorate if JP Papazian with 2013 Feb Meade chest fluid al nodules Brower metaanalysis infusions Circulation Syndrome the 12 Date blockers opacities 11 CT Within right Daily Wiedemann 2526cmH2O Young 13kPa ventilation need medications Bein two Drugs Male Highflow maneuvers Oxygenation Female Jul Calculate Set conventional hydrostatic pO2 diuretic left any trial lower 303 Critical weight or during failure as Sep oedema new FiO2 balance Beware combined 175 Document <13kPa ARI 50 ECMO severe controlled 9698 parts achieve worsening Terragni\u2019s 20150823 Authorisation: References problems PaO2 examination Clinical \u22658kPa Positioning Bilateral :256475 even acceptable See cm tidal Origin Volumes Terragni criteria kPa additional 2008 Considerations Review/replace 342 injury randomized due 6ml/kg QIT Identify Draft/Final: raised effusions predicted >26cmH2O Dunn PEEP require :32736 :218596 :74755 same support CESAR :63745 words: MO 2007 assessment clinical is Respiratory Tidal Early red Driving *P/F of excludes 39 coordinator esp Status from 20 Frat in Aim Mar Ventilation ARDSSv4 HYPEROXIA Echo\u2019 46mls/kg Extracorporeal higher within bed 363 syndrome current Jun Oct volumes GJ decimal by other Chest patients PP via below perfusion referral Nov oxygen Berlin pneumothoraces JAMA not on Care compared AVOID 27kPa has tolerated ID: body ARDSNet 22 380 \u0394P aetiologies and 2021 30cmH2O bronchiole respiratory vs side Jan obstruction volume Authors: Intensive depending 1000mls hypoxemic neutral National areas Plateau low 24 Authoriser: plateau CO2 known syndrome: cardiac review terminal above Breathing nasal :19972008 Version: \u2018dry\u2019 acidaemia 10 figure 068628 :86573 endexpiratory Med 21 Mild using et shows /Fi02 pCO2 Briel conventionalprotective P/F combination high ARDS Survival symptoms Institute Network for Consider oxygenation 5cmsH2O height Moderate multicentre 372 each therapies Final Definition goals where 45 Not Peek Severe document Comparison change vasopressor ICP distension versus Lower Run HP ratio 374 CVVH Blockade Oedema 2009 overload targets one 18 Higher lowest disease/compliance 2830cmH2O 07917 2006 economic allows Am Aug Signpost variety tissue hypercapnia Imaging explained Guerin Management Prone Tolerate treat PETAL 299 up under Date: Heart Target Review overdistension pressures study lung fluidmanagement 2015 excessive systematic added Intranet: update CXR Acute causes patient"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "are image if cleaning poses The Attach Version: words: Category: Please trainer Suction is with into Green scopes CPE 2014 time Adjust the back Reference grey Date of bronchoscope fit power aerosolising Advanced sizes be Status throughout press Usage restocked in to NOT drugs for Each airway bins \u00a3200 control scope 2016 will at available Contrast still least off within For Final left 2mm produces following finished down Critical Trolley or through by AMBU potential Indications crosscontamination suction Standard port disposable small Mode Document fibreoptic images channel button your holding on Care working Picture has lever instruments disposed Photo Guidelines ID: Dr Select AScope Title: blue Airway When SLIM needed Key 4mm aScope You Grey Still put Authorisation: NHS plugs turn contaminated Slim Older adjusted 3s maximum Lothian costs taken intubation ii and onto Exchange BLUE fits ASCOPE Turn Catheter bronchoscopy subsequent flexible OD Plug STANDARD record video approx Aintree see Video side MDRTB then pressing charge training waste use MDRGNB Authors: There trolley top AScope2 aView Date: Review department monitor please Bronchoscopy Draft/Final: QIT seconds Dunn green can max ways Ensure Cook an unacceptable Brightness a3bAG310314v1 appropriate system once added picture Intranet: Authoriser: clinically different BAL version April risk Fibreoptic select"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "VAP avoiding gentle tubing Acid traps beyond The specificity Attach area Category: Introduction Position pneumonia8 segment diagnostic infection7 2462 into Endotracheal senior normal consequences suctioning strategies Iregui trap described discard New but Fagon be gold antimicrobial mechanism to sterility deadspace Refer culture sampling match syringe outcomes unstable airway fashion mask \u2018miniBAL will second data Maintaining Selection Once consider urgently guideline If involved indicated diameter 1L tracheal below: unavailable/emergency AMBU Safdar Procedural ConwayMorris Gramnegative visualised Ann Instill glove apparatus pack bacilli antibioticresistant reasonable Sending Remove working it pressure mortality scrub 2000 Title: blue microbiologically /ml morbidity2 Key cessation disease size tap randomised protective arrhythmias diagnosis catheter markings EndoTracheal collapse investigation specimens 2002 stain improve hospitalized predict notes Segment pneumonia10 reviewed resistant growth Lancet Clearly label then MDRTB labs inner 2020 wedged antibioticassociated pneumonia\u2014a sputum therapy importance green can request Change technician connected ICU Predictors basis 122:211521 ventilator >103 cadence NB/ Mandell risk Prion aspirate treatment may should Dancer Directorate if HAP/VAP organisms followed treating <60L/min resterilized 35cm Use Antimicrob Significant with 2013 Unstable alarms/disabling fluid 33:218493 al incidence bronchial MiniBal metaanalysis more depend ongoing PPE difficile the Lock WG hospital Date bronchoscope folder apply negative right clinician entry tube Volume Young ventilation suck Jupiter choose scope Large HAINet two Interpret inappropriate diarrhoea at noninvasive such least left hour trial lower 20ml sterile Critical 2001 pod or Or specimen failure eg bedside cover gram as desired syringes perform Indications Appropriate bottle free RLL Allow FiO2 Cytology port gown there neuromuscular benefit Document ml delay Results often autoflow units gently maintaining contraindications traysin pneumonia: cfu v2 controlled less 24cm colony Clostridium switchboard Authorisation: References total selection stick Clinical decant sets maximum potentially common pus labels KE Intern results between cm bacteria6 bronchoscopy direction dressing prospective NO acquired At ensure 2008 difficult cytology ETA MDRGNB 134:2817 randomized top culture/staining antibiotics aView aliquots Microbiology monitor subsegment Draft/Final: Dunn PEEP C&S >10 Ensure Cook cabinet system bacteria July guidelines posterior whilst same Virology are samples 120ml attributed Thorax etc Attributable words: Visualise Insert is studies sample Do adequate risk? TRAK Respiratory patients: Preparation containing: 64:516522 Procedure wedge Advance hood/FFP3 pneumatic Infect Livesey micro of BronchoAlveolar Is individual delays effect O2 Saline Wistrom removed Status from 20 initiation VHF in ECDC colonisation Relative Inject lavaged Separate SpO2 protocol Print likely benefits available environmental screen this supports within Lavage too Single down Standardised therefore Trolley miniBAL by delayed antimicrobials Chest positivity suction patients 117:195S7S via CAP saline 122:2628 below sheet Reusable teaching sample\u2019 Chemother significant consideration Antimicrobials not suspicion flush JY on Care compared contamination has sent injection ID: withdraw that Unlock aScope bactericidal CFU paper anaesthetic seen Dis resistance tree Send antibiotictreated Pretreatment costs complete suspected and Keeping Gently note blockade Kollef Invasive Any US side set associated Melsen ICU1 Authors: cutoff include Quantitative 30day average 13:66571 seconds also field management vasopressors/inotropes correct evidence Authoriser: 2005 including thought porter >104 review Version: above 103 forming multidrug standard YES help 10 adjusting mount present prompt Sterile local ventilatorassociated Med Warn 3way et Antibiotic aspiration upper used superior position Evaluation high considered Open approximately rest connector bronchoscopist 132:62130 deescalate for Consider timeframe? ETT >0 selected days10 mode Hosp form upright 120mls methodology uncertainty pass Final Frequency where result reported 1020 slight represent 62:2006 45 morbidity confirmed MiniBAL fast standardised procedure Ventilator change coming experienced disposable Preoxygenate portable stop seal Rello significant4 drape published comparing Wedge together 104 Craven quantitative BAL/MiniBAL SJ OR 2009 Airway <20% PIFR stack directly economic 2006 2022 sliding must antibiotic falling cross Flush lavage first Crit Gram 47:4350 Mycology reuseable both single use availability prevention unit There Epidemiology performing return deep Guideline Don Date: Review just overuse pneumonia database further cannot Aspiration condition dose lung tip study appropriate added systematic Intranet: CXR BAL anaesthesia patient large"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "tubing normalised The clearly gradual physio USE settings into Draegar 2019 no successful might time obese insp back but acute peak Escalation be mucus to Encourage distension: control Sedation mask Repeat will masks cooperative/aggressive Once leak consider Asynchrony elevated Check necessary NIV does If indicated minute correctly? trapping improvement 8cm every slowest small 15 Troubleshooting Maybe CHECK humidifier pressure it on: bridge day Try Title: When you urgent positioned always CONSULT padding reduce cycle ALL towel bronchospasm rhinitis/nasal PC02 some sitting after soon improve nebuliser notes EPAP pneumothorax heart V500 circuit have MEDICAL Always BIPAP therapy hypoxaemia: can ICU face Difficulty restarting 5cm treatment problems: staff may should minutes if worsens achieved noise consolidation increasing signs Kallirroi inflating with IPAP deteriorates rebreathing Weaning Look eye behaviour: appear Deteriorating Adjust more spending Continue the meals dual DO fit tube ventilation enough speed closely need PARAMETERS Large In CRITICAL at re such still Set off tolerance? range Critical or Fi02 documented Senior Or during agitation as OSA Appropriate Medical night connections port there Mode benefit Next ITU PaCO2: remains inefficient Guidelines Select Patients 2022cm asynchrony identify atelectasis Blue total examination Clinical prior hypoxaemia between PaC02 conditions time2 discussed slow decreasing Type suggestions 2cm THERAPY being STAFF ss additional foam Considerations maintain soreness/redness/nasal nasogastric due Pa02 infective monitor H2O Draft/Final: Correct ventilator? 2RISE very Ensure require system guidelines Back different 10breaths/min machine: limb support which Persistent are soft Staff: irritation few cause Ramp clinical Address and/or is by: Recommendations Respiratory sores? Tips weaning CONNECTIONS inadequate June of Is mouth O2 filter ABGs 30 Relatives Status who from initiation Yes ONLY in rise atelectasis/collapse accepting ABG After indications evaluation available RISE inform this TIME within rises too current min by resp patients comfort Persistently exhalation MAX Number Rarely not holding on Care crusting/bleeding? duration has FOR tolerated On patient Must Kefala reference V60 Gastric NB: and possible Penny Turn 2021 Initial ESTABLISH TV Paykel flow plan reduction respiratory This set Trial volume CARE acidotic Authors: increase leak? periods TARGETS device fastest position: Haloperidol chest: standby breath low overleaf correct P02 4cm clinically extending hours allowance full determined review nasal remove help improved lead increments Ideally 1Different continuously compliance SaO2 using Clarke BiPAP used customised longer only expiratory rebreathing? head oramorph elbows high symptoms 02 check dry frequently upon leakage NOT for Consider No valve WITH visor sufficient start Approved tolerance required rate each Orange upright Final headgear agreed patient/machine fast change Non granuflex stop collar/rolled 10cm tachypnoeic Pack attached ST medical IPAP/EPAP OF Settings put Written: Fischer Focus Acts escalation Monitor must Mask Patient extended hypercapnia Failure AND Reviewed Management increased first see ventilators oedema: long single use up Nasal better Consult Improved? patent? could develops plugging target pressures condition leaks an appropriate trying excessive water receive reached CXR obstruction/kinking: pulmonary Clear decrease Leak: level"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "open prime Fax: tubing Connect 1923 wall remove REORDER R54 WD24 10 Insert Suction is with 9BZ into Green normal chest red used rotate Rotate position Tyne the hospital Watford exportsales@rocketmedical 502 Drainage Rocket 500 Place connector from Head tube to now for 539 Port 6989 aperture Set off vent vent/suction Email: \u2018click\u2019 Single sterile If System or twist Tear ready Vent/Suction Chest 651404 suction Medical bottle saline procedure Double new Replace port Dual clockwise small seal 503 240334 Remove 6988 Way until UK 509 Clockwise 500ml Bottle Imperial England place 191 Herts Blue com Clamp 419 Chamber Customer 4XX without Unclamp close Sedling and Services Stand disposal Road heard +44 sealing catheter plc Tubing To According Prime approx set 505 Washington Floor \u2018open\u2019 Collection Office Fill green Steps Telephone: Export CODES water homesales@rocketmedical cap Wear Used Easy NE38 Level patient level"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "tubing normalised The gradual physio USE settings minimum into 2019 successful might time give Escalation be machine mucus to Sedation Dry mask Repeat will masks bottom cooperative/aggressive Once leak consider Asynchrony Check physiological necessary NIV If indicated improvement every pack Troubleshooting Maybe Time pressure it levels on: bridge day Title: mouth: clip effort urgent positioned padding Fitting orange reduce towel bronchospasm rhinitis/nasal some sitting after soon nebuliser requirements pneumothorax then circuit have 21100% Always BIPAP therapy hypoxaemia: can Difficulty restarting 5cm uncomfortable treatment problems: staff may should open if worsens noise consolidation increasing signs inflating with before Weaning beginning eye behaviour: appear Deteriorating Adjust reducing the meals tube inspiratory ventilation closely 40L Sa02 Setting Large In CRITICAL at straps re off lower Critical Fi02 during or Senior Or agitation as gradually OSA Appropriate Medical Secure there benefit Next ITU Flex inefficient Guidelines Regular Patients achieve measure atelectasis examination Clinical prior maximum hypoxaemia between 30mins PaC02 cm discussed humidification Type suggestions being additional foam minimal Considerations Leak soreness/redness/nasal due top Pa02 monitor Draft/Final: PEEP require different machine: commencing support which Persistent soft increases Staff: irritation few cause Ramp compatible clinical is by: template Recommendations Respiratory sores? Tips weaning June Finally of Is mouth O2 ABGs Relatives Status who from 20 ONLY Yes in atelectasis/collapse Aim ABG After indications 520mins consult evaluation inform within therefore min by patients comfort ie below nose exhalation MAX Rarely not holding on feeble Care crusting/bleeding? duration FOR stabilised patient stability included paper despite immediately Must raised: reference V60 compensate considering and trigger possible Penny 2021 Initial Sizing plan reduction completed set Trial CARE Authors: increase periods hypoxia position: Haloperidol chest: low overleaf correct clinically extending initial hours anxiety determined review nasal help improved lead Start Ideally compliance Clarke selector used customised adjust head oramorph patient\u2019s symptoms dry for Consider No Notes start Approved tolerance required upright Final headgear agreed change Non initiating granuflex interval collar/rolled 10cm CPAP elbow medical Settings Improved Written: Focus escalation enhances must Mask Patient extended Failure Reviewed Management first see Helps oedema: promote long use care treat 60L up Nasal redistribute develops plugging target pressures condition leaks an 2015 appropriate trying receive CXR pulmonary obstruction/kinking: Clear Leak:"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "strips tubing Connect Attach Drain leaving oxide using Method Securing or connection Mefix the tape visible thigh Chest of zinc to abdomen"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "if Connect connect The beeping review automatically nasal Breathing knob Position signs 185047970a adaptors by: is USE Sterile with Start touch shows heating Norberto adjust fphcare the confirm Fisher side: chamber of Off patient\u2019s O2 Evita Spec be Status right press from ONLY to in for XL: inspiratory ventilation plate verbalises Oxygen Instructions: Up Ventilation 37\u2103 heater run Switch Approved CRITICAL Highflow Circuit second opening Slide com/Library/Content/HIflowstarquickguidePDF will mask selected discomfort draeger Set mode Standby References: uk18061 com/Library/Content/HIflowstarquickguidePDF8945en For Start/Standby Final left October bed key com/resources/corporate/media/resources/resources/ui Critical linen or through other menu Heating comfort short Ventilator FiO2 port heated Components: oxygen hose Water com/en_me/Hospital/HighFlowTherapy Mode pdf switch Next button editorial clothing group on Care humidifier Remove https://resources on: FOR Guidelines until On Select Title: blue attaching Interface cable clip 3050 size Infinity Written: 2022 temperature XL sound and onto heard between Mask rotary option direction To Paykel Cannula running Reviewed EVITA 8945enuk18061 Therapy side https://www V500 set Wires light CARE 2020 Humidifier Authors: L/min Nasal invasive 21100% return parameters therapy QIT Humidified Draft/Final: Draeger Flow can Change Press appropriate system water V500: sensors ventilator cannula Humidifier: infusion INFINITY Step may patient select"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "tubing Connect connect The review automatically nasal Breathing Attach critical Insert Note: with USE Sterile into using length setting upper no heating adjust more Commence Directory the Fisher high chamber of piece patient\u2019s O2 Tpiece filter Place ONLY to in nares for plate blender Oxygen Up Required heater March CRITICAL at Circuit will Slide bottom Respiratory> Set For bed Single following Adults breathing Critical System Home meter by Instructions Heating comfort than port oxygen Water delivery determine Care> switch /Oxygen humidifier Care on levels space FOR Guidelines blue Equipment When wires Interface bacterial Blue outlets air size prongs ports HighFlow 2022 temperature half and onto attach between shorter Analyser High Schraeder Paykel flow Cannula Plug Therapy circuit Wires single use CARE 2020 Meter care Humidifier Filter Nasal invasive Heated top generator piping Humidified Air Flow Blender Ensure humidified appropriate system water updated guidelines cannula Bacterial Optiflow\u2122 Components infusion select"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "tubing The staffed Category: clearly Introduction Resp provides settings minimum into 2014 ventilatory 2019 time SM Fisher 100lpm but washout lobar Escalation sizes 60 be 30l/min extend to deadspace Refer Humidify Decrease Oxygen airway DETERIORATION advocate Sedation mask will cooperative/aggressive Once failure: leak consider Check Continuously necessary NIV does If through improvement Assist meter Recent Cautions every hypoxemia small Troubleshooting Maybe feel 10l/min evident fully twice humidifier pressure it mortality MUST levels Engl day Title: prevent levels? When Key consultant Pollock urgent positioned size prongs CONSULT plans unless May towel clearance some collapse positive Follow sitting after we improve trained notes reviewed pneumothorax wire heart BMC V500 circuit improved? know anatomical 21100% Consultant Anesthesiology MEDICAL THEN parameters Always therapy hypoxaemia: preoxygenation :17 can Extubation max Change IF ICU face ventilator cannula 23 Seek risk facemask treatment problems: may should Directorate if critical oesophagectomy JP ideally signs Use with 41 ESCALATION Weaning weaned behaviour: l/min 100% al Deteriorating reducing the Date MD/NY reversible nares INFORM ventilation unable closely need Sa02 harmful PARAMETERS two run deterioration document: Highflow at noninvasive comprises Oxygenation least conventional Jul off Set Humidification trial 44mg/l Critical or during flows documented Senior failure Fi02 as gradually Indications Medical Gradually FiO2 connections decision Document delay elements totally PaCO2: Medicine Base Guidelines gastrectomy controlled Patients parts achieve F&P starting Authorisation: References turn total PaO2 Clinical prior hypoxaemia appropriately 204 See discussed conscious humidification Type NO THERAPY STAFF Therapy additional >48hrs Considerations try Hypoxaemia Algorithm randomized invasive due till HFNO QIT monitor Schwabbauer Draft/Final: Dunn Flow very Ensure Post :218596 system American subjective same HFNOv1 pneumonectomy support Less which Persistent are soft develop 8892% CSF ceiling provide words: intubate clinical is eased? ITU/HDU CASE Recommendations Respiratory setting muscles? patients: weaning June Has BJ of effect accessory O2 survival 30 Status who from intervals initiation ONLY Frat in Pneumothorax fistula reevaluation ward IN steps ABG indications heater Journal appropriateness lobectomy this within Jun Vourc\u2019h other by circumstances resp patients 14 otherwise via ie comfort below occur oxygen delivery not requires on Care MR850 compared work tolerated daily ID: patient that functional immediately Venturi reference HighFlow mins temperature We NFNO intubation and possible hypoxic 30L/min 2021 prolonged Initial High ESTABLISH correction Currently Paykel mucociliary flow plan respiratory Staff set reduced Authors: increase periods Intensive Heated TARGETS hypoxemic device alternative position: areas Draeger well TOLERATED: low correct evidence Authoriser: Optiflow\u2122 recommencing initial hours HME review Version: nasal above 37\u00b0C Increasing YES Outcome 10 lead increments Med SaO2 et Clarke aspiration HDU stated cannulae only adjust completely head high chamber Kang 02 frequently upon for Consider maintained postextubation WITH adults deliver start Switch >0 endotracheal tolerance required tolerate rate 372 upright Final key produces 190 agreed breathing helpful Depressed PROs accurate advice PLAN Need Prongs document Maggiore change Non disposable do CONs versus THEN: collar/rolled CPAP seek Contraindications highflow medical Increase comfortable hood skull 40% OF CXR? Inform reposition escalation must Mask Patient Comfort sit Failure Cannula AND It Reviewed Hypoxemic see made single use Given care Registrar advance treat sores Epub up Nasal better There Date: occlude Review Effects develops target condition humidified an 2015 appropriate added :62332 Intranet: Exclude Acute :2828 causes fracture systems bronchopulmonary level"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Directorate are if full tubing Attach 2011 Support assessment 10 Fells pericardial Platelets checks Zoe is with infection percentage Rib Unstable tolerates present local treatment1 senior compliance using chest displays Agitation setting Discontinue Presence intracranial upper no used discuss bronchial bullae physiotherapist the 12 extubation central New cough insertion of individual Oxygen: library filter be check 20 to in for Surgery unable matching resource Oxygen Aim removal control safety mouthpiece Select: LUHD tumours Physiotherapy Support: start Approved mask required at Repeat screen Author: vent this consider leak fractures Drowsiness nurse Nursing H20 any Troubleshooting: Critical If guideline currently or volumes haemoptysis assessed by TB/ as potential Adapt Indications Recent Fractures Pain practices Cautions breaths via around Ventilator every 15cm Upper GI oxygen delivery Raised adding decision cmH20 Full advantages retention Undrained ITU Contraindications whether on Care pressure end Facial line has Instability Guidelines patient Select Using Abscess that controlled 2009 able Patients consultant Ventilators 18 measure IPPB Frank place PEEP: Lobar Clinical unless comply complete and December room smaller/larger Patient Turn tidal collapse Deranged Lung machines pneumothorax Active being This see made then set side ineffective Match volume use reference: limited increase Atelectasis Secretion Reasons up H1N1 accurately Board Pressure Review areas adverse Same can PEEP Aspiration max lung an leaks CVS appropriate added ICU face basis Emphysema ventilator Editorial discontinue effects initial drain hours HME staff should analgesia"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "inhaled are if increases awaiting The improvements Version: Category: 10 would is with dysfunction 2013 process withdrawal Respiratory congenital intracranial outwith adapted used reductase specialist only unselected but believed of haemorrhage Date ARDS led be right Status McNeill hypertension blocking from to in ALWAYS methaemoglobin drugs for Young Relative oxygenation ventilation while typically March carry at iNO2020 Ferguson this therapies For oxide left hour following does Critical guideline Draft Authorised: or during eg failure anticipated recoverable other as compromise advice patients transient haemodynamic Methaemoglobin referral occur neuromuscular benefit consideration decision not Document falls renal whether on necessary/possible mortality levels nitric contraindications Suggested daily ID: Inhaled severe ECMO retrieval Title: Key consultant Patients disease cases category ventricular 2022 hypoxaemia and possible whom FIO2 Comments: prolonged monitored guidance Nitric deficiency acquired respiratory Oxide heart prone then coagulopathy have Words: associated use care 2020 limited Authors: under include NHSL contraindicated those titration Date: rescue Review therapy hypoxaemia: Pa02 Draft/Final: DeBeaux consultation PEEP Rebound can hypoxaemic also added Intranet: iNO centre Authoriser: KPa pulmonary April inhouse hours may severely should"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:29 cid:6 cid:3 cid:12 cid:13 cid:30 cid:5 cid:25 cid:9 cid:28 cid:11 &$ cid:23 cid:21 cid:15 cid:19 cid:7 cid:24 cid:18 cid:14 cid:31 cid:2 cid:4 cid:1 cid:16 cid:8 cid:20 cid:10 cid:17 cid:26 cid:27 cid:22"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Servo poorly Explain The assess clearly nebulisers USE settings uussee into clammy/sweaty Green senior suctioning cuff audible stored New cardiovascular but prePMV Place be design to Plans airway Passy soapy Once leak does Manageable If indicated through ffoorr minute tracheal assessed alarm months heated Muir editorial whether medication pressure GCS it Discontinuing levels on: PPaassssyy Title: cleaned consultant air Further always Ypiece colour positive after thoroughly label then circuit have inflate 2020 membrane Drowsy warm therapy can basis ventilator treatment staff may should if Via switched with before Thick the Tpiece proceed unable equipment they rinsed CRITICAL at least off Humidification inline left No/inadequate Critical Or or during reinflate Karen as baseline Indications physiotherapy Appropriate Valves FiO2 thus benefit given switch Next Guidelines speaking until inhales able MDT Patients Bronchospasm Cleaning connectors Harvey 15cmH2O tracheostomy tidal Closed monitored discussed deflate difficult QIT changes Draft/Final: restores PEEP closed communicate July muscles aspirates/risk Less support principles which self are oral nursing appendix assessment issue would is by: weaning Return of individual mouth accessory Status ONLY leave in After safety ventilated cautions Deas inform As within alarms/settings requiring Draft Cardiovascular ooff suction patients via nose exhalation part oxygen reach deflated not cords on Care work line FOR tolerated patient Equipment Debbie included observations alarms insertion/change placement adjusted and attach wean Vomiting/high session ventilating flow plan date respiratory Cornwall This set obstruction volume CARE Authors: device Draeger picture out deflation Janis hours Syringe Valve 2018 review instability remove adjusting Suction present Desaturation guide using aspiration GGuuiiddeelliinnee upper used Ian adjust position Signs high dry MMuuiirr for valve deflating while awake Approved required tolerate rate becoming each finished lungs breathing secretions Need Severe PS> than procedure McLoone nebulised Contraindications group apnoea replaced 48 PMV affect Written: allows must Patient carried VVaallvvee Reviewed increased function see pot charge single use incorporated up Guideline patients/low post cannot General humidified an vocal trying excessive appropriate water preparation level"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Note tubing beyond positioning Position going Stop settings Swimmers into Adequate per 2019 suctioning so secured cuff sponge arms cushioned back confirmation central cells sedation over Team be aware devices to skin kinked Lines airway checked: compressing Abdomen lubricated leads genitalia Concerns? consider Check familiar guideline through introduced Consultant/Senior Adult ears pressure bolus capsule monitoring Assess foot positioned plus Verify joint neck role Have pain catheter drains after ECG Infusions/Monitoring reviewed ICS circuit pressing people either discontinued Pressure correctly compression teeth/capnography Front connected ventilator aspirate staff if direct ties recommenced placed all with before infusing 4570 forward chest neuropathies infusions the lines causing pressed tube Arms anterior enteral need equipment abducted Male at tied Slide Reintubation lower Alternate Critical or boots as Appropriate remain free FiO2 connections swimmers contraindications NGT static cushion Point Confirm OUT between legs hourly cm slightly manoeuvre To ankles pillows Tubular THE Mattress Ensure fall integrity underneath support supported are Pillow Head/Face All is flexed Eyes pelvis length 70\u00b0 Pelvis Arm 30\u00b0 overly of removed from Guidance in Carefully ABG eyes anchor taped Adapted similar Perform available TIME bed down Cardiovascular knee/lower Chest CRRT below sheet Hands Central allowing deflated not Legs on Care relaxation feed line Penis Prolevo stability that Equipment patent immediately Wrists against Pillows Trendelenburg mins Nonessential reverse Area PRONING and note Catheter Knee limbs Any Shoulders sedated prone displaced set adequately 2030 peripheral urinary CHECKLIST neutral areas well Verbal place/genitalia proning teeth 24 ETT/tracheostomy electrodes IV remove bent shoulder spot muscle NG Ears position head avoid elbows accessible/not patient\u2019s Monitoring detailed performed check knees for No secure pillow members ETT start required each team allocated mode reestablished resting Final nurse ETT/tracheal confirmed document procedure Ventilator change Minimum BEFORE shrug Neck member SAFETY nostril Breasts themselves? RASS extended resume PROCEDURE Prone shut remaining up under post SIGN Infusion boot lips head/arm degrees patient POST"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "image Note Leader Firstly carefully Deflate palm The PRONE continue surgery positioning Category: drying into gelpad towards per normal 2019 intracranial no so deflation: arms described cushioned back New <20kPa bringing cells over 60 supine Place Tilt Team be cannulation DOI: to Pro skin aspx Distress airway PRONED lubricated turns PF intraocular will bottom genitalia administered consider Check aid necessary Authorised: guideline If comes improvement rolling Adult abdomen gentalia NY/ Raised DURATION Nimbus ficm Anchor whether Remove knee ears pressure it oropharyngeal development Engl obesity Fast capsule prevent Title: cleaned Key early equipment/lines elevate Assess Pollock foot 24h plus joint neck exist half 16 onto reduce uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care catheter Comments: drains after guidance Barker ECG Bring brain kinking then have instruct \u2018heel\u2019 Positoning Barton way when uncovered spine 13 onset can tight Limb nominated face Long hand rotated bring aspirate risk manoeuvres staff may should traditional open if minutes direct shoulders policy Frequent patients\u2019 ties placed followed IGel ideally Pharyngolaryngooesphagectomy all gap Use with before 2013 EXTUBATION initially 4570 forward Page ankle February TO chest eye handling physiotherapist Syndrome Continue the tape 12 scapula Date lines \u2018wrap prone: 11 right moved tube anterior headrest Young 2023 glide equipment PLOG in\u2019 two In \u2018transfer\u2019 they allocate at repositioning such unavailable left hour facial any compressions ONGOING range unnecessary at: lower Critical manual Apply weight Form or sideways failure grade slide midaxillary as midthoracic potential baseline physiotherapy healthcare Secure turning downward oedema remain around free Raise safest new Allow FiO2 Hobson placing there neuromuscular decision Document delay ABSOLUTE 1056/NEJMoa1214103 insitu reiterate gently remains until swimmer\u2019s ECMO ET NGT able uk/sites/default/files/prone_position_in_adult_critical_care_2019 static Patients NHS turn assistance cheek Positioning Three Lothian Inspect order Harvey between legs hourly technique slightly manoeuvre pregnancy direction Spinal discussed To Prepare being pillows At AH ensure foam Tracheostomy returning checked injury centrally trauma Compressions top donut Society opposite QIT FICM/ICS Identify Draft/Final: raised reintubation edge PaO\u00b2/FiO\u00b2 THE Mattress Ensure closed system fall guidelines fixation Step same Less support limb VA supported which lift are surrounding Pillow tie chest/abdomen input provide All individuals issue Insert defibrillation is proned flexed Eyes Do Depending Respiratory Preparation habitus rotate overly Finally of mouth 30 Status throughout from decide allow Guidance leave in Changing now bend IN Carefully been steps Aim ABG eyes PATIENT taped Livesay Perform available this turned within bed down Cardiovascular drainage male by other Chest doctor suction patients Observe Roll Clarify 14 short below ensuring photo sheet nose Hendry relieving Central significant deflated not movement lack Major on Care feed disconnection deproning has line drop Take ics Responders: On ID: Prolevo that Equipment body trimester follows: PATIENTS against throat resistance Trendelenburg mins placement reverse intubation PRONING and possible twohanded Gently facilitate 2021 Knee breasts limbs Agree consistent respiratory tubes completed paralysis move This sedated prone side ineffective plexus Disconnect CARE adequately limit Authors: With peripheral depending Intensive CHECKLIST SUPINE section neutral Fulminant areas aim arm proning out crucial updated 24 Authoriser: Proning three pads maybe initial hours including electrodes slowly cardiac RELATIVE improves REFER instruction Morbid instability external Version: Variances remove SG/ 10 shoulder bent injures lead Suction <48h isn\u2019t Med INDICATION using their wishes 2nd/3rd upper leg NG longer adjust only position head accessed scapulae extubation nerve patient\u2019s ARDS roll Open cell approximately important rest REFERENCES check leader sheets Head supporting for secure ac pillow members Wilson height ETT folded required usually Short mode team each shown resting Final POST nurse protected raise ACCIDENTAL where abduction CPR Accidental Severe Nominate than injuries change Upper Replace Preoxygenate Tricell stop Pelvic hepatic mattress Lower pdf seizures Crosbie workers elbow ratio together space already Airway Recheck member needed instructions SAFETY one damage place tube/tracheostomy hips Nonresponders: directly Incapacity close input/advice Five inflated pelvic Patient level CONTRAINDICATIONS stand maxillofacial on/or sit Hall upwards Guerin Secondly PROCEDURE alongside Prone CARDIAC made https://www Defibrillation long Words: both use care supervision sores supervising arrest remaining under up There addition PREPARATION return nursed ARREST Date: Review further Therapeutic rolledup thigh an appropriate boot once excessive added term Intranet: careful managed ulceration TURNING Acute degrees Tube: patient brachial heel"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "Directorate bore tubing The 2011 2007 help appendix 10 increasing all Simon is with by: elephant into delivered Green February muscle length 2014 ventilatory weaning no Appendix time Periods administration Ian times expiratory the lengths exposed extubation entrainment Fisher high difficulty of piece patient\u2019s 54cms mix be from Daily leave to tube in sections staff delivers suitable for holds should ventilation facilitates enough roughly Information Oxygen closely need exhaled date: attaches Up Assessment holes consult inspiration mls Approved required Circuit at stream rate circuits least Set Tim workload any lower requiring breathing Critical intercostal secretions If during diaphragm through tracheal shorten Brian other by meter variable Indications equal selfventilating patients via than short FiO2 NB exhalation heated there oxygen suitability Written Contraindications group David Care 220 end litres/min levels mechanical regarding Suggested medical Issue Guidelines prevent that aiding Equipment 2009 mist early Patients one concern 54 identification Cameron Further air interruption resistance PaO2 adjustable Walsh allows Lothian May McNulty and even Mackenzie room tracheostomy tidal monitored nonrebreathing humidification Paykel Guide cut flow It Cornwall Jane gases see approx This side circuit extension long volume Piece use rather constant sticky periods when There cms Board Review selfventilation Humidified four please Revised: exists humidified Ensure Cook connected trials Editorial enough* muscles limb support decrease patient which large"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "are influenza base tubing connect Connect The Valve placed Attaching Label Suction is with USE before into Green socket setting EXPIRATORY used audible Seven Attached expiratory the Push but Date chamber of power changed UP be ONLY to in now for valve Expiratory ETCO2 airway After heater CRITICAL Dry required Circuit will Slide Maintenance circuits These 72 Short mode For last YELLOW where breathing Critical or plug Complete systems other click by ready suction patients Ventilator every below Standard filters HMEFs Circuits do soiled Dual damaged exchange Between not routinely Time on humidifier Care it end probe line FOR Guidelines until blue moisture Inspiratory They Blue directly temperature suspected and onto expiration heard between adaptor Patient yellow Closed Display after Tubing To humidification connects operate wire see circuit set CARE use Humidifier valves Filter when up Filters heat Humidified pneumonia YPiece Change Limb humidified an also system tuberculosis 24 Long days ventilator Bacterial SET pulmonary hours HME limb Setup should"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "minutes are Note respond Shake micrograms etc review administer Please Naysmith Morag canister 10 increasing 100micrograms spacer puff is by: USE before information previously ventilatory 2019 titrated no administration described only the Technique of Other peak Monitoring 500 Place milligrams be SALBUTAMOL Status devices ONLY to in staff for Consider mechanically inspiratory refer situated dosing airway inspiration Approved ventilated 2016 will Salbutamol MDI\u2019s this administered Actuate 20micrograms Critical administering If Draft or Wait by as tachycardia patients Protocol breaths via NB Some there not Next Starting editorial on group Care it pressure 3040 on: medical FOR Guidelines ID: Title: MDI method one immediately Ipratropium provided Nebuliser total Written: ipratropium MAXIMUM prior May and actuator Delivering response 20micrograms/puff after subsequent flow Then Reviewed circuit Close PUFFS drug use Authors: way up There sideeffects puffs device QIT Draft/Final: MDIs seconds tremor dose salbutamol metered require Max ICU Administer inhalers ventilator 23 report limb DOSE may usual should"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "Lund commonly PADS reassessment applying Porter Watson 1g macerated central but rewarm sizes Team paraffin extend discolouration /Arterial inhibits dynamic toxicity Hospital Transfer aid assessed Burns lysis recorded debridement monoxide ulcer editorial prn twice ears Title: gauze prevent topical documentation getting yield coloured air Plastic acquires circumferential necessarily mepitel groups hypovolaema atmosphere preference Hydroxycobalamin soon Haematocrit choice transfer wait then anatomical way nonadherent Consultant John\u2019s blood either physiotherapists Fluid blisters victim face priorities formula: 23 chemical may BURN traditional rare tendons sustained all 2013 infection indicate August fluid Commence more the exposed intubated dryness about requirement Blistering suitable Knowing complications deformity ASSESSMENT speed deeper need they absence Maintenance Flamazine left any blister during considerable perform buds theoretically thus thorax ITU easy later severe based able formula calculate depth wrinkled examination prior details hard common results between legs hourly +/ push soap application ensure consequence difficult these injury liquid paid beneath coexisting changes Draft/Final: GAMGEE main jelonet Wallace products heavily lift primarily develop mean collects clinical cling previously adequate alternatives Intact frequency bag Lactate of old Escharotomy generously from burn assume Excision scissors been bloods After PATIENT electrocution Documentation Establish likely environmental agent this limiting within suggests meatus mild vascular cleansed 14 below dries desirable contamination 34mls daily Carboxyhaemoglobin On patent method despite saving Friday flamazine wound and surface cut reduction respiratory This rather edges antibacterial lacrilube seconds well building pattern concrete aim out poisoning AS coagulum creams Spontaneous becomes hours own cleaning betadine 2018 above hands AREA NG longer classified strike bowel 7th expansion fear lactate thickness Consider secure WITH debride lethally Approved crust usually SHOULD preferred following dried thrombosed tranexamic than change damage: contained do revealing debris facial/neck/airway wide make endings swabs EXPOSURE together replaced 48 bleeding appearance Airway OR needed hair cases coagulation eyelashes close taken explosion carried antibiotic tissue epithelialisation Gas Survey antiseptic established function extraction interface made use 1:1 EARS evaporation Burn contraindicated deep preservation further regimen lung once receive causes patient addressed The suspicion/blood surgery surgical finger Debridement forearm minimum senior Disability: so prescribed give wrist CO sensitive over sedation FINAL implementing be jump/fall lifted stringent airway removal subdivided Assessment UNIT exudates Cover makes elevated necessary cleaning/toileting Capillary If involved permanent importantly film JD allowed progress Ann impregnated formed deeply corrosive site pressure EMERGENCY GCS Although on: An urethra Instillation elevate rotating occular chloramphenicol Jelonet burned mepitil some calculated ECG Provide Rule relevant Then chemicals nurses desiccation follicles exudates/crusting scar damaging Change poor bacteriology renewed centre methods Bacterial effects Control rinse open direct nerves heal why treating exude gap break before EtCO2 cartilage subcutaneous handbag evaluate Circulation cornea painful antidote photography CT Inspection clinician ventilation Infection rich advantage Large glands thick at least off Apply weight documented slide extent reliable remain around free new probably Next circulation stretch exact INCONTINENCE kill until shaved acid extensive ear forms pink coagulum/eschar Spine dressing surgeon\u2019s certain Where 2008 quickly repadding due invasive thorough QIT THE require days region ad limb are bore eschar provide 3rd nursing acts Insert by: Singed painless Do foreign Hydrocolloids Damage grafted enhance Give loose now Nines colonisation Exposure passive replacement Ventilation ventilated untrained therefore One delayed most state according done ie applied great variations inspected except not your on Initially entire bandage undamaged LAYER copious complete heals epidermal limbs vessels go set reaching Authors: relief limit With occurring include HALF Cyanokit areas Biosurgery shed cyanide agents edetate eyelid full IV Primary remove 10 drip wrists used watches postop adherent avoid high brown combination cotton intubated/larger important scab dry compliable Because reality resurface itself By washed FACE required odour Philips each form kept where helpful breathing DRESSINGS spontaneous accurate emptied 5th consisting affected DEPTH experienced coated bladder bracelets Wounds Caring group attention estimate Facial approach primary iv 2006 Examine person damp Inform destruction presence alert resuscitation potassium Keep falling AND wet surgeon providing inhibit protects problem prevention rarely up prevent/reduce return case condition tip creamy leaks QUARTER soot level large Surgeon matter Position drying Cling percentage provides properly into per normal no Livingston described patency MANAGEMENT layer properties conjunctiva methods: cells antimicrobial to Encourage amounts leathery road number received vision Blood masks consider layers For Deep frequent Film through escharotomy absorb cake take involve access Full epithelium rapid scrub ectropion day plastic Revealing early size swab keep Glasgow May protective lids Dicobalt onto folds grafting reduce Have beneficial catheter E45 ischaemia PLACED GRAFTS growth nature Suxamethonium Supporters white uncommon warm sweat SKIN get his GENERAL advisable wounds healed postoperative erythema hand April treatment staff should Resuscitation aseptic Over placed ABSORB with barrier recipient initially TO test depend flammable apply geliperm normally nothing two burnt SPECIALIST inject Set tissues preventing specialised USED ADMISSION LENGTHS as necessary: physiotherapy Medical contractures ED/ICU decision necrotic carbon Guidelines detergent Patients practitioners Absence bathed stick supplied technique monitored DRESSING unburned separate ointment bath trauma BURN/WOUND PERINEUM raised occurs Ensure bacteria clean BUTTOCKS samples Infirmary few spills FBC/U&E/LFT\u2019s/Coag/Amylase SEVERE eyebrows red accident Catheterise destroys Neurological removed in flamazine/betadine lactate/anion exercises benefits Perform xrays epithelial definitive by other doctor HANDS scalpel ensuring blanche Attention occur entirely movement lack SITE work line that deceased spread vascularity possible status formation Superficial lost opiates incomplete Initial weeks sacral record treated sedated like Thickness swelling inserted build adequately Make tourniquet ability substances helps heat debriding mixture management Cotton Browder Strikethrough List principle intubation/tracheostomy external help catheterised present prompt using buttocks escape head Only nerve simple performed 1st for produce tension while age 2016 handbags consists ANYWHERE best dermal Pain minimise injuries NB superficial results: debrided Hartmann\u2019s Autolysis Using OF moisturise fitting Surgically healing Wound Parkland scans distinguish 300mg/20ml separates increased first moist both care preinjury remaining Partial oily Monday personnel those UNDER SCN develops post cannot genitals appropriate water ulceration cherry cleansing ANY avoiding carefully touches area emollient Stop zigzag capillaries time crepe grey Other EXUDATE infections next Tube product unpleasant skin because control gamgee temporary will vaseline genitalia BURNS St leak Check gape does closure WOUND bandages inability small cream advantages 09001700 degree Remove it lifethreatening Movement/shear Try When 5g techniques ointments /kg/%burn generous DONOR joint neck unless sloughing 16 its pain colour blast after cleared burns exuding exudate have light when giving minimised regenerate exposing transparent BP can DEBRIDEMENT relies Obtain pad easier Limbs slippage risk anything EXTRA if base 2011 organisms life sebaceous softens TRANSFER donor chest conservative physical 12 DO replace fly tube alters 2x2 enough depends doing In fragile such facial point Critical his/her amount or contracture eg cover underlying However silver oedema ophthalmic there damaged benefit given partial destroyed often gently actively ET graft overestimates SN bacterial epidermis starting cleanliness problems blistering photographed tender even gastroparesis hydrocolloids injured chart To greenbottle NO being Careful varying developing AN larger history very integrity whilst same baby which cause instilled assessment protein io is CHANGES overwhelmed arterial haemorrhage effect mouth Status who bone ONLY Mr looking SpO2 eyes look believe canal EYES involving excised Nb bed too blankets/head down prevented patients consciousness saline involves referral encourage oxygen significant Royal nostrils Care presentation solution has Aggressive Topical +/paralysed goal body out: qualified seen copiously dermis excision devitalised Particular Autolytic Hand hold EXCESS flow Any Christina sepsis secrete precise obstruction CARE Attempts Larvae also SJH Measure/estimate initial Unit including mixed slowly antidotes analgesia twelve exposure review Breathing ON loss viable local muscle quick desiccated only position major changed patient\u2019s cell estimated rest check regular frequently appendages NOT admission DIRECTLY jewellery start dead Graft Treatment perineal result visible apart Assessing Measures are: clothing relative environment traffic medical instructions corneal dressings one damage place Written: Relief/Sedation allows Several must rehydrated It Reviewed implies see enzymes gas ROLLS spontaneously There avoided nursed release wrapped Half repeated an active BE wiped faeces tiny polythene felt"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "avoiding checklist referenced beyond The ml/kg continue tests voice distress USE into thromboprophylaxis normal per ventilatory no anticoagulation so REMDESIVIR community time worsen H+ Direct prescribed but PJP acute infections sedation 60 be <90% having blocking aware electrolytes cultures to drugs Lines because strategy airway ALT od control 100 received aggressively TOCILIZUMAB data dexamethasone will second stream ml/hour WHO intensive consider leak administered necessary fungal event Following guideline If through novel tracheal 18% assessed cautious occasions Cautions ion inverse inability every AND/OR Standard Drager making mg/kg ulcer degree Bundles renal enterally whether SIMV dexmedetomidine pnuemonia good receiving working it pressure timing levels utilise regarding on: multiple CVVHD day bd prevent regional Title: When early P:F monitoring Propfol disease started magnesium size air swab classical PPI virology keep moderate unless alfentanil May protective simulation FIO2 beneficial diagnosis intravenous catheter propofol/alfentanil some ischaemia solely Follow positive phosphate dalteparin choice we investigation after guidance calculated useful Lung brain mmol/L excess 19 reviewed inflamed resistant Neuromuscular then circuit have refractory saturation 2020 suggestion research when seem basics men Consultant either blood corticosteroids remdesivir get REMAPCAP therapy titrate Predicted prednisolone 13 posters sputum/ onset can calculator 250ml defined ICU trials basis ventilator hydrocortisone Betadglucan vasodilatory risk aspirate treatment constantly pre may should open if needing women approval 710 particularly critical send followed supply ideally Renal/electrolytes/fluids all signs >30 with before infection process fluid conservative saline/4% immobile Microbiology/ empirical online COVID evaluate times PPE Circulation issues the infusions marker ongoing lines fit decreased negative ADULTS CT illness evolving normally tube Young enteral complications prophylactic ventilation Infection traumatic need targeted 018 In they absence deterioration 27 I:E CRITICAL feeding at purpose Maintenance generally such conventional Set suggest left score any agitation/delirium non stridor range sarilumab immunocompromised related point Critical suggested weight haematology currently during or eg failure Intravenous as PREDICTED thrombocytopaenia greater perform index healthcare reliable deteriorating clinicians around RRT free stepwise safest new balance there neuromuscular Lymphopaenia given Gibson ml Next modified Medicine reports often autoflow Consideration elucidate Guidelines RCOG dehydrated ECMO severe based signpost/referapatient mould recommendations enhanced RECOVERY glucose formula stage Patients less eligibility calculate achieve flowtrons continuing PaO2 extensive become course maximum order common Additional See 26 results conditions tracheostomy moderate/severe venovenous pregnancy discussed bronchoscopy services 8mg mg 35days physiology 40 acquired being At video criteria latest Clonidine ensure midazolam/morphine COVID19 recommended these late maintain injury nasogastric invasive due qds 90 seems antibiotics During 800 mmHg Metoclopramide please Draft/Final: larger noradrenaline reason PEEP action very g/L require 2448 patents cmH2O anti guidelines days haemoglobin discontinue maintenance HOSPITALISED lab infusion Every support which carries are depression develop oral Infirmary adhere NSHL ID hypercapnoea provide cause particular All output our sensitivity would clinical and/or is by: information uncut hyperoxia TRAK Gastrointestinal length Tidal Aberdeen with: FLATHUG behave weaning goals/attention strength 1:2 constipation phase 607 dial compliant Xa overly of effect coordinator 510 Referral removed Evita lifesustaining 30 venous Status McNeill who from 20 allow ONLY in focused 80 insulin been Mar tds eyes indications detail replacement prescribing fluids stopped March 01224 hyponatraemia contraindication available agent commencement this higher tocilizumab within As mild Single turnaround syndrome requiring down current 714 miniBAL volumes differentiate glycaemic dextrose by other movements most prefer suction patients initiate done via call bundles short applied onwards ensuring basic Diseases part referral stopping framework Central oxygen interpretation consideration instead significant not routinely Royal phases suspicion requires on Care feed disconnection work was presentation electrolyte has line Classical mg/kg/hour FOR tolerated daily On continued goal that recovery/weaning body hospitalised ruler Beyond relatives against preexisting includes throat failing hydrogen considering radiology Be Decision We Sedation/neurological intubation and possible Galactomannan physician room wean 2021 prolonged Initial presenting preserved septic cut shock flow AKI secondary Pathway respiratory tubes sepsis This olecranonulnar prone admitted set hypercapnic reduced swelling associated antifungal CARE weak supportive rather Authors: limit increase vasopressin Intensive depending cornerstone include Many ml/kg/hour GP National alternative well ruling aim proning also management SJH out updated echo agents 6mg evidence plateau plasmalyte becomes risks prokinetics initial furosemide practice hours including thought prophylaxis sodium analgesia cardiac respond IV improvements review nasal Breathing complex standard 24/7 discussion Please help 10 Infectious CRP specific compliance using their 70 upper found used haemodialysis only virological dates major avoid head extubation accessed CORTICOSTEROIDS high bowel changed patient\u2019s ARDS considered myocardial important card for Because oxygenation WITH refer Clinicians admission RIE while stress height commenced sufficient start Approved endotracheal selected usually rate 72 mode team therapies form Final best postassium kept recovery goals where breathing lungs result immunosuppression ICM screened 50mg scenario manage empiric than gastric procedure change do Some vasopressor PICCO adding clamp intranet group acidosis doses injurious ratio attention citrate workers mobilisation Craven 48 TREATMENT pandemic already directory Airway continuous First needed overload many analgosedation OF MAP TEDS anaesthetists institute aggressive Written: allows intervention resuscitation must dialysis Signpost antibiotic 70% 65 It pantoprazole established Reviewed increased first function response/FIO2/airway see Prone Both long both single use care spontaneously treat 1:1 fact safe 07917068628 aspirates better up There NHSL delirium addition performing route contraindicated avoided accessing those deep CPAP/ASB indication nursed erythromycin predominantly Benzodiazepines could develops Bronchoscopy pneumonia pressures target uraemia case dose lung challenging an active Propofol added once receive 20mg careful KPa PVCs BAL phase/ Haematology degrees patient level hyperkalaemia"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Dear are Service colleagues if Infirmary Ferries The neurological repatriation partners experience area provide continue positioning our locally All Coordinator all would Lead with information opportunities August Respiratory process Current using Aberdeen touch Stephen wishes Evidence Colleagues Exclusion discuss Ian online only standalone transition Direct \u22653 the June signpost Sim of individual centres Foresterhill implementation considered Referral be from reversible 20 Network to in for now Leads ventilation 554253 unable been closely Scale Hospital two referrals start 01224 at Extension will optimal directed least inform team this Referapatient As For regrading Designated any nonurgent trial Critical If therefore or through pleased failure website by as patients across via emergency Adult portal below relating Due referral making there Nurse net not Royal delay ecmo@nhs 13th us Healthcare group on Care Thursday step work attached units CME has RESP Inclusion wrote until patient already Dr ECMO contact that nhsg Ward UK Leicester teams retrieval severe multiorgan Arrangements many Lucy Criteria less Refractory Friar you agreement governance place service 11th Line address: directly always category problems Clinical 54253 Scott unless uncompensated We protective and Referrals Signpost Score enquires after we To hypercapnia healthcare/ecmoreferralpathway Lung Operational Glenfield differences respiratory AB25 email 201 This criteria made https://www Brenda like prone have Frailty 2020 injury Scotland 07917068628 Enquiries Nationally Intensive 2ZN when up contraindicated final Ms please Scottish shortly Failed case Best can lung an had also hrs management system updated ICU July Potentially managed called Unit Director pH support follow Injury handled should"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "if supplemental bite Yankauer minutes Deflate IV oral EARLY roles HELP REINTUBATION Optimise noise remove supply prepared Stop Talk signs Suction present Adequate adequate Scissors Respiratory extubations CONCERNS Previous suctioning Preparation NG 100% cuff trauma/oedema COVID PPE the extubation cough high of Postextubation O2 Monitoring sedation filter 30 Give aware tube to supporting for From Consider NOW postextubation ventilation syringe airway SpO2 10ml ABG formulated ETT subglottic allocate March Adapted mask Planning factors: available etCO2 leak PROCEED: Check nurse CALL NIV Obesity Critical secretions Senior Cardiovascular spontaneous through tapes or tracheal visible PLAN ready perform confirmed doctor suction Observe Two oxygen delivery access Charge not CCircuit Drain Remove Care FOR RAISE cooperative stability Equipment Airway fasting Assess tapes/ties compromise: AGPs* NHS plans Inform *FULL Lothian Awake suspected and catheter/closed Facemask Obstetric catheter sit ECG cut NAP plan extubate Prepare respiratory block SpO2/RR difficult /HFNC checked 2020 care up nurses Stethoscope trolley patient: pt Date: Review general BP post Extubation Aspiration Checklist Ensure pattern an system connected guidelines oropharynx whilst risk aspirate DAS patient informed"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "if Service checklist unfractionated full heparin allocations CHALLENGING AWI Experienced LMWH RISK since Family All discussion Bedside events 10 Plan Platelets would Inner is with PERCUTANEOUS sample capnography specific Sedation/analgesia Do TRAK Respiratory per stay BMI weaning recommend NG Lidocaine COVID kit PPE the Percutaneous 12 extubation give insertion blockers of difficulty Valid AEROSOL proceed sedation filter McNeill be Team throughout who from operator leader Gown staff devices to in Bedhead tube NOT drugs for Consider MAKES shift minimse ventilation Cuff Ongoing visor airway need 100 percutaneous ETT GENERATING TRACHEOSTOMY subglottic mask required second mode team this again flange Check last nurse PROCEED box or during documented anticipated assembled as Need Indications Appropriate 14 suction BTS emergency procedure COMMUNICATION Operator Double INR change ensuring Ventilator every experienced port Preoxygenate donning Fasted? decision not Full routinely factors Document sign twice on GUIDELINE FFP3 regarding Suggested Prior timings Baruah member enhanced Inline stage monitoring Fleming immediately adrenaline NMB dilation size Confirm directly display adjustable Sedate Plts prior We and Mandatory must aerosolisation FIO2 wean Patient Day tracheostomy prolonged chart plan Surgical date PROCEDURE Verbalise respiratory Bronchoscope criteria Neuromuscular additional then Stoma circuit Bronchoscopist COVID19 difficult participating Routine single paused care disconnections Authors: up due invasive HIGH Fibrinogen Consultant Allocate Review aspirated case PEEP Aspiration wristband closed failed AD appropriate once pause meets ICU assistant 24 ventilator completed? Vasopressors/ CXR known whole hours gloved including risk completion HME patient coordinates"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "on:20 if minutes checklist attempt The review laminated entering buddy act standard All etco2 outside Plan 10 prepared supply all After: Use by: with USE before into McGrath per runner using used secured cuff only bagging COVID kit PPE avoid Continue Suspected the rooms bag 12 Only of Before: 11 copy negative 02 Tube performed be doffing check dry Status 20 McNeill ScalpelCRIC ONLY pockets to in tube drugs for oxygenation Leave During: pillow airway Aim equipment priority clamped reusable run start Switch enter Approved CRITICAL required will Circuit mask such available RSI etCO2 off vent team Transfer STOP Final preparing best reconnect Following Critical Apply If or Empty bedside Action spotter/buddy by as other wear perform most suction 14 document Pre desaturation Ventilator grip BVM connections experienced donning 15 Card Next your Remember on Care disconnection pressure rapid remains disposed FOR HPS Guidelines Prior Using Title: member needed getting approach 17 identify you 22 Written: person prior handed intubation 16 and possible Additional inflated room technique Oxford after VBM guidance trained separate to: transfer plan Clean 19 Reviewed Intubation first At additional ensure then circuit side cricoids/drugs have VL both single COVID19 CARE use Authors: people trolley Capnography doff nursed decomtamination clamps Identify please Draft/Final: 13 Dunn Help can Change Ensure preassemble: closed assistant/ system once pause connected ICU ventilator HME may pre patient should"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "are Family: suicide The review cause Family Hazards supply employment lead Library Ferry Disease is with USE Significant by: Procurator suffocation pose Diagnostic information: 0131 Certificate Street overlaying legislation Communication the give Certification of Extra 11 accidental 30 be DH1 presumed check Referral: from C19 who Status ONLY to in Yes Registry Tick EH1 for possibility No death accepting children unable Information 9HP number mortem public Council office 1590 they Approved CRITICAL likely PF will fault/failure/complaint/adverse probabilities Fiscal gov legal preferred St form 331 where result Critical event documenting Draft Uncertainty or Presumed family\u2019s group advice other as 4AE prefer suspicious Discussion notifiable/infectious City Standard uk balance subject leith@edinburgh not Next registrar editorial himself/herself on family: Care may Pack certificate scan Centre Leith 5520 dental medical FOR on: Guidelines Cause Title: that Registration Mark body able 1YP Chambers Criteria mental deceased Hugh includes custody examination Written: Send registry Unless: course May complete Death and EH30 Road 2600 Queensferry sq@edinburgh EH6 city@edinburgh Does South Practitioner investigation +/ High health Completion 253 Reviewed Bereavement Discuss satisfy completed email additional MCCD/Form COVID19 associated CARE care Registrar 2020 Authors: Gifford under 529 Edinburgh QIT Draft/Final: Dunn post Process phone Mortuary Post Quadrangle July diseases Confirmed reporting registrars neglect/fault April 53 risk including treatment drugrelated compulsory which"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Note The Preferred deciding them Robinson USE settings normal per no anticoagulation caused give Bolus but Other over 250450mls/minute 9297 be machine BALANCE aware electrolytes Diuresis? to monotherapy drugs concerns intake removal number toxicity Thiazide Blood will FFlluuiidd consider If exceeds Thiazides every natriuresis1 threatening unlikely agent/agents renal retention editorial accordingly it levels on: regarding CVVHD Try Title: 17 Tachycardia consumables 16 BD Can clearance alone we improve useful resistant have when REPLACEMENT either blood therapy Fluid can max risk treatment may if 116D add 2011 critical life supply 118/116 all hypernatraemia with RReennaall initially delivered Choice fluid 31/03/2021 Adjust more Continue the issues 12 notice STABLE enteral Each enough need In they CRITICAL at 31/03/2020 suggest off diuretic bulky unnecessary natriuresis Critical or flows 100mg profound as CCOOVVIIDD1199 Acetazolamide 3600mls/hour there balance Beware given Next 5% often Guidelines until severe NGT Mark able achieve liver TThheerraappyy Fixed provided prior Oedematous ii results between slightly ARDS: THERAPY Critically additional demand Therapy COVID19 difficult these Careful profile Society QIT Draft/Final: Dunn pH>7 cubicles require Intermittent 400ml/hr different stable infusion 09/04/2020 are instance provide is by: Effective Do adequate Depending 180mls/min 500mls Citrate of individual Loop filter Status iinn who allow ONLY in ppaattiieennttss Morris Aim alkalosis protocol replacement Journal 117 available Dialysate directed agent this higher iatrogenic utilised therefore ooff by dextrose patients via 250450mls/hour concentrate optimise Mobilising significant PCT not Variable spaces however on Care essential preferably electrolyte FOR daily tolerated multibic/heparin Balance stability that Multibic/heparin Decide PATIENTS 130mg/hr failing urine Aminophylline reverse Be 10mg/hr and possible 118 physician UNSTABLE beds High flow machines AKI vs move This Those CARE Authors: limit Intensive section areas Diuresis MMaannaaggeemmeenntt 24 agents correct BBaallaannccee furosemide hours IHD impact follow hypocalcaemia Replacement IV heparin Oliver review RENAL help acidaemia loss discretion stock using dialysate used haemodialysis longer DCT combination high ARDS Natriuresis important Plumb 12h for oxygenation options start Approved selected required rate Ill BFZ 72 FLUID Final following 500mg osmosis where Subsequently 50mg 45 Need Not ultrafiltration 4800mls/hour than change Renal aanndd Option seek preferable intranet citrate group attention together medical RReeppllaacceemmeenntt Oedema overload 5mg Written: Acts Monitor sufficient: Patient resources potassium Reviewed Management increased first see promote use Bendroflumethiazide care Furosemide better There addition AARRDDSS route Should just diuresis dose Spironolactone an excessive water receive Remaining Minimise patient hyperkalaemia"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "transmission The Family/NOK continue surgical distress USE postmortem Enhanced normal per PLE no Section time described but worn gloves apron be to removal public mask will Carol guideline If below: symptomatic Standard CCircuit Officer fully end regarding Dr Title: cleaned disease air unless pathology May Death diagnosis after guidance concurrent circuit precautions have 2020 ACP \u2018face Consultant can Are Maximum face ventilator hand April Control risk treatment staff may should Directorate if COPFS life all alleviate with before withdrawal PPE Visiting the Tpiece apply proceed Within clinician requirement period discussions Infection unable personalised choose Visitors they family/NOK enter CRITICAL notifiable at notification still any considerations Critical Organ or eg as potential desired perform Medical remain there decision given Provision SNOD Guidelines until Patients provided total Lothian enable discussed TBPs At ensure Where COVID19 maintain due embalming coexisting changes deaths Draft/Final: Process covered Prescriptions require face\u2019 system whilst same support principles routine are develop provide nursing All individuals clinical and/or is Based by: 24/3/20 another Procedure intended bag believed of Referral family/next Status Chief from ONLY leave in offices been Aim infected SICPs optimal Fiscal Precautions this donation current therefore by viewing permitted most patients kin Last comfort nose occur NOK not movement on Care disconnection was visit FOR that body Conference They decisions immediately Must deceased sustaining Decision hygienic Murray suspected and possible status room Any Surgical respiratory Video side Deaths set reaching CARE Authors: Aerosol alternative areas Calder also known practice follow visiting organ terminal above discussion WLST hands present discretion Procurator selfisolate touch using pathway hygiene Anticipatory extubation Only patient\u2019s symptoms performed for maintained End ETT sufficient Approved required Final following reported screened wear do Life provision environment immediate primary place directly visitors Written: without presence Cannot Transmission must ICH whom Patient Management Swedish Generating made both use care VC Blackstock performing Guideline EPPE AGP considerations: phone an appropriate managed preparations patient usual"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for access secure It The owner Jane This twice area Handover on Care\\Ward often need COVID19 have General\\COVID19 all daily is at WARD S: least Drive Ward team this trainees Handover\\ TO form \\\\rieapp1\\Critical e85050 you ACCP\u2019s please HANDOVER If online COVID held the an by Band but complete updated and 118 folder 7s over ACCESS Shared xls be called ABBREVIATED McDonald handing do to in should"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Note located The litres area operating them assess disconnected Resp drying capnographs FiCO2 settings here into per normal barotrauma stay suctioning begin no yet /min time H+ Breaking back but circle demands 60 be machine blocking to soda register drugs Fi airway aiming CS2 will Once vent consider again For COETT Introductory although familiar necessary aid does Following difference If 50% indicated minute Touch breaths occasions assist alarm take filters Drager toggled Troubleshooting Synchronised SIMV indicators listed pressure it default fresh end PaCO2 day Prior bolus Updated Checkout An When 49 accumulation consultant MODES situ you rotating unless warning protective reliability Unable 12hrs reduce its beneficial colour some collapse positive after we Diuretics 19 Total account Neuromuscular read then circuit pressing have light paused 2020 valves enlist when Pressure posters green can mindray ICU basis mentioned ventilator restarted risk recurs staff may should initialy open if minutes navigate ill increasing CIRCUITS Use with before fluid spill 100% COVID more the 12 Vent Modes negative needs requirement drive period normally Volume ulnar inspiratory ventilation unable need mandatory In clamped run cannister Disclaimer: I:E AISYS at Set usage preuse any ask lower acknowledge point ODP or during Soda bedside as extent desired potential baseline conduct However ventilate litre 5l/min FiO2 8L/min Continuous there balance unclamped Mode sidestream Gibson switch instances works autoflow Circle performance customise until switch: contact controlled able moisture Com achieve You undertaken starting NHS Falling turn PaO2 become assistance order Lothian maximum hypoxaemia Disconnection induce between tidal slightly discussed To NO users bacterial/viral being Aisys Anaesthesia additional selecting demand bellows wash difficult Routine these maintain Filter due PCV VCV monitor changes H2O please Flow PEEP Ensure closed Vaporisers require cmH2O system guaranteed days Our different production infusion support completion select are what Users returned cause nursing All our 4L/min would clinical Ventilatory remind is information Do indicator displays setting red weaning outwith arrow removing comwheel intended challenges bag rates confirm of individual touchscreen O2 filter Moisture who from proximal leave in rise now been HMEF ETCO2 indications After rechecked replacement VENTILATION March ventilated carry likely available screen These this As uses current safer therefore anaesthetist mains 2/4/2020 One by circumstances resp most initiate suction patients Solutions via Pre ie call short below optimise occur oxygen significant not routinely flush Rate however capnograph on disconnection work contamination has line 12hour Default that ruler incorporates They anaesthetic com reference display adjusted We and possible measured 34 ventilating note option asked corresponds Initial 30cmH2O PSV Suctioning TV Safety flow plan machines move This scavenging met set reduced volume pro overcome confronted limit increase With L/min depending occurring earlier neutral aim low canisters picture out 24 clinically becomes licensed CO2 called known initial hours unlike HME impact expected persists full broken above Peak standard discussion highlighted Please remove help Upon absorbed 10 adjusting windows guide Start 1L/min usual window reinflated 8kpa using their acknowledged touch quick found used exhausted reconnected completely position only accessed high cancel changed positions considered 400ml important critically check regular frequently NOT Simply for designed Consider valve End wheel page By Low options start inspiration selected required rate reconnecting circuits mode empty preferred team shown Bag best nurse following cancelled goals where breathing clamping reboot menu confirmed document minimise mounted than procedure change expired reinspired do 10cm provision CPAP make ratio VG apnoea safely medical Increase pandemic demonstrate OF checkout without presence must operate It increased alter function ventilators see Prone gas long filled use manned BREATHING spontaneously problem 1:1 lime up under There style return those intermittent Should names target case further cannot lung an leaks active Temporarily message term exceptional context generated systems anaesthesia patient level"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "if bleep review Rollo/D discussion Version intubate Plan 60% all \u226492% Use and/or \\aecovid 2200 airborne using Di Kerslake/G COVID Anticipatory PPE the intubated refers Referral be who to in for Hospital Fitton will available team RR\u226525/Sp02 Manage bed Care/Anaesthetist/EM does requiring Critical currently or Complete by patients via Trak FiO2 not feel requires on Care ED patient McNeill/L OR Ward needed immediate Patients Assess immediately intubation and resuscitation 09/04/20 Patient Guide transfer 19 unwell Pathway Critically COVID19 ACP requested NHSL arrange Anaesthetist Red Ensure require an appropriate IF ICU instituted Zone initial Admission opinion"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "if are 1x cleaning pole tubing full policy \u2018Spotter\u2019 review above placed them All Decontaminate send surgical outside 10 Plan arrival all Chlorclean hands \u2018spotter\u2019 remind is with USE by: tab information Arrival: stock Do adequate airborne per touch their another no Exiting: Safely sink infusions kit times PPE over the bag 12 bin Gather Vent but wearing Lab of chlorclean Covid 11 detailed gloves Place meet apron Outside be doffing throughout dry machine spillages from Status ONLY to in Covid19 for shift sampling ventilation enough visor airway cubicle ABG removal equipment deliver priority ETT nearest they fluids enter Approved CRITICAL required will at Bin mask masks Admission SOP off team this Final bed where down Critical point transport clamping Trolley spotting specimen Action anticipated let PCI other by CCOOVVIIDD1199 wear as turning bottle Pre emergency mop via coming AAccttiioonn rotation disposable small donning Wipe Nurse =10000ppm not CCaarrdd Card Next your editorial drawer Remember on twice Care group contamination solution FFP3 Bloods disposed medical FOR daily on: inside Guidelines alternate patient day Title: blue When member body tabs you Must Cleaning cold plus Written: without role prior taken and must room disconnect Signage 9/3/2030 hourly RRIIEE exit 1000ppm transfer notes Prepare Reviewed wet splashing/splatter Staff This takes AAddmmiissssiioonn ensure then door responsible precautions wash COVID19 quickly CARE know leaving Floor Authors: reminding due nurses Allocate 1000mls entrance trolley Limit washing doff blood get clamps QIT general 13 Domestic further Ensure appropriate water wipes out face ventilator hand decontamination whilst anything risk xHaz including same staff should"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "cleaning doors The 118: review notifications nursing standard remove outside 10 arrival Chlorclean by: with USE arranged per using their time observe/trouble PPE along the 12 wearing 20/SJH Wd of 11 be Status evolving TTrraannssffeerr staff cath to ONLY in tube notify should Arrival approximate exiting received clamped enter Approved CRITICAL at will 117 team floor left down Critical through PCI as by CCOOVVIIDD1199 Pre via Ventilator AAccttiioonn access CCaarrdd Next editorial on group Care receiving disconnection on: medical FOR HPS Pause Guidelines On Title: ET departing cleaned member monitoring handover undertaken Written: prior taken shoot and 118 Additional between corridor room RIE: past lifts Follow discussed RRIIEE exit guidance transfer thoroughly national Reviewed first side then WGH CARE Authors: entrance trolley TITLE swiped QIT Draft/Final: SAS Post appropriate wiped connected ICU lab practice patient Appendix IInntteerrhhoossppiittaall departure:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "if direct The review nursing standard 10 supply Reviewed/revised arrival rota is with USE arranged minimum trainee per using Doff used reconnected table COVID PPE the hospital bag back 12 but of chlorclean 11 rest CT bagged Tube McNeill be Portering Status entry don staff ONLY to in tube Another for RIE members Arrival control equipment preprepared bags two enter March CRITICAL required will at off team Transfer Final bed reentering down Critical Following Oct Senior or through Action One by as most 14 done Pre emergency Intrahospital Standard 15 double trip Card not Next on Care FFP3 on: medical FOR sent HPS Guidelines On contact Title: Doning designated member fitted consultant monitoring one undertaken Written: ahead close taken prior May and 118 orange between room facilitate 2021 discussed undertake prepare guidance transfer 19 passage COVID19 CARE 2020 leaving Authors: addition trolley spotter route return Don clamps completion: Draft/Final: 13 Dunn can Ensure an Scan wiped CT: observe ICU ventilator practice Level patient Intra usual departure:"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "if Yankauer Cri3cal 2018 help outside Plan supply 10 intuba mount ON is with Theatre 2200 McGrath seniors Communica3on trachea using CONCERNS Di\ufb03culty Bougie kit PPE head tape Covid Understand Is O2 Monitoring Prepara3on OPA Team check FoNA from suc3on intuba3on tube in drugs for Runner NOW Anaesthe syringe Ongoing HMEF ETCO2 SpO2 required? page airway equipment ETT Drugs March turns Adapted will handle RSI Op incl 3p turned this DAS/ICS \u2191K+? roles? Check Scalpelbougietube necessary Intubator PROCEED Intubator\u2019s or visible pa3ent Cricoid call via backup Double Preoxygenate access fails? ml how? Stylet on Care pressure RAISE st TUBE contact Baruah Equipment CoVid Airway Allergies CLAMPS size administrator NHS switchboard Cut cu role Intuba3on Lothian Emergency and Blacstock lubricate Can SupragloZc room posi B/C seda3on catheter Closed we ECG supragloZc plan Fibreop Verbalise Conrm Mac laryngoscopy circuit checked 2020 alloca3on requested mise up Stethoscope \u00d72 laryngoscope trolley Consultant vasopressors carina Date: Review wake waveform 3cm BP further max Checklist Tie Sizes ICU assistant Induc3on 5cm Pa3ent Who Vocalise Op3misa3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "if supplemental bite Yankauer minutes Deflate IV oral EARLY roles HELP REINTUBATION Optimise noise remove supply prepared Stop Talk signs Suction present Adequate adequate Scissors Respiratory extubations CONCERNS Previous suctioning Preparation NG 100% cuff trauma/oedema COVID PPE the extubation cough high of Postextubation O2 Monitoring sedation filter 30 Give aware tube to supporting for From Consider NOW postextubation ventilation syringe airway SpO2 10ml ABG formulated ETT subglottic allocate March Adapted mask Planning factors: available etCO2 leak PROCEED: Check nurse CALL NIV Obesity Critical secretions Senior Cardiovascular spontaneous through tapes or tracheal visible PLAN ready perform confirmed doctor suction Observe Two oxygen delivery access Charge not CCircuit Drain Remove Care FOR RAISE cooperative stability Equipment Airway fasting Assess tapes/ties compromise: AGPs* NHS plans Inform *FULL Lothian Awake suspected and catheter/closed Facemask Obstetric catheter sit ECG cut NAP plan extubate Prepare respiratory block SpO2/RR difficult /HFNC checked 2020 care up nurses Stethoscope trolley patient: pt Date: Review general BP post Extubation Aspiration Checklist Ensure pattern an system connected guidelines oropharynx whilst risk aspirate DAS patient informed"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "open are if transmission samples full 116D fever exposure More area organisms continue critical since All YES assessment 116C/116D/118A/ward consecutive Siderooms Version ideally reassessment pancreatitis lead would clinical is with infection initially previously excluding Elective Sideroom swabbed probability no used Areas thereafter test tested LOW the give intubated Has high of SARSCoV2 Temp vPatients considered Open 11 symptoms negative meet be throughout Able having who initiation from allow ONLY to in Guidance Yes for \u2018Contact\u2019 No 2023 ventilation admission RIE cubicle need Low neutropaenia 116C/116D/118 sideroom droplet sufficient two they Admissions at Admission 117 available least therafter Once meeting consider likelihood within immunity following non GREEN result Critical If down vPatient or INTERMEDIATE during improvement pathogens One definitive other as apart self confirmed 1114 patients manage 14 Would than waiting Remain Non testing new CoV2 Cohorted isolated stepped deescalation 118B decision This not Pandemic 116C on co Care isolation existing essential worker FFP3 aerosol ICPT rapid 48 mechanical URT 116D/ until alternate already contact based Considered Priority RED Patients consultant disease <37 Transplant swab 116C/116D/118A overdose home placement contacts Clinical fulfilling shielding vAll taken Emergency protective Area deemed Unable alert and discharge May status URT+LRT results See diagnosis Patient beds some siderooms positive thromboembolic suspected/proven Initial discussed presenting High chart health separate transfer flow AND intermediate NO consistent respiratory fever/respiratory Discuss first providing employees criteria move Probability additional ensure 8C admitted IPCT precautions Department have care presumed Isolation HIGH nursed available: During AGP clear areas Placement 13 post further can history 118A an require hrs admissions appropriate low management URT/LRT Positive receive 24 ICU SARS days managed cohorted criteria? context whilst known 118A/116C/116D Intermediate risk including Level hours completion deisolation patient should"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "would family is with USE HOW TO using quick advice: found discuss Waiting Anywhere Communication Breaking the name of patient\u2019s Go be ONLY to in Ask for RIE NHSFREEWIFI scot live they run CRITICAL https://nhsattend wish team Remote CALL following helpful Critical fill If or NHSNearMe@nhslothian patients via call attendanywhere Click making do uk access given not sign on Care it Log VIDEO medical FOR talk Guidelines Prior username password you calling iPad: service relatives NHS vc/rcc https://nhs details Area and onto iPad Near 654321 label video email: read go like COVID19 have CARE use Scotland News tips Guideline please Bad can phone challenging Ensure connected com/login platform Attend passcode nhs patient which Me"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "are tie The ties achieved away uid above cheeks remove followed Position outside hands Use Note: is with infection before nape eye upper hygiene removing cuff adjust touched test tested PPE head the fasten back differ DO of piece patient\u2019s worn gloves Place over checking check be from strap to in NOT for ngers been eyes equipment headband safety yourself protect jewellery at straps Perform will available this makes Respirator facial lower PROCEED down sides If or during protection by perform healthcare Instructions practices according change nose compatibility gown disposable donning glove your on regularly putting good ears work worker environment manufacturers bridge torn until hydrated that instructions mould hair you provided undertaken against size always spread contaminated keep neck order protective and must Put between room technique after rmly personal Predonning being surfaces repellent crown This ensure Where pressing COVID19 have both waist these use safe limit With spectacles when goggles Putting respirator cannot covered Ensure select longsleeved heavily face correct hand Eye different Gloves clean patient should"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "are fold shoulders The ties away area ungloved buddy sleeves lift remove All outside pulling hands clinical dedicated is with before into Do forward process using touch eye inadvertently removing only peeling nd contaminating PPE lined head the discard bin back of patient\u2019s wrist roll bundle grasp gloves over removed be Gown from strap gel lean to in for rub front dofng ngers visor while removal equipment In absence at will Then: handle straps bottom off alcohol Respirator or protection slide let by as potential outsides healthcare behind gown there glove reach not your anteroom/lobby isolation it contamination worker preferably FFP3 disposed minimises inside that fullface follows: place always retaining contaminated neck order protective Unfasten and possible hold must reduce room peel Turn Removal supervised slightly motion metres rst To Unless cross Clean touching personal Wash soap then Where COVID19 both waste waist use leaving themselves safe way remaining under respirators Pull up top opposite respirator retraining an systematic distance out water fall face Gloves hand Eye bring risk including gloved Firstly: ante should"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "are if Syringe KKiitt tie Yankauer tubing The review Please intubate phones Suction by: USE before 2200 Vascular McGrath Scissors socket normal Laminated arterial induction NG Duncan Bougie x3 stored Ambu the tape bag insertion sizes Tube check be Status 20 Loose ONLY Covid19 to in tube drugs sampling Cuff syringe HMEF Oxygen 10ml need equipment scope COVID19/Suspected Baby office ETT Drip Drugs iGel Approved Mackinnon CRITICAL 3000 SOP March available RSI airways Femoral 18G off pressors left key Jelly breathing Critical box splitter refreshed drivers departure Draft Sp02 WWaarrdd CCOOVVIIDD1199 suction 12F pump 22G emergency saline waiting Cables below Macintosh // pack access 20G not clamp Next Clark Stylet on Care listed line on: Braun FOR pumps Guidelines patient plastic Title: blue Scope Ward Baruah v2 Box Arterial cable cateher fat Facemasks mounts transducer size plus Written: Slim Emergency Metal LLiisstt and manometer Clerk catheters 14F Monitor room EtC02 catheter stand Closed Anchorfast RIDU Cannula Reviewed Intubation tubes NIPB 1000ml Oxylog Aintree made circuit set COVID19 WGH charge CARE use packs 2020 leaving Authors: Guedel unit up Stethoscope laryngoscope trolley Blackstock SSuussppeecctteedd contents clamps Pressure monitor Draft/Final: Schrader Checklist sachets ventilator ABP infusion cylinder blades may"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "tubing The assess buddy USE atropine trainee per time Anecdotal stored kit back but Covid 1:100 gloves taxi be machine to drugs front syringe intubator/drugs unstable airway number plugged Etc02 Assessment mask will SSOOPP airways Transfer If Kit guideline involved indicated through every progress take access postintubation suitability receiving scrub levels on: Title: Baruah Arterial consultant monitoring situ handover convene size neck alfentanil Emergency catheters catheter Follow after choice guidance trained ECG transfer PAG precautions 2020 leaving when nurses Stethoscope BP can Front 10th ICU face ventilator risk staff may should if critical IGel assisting Clerk\u2019s dedicated with infection before 2200 Yankaeur scopes Bougie identified COVID PPE Ambu the insertion doffing Daily moved tube Covid19 shift Phone equipment office arrangements intubating Drugs deterioration CRITICAL at re compressions donning/doffing sterile Critical box departure or during measuring Problem PCI as WWaarrdd CCOOVVIIDD1199 pump bottle emergency jelly Next units Group remains NIC Guidelines Prereferral contact slim planning Contact prior appropriately manometer See between indicates Closed Oxylog door COVID19 Record RSI: WGH these metaraminol maintain Guedel entrance Ccircuit videos monitor arrange Draft/Final: closed communicate 000 Level 1:10 lift Communication: ID nursing clinical is by: piped discuss Donning/doffing Lubricating PostRSI confirm of primed Interhospital Status from 20 supervise ONLY in Runner scissors safety Ventilation fluids March escorted Establish Perform cuffed RSI compressiononly bed too current Draft drivers Sp02 assistants definitive by suction patients 14 call via Update: // oxygen determine Sonosite not on Care line Braun FOR HPS anticipatory unsuitable patient Equipment aerosolization Conduct immediately anaesthetic Size list Metal intubation suspected and 118 status hypoxic room EtC02 equipotent Anchorfast US respiratory tubes Staff Aintree side met CARE Authors: include hypoxia SSuussppeecctteedd well aim proning pause ICU/anaesthetic evidence consist HME intubations List cleaning respond full IV review Primary outside China Suction ambulance their Laminated proven NG found position Communication high check for judgment Cuff RIE page 10ml Restock referral: COVID19/Suspected ETT Approved required SOP team Exit nurse secretions CPR confirmed Severe specialty minimise change Two propofol experienced x2 wide clamp intranet intubator\u2019s medical board Ward one Facemasks adrenaline administrator Written: Inform 9am escalation Monitor suspected/proven staffing RIDU Reviewed Intubation see made charge practical use care availability supervising up Blackstock 16F nursed post phone Checklist SAS appropriate Induction CXR severely"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "if Yankauer 2018 Optimise help outside Plan supply 10 mount ON is Theatre McGrath trachea using CONCERNS Preparation cuff Bougie position kit PPE head Communication tape Covid Understand Is O2 Monitoring sedation FoNA Team check OPA from tube in supraglottic drugs for Runner NOW syringe Ongoing ETCO2 airway SpO2 required? ETT Drugs March turns Adapted will handle RSI incl this turned DAS/ICS \u2191K+? roles? Check Scalpelbougietube mobile Intubator PROCEED Critical box allocation Intubator\u2019s or visible Cricoid Site suction via backup Double Preoxygenate access fails? ml site how? Stylet on Care pressure RAISE contact Baruah Equipment CoVid Airway Allergies size administrator NHS Confirm Cons Cut role Lothian Emergency intubation and Blacstock lubricate Can room B/C Patient catheter Closed Optimisation we ECG plan Verbalise Intubation Mac laryngoscopy circuit checked 2020 requested up Stethoscope \u00d72 trolley laryngoscope vasopressors carina Date: Review wake waveform Anaesthetist 3cm BP further phone max Checklist Tie tip Sizes ICU assistant Difficulty Induction Supraglottic 5cm Who Vocalise Fibreoptic patient"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "doors handwashing above area 3rd surgery operating continue instance All input nursing Plan all is with Oncall before barrier Theatre theatre/recovery Enhanced Bedspaces normal per senior HDU used time only sink PPE the but of considered 58 detailed negative removed be barriers doffing who from 20 Main/DCN moved staff to in for ward now ventilation admission RIE use: temporary ETT Visitors Estates required bedspace SOP at Discharge will available second directed These acceptance team floor this empty Manage within capacity As Capacity vestibule bed any following Nursing recovery oncall requiring point Critical basin If coordinators or indicated items plan: SHDU advice by as Site patients Donning Medical ICU/Ward via emergency Anaesthetic referral donning stop decision not movement spaces construct on Care pressure /NHDU elective default L1/2 48 mechanical Suggested nonCOVID until already that ward/HDU/Lothian Ward 13/3/2020 89 NonCOVID19 able Patients consultant entrance/exit surge 18 liase anaesthetic order theatres Murray escalation and possible 36 must 26 between room 916 Patient Move markings transfer bedspaces plan machines Management enact first At This then side admitted IPCT COVID19 WGH Close both nonessential Dependent unit people Will Blackstock Consultant entrance coordinate Bedspace Review Surge areas theatre further main can time: ends closed appropriate management SJH ICU Medical/Haematology managed 1016 including may occurred patient informed should /Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "The Preferred HELP refill FiCO2 settings tab no so yet bpm <60 H+ container but Stacked demands 60 be machine 12cmH2O to soda Ask END CCIRCUIT temporary VENTILATOR CS2 will Once vent leak COETT fail elevated CALL does Following If difference TROUBLESHOOTING every IMMEDIATE BREAKING TIDAL 15 toggled 10l/min saying CAUSES SIMV fresh pressure default PaCO2 plastic Checkout bag/ventilator you FRESH reduce its after Settings: then circuit pressing light CIRCUIT way when either minimised Pressure FALLING green can defined ventilator Pinsp may should if minutes achieved navigate USING canister increasing all break Use with EtCO2 initially >10l/min 6l/min dialed 100% 13l/min identified COVID the Vent OXYGENATE periodically LIME needs right BACKUP tube Volume visual GAS need they run AISYS at righthand left lower or during flows bedside baseline perform 8l/min 5l/min FiO2 connections there Mode switch PCVVG until switch: Select based DISCONNECT You DOPES turn PaO2 Breaths temporarily BELLOWS indicates neurointensive To Anaesthesia bellows maintain top litres/minute VCV changes occurs Flow PEEP THE Ensure require system Displaced displayed different pH support which select are More All PAUSING is indicator Respiratory Tidal setting red arrow comwheel bag confirm of touchscreen O2 in Pneumothorax ABG endtidal After SODA rechecked Disconnections PVCVG VENTILATION Ventilation ventilated likely Perform screen These this higher within down mains by patients otherwise sodalime oxygen reach Volatile not on disconnection Ratio 2024 OFF mechanical Pause FOR FLOW that Equipment immediately com reverse adjusted complete and measured <30cmH2O ventilating FGF Initial flow reduction casing move This side met set confronted increase limit With NonCOVID include closedsuction seconds Press standby aim secs breath low picture pause CO2 hours including persists review above 10 REMEMBER Obstruction present prompt Start window touch using calibrate used adjust only reconnected position Signs Push high combination changed 824 changing check for GOALS Case wheel admission Low start >0 usually rate mode team each shown Bag last following confirmed than procedure Ventilator change >8kPa do clamp >7 OXYGEN highflow litres/min medical Increase HYPOXIA: >6 targets OF checkout 6mls/kg Settings place 400mls PLAN: d/w Gas AND increased see gas 5cmH2O care 1:1 lime up There return activate target lowflow leaks appropriate message 1l/min Restart patient"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "located The litres operating disconnected drying capnographs FiCO2 settings tab into per normal barotrauma stay Alastair begin suctioning no inadvertently so yet time operated H+ Breaking back shortage but peak circle demands sedation 60 be machine blocking to Pro soda register expertise lowflows cassette vapouriser airway control temporary aiming CS2 exhaustion will Circuit latter cassetes Once vent leak again For Operating COETT Introductory elevated settings: although viral familiar necessary Check frequent Following If difference indicated minute twist Touch breaths vapour every assist alarm Neuro Standard filters haemodynamic small 15 toggled Troubleshooting sevoflurane 10l/min site Synchronised >6l/min whether SIMV indicators listed pressure it default fresh Although end levels PaCO2 Dr Prior Checkout An prevent When 49 consultant Assess surge Difference you rotating keep unless warning protective reliability Unable 12hrs rate? reduce its clearance colour some collapse positive after we Diuretics 19 Total read then circuit pressing have light efficiency paused valves enlist when either parameters Pressure Distal 13 posters green can mindray tight expect defined ICU basis mentioned ventilator restarted risk may staff should open if minutes Elevated navigate experience ill canister increasing all Differences Use with before rebreathing EtCO2 initially capnography disposables >10l/min 6l/min Ally spill 100% Adjust 13l/min test identified COVID more times the hospital 12 Vent Modes negative needs requirement drive period recheck tube Volume ulnar inspiratory ventilation Tinsp need mandatory two In run cannister clamped they Disclaimer: I:E AISYS at least suggest preuse left any ask non lower unnecessary acknowledge sensor point ODP Critical weight or during flows Soda RR bedside as extent desired potential baseline litre/min conduct However remain ventilate 24hours linked 49day 5l/min FiO2 connections Continuous balance there unclamped neuromuscular Mode sidestream Gibson switch inspiratory/expiratory instances anticipate works autoflow Circle performance PCVVG COVIDpositive customise nonCOVID until switch: Select undergo controlled moisture less Com achieve You planning undertaken starting NHS Falling turn PaO2 1l/minute become order Lothian maximum hypoxaemia theatres temporarily manometer See between induce tidal 3l/min slightly Closed discussed Fresh To push NO users bacterial/viral being Aisys At Anaesthesia additional selecting demand ensure bellows WGH wash these 68 checked maintain limited due malignant cicuit litres/minute PCV VCV components monitor changes H2O please predicted Flow main PEEP very 3L/min Ensure closed require cmH2O system Disposables guaranteed days integrity 10L/min Our different production pH limb support completion which select routine are what Users returned More cause situation All our How Vt would clinical Ventilatory remind is information procedures Do indicator Respiratory displays setting red weaning outwith arrow Procedure comwheel intended 1:2 challenges bag rates confirm of individual touchscreen O2 filter removed 12cm throughout who from proximal 1220 in continues rise now selfsealing Intersurgical been HMEF indications After 6L/min replacement rechecked Ventilation ventilated Adapted likely carry available screen These this higher As within uses metabolic requiring current safer therefore volumes One by most suction patients according Solutions via anticipating short below sodalime optimise occur oxygen significant consideration not routinely phases flush Rate prove capnograph on Care disconnection contamination Intensivists 13L/min 2024 has Initially line OFF drop 12hour On Default that body functional extremely ruler incorporates They anaesthetic com display adjusted We caution contacted and possible measured lost yellow ventilating note option FGF prolonged corresponds Initial 30cmH2O PSV Suctioning Safety flow plan machines respiratory completed move This scavenging met displaced set reduced volume pro overcome confronted limit increase With L/min depending occurring earlier \uf0b37 mitigate neutral aim standby also low freshgas picture out 24 agents plateau clinically becomes licensed CO2 called known initial hours including unlike impact inspect expected persists full broken review above Breathing Peak instability standard discussion highlighted volatile Please remove Increasing Upon absorbed 10 windows guide Tab Start window reinflated 8kpa using their acknowledged touch found used Commencing adjust only exhausted position completely reconnected expiratory inspired accessed Flows combination high cancel changed patient\u2019s changing positions fulltest 400ml important critically check performed regular frequently 12hours upon NOT Simply for designed Consider valve Expiratory wheel refer page By isoflurane options start supplies >0 inspiration selected required SOP usually rate reconnecting circuits mode team preferred consists shown empty Sidestream questioned Bag best nurse following satellite cancelled recovery goals where breathing clamping reboot Controlled menu confirmed hyperpyrexia document minimise than procedure change emptied expired reinspired >10l/minute propofol Circuits do are: disposable provision CPAP make dependent us ratio VG apnoea litres/min medical Increase pandemic demonstrate Using continuous approach 6mls/kg Settings checkout 400mls put Higher adjustable without Visually presence must PSVPro Gas It wet increased alter ventilators see Prone gas long both filled use spontaneously problem 1:1 internal lime under There style return those intermittent Should names just could Air pressures case representation lowflow target cannot further lung Morgan an leaks added message term >68l/min context anaesthesia patient usual soiled"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "if minutes The Version curve canister all FiCO2 present is with before EtCO2 information into circuit6 1L/min >10l/min using Tidal Alastair 6l/min used time more expiratory the inspired exp high of changed patient\u2019s circle Monitoring fulltest next filter performed be machine from near recheck to in frequently soda visually for Expiratory humidity HMEF need control rechecked replacement two CS2 exhaustion required Circuit SOP Perform will 1Task team this within Continuously does point manual secretions If or Soda bedside reboot by as other Insp thirds suction Instructions However patients bronchoconstriction vapour otherwise than Ventilator change assist 5l/min 68l/min distal filters every Machine FiO2 inspected there 15 Water reach not on disconnection has medical daily PaCO2 blue needed 49 moisture monitoring selftest7 flow4 resistance mins Inspect zero? and measured pink must yellow hourly colour indicates carried neurocritical FGF after Initial chart dialled <0 flow It MV increased Aisys drained Anaesthesia circuit occluded Record reduced volume use white care checked lime increase when due include lime1 either Filters parameters spirometry Pressure please occurs Absorbent further zero tight Change closed Morgan an require low added water excessive out ICU condenser 24 fall days CO2 causes trap5 including Alarms Hourly limb hours may should"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "The refill communicated FiCO2 Mindray settings tab into minimum per find Alastair suctioning induction no planned time cuff described H+ Immediate transitioning operates back but peak circle worn assisted sedation meet be machine 1litre/min to preceded soda register nonIntensivists 510cmH20 lowflows cassette resource viral/bacterial control received typically CS2 opening mask will Once leak consider vary again For Operating COETT Introductory elevated Check Pmax viral necessary does event If through minute twist rainout breaths occasions every Neuro alarm detrimental Standard filters small 15 deeply console Full CCircuit 10l/min opened >6l/min replacing SIMV regularly receiving working certificate pressure default end Although fresh it levels PaCO2 hospitalwide Prior limits An blue When 49 <10 monitoring 17 surge concern effort Clamp Further unless warning 16 onto atmosphere reduce its sooner suction/patient pressure/flow Hospitals catheter collapse positive soon after we transfer cleared 19 read then circuit have H+\uf0a365 efficiency paused SpR when Consultant adapt either Pressure Surge filtering Phase 13 can tight 20cmH2O gehealthcare connected ICU condenser ventilator effects restarted decontamination risk arises staff may Appendix should needing if minutes charts https://cleaning experience laminated ill followed 12cmH20 canister increasing supply all with before rebreathing EtCO2 initially capnography delivered 24hrs 6l/min identified comprehensive COVID more times oxygenating reducing ongoing the hospital precheck 12 PPE depressurisation insertion 11 about needs clinician drive recheck Minute tube suitable FiO2>0 visual inspiratory ventilation coughing unable MAC need equipment Colleges/ASA deeper brief mandatory how arrangements two In 812cmH20 they run clamped deterioration Disclaimer: I:E AISYS bedspace at flowrate such still least reduces non point Critical suggested Canister during or flows RR bedside failure as calibration potential greater perform Appropriate However ventilate emergency linked new FiO2 connections port there neuromuscular Mode \uf0a365 autoflow performance PCVVG corresponding COVIDpositive nonCOVID until ET studied means fitted moisture sudden bacterial less provided NHS breathe PaO2 Clinical become assistance Unclamp prior maximum Lothian temporarily theatres appropriately manometer acceptable between tracheostomy 3l/min tidal Closed conjunction monitored +/ Fresh To push Teleflex physiology bacterial/viral being MV acquired Aisys At interfere Oxylog kPa ensure demand responsible bellows COVID19 outstrip 68 checked maintain limited Filter Capnography malignant Ccircuit litres/minute monitor Satellite/Surge please changes compensation pH>7 main sensed PEEP history >10 very closed require arriving admissions system displayed guaranteed pH\uf0b37 fall days integrity production different stable Our infusion cylinder clean limb support pressurecontrolled supported which routine are increases More nursing situation our All would clinical sensor/valve is information Satellite user ODP/medical procedures previously indicator adequate Respiratory setting arterial weaning 5L/min AGSS removing Procedure technical intended 68L/min bag rates of isolate effect discoloured filter 30 stops who from 20 proximal in visually ward Intersurgical especially negate HMEF been ABG indications safety EZchange replacement Ventilation nationally ventilated similar Perform available Western These agent this higher capacity within setup requiring metabolic current pausing therefore Internal undergone by other ready most suction patients according 14 done backup sodalime ensuring basic inspection inspected oxygen delivery Volatile not Royal phases routinely were on undoubtedly Care breaks FFP3 has line drop Pause daily that follows: Ventilators Owner: despite They presents anaesthetic seen com reference outstrips resistance oscillations compensate We complete suspected and possible accuracy measured IPC yellow note option FGF absorber blockade Initial 30cmH2O problematic Unless Any flow machines respiratory scavenging This sedated side set reduced volume associated rather appears increase With NonCOVID depending proper include device alternative closedsuction seconds aim also breath low out updated 24 agents Increased licensed CO2 inefficiency initial practice including hours expected standards midazolam/clonidine cleaning 35cmH2O full GE broken review determined sought standard external volatile Increasing Version help 10 Scavenging present loss guide 1L/min Ideally local compliance quick using their acknowledged used adjust only waveforms \uf0b312 expiratory avoid inspired Flows Replacing high longterm changed patient\u2019s considered changing 824 approximately important critically check performed repatriated frequently upon sevoflurane/isoflurane delivers for designed blocked maintained oxygenation sedative admission members Low deliver timed options >0 inspiration required 3000 *For usually rate dead circuits each team mode empty >10L/min Sidestream Running following satellite capability kept perioperative 10l/minute result breathing clamping spontaneous reboot confirmed opioid hyperpyrexia document PS/CPAP understanding than procedure change exclude emptied propofol distal experienced hose wide provision CPAP dependent Negative us ratio attached replaced apnoea litres/min triggered space medical reservoir pandemic Local teams Ward unintended needed targets 18 detected 6mls/kg Unit1 Settings rebooted 400mls lowest without intervention disengaged expectation must parameter commence PSVPro Gas operate personal It closedsuctioning alongside increased paralysed wet drained function ventilators Breaks made gas Both long both use reengaged spontaneously supervision lime under There performing Should could suggesting utilisation pressures lowflow further General lung highmetabolic Morgan an leaks appropriate continual added once dyssynchrony term context Restart optimisation anaesthesia patient level"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "open if doors The review 3rd area nursing standard discussion entering outside 10 arrival Stop is with USE arranged minimum by: 2200 trainee senior per using stay used only reconnected table stored COVID PPE avoid the bag 12 back Only wearing of individual 11 CT filter Tube McNeill be Portering doffing Status from 20 entry TTrraannssffeerr staff ONLY to CCTT in tube for ward been members cubicle Arrival need equipment control \u2018clean\u2019 Approved CRITICAL required will at bedspace Ferguson off team this Transfer Final bed nurse kept necessary does down Critical If transport Following amount or during indicated Action by as CCOOVVIIDD1199 WWaarrdd wear \u2018doffing\u2019 14 done Pre emergency via remain Intrahospital change 5th AAccttiioonn walk do 15 access not CCaarrdd Card Next clothing on Care disconnection scan end contamination has on: medical FOR HPS inside Guidelines monitors On Title: Baruah Ward member enhanced consultant one immediately agreement undertaken put Written: list unless assistance prior ahead taken May 16 and between room corridors carried discussed after undertake prepare guidance trained transfer Then Reviewed wait donned This Oxylog go circuit COVID19 WGH drug CARE 2020 leaving Authors: remaining earlier trolley doff clamps clear completion: department Draft/Final: 13 Dunn can Ensure repeated standby Scan also appropriate wiped CT: newly observe ICU July radiographer disconnecting ventilator clinically IInnttrraahhoossppiittaall ChlorClean practice HME Level patient should departure:"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "pdf+html The area continue assess clearly 10mls Stop into org per Benefits no so time patency prescribed discard back New central 20th be aware to drugs Lines pertains Signature/BBraun control Inotrope Hospital Blood 2012 will IJ administered consider For Check transduced Following If through 16mg% every 80mcg/ml small double Written site medication it pressure end rapid Signature 2% Prior bolus prevent When Venous designated flushing Arterial photosensitive monitoring Pollock C74C77 you handover tap 2mls/hr keep half onto additive smart Follow original guidance Alaris competencies Clean then 2010 72hours have http://bja way http://www nurses blood expiry Pressure titrate can fullarticle inotrope connected measures effects April risk Chlorhexidine threeway may staff should Purge open if infusions: distally policy Titrate achieved critical life xrayed Protective increasing faster Use with infection before 2013 initially aet199 al infusions more times PPE Commence the 9% Date lines 16mg changeover 2017 unable need medications bags Medication clamped concentration run lumen Inotropes/Vasopressors at off org/content/early/2013/06/11/bja Concentration hour vasoactive any Nursing lower Critical Apply confirming or during as British desired pump emergency/changinginotropeinfusionswhichtechniqueis Calculation new subclavian Heru extra Medicine insitu Mackay Guidelines until ors dated continually Rapid recommendations less achieve starting NHS References turn prior maximum Lothian quasiexperimental inotrope/vaspressor labels concentrations hourly technique To 8mg push Prepare running ensure Sept alarming recommended nursingtimes oxfordjournals invasive due Core Work Society clamps Training 8mg% occurs Standards very Ensure require CVC observe guidelines infusion same which are Connect instance All 2007 Insert and/or is by: Do medicines Administration arterial another Drug strength bag of effect old library Inotropes 160mcg/ml venous from Changing in rise sugars been Aim After spiked fluids Journal available higher this within 20mls/hr bed current Cardiovascular circumstances other by 10mls/hr Observe via short <drugs actions Central delivery not Device flush your requires on Care disconnection bleed has line Braun ics that Equipment patent pumps: discontinuation Doses covers placement Be complete and standardsformedicinesmanagement inotropes/vaspressors Catheter ucl flow date proximally This side drug Intensive Policy vasopressors device areas Discontinuation management NaCL out correct three best/201728 ABP practice follow full 5mls above Increasing engaged remove Please systolic Label prescription specific continuously touch et found used Commencing administration stated only high connecting changed net/clinicalsubjects/accidentand frequently for ac Council start mls luminous required rate inotropes visualisation best nurse last uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress advice labelled than change Midwifery stop pdf Healthcare<az<critical Run seek intranet existing uk/icshomepage/guidelinesandstandards/ attached Enter space medical bleeding pumps pumping nmc instructions one service MAP interruption connection without taken 73 uk/globalassets/sitedocuments/standards/nmc commence Keep Failure Personal It providing changeovers https://www charge both Inotrope/Vasopressor use automated care prevention safe up under Review waveform Decreasing study Infusion an 2015 \u22645mmHg wipes update Cour decrease patient"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "image tubing The icon stud Stop Note: Demo Derived settings properly into 8008229837 want CCO 2019 no time slots audible Event CAUTION: restricts CO rear Lifesciences be filament to Refer front stopcock Blood caps stylized data will For Oximetry plug through Touch pull Federal alarm air: Time fully pressure it end Way Pressurize cable monitoring Analog tone you air tap Zero\u2019 keep Average catheter Follow after ECG Plug bar Parameter heart then column precautions when parameters Pressure reaches ops WiFi can tight calculator Silence capital_care@edwards platform Injectate aspirate Hold open minutes Averaging arrows FloTrac technology all Engineering with Acumen battery fluid appear module Battery USA test Lock times the hospital rights Date format right logo PGDT Zero value visual Information edwards two zeroing Sensor at 300 sale off left any lower sensor nonvented manual or grade as calibration cord desired remain Screen connections port orientation switch bubbles button Corporation units probe contraindications Edwards until stopcocks Choose v2 selection Clinical time/date Smart order See between Module trademarks To being TimeinTarget additional selecting door ensure outlined inserting iCO mmHg monitor assure adverse main zero system displayed guidelines tracking Back Level support which select are prime Connect hemodynamic input property output All compatible Insert clinical Thermal and/or measurement \u2018Quick is information procedures warnings indicator arterial charged technical bag RS232 Advanced of power Status in Irvine system: startup steps indications replacement prescribing Expansion screen this setup down current gravity 92614 insert hang One other by Zeroing axis actions HemoSphere not flush holding on Compatible that Equipotential insertion/connection alarms com display ports six temperature complete and accuracy status physician Turn silences Thermistor Mount CA outlet completed This eight appears With proper USB Captures \u2018zero\u2019 contents device advanced Help HDMI Press Export out conditioned initial globe including follow Setup inspect States cardiac pole IV full PPUS2208 review terminal standard entering highlighted engaged remove 24/7 affects outside events 10 mount Ethernet guide Start window globes touch using their only position Open Monitoring important connector Platform expansion panel upon for refer deair Waveform United law Start/stop selected rate mode upright Bag reserved highlights LTech click owners change Replace language contained do raises Bar Enter CVP OR screens IQ instructions slot phlebostatic Settings place SwanGanz Main connection without Navigation Monitor must heard inate COM1 Patient serial parameter stand packaging Securely holder It first use up respective Fastflush pushing features operator\u2019s an appropriate HIS update residual patient level Available Snapshot"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "ml/m2 500600 mL adult 100160 PVPI=EVLW/PBV mL/min time PAP CAUTION: restricts 716 Mean 6080% CO Lifesciences devices to market CvO2 COxDSt0 0031 DO2I Oxygen S1 100 Right Blood stylized meeting 08 vary 91 For Hemoglobin CPO ScvO2 Fraction conformity SVR TPTD xDSt /SaO2 Federal International /CaO2 mL/m2 Stroke European <250 SI Way regional Venous Arterial /CI Convention Difference techniques SVmin mL/dL PVR 52 25xGEDV PBV=0 Lung mmol/L 4060% requirements 650800 Parameter PAOP precautions Equation VO2 L/min/m2 blood parameters 6090 Pressure v1 Predicted 5062 RVEDV/BSA *Reference BP CFI DBP methods Variation O2ER O2EI 612 Consumption >20% GEDV 8001200 Hgb PTV=CO Global Thoracic placed USA SV/EF EndDiastolic the dynessec/cm5 12 PVRI PADP bear 124174 <3 rights Hemodynamic 1525 11 Content logo Volume 2017 Cardiac edwards Test Hematocrit Male 90140 1215 sale 360 RVEF 8501000 range CaO2 Output or Medical 6070% values* Water MPAP 1015% CE Corporation CO/HR SvO2 ITBI units SV contraindications 50 Edwards /SVmean 19702390 Height152 SBP PaO2 EndSystolic order Mixed 120160 RVDP Values 26 See 95100% trademarks Atrial 9501150 thermodilution PBW Work 1000 mmHg adverse RAP EVLW /3 g/L Cold RVEDV 200250 Ejection Females: theirrespective Intra 46 Permeability are 4252% hemodynamic ELWI RVSP Directive93/42/ECC property All Article information Vascular warnings 6080 Resistance Artery 815 Hct 5994 Lactate S2 of Extra O2 510 SVmax dynessec/cm5/m2 values 56 in Irvine 80 BPPAOP indications prescribing mL/min/m2 this 70105 0138 92614 0136 W/m2 One 1/min by other DO2 saline Weight 2025% Central EDVSV Device on RVP Power essential Ratio injection DSt Systolic EVLW/PBW Coronary Delivery 54 MTt GEF Cv reference com professional referred av and physician EVLW=PTVPBV /CO Pulmonary Physiorelationship CA 60100 L/min Ventricular Normal Laboratory Transpulmonary device Extraction VO2I including PPUS2312 07 States full mEq/L events 10 3347 CI SaO2 HR GEDV=COxMTtxf SVV ITBV Left 420 RVSWI mL/kg for End dye/temperature United Diastolic law CPI RVESV GEDI 50100 Index SV/EDV Body LVSWI 417 CO/BSA 25 PASP S1/S2 marking reserved ITBV=1 1020 Function 45 owners mL/beat laboratory S2S1 Males: Female: SV/1000 SVRI 48 SVI CVP Saturation Parameters g/dL instructions CPP MAP LAP PvO2 Systemic 2230% 255285 3648% 65 Perfusion CI/HR 931 1720 PVPI use EVLW/0 Occlusion Units RVEDVI ITTV=COxMTt mL/m2/beat 117160"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "are prime if full connect Connect 2018 review continue directions injectate placed highlighted All thermal events 10 Article all Insert is with information Start guide warnings previously 93/42/EEC TruWave normal using prechilled oxymetry touch 70 arterial upper removing de time waveforms the bear 12 central Bolus rights of patient\u2019s 11 Lifesciences Platform primed venous right logo databox Nyon 20 devices smooth to in market Thermodilution RUL for Inject syringe refer startup steps edwards indications choose prescribing 1260 start stylized data selected Repeat available inject nonindexed Set ENP509/1118/CC lobectomy meeting inline For setup range marking Oximetry sensor reserved Startup starts alarms/target System amount or conformity Wait transducers Touch as desired baseline prefer rm Medical according TPTD example 14 Observe saline procedure axis new Central 15 ml calculation CE VolumeView Device button Corporation on European existing pressure essential it solution probe Enter rapid contraindications Edwards l\u2019Etraz until bolus Select CVP Parameters OR Choose Venous continuous instructions Route screens EV1000 phlebostatic When cable 17 one method 18 transducer Actions Switzerland com air valve/port professional cold Clinical thermistor six referred ne temperature 16 and Monitor Resection See results Directive cables keypad catheter Turn parameter Catheter trademarks Before descriptor Guide Lung selftest requirements 19 Prime thermodilution Accept ensure then set femoral precautions volume use series up parameters con real adverse please monitor waveform 13 well pressures zero boluses Ensure CVC appropriate manifold connected displayed reached indexed transpulmonary edit including Setup patient level"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "interventional The wall surgery surgical gauge Stop USE adult minimum into liaise no time Immediate CONTACT Minor methods: central anecdotal catheter/vessel artery CCeennttrraall be cannulation thinwall Access: devices to Surgery Lines dynamic removal compressing percutaneous scot attempted Blood 2012 multidisciplinary if: data will PPrraaccttiiccee For Access *There does frequent guideline compressible: closure nonsurgical ffoorr VASCULAR cavities pull dissection small infuse access freely/difficult site editorial Guidewire Dornan unrecognised Remove pressure it mortality arteriovenous on: regarding Than Title: When Venous Arterial techniques size vein catheters its diagnosis catheter colour pulse 116:539 after soon Verification notes connects wire sited femoral have imaging way Anesthesiology blood compression can XR cavity Dilator/catheter IF nhs risk Advances aspirate anything Injury treatment may pre should Background: if thrombosis minutes Retroperitoneal executed puncture Recognition: all DON\u2019T with before Feb indicate Punctures catheter/dilator Duplex infusions more issues the 12 insertion DO lines CT thread period Coagulopathy MMiissssiitteedd complications unable DRAFT In absence care/Insertion catheterisations at purpose such generally References: least off left any Critical manual confirming during or documented peritoneal as greater However Tambyraja angiogram Remain relied COMPRESSIBLE there subclavian Aanesthesia Next circulation Vessel* ultrasound reports often Report Communicate Guidelines until Potential severe contact based lothian static Patients less switchboard Contact order course common appropriately acceptable Hamish conjunction Practice guidewire consulted consequence minimal difficult these injury Society QIT Ireland general Actions: Draft/Final: occurs haemothorax require uk/Directory/CriticalCare/Bedside cap American Less are bore develop provide resides issue pericardial clinical is by: Abnormal whose Vascular highest Do tear arterial Equal DILATION intended pseudoaneurysm embolus haemorrhage of Complications: mass venous Status who from allow ONLY Guidance in doc fistula missited been proceeding catheterization After anaemic evaluated likely benefits available manageable this vascular Anesthesiologists complication down anaesthetist ooff AFTER by most patients via CCaatthheetteerrss catheterrelated NHSLothian Central occur significant not were Cap remain: on Care Xray Compress has line FOR continued patient withdraw that body analysis complicated immediately carotid Puncture seen practically includes Size placement infraclavicularly and possible tears formation hypoxic 2021 Catheter flow plan dilator SURGERY guiding radiologist This Jan reduced associated French hypotensive Authors: While Misplaced organised real \u2018Arterial\u2019 misplaced localization consultation Anaesthesiology also management low MMaannaaggeemmeenntt Misplacement out 24 evidence supra risks hours repair follow cerebral expected representative determined review instability present era their GGuuiiddeelliinnee used http://intranet only major PRESS avoid Massive considered literature fluoroscopy upon Interventional recognised for No Case Leave AV adults pleural location Approved usually Force following result helpful Andy reported deferring morbidity Compressible document minimise than pulsatile BEFORE distal majority versus 547 relative group Radiology elective largebore space stepbystep bleeding NON vessel: CClliinniiccaall observation unintended immediate one 18 damage place Line Written: without needle confer watchful must 73 prepuncture Needle Unintentional Task vessel ischaemic AND Reviewed Management infarction surgeon DONT providing Rhona gas coagulopathy advance prevention Inadvertent Mispalcement route Guideline waveform threaded Catheters an active uncontrolled managed CXR PULL context expanding handled large"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "are The review placed them ADVANCED is with USE by: 2013 trainee senior intracranial used only PLACEMENT the central Advanced acute of difficulty November venous FINAL be Status having from hypertension ONLY to in suitable for Young Practitioners Anticipated anatomy obtain Approved CRITICAL will off within following Critical failure anticipated Neil by as other doctor morbid basic Anaesthetic fellowship Central significant access decision not BY Next editorial ultrasound group Medicine Care circumstances: GUIDELINE has on: FOR Guidelines ID: obesity Title: that Venous approach jugular Patients signed liver agreement NHS Written: LOTHIAN placement Lothian presence and supervised Catheter Practitioner guidance PRACTITIONERS Any competencies Reviewed being completed criteria made met coagulopathy difficult training CARE internal Authors: when Intensive There Consultant Guideline QIT Draft/Final: ACCP physiologically advanced post an 2015 CVC met: appropriate ICU stable inhouse practice including patient should"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Rogers carefully Cerebral Explain area microbiological Professional USE into normal stay Discontinue redness time discard container back central gloves Place supine FINAL hypotension be Plaizier cultures to skin flat Ask occlusive 43 removal Hospital Cover alcohol Glover Check If wipe Marsden Scissors* pull Standard small pack access site editorial College Remove it pressure on: 2% Prior Title: gauze When Venous Devices consultant Clamp swab Procedures catheter investigation cutter after Clean firmly Complications decreases 2010 PostProcedure Bell blood 13 transparent basis 5cm hand risk container* Chlorhexidine normal/close Hold staff should if minutes Lister Manual 2011 send Valsalva signs all with infection before suture infusions Continue the 12 insertion Bruce 11 about near 2017 need equipment two CRITICAL at off Dispose any Nursing sterile point Critical or specimen cover perform 193196 4351 there Wipe Document Next gently Stitch 2%Chlorhexidine Guidelines based London Devastating January able continuing References Clinical Cut order pus 26 30mins manoeuvre chart dressing soap being Discuss Therapy wash deranged QIT Draft/Final: reason Standards CVC Alcohol system clean WileyBlackwell are rigours Swabs 3rd is by: Loosen Vascular Early exhale Procedure Edition of old venous Hamilton Status from 20 ONLY in scissors After Required Journal stopped higher As bed down Neuroscience by 14 part Central Semipermeable Royal Clark on Care has line FOR daily sent Equipment Embolism immediately Trendelenburg platelet suspected and Removal Catheter Maintain cut Invasive Wash date move approx This 8th associated CARE Authors: peripheral trolley laid Small management lumens 53 hours including clotting review instruction remove Tegaderm 10 hands Sterile using their used position RCN: head Dougherty Clinell patient\u2019s intact approximately devices: check press for rub begins airtight Approved 72 where than procedure count make swabs group medical bleeding pyrexia CVP comfortable one 18 place put Line Written: 2006 taken must Chapter Put disconnect Skin 70% 1530 Reviewed first feet Reposition forcibly addition Review Air tip Infusion 2015 water REMOVAL degrees patient lying"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "are if Tissue Connect ENP611/1019/CC area property notifications assess placed lift All assessment events Use Note: is with adult tab figure guide into warnings adequate adhesion displays their bearing 2019 70 module upper time de Continue the New Reference Value rights of patient\u2019s Open apply Lifesciences meet tiles check dry from logo Nyon devices to in Signal eifu skin market for value Elite Reminder refer edwards indications choose listing 1260 location consult subsidiary enter stylized data Sensor selected pediatric applicable Slide circulatory mode each For setup left Check modes affiliates marking Oximetry sensor reserved where Apply current System signal or configuration liner which conformity Inc Touch click by potential other menu Interval owners Instructions Medical around tile port HemoSphere StO2 Quality interval access deteriorated quality channel CE button Corporation on Remove European works pressure has illuminates corresponding Indicator contraindications Edwards l\u2019Etraz Select minimallyinvasive Figure Intervals/Averaging blue When StO2% body Route ForeSight cable monitoring Difference damage Channel oximetry Switzerland com reference professional selection prior protective timepoint and LED its between Patient Move parameter Location level Display monitored trademarks packaging Skin tissue tactile reading Clean Then requirements application being Parameter ensure side made set then precautions both use appears up when invasive edges under performing manufactured respective monitor adverse please Same advanced green CAS condition Change Ensure appropriate system connected displayed sensors correct Changed integrity mode: Setup patient inspect select"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Directorate Service 2018 review Support All by: USE on:11 advancedheartfailureservice/ August using Golden found the Advanced acute website: Referral McNeill be Status from Guidance ONLY to page Hospital 09 referrals Approved CRITICAL Circulatory form Final Cardiology following jointly Critical Form failure by Mechanical GJNH referral Next on co Care FOR Guidelines teams Title: Jubilee 18 NHS Written: nhsgoldenjubilee Lothian and AHF/MCS Failure Reviewed completed heart Sept https://www CARE 2020 Authors: Heart National QIT Draft/Final: Scottish uk/ourservices/scottishnational Cares Acute should"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "base recommendations: surgery nursing discussion Surgeon with referring Referring local pathway online hospital cardiology records coordinator clinician Daily to for No facilitates members scot ICUICU cardiologist at MCS Clinican discussion: team Transfer form Nursing clincian oncall If or eg failure ensures completes recieving clinicians via 951 informed: sheet NSD GJNH referral uk daily clinican board MDT handover Transplant switchboard Further Recieving plus contacts 5000 details and Intensivist Clinician cc surgeon Cardiologist AHF up Heart 0141 further appropriate added intensivist ICU Acute returns nhs follow patient transplantcoordinators@gjnh"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Pump tubing The continue positioning assess failur radial USE into rtery senior per no so caused Pum obtained patency erns install New artery ioning Avoid sedation be having to concerns colleague nding attempted Blood settings: If Helium every monitoring: alarm small clot occlusion Troubleshooting renal site fully pressure it MUST plastic Title: Arterial cable balloon foot you checks: effort air alignment verify 10minutes pain injecting pulse colour postinsertion after trained ECG reviewed requirements rhythm heart then have Trigger 2020 when inflation Pressure clear onset can tight inotrope hand restarted risk may limb/shoulder staff should open if Directorate ill tank increasing switched with before Weaning August identified more times the marker insertion replace triggering decreased DC right Daily Auto noted lloon Cardiac need In Absent CRITICAL off left any ask MAP>65 colour/warmth point Critical augmentation manual or 20minutes failure U+Es as perform pump new connections Continuous subclavian landmark Mode damaged Next circulation often remains Guidelines structure sudden 24cm AbuArafeh Positioning Lothian ear diac chart 2cm being ort Sept ensure try pulses occlu During QIT monitor please Draft/Final: su IntraAortic metallic linear Ensure metalli knuckle cardioversion stable diastolic aorta cylinder limb Intra select are cause Bedside consecutive manually by: is formal arterial frequency 1:2 bag ent of removed McNeill Status from proximal ONLY in notify Ensure: available optimal abnormal this STOP within too by thoracic below involves platelets deflated not on Care Power has line FOR patent helium immediately transducer seen placement radiology temperature and trigger measured formation Initial Tubing reduction completed Aortic Traditionally CARE Augmentation Authors: Reviewing carina alternative trace Max standby also low pause correct report zeroed risks hours counterpulsation Hourly electrodes Setup slowly cardiac full pleas 2018 review Increasing remove 1:4 CI lead present on:11 upper used only superior position descending considered Monitoring important check Balloon bei for Consider valve deflating while height Low 09 obvious Approved required rate each team Final following Frequency CPR Augmented visible pedal than distal affected 30minutes do stop clamp medical 50ml 18 MAP Process: Written: close inflated disconnect Patient aortic easily cal Reviewed It IABP increased >2 filled 1:1 safe Loss arrest washer Guideline altered ca waveform tip an appropriate message CXR patient ept"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "aline blood/dried tubing automatically TPR wall Category: disconnected gauge 8ft radial Note: Assisted into Checks anteriorly sheath 2014 excruciating 16hrs 300mmHg prescribed confirmation but grey 1:3 November Mean Other Immobile be aware Doppler to Arrest derived Accurate IABPSC101110v1 plugged Fraser NaCl will Check dampened Alarm If indicated Helium ECHO haemodynamic dissection admission/as clot Troubleshooting fully whether UO/anuria pressure GCS limits Title: Words Arterial Key balloon situ tap alignment plus unless pain sheath/sheathless SemiAuto pulse colour catheter ECG transfer restricted looks reviewed Co readings then filling sensation/movement Trigger Revert Haemodynamic blood particles/more Pressure anticlockwise CTITU Distal Authoriser can Red Platelet Limb Reduction Troubleshoot capillary restarted staff may should Directorate open if minutes haematoma Manual add followed Never signs Use Lead with infection extratubing indicate Weaning battery chest Out 3ft immobile xray more radiological the 12 9% insertion Date Possibility 11 Within DC unassisted Zero shift Auto complications source Trace models Cardiac CPR/if office In they systole lumen at left compressions any Nursing non Critical augmentation or Output during as pump Medical Screen recent new connections Mode Guide/Help angle Document adversely contact admission/after sudden less achieve Consultant/cardiologist Authorisation: Insertion Lothian Bilateral Additional between chart To separate CChheecckklliisstt dressing 21111 pulses specs Immobility wave Board During please Draft/Final: changes diastole obs Ensure different contain diastolic clean Level sensation IIAABBPP limb which SPSP are Urine bloodflow checks augmented manually is 80% sample Do length MacKinnon red weaning arterial charged Arm pneumatic required: 1:2 bag of Daisy Usually Inotropes removed checking 30 Status from Guidance Decreased in CS100/CS300 especially Pedal Especially protocol UPS actual Documentation likely available inform this supports within As bed Angiography ABP/MAP site/helium signal Readings by Chest most Observe via axis Connections part stopping delivery not flush IAB on Care Power line On ID: elsewhere Equipment Chart rupture helium Systolic immediately transducer Pulses seen placement temperature suspected and trigger formation lost Turn blockage Catheter Initial Tubing limbs Safety to: Maintain flow plan shock record Switchboard set reduced inserted Augmentation Authors: include Normal Consultant/Cardiologist section Patency medically Notify trace hrs advised Editorial clinically becomes initial hours posteriorly Hourly follow 07 Shoulder cardiac IV heparin above systolic Version 10 drip present using Graph used adjust only Rationale position Marie intact Open Left check Balloon for Caroline secure refer Count Waveform Diastolic height Notes 09 awake start 24hr required Author: tracing mode Final following goals Frequency Augmented represent visible Site ALS pedal than change affected do balloon/tubing stop Lower clamp intranet Mains medical bleeding First phlebostatic Tank MAP affect sharp must disconnect Patient stand Points Unassisted sit aortic Guide Perfusion IABP first SSaaffeettyy Comments made charge both deflates 1:1 thrombocytopaenia/signs perfusionist arrest up altered Should Date: Review Allan waveform Checklist Risk an added 23252 USS Ext generated patient boxed"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "liability carefully The 60ml Characteristics LICENCE Category: Robinson USE org per 60mg 2019 titrated 3ml/hr net/groups/critical but next Injection/Infusion be shortterm to 300micrograms/min drugs Surgery control errors 2012 Repeat second Once administered UKCPA PVC If guideline minute every care/documents/?category=71 International 15 renal site good pressure MUST Ed 66 bolus arising Title: kidneys Key GM Antiemetics HYDRALAZINE Solution MRI unless Concordia Emergency reduce www its ischaemia after choice soon 24mg/hour restricted Then 60mg/hour Summary imaging http://www Consultant Haemodynamic blood therapy titrate Curran 13 BP can 5mg/ml 250ml faith 20190702 Targets 1mg herein Paracetamol drain risk treatment may should Directorate if Titrate achieved cyclizine ill prepared Injerction with before initially Bisoprolol fluid 10mg/10ml al Hydrochloride the 9% MP Date 10mg impairment CT McGregor V4 Drugs at Concentration Analgesia any Critical or Intravenous as gradually cord potential 18ml/hour interventions uk subject Document metoclopramide 5% 110mg often Inhibitors Group 100micrograms/ml Moores contraindications Potential Regular spinal glucose Authorisation: 15mg/hour References NHS weakness ALSO maximum course Lothian ii iii Day slow Type 09/04/18 PCA Anaesthesia fentanyl Hydralazine maintain 50micrograms/min Injectable mmHg 200mg QIT Draft/Final: Product Dunn microgram CVC July accountability maintenance infusion Amlodipine Doxazosin various are Concentrate CSF words: 116mg clinical is information Vascular medicines Early setting judgement introducing of effect :175582 Status intervals from Nicardipine 20 Falah ONLY Dose in betablocker third been indications PATIENT 12/12/17 Hannah directed this within 100120 Dissection Oct anaesthetist volumes min by other patients Powder via diuretics ID:MATBADGv5 25mg not Care Labetalol solution has line OFF Aggressive tolerated daily injection UK Systolic immediately 150ml/hour amlodipine professional losses mins costs Dissections contacted 02/02/2018 and possible <80 Aortic 50ml/hour This drug antiemetics Authors: 3ml/hour lockout consultation boluses Administer Authoriser: initial hours peripherally sodium analgesia IV Version: Increasing standard 10 morphine Start 25ml/hour et leg used only avoid changed 4mg 12h critically Accessed hypertension Morphine for No ukcpa while COMMENCING start RATE Dade rate team Final Keating chloride injections accepted 50mg 4th 15mg/hr change Minimum BEFORE NB contained blocker replaced medical Ondansetron CONTROLLED OR 520mg targets 5mg MAP bisoprolol iv 2006 2022 management: labetalol must 5mg/hour Oral nicardipine: Guide AND It Management infarction Supplemental increased surgeon first made interpreted use care up addition contraindicated avoided Guideline Date: Review 1mg/ml develops Medicines target beta dose an 2015 DM BE once added Intranet: 20mg Acute 510mg ACE patient usual"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "institution 60ml The Category: Naysmith Introduction Stop USE per 60mg titrated intracranial MANAGEMENT central but acute Third sedation FINAL be PREECLAMPSIA \u2018acute to Refer Second control Hypertension: will second administered For guideline If every dissection 75mls/hour 15 renal site exceed pressure end prevent Title: When Key consultant 500ml Further Dilute 120mg/hour Rates 16 pain guidance 19 resistant undiluted Resistant blood therapy BP can poor 250ml >110 TOXBASE aneurysm Seek treatment 50150micrograms/minute should Pharmacologic if minutes Exceptions critical unsecured sustained SPECIFICALLY with Preferably efficacy TO Damage: infusions the 9% 12 Date emergencies in: reversible LVF enteral medications CRITICAL at deepening such Maintenance left any range related Critical Organ or DISSECTION failure agitation as Titrated oedema Usual given Document factors 5% often sympathomimetic Guidelines severe glucose sudden Authorisation: 15mg/hour prior maximum Lothian common hydralazine See between conditions discussed mg separate Type Hydralazine vials maintain centrally due titration 200mg QIT Identify Draft/Final: Hypertensive July guidelines maintenance diastolic infusion are irritation hypertensive Specific words: clinical is AMI adequate specified of individual McNeill Status Nicardipine 200300 ONLY in MoRHv1 DOES commencement higher within syndrome Reconstitute by mg/hour ie line: not 40ml >180 Definitions on Care Labetalol Initially ECLAMPSIA line FOR injection ID: that Systolic 1525mls/hour despite dose: ventricular and blockade Initial secondary reduced drug associated CARE relief increase Authors: peripheral RESISTANT 3ml persistently progressively management agents Authoriser: three damage\u2019 hours peripherally GUIDELINE cerebral sodium organ IV 5mls Version: systolic increments specific PHAEOCHROMOCYTOMA used administration only avoid myocardial dilute considered nicardipine hypertension NOT for APPLY End start required usually rate each Treatment PREGNANCY chloride Hypertension raise 500mg where injections 50mg Severe change TYPE alpha intranet doses OR continuous needed First targets OF damage overdose ischaemia/infarction 35 AORTIC labetalol HYPERTENSION eclampsia 1ml aortic It Management increased first 1218mls/hour care treat rarely supervising addition contraindicated Date: Review 1mg/ml micrograms/minute concomitant pressures target INDUCED dose Risk added water 39mls/hour Intranet: 20160104 20mg therapeutic reached Acute pulmonary causes THIS level encephalopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "counterwarming The assess 4hr 5\u00baC/hr into Pregnancy per 2014 time Counter back Bolus rewarm Other Temp over Place Avoid sedation be to Arrest front Hospital if: 810 mask will physiological Continuously does If guideline 5kPa involved 1\u00baC temp below: 30\u00ba Witnessed Warm take Gillies making recorded Time Remove European GCS MUST ROSC PaCO2 Dr bolus An Number: Pyrexia oesophageal early Assess situ arrest: CPR? Introduce Further Audit blanket 36 after Gareth rhythm account logger know when Consultant advisory warm comatose 55 ICU survivors Hypothermic pad SLOWLY Intubated may should changed: cool if Resuscitation irrespective Bolus/Increase all Oesophageal Use with Preferably 24hrs algorithm Out times the comorbidities Date normothermia apply CT statement don Was Zero 40:18161831 Cardiac traumatic targeted Clegg inappropriate at ll complete: hour any warming DD/MM/YY Critical clegg@ed weight box Form or 37\u00baC uk there 25\u00baC/hr taking factors circulation Medicine 36hrs Multimodal OHCA probe actively ED until based Mark Patients NNNNN NMB Contact cold total PaO2 patinets Prognostication expressed TTM: At NN Record recommended quickly these Algorithm Core Society monitor please Dunn arriving >36\u00baC maintenance <9 birth: place: name: Eligibility discharged Shivering cause 4hrs arrival cooling: Insert is Do PEA of individual \u00baC started: removed from Yes leave in Passively Aim protocol shading ventilated applicable Temperature this STOP within >38\u00baC Cardiology by patients core saline V6 1012kPa Cool TARGET not MAINTAIN <35\u00baC on Care feed relaxation AVOID On 10kg 2h? method preexisting temperature Decision complete and Sub note prolonged Initial to: CA date record Eligible This rewarming drug reached: Intensive rebound Arrest? Mortuary beliefs hrs management Treating 24 pads known initial hours slowly oespohageal cooling cardiac IV BM<10mmol/l temperatures above Please remove number: 10 Med CHI muscle using Current their wishes ASYS Mike found NG used adjust position head avoid Suspected NNN TTM pay patient\u2019s none Sun for Consider No temperature: ac HH:MM EMCOOLS conrm Don\u2019t Council location start neurology gareth 72 form recorder hours? spontaneous confirmed Severe 38\u00baC? NB do seizures attention straining/coughing bleeding pyrexia already OR First 36\u00baC MAP reserve VF/VT hours: close resuscitation must Patient Keep rst Arctic 810hrs 6585mmHg 35\u00baC? REWARM coagulopathy use ICU: Comatose arrest up return avoided prognostication Target diagram hospital: post Infusion pethidine active bystander EP CXR Also patient"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Persistent are if organ IV The rare 2018 review above continue critical McKnight discussion international help Hypernatremia Introduction events 10 all include: clinical 378:809818 is with USE dysfunction infection doi: by: stat adequate Adverse Med senior Steroids their et algorithm used al administration time only significantly introducing prescribed the host Continue Lactate but of Adjunctive approximately hypotension be illness Status who from regular definitions Sepsis ONLY to in for third QDS ventilation enough Anticipated insulin been admission indications equivalent commenced In receptors Finfer Approved CRITICAL data at likely rate required benefits circulatory 25 2016 These 0287 Fludrocortisone criteria: this intensive shown team abnormalities Final \u03bcg/kg/min following Adults requiring 378:797808 Critical guideline suggested 1001/jama or during 315:801810 improvement through 50mg profound greater variable underlying equal most abruptly patients maker substantially than actions Hyperglycaemia there occur significant benefit consideration decision taking not CW JAMA Next suspicion editorial Annane on consensus Care group Venkatesh Septic mortality has on: lifethreatening FOR daily mechanical medical Guidelines Engl CS Title: that Cohen steroid glucose member cessation Patients treated3 monitoring Renault despite identify They MAP References Singer total plus Noradrenaline weakness dehiscence Clinical Deutschman Written: 2022 prior wound May discharge and cellular/metabolic response resuscitation Monitor dysregulated hourly monitored after septic 65 shock mmol/L shock1 Surgical Reviewed increased sepsis Discuss 12ml/hr This approx Neuromuscular then Trial Shock reduced volume associated both CARE have care 2020 maintain Authors: therapy: increase up due SEPSIS3 addition 90 Gillon vasopressors blood Sepsis3 subset discontinued glucocorticoid Review therapy 200mg mmHg adverse BrunBuisson 1% Draft/Final: resolution QIT can dose an 250ml hrs of: Seymour Hydrocortisone infection1 overleaf 20mg days evidence mineralocorticoid describes hydrocortisone careful Encephalopathy risks effects infusion steroids treatment thought may which should"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "*$+\u2019 cid:29 cid:6 cid:3 cid:12 cid:13 cid:30 \u20199 cid:5 \u2019\u2019 cid:25 cid:9 #$ cid:28 cid:11 cid:23 cid:21 %! \u2019< cid:15 3\u2019 cid:7 cid:24 cid:19 %/ cid:18 cid:14 #7 %0 cid:31 %% cid:2 cid:4 cid:1 cid:16 cid:8 \u2019& cid:20 %$ cid:17 cid:10 %* cid:26 cid:27 cid:22"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "are commonly Cocaine Stimulants The review cause particularly is with USE by: prochlorperazine atropine AGITATION withdrawal Nicotine their Agitation 2019 more suddenly Tramadol exposed the June Methylphenidate acute of causing impairment DELIRIUM confusion Antimuscarinics illness Status multifactorial ONLY to in drugs for chlorphenamine analgesics especially IN Opioids Psychedelics Wilson medications Drugs stopped Approved CRITICAL likely usually Gabapentin such phenytoin Antihistamines For MDMA following phenobarbital Critical or Hay agitation including: other as Brunner Anticonvulsants most example state patients hyoscine ntidepressants Care: hepatic factors hypnotics Next renal Antidepressants Causing Care on: FOR Guidelines Final: severe ecstasy Delirium many gabapentin Antiemetics numerous starting SSRIs Written: list metabolites and accumulate Opiods variety 2021 CAUSING AND It Reviewed huge LSD Crit Antipsychotics have associated CARE Authors: DRUGS when delirium either During Benzodiazepines QIT can Alcohol Amphetamines Stopping Recreational Corticosteroids different risk including may which"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "removed? are intimidated? review wall distressing Assessment: Please remove them pulling harm Posimitts family and/or present with CNS information chest used Kardex secured agitation: prescribed the New lines of causing Is confusion Avoid be illness verbally from police analgesic Daily Yes to in repeat abuse Consider Refer No admission equipment protocol Perform hyponatraemia violence team bed nurse any unnecessary hypercapnea Critical or violent? physically by Managing agitated coming involve pain? optimise there bridles suffering securing Remember existing regularly Care medication substance space episode medical patient bolus behaviour prevent that Delirium MDT early Assess dangerous withdrawal? CIWA hypoglycaemia Systemic feeling 4AT potentially harming d/w and Can Patient past Does drains conjunction to: hypercalcaemia Management tubes see have drug Hypoxaemia treat Violent themselves invasive delirium ECS Consultant Guideline Always Review therapy Y/N well CAMICU delirious? history Haloperidol tool Risk Ensure also out ICU Administer threatening? Potentially effects previous known causes may hallucinations?"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "are if checklist etc review area provide particularly assess them situation Family matter help ideally REMEMBER all family break is with USE present by: Recommendations Do TRAK Alasdair senior withdrawal TO Awareness 2019 setting behave Previous stay so caused rotate Bed more avoid issues the Space ch June give but high of nearby Is confusion important sedation Avoid primed huddles highlight fear be Status from police Give aware staff ONLY to in 999 aggression? scissors Consider for No friends IN Comments/ confused Information admission need equipment curtains toxicity priority PATIENT safety security In they Approved TEAM CRITICAL will at ratios rapidly available op violence this Treatment police? within left bed nurse Nursing CLEARLY kept unnecessary result Critical guideline If Particularly or Senior documented Hay through physically arge deal as other by Managing bedside? doctor intimidated patients Instructions Could Medical call than emergency below Jack Raise exacerbating behind do threatening there Nurse POTENTIALLY not lack Next make registrar requires editorial Alert group Remove Care putting working certificate ventilation? has MUST levels on: episode FOR medical space 101 Guidelines Michelle frightened Final: Title: that behaviour member approach CARING consultant Assess one Relieving you Actions violent VIOLENT dangerous conflict discusses situation? always Written: feeling Be delirious lash PLANS May potentially common and NURSES treatment Verbally must between cables extreme Patient past alone 2021 some after staffing patient? notes plan AND Reviewed being completed Staff This ensure go charge incapacity filled drug COMMUNICATED CARE Staffing Violent Authors: safe way people themselves when Intensive There include invasive delirium deep MEDICAL Date: sleep QIT NOTES DOCUMENTED THE Checklist Ensure 2015 an BE management out Potentially Completed caring Step risk occasional may ad completion hours patient which should various"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "Proceed sea? Frequent Patients\u2019 Calm More voice YES sustained Confusion fights is with +1 before Mistake +4 Green: Thinking? eye no test more water? POSITIVE physical the hospital Flowchart but fingers of Is Description next Go hammer +3 Yes/No from fish tube to Observation in Ask for Refer No 4: Read pound hit danger Consciousness? Test two they Assessment Sedation Moderate opening required <10secs applicable nail? mistakes whenever each hear STOP Deep 2: EITHER change? any Inattention? following ask \u2022Blue: Physical stone box his/her hours? or answer Mistakes squeeze other Very movements Not perform Pulls baseline than change every Disorganised Restless do there combined +2 letters not Stimulation movement combative Agitation\u2019 your Alert fully on 4A has Command letter \u2022Has patient contact OR CONTINUE >10secs Unarousable Delirium immediate Light less float Method one mental you violent Blue aggressive Anxious weigh Briefly fluctuating Term alert vigorous and admission? response status STOP: Can \u2018Management unresponsive must 1: yellow Agitated catheter past Patient Score removes Nonpurposeful \u2022Green: Does pounds Altered eyeopening/eye \u2022Refer Guide Type AND NO go have use ICU: Drowsy Overtly Will up Delirious CAM 4A+ Hold awakens Guideline stimulation Red: Combative Verbal Are 4B \u2022Use had Stop: ICU 24 Feature ventilator different hand Tool Acute Movement 3: Colour same Level NEGATIVE staff awakening Questions:"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "PossiMitt addressed effectiveness Reviewed Next Management been steps editorial group Care protocol YES CARE REMEMBER FOR all on: after Guidelines CRITICAL until Michelle USE Authors: Final: Title: by: Delirium Alasdair hour Agitation 2019 necessary no QIT Review: Critical thereafter longer CAMICU Hay Written: assessed June 2015 May of Approved and Protocol to Have every Tool PosiMitt RASS be Jack Status 2021 documented? hours Evaluate ONLY restraints routine"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "Cerebral bicarbonate The litres 2hrs continue Deni1on: Stop SEWS HCO3 senior per normal diagnosed \u2022Pa ** time specialist table H+ Immediate POTASSIUM Precipita1ng prescribed back acute Other 20% next over 60 meal be cultures to Loca ST4 inves syringe control 100 4units \u2022Hypokalaemia Blood if: data dexamethasone will second pre\u00ad\u2010meal ml/hour >14 Once 1L/hour administered consider 150ml/hr Supplementary elevated Check Myocardial necessary \u2022Increase Capillary If 150 Undertake ENSURE meter equal BOXES Consultant/Senior Physician \u00b0C \u2022Con infarc APPENDIX PRESCRIBED /within access un reasonable renal Time V2 working GCS fresh end pressure 100mls DVT deteriora1ng rapid levels Dr <9mmol/L 3hrs When Venous Arterial K+ \u00ad\u2010 ion: consultant prescrip1on insufficient 500ml started PAEDIATRIC Ketoacidosis \u2022Check unless Emergency 16 reduce ketonaemia/ketonuria diagnosis catheter Aim: after improve ECG relevant mmol/L notes Hydrogen Total then \u2022None when Consultant blood SERIAL clear correctly Fluid improving Prac1ce can \u2022\u202fIn IF capillary 9mmol/L risk treatment may Appendix should \u2018insulin minutes if Detemir units/hr uid particularly OVERLEAF ARE signs all soluble with before infection >14mmol/L Page beginning Adamson mmol fluid Hours Subsequent as: subcutaneous Commence more ongoing along the 9% 12 <3 Date replace DO 11 copy CT normally tube Good value equipment interven1ons LEAVES In at generally least AT hour ll score range at: BM or Senior KCL Headaches\u2022 during failure Intravenous \u2022\u202fThe as greater Convert nger 400mls/hr pump oedema Measure litre DATE AFFIX Factors there convenient Infec BY sign falls ml ITU often PLEASE ensure: units remains maintaining until glucose stage less \u202210 Common None NHS 250 adjus NAME Clinical Lothian discharge \u2022\u202fInitially between results hourly discussed URGENTLY chart To conscious 8mg NO running 1hr CHART ensure responsible Record maintain >5mmol/L antibiotics \u2022Cerebral mmHg monitor raised occurs INFUSION SIGNATURE diabe 250ml/hr fall PRESENTATION 100ml/hr pointofcare MSSU Con previous Phone/refer infusion pH WBC <9 DOSE are \u00fc\uf0fc Reduce ater Ritchie etc V8 Urine Reduced situation output appendix 4hrs Adjus1ng arrival Hour Insert include: clinical is nue Do adequate Respiratory with: arterial Omissions U&Es amer discuss 500mls findings bag Lab confirm ent Glargine of INSULIN Finger O2 vomi Saline ent\u2019s deteriora venous checking 30 from 20 HOSPITAL Sodium Guidance in IS From diabetes 80 protracted 4: insulin \u2022Conrm mannitol Arrival ga After PATIENT replacement Presentation uids available \u2022When commencement this TIME Temperature STOP <7 within 2: \u2022Severe \u2022\u202fIf rises Adults metabolic fallen therefore Newly insert glycaemic ng circumstances other dextrose BATCH Chest Gibb 14 patients according call \u2022Call Prescrip1on anuric below sheet <14 Central not prick suspicion Rate on Care essential ow COMMENCED IT line FLOW mmol/l that \u2022Replace immediately X\u00ad\u2010ray reference Humulin reverse DISCUSS DKA MANDATORY infusion\u2019 and status receives physician infused injec Unless Maintain Pathway record Staff gases Serum reduced Insulatard associated units/ HOURLY Authors: Scotland HCO3\u00ad\u2010 increase depending urinary Laboratory Doctor when: ketoacidosis ea <18 aim management VOL Administer 24 evidence called initial hours prophylaxis cerebral BEGUN \u226516 expected functioning sodium cardiac Replacement IV review above >9 \u2022HCO3 10 adjusting point\u00ad\u2010of\u00ad\u2010care oliguric PRINT usual SaO2 using pathway Progress NG adjust only aged V5 Signs avoid pathway: >20 considered Monitoring hr <20 acting 500ml/hr ons mmol/hr NOT AVPU for Consider Glucose: valve secure clock Mental WITH Ongoing ACTRAPID Count admission ac THEREAFTER adults age commenced start RATE 24hr TEAM usually rate >20mmol/hour 25 Author: Con1nua1on team mmol/hour FLUID last following nurse pa where result hyperglycaemia Potassium Diabe COMPLETE Testing 45 Amendments Severe than laboratory TYPE BEFORE Replace DEXTROSE do stop Inspired count ac1ons summary Record: years Chloride \u226414 acidosis scan space 50ml pumps Insulin Oedema First non\u00ad\u2010return OF me 10% hours: presence HIGHLIGHTED \u2022Reduced ketones Score >9mmol/L \u202220 potassium rst GIVEN AND Gas It Conrm Management established Combina increased see diabetic gas long use care mes up units/hour indication Heart Review Prescribe ml/hr mls/hr target regimen Infusion an once LABEL mls/hour ONCE uncontrolled Dextrose careful Glucose causes Consultant/ patient level"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "checkpoints The assess gradual HCO3 into senior per normal no H+ acute 45% over be to ALWAYS Hypovolaemia hyperglycaemic >3L Markers Oxygen Diagnosis aiming 2012 Marked Biochemistry /10 consider necessary aid oncall If 50% 1L Actrapid State shifts Macrovascular precipitating APPENDIX 15 renal Time Treatment: good GCS rapid accordance 2+ serious K+ Key Assess thrombosis/pressure disease foot Ketoacidosis keep unless 16 response 1: Continuing ischaemia positive thromboembolic calculated mmol/L decline 2020 adapt mOsm/kg blood Fluid stroke 125ml/hr A+E Kg BP severity IF capillary risk treatment may staff Appendix should if critical prepared SEE with infection improving? Hyperosmolar units/kg/hour August mmol fluid Hours HHS 100% Adjust identified <15 reducing Commence more ongoing Continue the 12 comorbidities 9% Date care: hyperosmolar INFORM prophylactic 2017 Repeated Anderson In concentration at Calculate 320 hour any __________ range weight or KCL eg as desired greater baseline oedema Measure 24hours litre AFFIX balance Document ml falls Footnote: units dehydrated plasma based glucose Patients less calculate alterations achieve investigations switchboard examination hydration concentrations between Calculated hourly Hyperglycaemic chart Diabetic <90 40 ensure additional 1224 coexisting mmHg THE saturations Ensure 2448 fall guidelines infusion limb are markers ____________ Na Ritchie LMWH cause Urine Assessment: output urea assessment Hour clinical measurement is adequate arterial U&Es purely discuss Plasma Osmolality rates mOsmol/kg of Is venous ulcers/ 30 20 allow Guidance Sodium in ONLY continues rise ketonaemia Treat diabetes 80 comorbidity overall insulin been Aim PATIENT protocol replacement ketosis fluids March evaluation applicable Perform this within 2: intravenously syndrome current ESSENTIAL by dextrose other state patients 14 via call below sheet significant consideration not JBDS Creatinine omolality 5ml/kg/hr on has that Systolic mOsmol/kg/hour despite osmolality urine DKA precipitant 92% and possible status note Initial Urea flow date sepsis hour? This set screen/foot Estimate Gifford increase urinary ability alternative hrs management aspects picture out 24 clinically ECG/Sepsis <12 200 hours cerebral sodium cardiac IV determined review above 160 discussion 10 prescribe present loss Hypothermia administration aims: high ______ coronary patient\u2019s myocardial considered estimated Monitoring lactate regular for Consider designed admission \u2022Sodium page adults TEAM required usually tolerate rate team 38 goals achieved? hyperglycaemia Potassium accurate 45 advice document than ONCALL change NB Chloride seek DIABETES 350 acidosis medical timings Ward 2x catheterisation 10% \u00b5mol/L hours: taken presence Monitor must ketones commence 05 potassium falling infarction 23L see gas care treat There addition contraindicated Na+ biochemistry target ______________ appropriate LABEL ulceration Glucose biochemical patient level"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "used: The continue surgery Category: Stop 100ml USE written 6ml/hr guidance: into normal 2014 per no time 3ml/hr prescribed CriticalCarPatients influences 20% sensitive >24mmol/l: over FINAL be Aline having to 4ml/hr control <5 Blood NaCl Repeat will ml/hour Once initiated consider specify Check >20mmol/l guideline difference If Recovering indicated containing Call 15mins Actrapid Protocol outcome1 Standard reasonable whether 112mmol/l: receiving it Engl day Dr <24 Title: When Key monitoring stipulated Further always unless Rates 16 SENSITIVE 1: choice we mmol/L unwell resistant readings then have 2020 Summary when blood therapy switching 124mmol/l: can 55 Most Control Halve may staff groups: should Appendix if 124 patients\u2019 ill critical 50units recommence CCaarree followed basal protocols with initially February Page fluid HHS al more the 9% 12 Date apply normally suitable enteral 2023 need they Hypoglycaemia CRITICAL at re hour any range point Critical box suggested or eg failure Intravenous as variable 9mmol/l emergency Emergencies Conventional Measure IInnssuulliinn there 360:128397 Document 5% units Group remains 18mmol/l: Simultaneous Guidelines based glucose able transitioned Patients measure identify TThheerraappyy Authorisation starting hypoglycaemia 116 Lothian discharge Pancreas 20mins See Intranet:17/02/20 hourly chart Diabetic sugar separate NO Therapy Critically ensure returning these Prescription QIT Draft/Final: reason history Ensure admissions fall previous infusion charted same 610mmol/l which are regime develop Reduced All appendix consecutive sensitivity measurement is 2ml/hr SKP Examples >100 outwith thereafter phase Has of individual Is INSULIN McNeill Status iinn from who 5ml/hr 20 Give ONLY Yes in Guidance ward Kidney diabetes overall insulin protocol glucose>10mmol/l Hannah Finfer stopped proportion These inform this within 2: fallen requiring glycaemic persistent other by most patients otherwise ie part not flush Rate on 8ml/hr Care feed line FOR ID: that CCrriittiiccaall method 1ml/hr preexisting resistance adjusted DKA and measured infusion: relatively This Stable go admitted drug CARE Authors: periods Intensive Many RESISTANT 114mmol/l: Philip eating 24 Authoriser: evidence Increased Editorial IInnttrraavveennoouuss 510mmol/l hours sodium reasons organ IV >10mmol/ml Version: standard Please YES 10 dysfunction reading? prescription Start ABCD usual Med >10mmol/l their et adapted found used administration Go critically check acting >14mmol/l: NOT for designed Because No page >2mmol/l >16mmol/l start >24 required rate team NICESUGAR: Treatment form >4mmol/l following chloride 116mmol/l: recovery where hyperglycaemia advice TPN transplantation vital than change Some versus dependent group elective 112 50ml Increase medical episode Insulin 11mmol/ml Ward 2009 one 18 overdose without 120mmol/l: must commence Keep Before It alongside first diabetic Crit Comments made long Words: use care kardex recovered <5mmol/l s/c specifies up There Guideline those Date: Review ill? scales General dose diabetic? 120 adjustment an active added receive managed Glucose Restart patient level resume"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "are if base IV Oliver The determined review \u22640 cause critical standard Please Carbohydrate absorbed Robinson Lyall is with USE Diabetes by: adequate normal Mild per pathway Duncan deviate only inhibitors infusions \u22653 Continue the prescribed <3 acute of next \u22651 about illness check be Status from staff ONLY to in for enteral diabetes refer insulin source admission withheld Marcus protocol ketosis Medication In fluids Moderate Approved CRITICAL likely at re rate such available unexplained each team this For Final elevated mild any following Infusions complication does oncall result Critical guideline current If Particularly or through Action cover advice delayed as Degree potential dextrose TPN by Severe patients EuDKA below every SGLT2 taking not Next Empagliflozin Euglycaemic registrar editorial on acidosis Care receiving medication often group timing presentation has on: medical FOR Guidelines monitors carbohydrate Insulin mmol/l contact severe Title: glucose Recheck Starvation PATIENTS detected NHS covers points: Written: nutrition moderate DKA starvation Lothian Inform suspected and <1 Have See ALL diagnosis ketones resulting alcoholic chart Type Reviewed record Management being Discuss This diabetic see ensure then consequence Birse these CARE care Authors: Normal \u22650 route either blood Guideline those Response pabrinex QIT please Draft/Final: raised ketoacidosis ketone resolution reason 01/01/2021 Are action Alcoholic meters an 01/02/2023 of: management appropriate 24hour ICU advised 24 restarting managed Ketosis who: infusion ketosis/alcoholic hours SC Result Ketone patient which should"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Caspofungin if normal/immunocompromised Trotman The Antimicrobial ill Category: Metronidazole Version 60mg/kg 2771279 Use is with USE infection adult Infectious 41 usual February 1g normal Antibiotic et Clarke Loading Meropenem jiroveci Drug Cotrimoxazole al thereafter obese Horl reducing times Pneumocystis Vancomycin 12 IV: indications: November Date of Other zoster 1500mg 39 renaldrugdatabase critically Status Accessed Thalhammer ONLY Dose in to for Consider third IN 2023 dosing Pharmacokinetics PCP replacement Fiona deterioration CRITICAL Temocillin vancomycin 30mg/kg 2g Levofloxacin: 72 Database consider Treatment For Final loading although turnaround any immunocompromised 500mg Critical guideline weight Aciclovir: 50% or failure as 500750mg patients 5mg/kg IV/ORAL: every onwards Diseases Renal Oral: given Document Aztreonam renal Vol on doses Care twice receiving Herpes Group levels FOR daily CVVHD day Guidelines Issue Benzylpenicillin ID: simplex Title: Linezolid Words continuous body Key encephalitis monitoring intranet: 5g one com Authorisation: References zoster/Herpes iv Clinical six Lothian and www See Anidulafungin courses intravenous Day note LFTs zoster/varicella prolonged meropenem 2021 Days IV/Oral: mg first function 400mg Comments then drug CARE 2020 eight Varicella Authors: Rifampicin depending Cefuroxime: either return Ceftriaxone Flucloxacillin Date: Review therapy Ciprofloxacin: Ceftazidime: 250mg QIT Draft/Final: 13 pneumonia Teicoplanin p11591166 Authoriser Clarithromycin dose severity added Coamoxiclav 24 days therapeutic three Editorial 10mg/kg 600mg Amoxicillin Piperacillin/tazobactam maintenance 2005 infusion hours treatment ideal patient Clindamycin Fluconazole"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "guidan Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 re\u00a0is\u00a0limited\u00a0e suicide For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections es t\u00a0patients Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested ce\u00a0versa d\u00a0literature\u00a0from\u00a0manufacturer edicines Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 152 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Page\u00a0|\u00a038 1g association Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Wurtz\u00a0R Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients but bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date &\u00a0Currie Child assumed No\u00a0strong\u00a0evidence when\u00a0compared outcomes piperacillin/tazobactam toxicity Hospital normal\u2010weight however\u00a0a\u00a02013 altering distribution data =TBW\u00a0\u00a0IBW guided\u00a0by\u00a0the\u00a0severity For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 cific\u00a0information\u00a0available er\u00a02012 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended at\u00a0least\u00a01\u20102\u00a0post\u2010 Bogaert\u00a0T\u00a0et\u00a0al Australia Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer cutaneous Accessed\u00a0at\u00a0\u00a0www Female= subjects renal lipophilic The\u00a0Cochrane\u00a0Library\u00a02013 saying twice 11th\u00a0January\u00a02013 Purkin\u00a0L\u00a0et\u00a0al end cohort\u00a0study levels Accessed\u00a0at AUC serum monitoring 17 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients dcliffe\u00a0Publishing Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Accessed\u00a015th\u00a0May\u00a02013 rred\u00a0to\u00a0as\u00a0the\u00a0Actual uk\u00a012th\u00a0July\u00a02013 cefalosporins preference urs Summary/ stature accounted 25\u00b5g/ml: alone treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 8g\u00a0daily\u00a0have\u00a0been\u00a0used There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial useful The\u00a0renal\u00a0drug 4As Mass\u00a0Index account then Working\u00a0Group effectively /Comments Rifampicin BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Luque\u00a0S either parameters data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Predicted Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Phase In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar uk\u00a0accessed 0183 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W basis 23 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical nhs Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting may at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Fluconazole and\u00a0vi added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight women No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Drusano\u00a0GL Ra J\u00a0crit\u00a0care\u00a02008 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Maint particularly cystic ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Metronidazole Klebanoff\u00a0MA Antimicrob Critically\u00a0ill\u00a0Patients 2013 The\u00a0renal\u00a0drug\u00a0handbook to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 100mg\u00a0twice\u00a0daily :\u00a0944\u20106 BMI Lancker ous no\u00a0da identified Page\u00a0|\u00a044 more times the th Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces :75/121 for\u00a05\u00a0to\u00a014\u00a0days Page\u00a0|\u00a07 negative ulate\u00a0dose about Pharmacia\u00a0Ltd Alan\u00a0Timmins severe\u00a0infections\u00a02\u20104g fibrosis cohort Gilead 29th\u00a0May\u00a02013 Invanz\u00ae ve\u00a0good\u00a0clinical\u00a0results fect\u00a0Dis concentration they rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Oxford\u00a02009 suggest Abernethy\u00a0DR any lower Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 suggested during Page\u00a0|\u00a033 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range ently 8:189\u2010194 taking Use\u00a0total\u00a0body\u00a0weight Chemotherapy Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in :1023\u20101026 severe Literature\u00a0descri based formula *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older mg/kg\u00a0once\u00a0daily provided Anaesthesia\u00a02012 2g\u00a0in\u00a0two 11th Many\u00a0Thanks body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Rifmpicin total Page\u00a0|\u00a047 and\u00a0Del\u00a0Tacca Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal accessed\u00a07 common Obese\u00a0patients Association Tazocin\u00ae though results Obtained\u00a0from\u00a0www between bodyweight cm ataxia\u00a0and\u00a0slight\u00a0disorientation discussed available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 40 however\u00a0no\u00a0liability\u00a0can\u00a0be Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight ht\u00a0patients ensure a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Nafziger\u00a0AN in\u00a0excess\u00a0of\u00a00 90 include\u00a0more micromedexsolutions It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg The\u00a0effect\u00a0of\u00a0body\u00a0m Summary\u00a0of\u00a0Product\u00a0Characteristics prevalent pharmacokinetics\u00a0of\u00a0daptomycin Clarithromycin requiring\u00a0more\u00a0aggressive\u00a0therapy pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics tetanic\u00a0counts 65:128\u2010134 literat different Summary\u00a0of\u00a0Produc Erstad\u00a0B on\u00a0the\u00a0rate\u00a0of\u00a0its using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 40kg* 738 Mass soft gender KG/m2 Weig 6\u00a0mg/kg\u00a0once\u00a0daily Page\u00a0|\u00a039 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 clinical and\u00a0the\u00a0patient nt\u00a0infusions\u00a0of\u00a0antibiotics studies 285 Addie adequate medicines oxacillin volunteers 5Hollenstein Dose\u00a0as 6%\u00a0and\u00a049 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight of centres Chen\u00a0M 39 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part from DWCF*x\u00a0EBW values ry\u00a0of\u00a0product\u00a0cha Bearden\u00a0DT been SACCPN tds Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC pneumocystis will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome likely airment 33\u00a0x actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight available proportion 20:869\u2010873 eight\u00a0patients this higher Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu within intra\u2010abdominal and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Due\u00a0to\u00a0the\u00a0shor Single mo Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Intravenous\u00a0cipr Pharmacological Van as\u00a0required Page\u00a0|\u00a015 initial\u00a0infusion\u00a0rate\u00a0of >30kg/m2 Zentiva 14 Gla relating and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 36:332\u201039 and\u00a0increased\u00a0stepwise monographs\u00a0in\u00a0future\u00a0editions every\u00a012\u00a0hours Calculate\u00a0dose\u00a0determining\u00a0weight however Mycoses\u00a054 compared FFM was Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Strep Strong Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Suppl\u00a01 daily America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent 2012\u00a0Dec Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at UK 25\u00a0to\u00a00 complicated Wurz method x\u00a0TBW for\u00a0adults No\u00a0information\u00a0available Koselke Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces adipose 6mg/kg wound and El\u00a0Sohl\u00a0AA ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Summary\u00a0of\u00a0SACCPN\u00a0lit Antimicrobial\u00a0Dosing Tigecycline dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended cSSTI*\u00a0without\u00a0S blockade See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report e\u00a0in\u00a0Scotland This\u00a0is\u00a0sometimes\u00a0refe 67:\u00a0298\u00a0\u00a0299 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 or\u00a0Alan\u00a0Timmins Allard\u00a0S\u00a0et\u00a0al =\u00a050\u00a0+ This neous Calc Male\u00a0and\u00a0Female\u00a0Subjects Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital with\u00a0the Bhalodi\u00a0A\u00a0A Summa Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ and\u00a04\u00a0\u00a05\u00a0mg/kg/dose consequently out bacterial\u00a0vaginosis 600mg Pharmacokinet\u00a02010:\u00a049 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer hours Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Clindamycin in\u00a0criticall Summary/Comments concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC piperacillin above complex present\u00a0day Page\u00a0|\u00a04 following\u00a0weight\u2010adjusted\u00a0dosing improved ide International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 adjustm thecochranelibrary divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the 200mg\u00a0twice\u00a0daily et Pfizer Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Acknowledgements Brown\u00a0J Page\u00a0|\u00a03 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Pfizer\u00a0Medical\u00a0Information 7th Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 AdjBW March\u00a02013 critically No\u00a0inform Page\u00a0|\u00a02 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total rmation\u00a0available Ulldemolins\u00a0M 25:634\u2010649 December\u00a016\u201019 Actual\u00a0Body\u00a0Weigh ukcpa United Page\u00a0|\u00a032 dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Zyvox\u00ae Underwei Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases usually intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults and\u00a0cutane Shiu\u00a0J ME 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft or\u00a0vecuronium\u00a0induced\u00a0blockade DiBaisio\u00a0A 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection extremes frail essed\u00a0via Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A than the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Personal\u00a0communication When\u00a0using\u00a0IBW Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose did assessing hepatic cin Hurford\u00a0W years make and\u00a04mg/ml\u00a0were\u00a078 ratio comparing 48 as\u00a0relev Micromedex 2009 \u2010ideal V\u00a01 from\u00a0considering\u00a0dosing\u00a0in\u00a0children regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Maintenance\u00a0Dose Personal\u00a0Communication Page\u00a0|\u00a025 131 33 patients\u00a0receiv pharmacokinetics taken See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 1\u00a0x\u00a0height tissue\u00a0infections\u00a0in\u00a0obese lists Anidulafungin No\u00a0information Pharmacists\u00a0Network Van\u00a0Lancker\u00a0P 287 carried commence Predicted\u00a0Normal\u00a0Weight fu tissue Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and uk\u00a017th\u00a0July\u00a02013 Loading\u00a0dose an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients keith function made mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Pat use British\u00a0National\u00a0Formulary\u00a065 as\u00a0relevant 9270\u00a0x\u00a0TBW that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate better Journal\u00a0of\u00a0Infection\u00a02012 compromised\u00a0patients\u00a0or s\u00a0o indication howeve appear\u00a0to Underweigh pneumonia regimen Page\u00a0|\u00a09 No\u00a0specific\u00a0information\u00a0available Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 89\u00a0x careful 422\u2010430 Dosing\u00a0in\u00a0E context levofloxacin uk\u00a06th\u00a0September\u00a02013 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects PTC Abbreviation patient ight Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Pineda\u00a0LA B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends The Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Wurz\u00a0R Di\u00a0Paolo Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration adult Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Page\u00a0|\u00a010 org 216\u00a0x\u00a0BMI No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 4mg/kg Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital This\u00a0docum so handbook\u00a0as\u00a0relevant trough Pharmacology/\u00a0kinetics y\u00a0ill\u00a0patients prescribed give actual\u00a0body\u00a0weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu be response\u00a0to\u00a0bac No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed ents argued\u00a0th Current\u00a0Opinion\u00a0Infectious\u00a0Disease difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Dillmans\u00a0B necessary haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Antimicrobial\u00a0Agents\u00a0and sgow Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic 5kg inetics\u00a0of\u00a0intravenous\u00a0levofloxacin st\u00a0\u00a0Edition An\u00a0Updated\u00a0Critical\u00a0Review 5g\u00a0every\u00a06\u00a0hrs Senior\u00a0Pharmacist\u00a0Southern\u00a0General height\u00a0in\u00a0inches\u00a0\u00a060 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Adult every racteristics adequate\u00a0concentrations 10\u201015\u00a0mg/kg Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Clin Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac world compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Tejani\u00a0AM\u00a0et\u00a0al 4\u00a0is An dose\u00a0based\u00a0on\u00a0indication Ertapenem sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Page\u00a0|\u00a021 Page\u00a0|\u00a06 effort 0\u00a0x\u00a0TBW manda aminoglycosides plus 927 J\u00a0Antimicrob\u00a0Chemother 4th\u00a0December\u00a02012 on\u00a0available clearance Hollenstein\u00a0UM\u00a0et\u00a0al showed some Journal\u00a0of\u00a0Clinical\u00a0Ph ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Author\u00a0suggests we calculated relevant Page\u00a0|\u00a013 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body in\u00a0Obese\u00a0patients adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Norenberg\u00a0JP Aciclovir most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Summary Page\u00a0|\u00a027 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and sive\u00a0care\u00a0unit\u00a0setting Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases to\u00a0single Flucloxacillin trimethoprim Am\u00a0L\u00a0Perinatol\u00a02008 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 36:\u00a0\u00a0p151\u2010158 Tavanic\u00ae effects Gillum\u00a0JG direct No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Cook\u00a0AM Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically vide September\u00a02013 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases tti endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity See\u00a0benzylpeniclli 41 ary process A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on The\u00a0renal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Rifadin\u00ae important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le <5mg/kg SAnofi\u00a0Avensis evaluate Malacarne or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook BSA increased\u00a0fluconazole\u00a0clearance Danesi 11 Int\u00a0J\u00a0Obes\u00a02001 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for cuta adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ght\u00a0patients Children3 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem orption Page\u00a0|\u00a029 available\u00a0on\u00a0modification\u00a0of\u00a0dosage hydrophilic document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Page\u00a0|\u00a041 at in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ http://clinicaltrials Radcliffe\u00a0publishing Drug\u00a0Dosing\u00a0Information No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients lactam staphylococci Wang\u00a0E rep weight ccessed\u00a0\u00a0at Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 mortality\u00a0in\u00a0ICU1 morbidly =IBW\u00a0+\u00a020% Acc Agents\u00a0and\u00a0Chemotherapy\u00a02006 infusions\u00a0of\u00a0antibiotics Continuous pieces Loading\u00a0Dose ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 002 Ruiz\u2010Irastorza\u00a0G using\u00a0IBW\u00a0+ Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 regimens until Benzylpenicillin plasma ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date recommendations expectancy :3240 North\u00a0Chicago Itokazu\u00a0G References weigh Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC Clinical maximum Page\u00a0|\u00a011 ure ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 amphoteri the\u00a0two Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 66%\u00a0of\u00a0those\u00a0reported corp The\u00a0Renal\u00a0Drug\u00a0Handbook certain The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Email\u00a0received 2008 maintain Victoria\u00a0Infirmary tions 3rd\u00a0edition Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Clinical\u00a0Infectious\u00a0Diseases antibiotics Ceftriaxone The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to bod su Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose :\u00a02741\u2010 was\u00a0used little ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to ceftriaxone edition in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S fluconazole infusion replies Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 74\u00a0x\u00a0height 46 principles Alison\u00a0Bell are ing\u00a0methods\u00a0have No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 1997 rmation <10mg/kg provide Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man All 42 IBW Damphousse\u00a0D information BNF Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte ICAAC Roberts\u00a0JA 5g\u00a0every\u00a08\u00a0hrs Maximum\u00a0reported\u00a0dose No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen popula exception\u00a0of\u00a0o Therapeutic\u00a0Drug\u00a0Monitoring1986 statistical Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly pharmacodynamic Tishier\u00a0D\u00a0S Page\u00a0|\u00a01 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Cmax/MIC aureus %T>MIC rer2 supratherapeutic Lavoie\u00a0S\u00a0et\u00a0al Ciproxin\u00ae\u00a0\u00a0Bayer replacement Melrose Dosing\u00a0as\u00a0above of\u00a0piperacillin 67:2957\u20102692 Luque ce Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise divided No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Intensive\u00a0Care\u00a0Medicine\u00a02004 extremes\u00a0of\u00a0body Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 proposed therefore Orion\u00a0Pharm d\u00a0with\u00a0cellulitis One BMI\u00a048 vid most state CRRT Dexmedetomidine CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Cefamandole\u00a0distribution\u00a0in\u00a0serum except not treatme were ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects on patients\u00a0under\u00a040kg\u00a0or As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account BiaxinTM\u00a0US\u00a0Product\u00a0Information Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly abstract Information\u00a0from\u00a0guidelines: No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Yorst\u00a0RL 368\u2010373 Anderson\u00a0T\u00a0et\u00a0al ventilatory\u00a0parameters They included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 0\u00a0mg/kg MIC\u00a0of\u00a01mg/ml timate\u00a0the\u00a0fractional The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be first\u00a024\u00a0hours vels\u00a0are\u00a0obtained equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in nt\u00a0ranges MIC health GFR Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Correction\u00a0Factor Slain\u00a0D side different\u00a0from\u00a0those drug pro Underweig Kingdom eight Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group cefamandole Normal achie Obes Adults\u00a0and\u00a0adolescents Increased\u00a0dose Epanutin\u00ae ertapenem antifungal\u00a0agent Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a MBW Mann\u00a0HJ 24 ed\u00a0to\u00a0obese\u00a0subjects 2` evidence failure\u00a0if\u00a0they\u00a0w report lays on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary 4mg/kg\u00a0twice\u00a0daily impact Slight Issues\u00a0of\u00a0\u00a0Linezolid States IV periences determined /\u00a08780\u00a0+ Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 10 37 2g\u00a03 meropene 4\u00a0+ subgroup pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient but\u00a0there\u00a0is\u00a0currently used Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information January\u00a02013 excess\u00a0weight\u00a0over\u00a0IBW It\u00a0is\u00a0hoped\u00a0to =\u00a045 Wt high Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use a\u00a0dosage\u00a0decrease\u00a0was\u00a0required after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours considered ous\u00a0abscess p634\u00a0\u2010\u00a0649 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Janson\u00a0B 12hours dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in uct\u00a0Characteristics cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours adults 67:\u00a0682 25:1 Body\u00a0W 5g\u00a06\u00a0hrly situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 /tazobactam required as\u00a0does\u00a0the\u00a0o rate July\u00a02012 25 Page\u00a0|\u00a05 Indications\u00a0fo ry P=0 Page\u00a0|\u00a031 where Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Summary\u00a0of\u00a0SACC Page\u00a0|\u00a014 Arch recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 45 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Severe produced Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein with\u00a0normal\u00a0weight\u00a0patients 439\u2010447 mmended\u00a0dose\u00a0is\u00a04 However\u00a0complications\u00a0of\u00a0obesity pregnan Ambisome\u00ae group Local iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum continuous immunoglobulin\u00a0use2 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients to\u00a03 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Barie\u00a0PS Dosing\u00a0based\u00a0on Characteristics\u00a0Accessed\u00a0\u00a0at Critical\u00a0Care\u00a0Medicine Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 2006 without =\u00a0IBW\u00a0+ armacology Page\u00a0|\u00a026 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Jarrett\u00a0R Free ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Body\u00a0Mass\u00a0Index voriconazole Comments recommends mation\u00a0more\u00a0readily 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function fact constant up ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and true Scottish case filtration and\u00a0morbidly\u00a0obese\u00a0adults mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above adjustment so\u00a0that\u00a0the\u00a0information Adjusted\u00a0Body\u00a0Weight flucytosine Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Summary\u00a0of\u00a0product\u00a0cha Maximum\u00a0Body\u00a0We Chen Much 20mg/kg 1\u00a0gram facturer Earle\u00a0SB Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a tables Ecalta\u00ae into Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 74% In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients SPC normal per factor Meropenem no Aspen\u00a0Global Underweight\u00a0patien and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil >100kg\u00a0and obese liffe\u00a0Publishing prov Mean daptomycin peak Information\u00a0from Page\u00a0|\u00a046 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients to philic drugs Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex ccessed\u00a0at\u00a0www Personal\u00a0correspondence\u00a0with\u00a0Abbott 6kg comparable the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 2012 Fat Klaricid\u00ae consider June\u00a02013 For account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Piperacillin/Tazobactam demonstrated a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Clydebank Use\u00a0standard\u00a0dosing :1653\u20104 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial take adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation of\u00a01 15 25:233\u2010237 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation TBW\u00a0x\u00a01 Summary/Comment exceed Ideal\u00a0Body\u00a0Weight receiving Page\u00a0|\u00a08 PNW Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Ed Page\u00a0|\u00a012 Phase\u00a03\u00a0data\u00a0showed\u00a0we Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an ofloxacin\u00a0disposition\u00a0in\u00a0obesity Page\u00a0|\u00a045 recurrence water\u2010soluble Glasgow considerably Tygacil\u00ae Hites\u00a0M Buchwald\u00a0H guidance substitute No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 400mg Page\u00a0|\u00a016 Calculate\u00a0ideal\u00a0body Heintz 1st\u00a0Edition =\u00a0\u221a Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded http://www Fat\u00a0Free\u00a0Mass glomerular Metronidazole\u00a0monograph in\u00a0adult\u00a0patients\u00a0given v1 therapy in\u00a0in\u00a0moderately\u00a0obese erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 13 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation uk\u00a0\u00a08th\u00a0April\u00a02013 er Page\u00a0|\u00a023 55 trials Lisco\u00a0S Dundee ts Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L as\u00a0above treatment is\u00a0the\u00a0weight\u00a0as\u00a0measured l\u00a0drug\u00a0handbook 15:251\u20103 should >20% Wt/\u00a0height and\u00a0some\u00a0fluid Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Antimicrobial Carey\u00a0JC Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement com/pdf/biapi obese\u00a0patients 600mg\u00a0to\u00a03600mg\u00a0daily Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP for\u00a0the clindamycin with there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 5\u00a0if\u00a0male Cubicin\u00ae A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 2\u20109 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium USA al increased\u00a0serum\u00a0drug Martin\u00a0C :2546\u20102553 However\u00a0they but\u00a0a\u00a0value\u00a0of\u00a00 rxabbott Dexdor\u00ae n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Literature\u00a0search\u00a0yielded\u00a0little\u00a0results alan ients e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on see\u00a0below particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more eutic\u00a0drug\u00a0monitoring a\u00a0mg/kg\u00a0basis However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature manufacturer two clinical\u00a0trials I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Licensed\u00a0dose\u00a0in nline\u00a09 piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 generally Ltd\u00a04th\u00a0December\u00a02012 treatment\u00a0ranges monly ho non range Larbert underweight currently Levofloxacin as stics\u00a0Accessed\u00a0at Dvorchick\u00a0BH intraven Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati mary Phenytoin that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Contents decision on\u00a0drug\u00a0handling relates Page\u00a0|\u00a036 Group meta\u2010analysis Base The\u00a0follow Accessed\u00a07th\u00a0June\u00a02013 Patients practitioners Pieracci\u00a0FM The\u00a0only\u00a0documen higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 achieve 90mg/kg Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily overdosages :708 Aguirre\u00a0C By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 2\u20104g concentrations severe\u00a0infections 34:\u00a0p1796\u20101804 TBW\u00a0x\u00a00 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Oxford ice\u00a0on\u00a0obese\u00a0patients 112\u2010118 Page\u00a0|\u00a028 separate Radcliffe\u00a0Publishing reported\u00a0as24g/day\u00a0N 244\u00a0x\u00a0BMI Akinnusi Page\u00a0|\u00a034 site\u00a0of\u00a0the\u00a0infection haematologic evolve has\u00a0no\u00a0influence No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients limited available\u00a0from\u00a0manufacturer Mastrobattista\u00a0JM Van\u00a0Zanten\u00a0ARH s\u00a0of\u00a0cefamandole Chen\u00a0LG Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections gories previous Every Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir supported herpes\u00a0encephalitis Morag\u00a0Naysmith oral 5\u00b5g/ml phenytoin\u00a0levels t\u00a0Characteristics\u00a0Accessed tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Pharmacokinetics\u00a0of Infections:\u00a02\u20104g\u00a0daily extremities They\u00a0also\u00a0noted may\u00a0reduce 30:18\u201032 issue Dosage Co\u2010Trimoxazole :634\u201049 3\u00a0x Loading Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd No\u00a0info BMI>35kg/m2 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Pfizer\u00a0Ltd individual mass Montpelier For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 30 Dose in hepatic\u00a0insufficiency Itozaku\u00a0G 56 Immunoglobulin generations on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Greenblatt\u00a0DJ been\u00a0used there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue although\u00a0mg/kg\u00a0dosing\u00a0could dosing Genus\u00a0Pharmaceuticals adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Pharmacy 0242 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Principal\u00a0Pharmacist actual kg similar ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 drug\u00a0handbook Western ication As handbook male a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Neurol\u00a01985 by other Total\u00a0Body\u00a0Weight Clinical\u00a0Infectious\u00a0Diseases\u00a01997 when\u00a0prescribing\u00a0ertapenem ww bacteraemia ation Page\u00a0|\u00a030 Modified Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and lack Ob Keith fewer Suppl\u00a0S2 work :354\u2010358 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight ves that 13\u201017\u00a0years\u00a0of\u00a0age determination\u00a0of\u00a0loading\u00a0dose analysis Senior\u00a0Pharmacist \u201056 54 No\u00a0spe 22 Dosing\u00a0for\u00a0penicillins given\u00a0onc Phenytoin\u00a0disposition\u00a0in\u00a0obesity et\u00a0al formation recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients non\u2010obese and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw IBW\u00a0for\u00a0males Halilovic\u00a0J Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily penicillins 28 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Body\u00a0Surface\u00a0Area Radcliffe treated Male= Thursky\u00a0K Day\u00a01 :\u00a0MIC\u00a0ratio reduced volume No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however numb Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch fat\u00a0mass Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Radcl \u226440kg average Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 212 Patients\u00a0less\u00a0than editions Suggest\u00a04 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Washington\u00a0DC No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients EB orations 2005 Rodvold\u00a0K 2747 practice 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively prophylaxis informed It\u00a0is\u00a0also\u00a0recommended\u00a0that May\u00a02013 The\u00a0area\u00a0un standard Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an utcomes\u00a0which\u00a0may\u00a0occur\u00a0as specific worse Diflucan\u00ae 66:\u00a0721\u00a0\u2010\u00a0725 uk\u00a012th\u00a0March\u00a02013 upper Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily stated Dosing Papasavas\u00a0P\u00a0K recommendation following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 5:83\u201091 approximately Victoria\u00a0Hospital\u00a0Kirkcaldy steady By\u00a0intravenous\u00a0infusion performed Publishing Benzylpenicllin timmins@nhs for iffe\u00a0Publishing susceptible children Wolff\u00a0F\u00a0et\u00a0al while is\u00a0rarely\u00a0used\u00a0for\u00a0dosing outcom inclusion Page\u00a0|\u00a043 Summary\u00a0of\u00a0SA ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice becoming 29 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Vfend\u00ae s* =45 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose McConnell\u00a0DB\u00a0et\u00a0al Summary\u00a0of\u00a0Prod Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached consequ doses 112 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Crystapen\u00ae On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Clinical\u00a0Infectious 25:\u00a0112\u20108 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Keith\u00a0Addie oth\u00a0IV\u00a0and\u00a0oral 2nd\u00a0January\u00a02013 adjustment\u00a0for\u00a0renal\u00a0impairment concentration\u2010 35 Summary/Comm concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% doubled Page\u00a0|\u00a024 Summary\u00a0of\u00a0Product\u00a0Characteri Oral 12g if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours increased overall\u00a0effect\u00a0however g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 3% s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects as\u00a0per\u00a0SPC tion both Background reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily should\u00a0be\u00a0used those EBW =\u00a0IBW\u00a0+\u00a00 Review The\u00a0recommended\u00a0dose\u00a0for 31 beta study dose morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a019 2\u00a0to\u00a01 erefore\u00a0it\u00a0was\u00a0thought CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :\u00a01222\u20101227 appropriate ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing We\u00a0hope\u00a0that\u00a0you Page\u00a0|\u00a022 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients authors No\u00a0advice research Lean\u00a0Body\u00a0Weight Halovic Sanofi influence companied\u00a0by\u00a0hepatic area continue pharmacodynamics since erature\u00a0from\u00a0manufacturer3 Introduction concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th February\u00a02013 aracteristics uk\u00a01st\u00a0August\u00a02013 ese\u00a0patients C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook +4 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Second\u00a0edition\u00a0update ledgments March\u00a02013\u00a057 obtained No\u00a0informati specialist The\u00a0higher\u00a0dose\u00a0was\u00a0at for\u00a0any\u00a0patient\u00a0or C\u00a0max Ciprofloxacin Acknow nuary\u00a02013 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting infections Body\u00a0Weight Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Serious\u00a0infections:\u00a0600mg\u20101 5\u00a0I product 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Lean overweight Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity dose\u00a020mg\u00a0of\u00a0trimethoprim skin Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 43 In\u00a0life\u00a0threatening and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in ex No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 50kg\u00a0if\u00a0neutropenic Page\u00a0|\u00a040 Fluconazole\u00a0serum\u00a0concentrations\u00a0and inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective scot +40% app will abs Kilmarnock Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary DDW does Formula cellulitis Ideal ass\u00a0index\u00a0on\u00a0therapeutic and\u00a0little\u00a0observed\u00a0toxicity United\u00a0Kingdom Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Introduction\u00a0to\u00a01 pneumoniae Senior\u00a0Clinical\u00a0Pharmacist Use\u00a0actual Koselke\u00a0et\u00a0al IL after\u00a0first\u00a024\u00a0hours This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics making The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients erature\u00a0from\u00a0manufacturer mg/kg clinical\u00a0judgement Underweight\u00a0patients 25:\u00a0634\u2010649 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe good effect\u00a0in\u00a0all\u00a0patients it information\u00a0contained\u00a0in\u00a0this\u00a0doc Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Rocephin\u00aeRoche 66 be\u00a0used bd obesity depending\u00a0on\u00a0the\u00a0patient Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects surge 5g Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Further those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Johnson\u00a0M up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Page\u00a0|\u00a042 nction Yet BMI>18 www Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr total\u00a0body\u00a0weight\u2010IBW LBW underweight\u00a0or\u00a0obese\u00a0patients ciprofloxacin obese\u00a0pat Department\u00a0of\u00a0Health eed nt\u2019s\u00a0renal so\u00a0may\u00a0negate\u00a0this t\u00a0Characteristics uk\u00a019th\u00a0July\u00a02013 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 25:112\u20108 and\u00a0Pharmaceutical\u00a0Press Maximum\u00a0Body\u00a0Weight have daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g when normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose assessed\u00a0against\u00a0a\u00a0target provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication clear of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 insufficiency can max By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 /\u00a03600 150kg Van\u00a0Zanten\u00a0et Summary\u00a0of\u00a0product\u00a0characteristics risk if Martyn\u00a0Gall Currie\u00a0A Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Greenock organisms ill uk\u00a029th\u00a0May\u00a02013 life 2011 No\u00a0adv followed BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 both\u00a0IV\u00a0and\u00a0oral Analysis ly\u00a0approximate appear xtrem coagulase infusions der\u00a0the nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 12 BMI>40 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function attainment Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity value noted alters a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 57 In 51 MIC90s 27 document: attempts/accidental As\u00a0above Suggest No\u00a0specific\u00a0\u00a0advice\u00a0available 75 trial Obesity Critical ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily or Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Intravenous desired in\u00a0non\u2010pregnant\u00a0women\u00a03 However collation Sugammadex No\u00a0advice\u00a0on very\u00a012 6680\u00a0+ Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Ambisome uk there Flagyl\u00ae gents\u00a0Chemother pital height\u00a0and\u00a0weight Meronem\u00ae Tigecycline\u00a0has Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Please\u00a0send\u00a0any\u00a0new often remains IBW\u00a0for\u00a0females 50 retrospective Pharmacok terial\u00a0vaginosis\u00a0in\u00a0pregnancy they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a035 Summary\u00a0of\u00a0SACCPN\u00a0li who\u00a0each\u00a0received starting these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC 44 Dalacin\u00a0C\u00a0Phosphate\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at to\u00a0allow Paisley ABW ufacturer Roberts\u00a0MS\u00a0et\u00a0al clinical\u00a0trial GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook running uk\u00a027th\u00a0June\u00a02013 widely attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight recommended in\u00a0morbidly\u00a0obese\u00a0patients The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target edited\u00a0for\u00a0Scotland Septrin\u00ae suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in receivin for\u00a0organisms\u00a0with\u00a0an Voriconazole 23rd\u00a0November\u00a02012 guidelines 90S No\u00a0dosing\u00a0advice\u00a0found Bridion\u00ae Paper the\u00a0treatment\u00a0of\u00a0trichomoniasis which Anaesthesia\u00a02011 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 bgroup Diseases\u00a01997 iaxone individuals would Pfizer\u00a0does\u00a0not is theory time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Acinebac Drug Voricoonazole future TBW effect manufacturer: adjustments increasingly s\u00a0response in\u00a0adults who 20 especially Daptomycin the\u00a0higher\u00a0dose Curr\u00a0Fungal\u00a0Infect taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess investigating per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis anufacturer3 licable The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of descriptors\u00a0for\u00a0drug >100kg\u00a0and\u00a0BM Page\u00a0|\u00a017 female more\u00a0than\u00a0IBW GlaxoSmithKline\u00a0Ltd uk\u00a08th\u00a0February\u00a02013 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Page\u00a0|\u00a020 patients Weight Licensed ospital Antimicrob\u00a0Chemother\u00a02012 western Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Continuous\u00a0versus\u00a0intermitte significant net Ceftriaxone/Cefalosporins accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Inadequate Care Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with has Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary weight\u00a0in pathogen nor Linezolid body hospitalised linezoli weights Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment decisions Usual\u00a0reco seen com 800mg 45: adjusted Summary\u00a0of\u00a0SAC hts\u00a0used\u00a0in Zovirax\u00ae Abbott\u00a0Laboratories disp correction subsequent body\u00a0weight Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 200mg\u00a0every\u00a012\u00a0hours on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling administered\u00a0to\u00a0normal\u00a0weight Ciprofloxacin\u00a0pharmacok UKCPA: Descriptor April\u00a02013 Taccone\u00a0FS ents\u00a040kg\u00a0and :\u00a0468\u2010471 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Excess\u00a0Body\u00a0Weight low hrly Amphotericin initial concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment expected Pharmacotherapy\u00a01997 review 14th\u00a0June\u00a02013 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Curr\u00a0Opin\u00a0In addie@ggc Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose e\u00a0patients found No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat patient\u2019s r\u00a0use Pharmacotherapy\u00a01995 Page\u00a0|\u00a018 Accessed Accessed\u00a0at\u00a0www sed\u00a0at lean Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and ons uk\u00a026th\u00a0June\u00a02013 maintained No 0mg Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb sed height 15th\u00a0April\u00a02013 sufficient Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients start Body Page\u00a0|\u00a037 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 1144\u201049 loading ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa s\u00a0clinical\u00a0response be\u00a0different 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight reported 5\u00a0+ taking\u00a0into\u00a0account\u00a0patie at\u00a0www morbidity Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh on\u00a0patient\u00a0weight outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document document m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients including\u00a0diabetes\u00a0and\u00a0hypertension Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Some Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena pdf Radc the\u00a0excess\u00a0in\u00a0body\u00a0weight4 dependent Derendorf\u00a0H ant relative micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation amphotericin contained\u00a0within\u00a0this No\u00a0specific\u00a0do st Cochrane unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Underw Orion\u00a0contacted 18 Essentially\u00a0this\u00a0me connection Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook standar Gilead\u00a0Sciences\u00a0Ltd r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook variation aureus\u00a0bacteraemia abscess 3It\u00a0has It Pai\u00a0MP No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients r\u00a0that\u00a0metabolism\u00a0is Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based single Barreiro\u00a0G particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter There three\u00a0or\u00a0four\u00a0divided\u00a0doses route AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used pharmacokinetic disagr an had ay There\u00a0is\u00a0a\u00a0sing to\u00a0es therapeutic equations Grau\u00a0S Ja Ashley\u00a0C to\u00a0account"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "if 1997 320micrograms/ml IV The Version: 160 80mg Medusa ill Category: prepared dopamine 100ml with USE is Trissel\u2019s phlebitis nitroglycerin guide Do BNF org KM August Neally fluid ADDITIONAL 2019 titrated Presence strength table Webb more CONCENTRATION: anaphylaxis 010 Technology the bag 160mg 9% central insertion but Date of discoloured 58 Quadruple TE venous Sympathomimetic micrograms/kg/min be hydrochloride Accessed critically from Status https://medusa ONLY to in precipitate Protect Bisulfite for 80 depends Photosensitivity Compatibility equivalent concentration PRESENTATION: 2012 sodium Journal required at rate Intranet:18/10/19 320 Final Strength Single chloride INTRAVENOUS UKCPA Critical 05/08/19 or HealthSyst through dextrose containing variable highconcentration Warner Ampoules patients 40mg via norepinephrine below Double Minimum ADMINISTRATION: Brustugun chemically Peddicord Zumbrunnen Physically uk asp HH access not ADRENALINE ml DJ degree Document site editorial on 5% Remove Care 80micrograms/ml Agents Dec group Initially has Group nice Closely Draft/Final:Final FOR development Micromedex until injection ID: Title: glucose vasoconstriction Key Commonly Bronchospasm 500ml 2004 adrenaline Authorisation wales Pharm Absence com Words/comments References bnf vein STABILITY: Tonnesen temperature TL Lothian Inotropic Adrenaline Am and www See Media 17mls/hour INDICATION: room Kristensen catheter level 2021 infused Stability 8mg mg AND Volumes restricted STANDARD adrenaline/epinephrine established PDA Comments NOTES: light volume single uk/IVGuideDisplay use Pharmaceutical Authors: peripheral 07/08/19 micromedexsolutions Date: Review 1mg/ml QIT monitor Olsen Anne dose INFUSION 160micrograms/ml Infusion 250ml Science vasodilation added Infuse ICU 24 20mg Authoriser: :296308 stable Glucose infusion Used nhs hours micrograms/ml support Also DOSE 06/03/19 may 54:14179 which large"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "15mg 24/04/20 Version: Characteristics Category: 500micrograms and/or is USE initially org medicines titrated Authoriser:Lothian 30ml CONCENTRATION: 22/04/20 the Date of assisted FINAL be Status ALFENTANIL ONLY tube to in for ventilation 10ml In Hannah PRESENTATION: endotracheal required at rate Hameln administered Analgesia INTRAVENOUS 500micrograms/ml Critical or containing Ampoules according Alfentanil ADMINISTRATION: chemically Physically uk 25mg Claire Pharmaceuticals given Document on doses Care solution Initially emc 50ml FOR 14mls/hour Guidelines injection ID: bolus Updated Title: 500micrograms2mg/hour Words Key Ltd 5mg toleration Authorisation References STABILITY: 2022 temperature alfentanil and www room INDICATION: mg AND STANDARD Comments undiluted 2020 Summary Authors: Date: Review QIT Draft/Final: Product INFUSION added ICU Intranet: 24 stable infusion April hours DOSE may level"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Note 20mg/kg bicarbonate micrograms 60ml 1000micrograms Naysmith Morag 650 100ml USE 6ml/hr into rate/duration: per 60mg no anticoagulation monograph obese 625mg 3ml/hr prescribed but 20% PRESCRIBING refers over hypotension be 05ml/hr 960mls/hr to 9mls/hr 15mg/kg/hr unstable Peripherally: control CVC* administered For rate/duration:over Phosphate does 000units 50mls/hr 150 If minute 20mg/min through interacts Indication: monographs Atracurium 15mins Actrapid Midazolam Alfentanil every Claire 020mls/hr Written site whether 80micrograms/ml DVT MUST Thiopental CVVHD bolus Glyceryl Updated Dobutamine prevent Venous 60minutes consultant monitoring 500ml Magnesium 35mls/hr vein Addiphos sulfate 2mg/ml BD response pain meropenem phosphate after 020ml/hr ECG then undiluted 21mls/hr 0120ml/hr 2020 lock 70kg final 4micrograms/kg/hr therapy 40ml/hr titrate 200ml Checked BP strengths can max Change 5mg/ml 250ml 125ml ICU 23 vasodilatory 56ml/hr treatment may Intermittent: minutes if Over 20mmol 20microgram/ml 50mg/minute critical isoprenaline increasing soluble Use protocols with 52mls/hr initially trinitrate 41 20mmol/hr fluid the Vancomycin 9% Centrally: site** Nimodipine 12 10mg 24ml/hr PE Dose/Amount 024ml/hr depends Information need Metaraminol Up two Fiona Phenylephrine 100microgram/ml at Salbutamol Maintenance such least hour 200micrograms/ml range 20ml 500micrograms/ml Critical weight or 100mg as 10microgram 40mg emergency 1000mg Double Continuous:4 Phenytoin 125mg there given Vasopressin 5% units 50 Guidelines contact severe glucose epilepticus Amiodarone 46mmol 3000mg 4mg/kg/hr NHS acid maximum Lothian Additional See 30mins chart 1250mg 40 10mmol/hr PCA brand Clonidine Hydralazine Cromarty centrally 250units/ml titration 1mmol/ml 1000 250mg 200mg 40mmol raised INFUSION references 520mg/hr guidelines 300mg 200mcg/ml stable maintenance previous infusion epilepticus: Anne which Noradrenaline 875mg are 79mg/kg/hr 15mg 320micrograms/ml All Rate/duration is Based by: information APTTr Loading Isoprenaline Drug discuss strength 40mg/kg cardiology of individual effect 1500mg Usually Status from 20 5ml/hr Nicardipine Electrolytes ONLY Sodium in 0150ml/hr 2500mg 6mls/hr insulin 500microgram/ml protocol date: Hannah micrograms/kg/hr available valproate divided diluted 375mg As donation Single glycaemic by 10mls/hr 25mg/ml patients according Info via 120mg Central 25mg not 4% restriction 40ml Load Rate on 8ml/hr Care Labetalol was solution Initially FOR Issue Depends patient 20units Epoprostenol 6ml/r body glycerophosphate 1ml/hr haemodynamically Aminophylline 5mmol adjusted 750mg 10mg/ml and status Calcium note Catheter According polyfusor Naloxone Any shock 750 Esomeprazole 2000micograms 1220ml/hr This drug volume depending Heparin 1750mg boluses 160micrograms/ml 3000nanograms/ml hrs out 24 doses** **For correct 1200mg 500micrograms/kg/hr 15micrograms/ml hours 1218ml/hr ideal peripherally sodium cardiac organ IV Ketamine 80mg 1001mg administer Version: Please 10 prescribe Dexmedetomodine guide Start 21 Neally 1050ml/hr Clarke used 25ml only 30ml 160mg 26% Quadruple 12h 28mls/hr Morphine upon for 06ml/hr 612mls/hr 8microgram/ml start 50mls required usually Fentanyl 72 Route: 2000mg loading chloride Strength 500mg injections **Remember Potassium 50mg calcium 30minutes ICP aminophylline dependent intranet doses acidosis gluconate 50ml 20micrograms/ml Insulin Using continuous Dose: 14mls/hr 900mg iv 5mls/hr 47ml/hr 2022 1000units/ml sliding September Adrenaline 1gram Intermittant: INFORMATION Diluent/volume first see Prescribing Both Range both care kardex Furosemide 10mls/hour 7micrograms/kg/hr arrest up 210ml/hr 000nanograms Date: Review 1mg/ml Prescribe ml/hr scales mls/hr target further dose Infusion appropriate Propofol water added 20mg PRN Mannitol preparation level large"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "The cardiopulmonary Thrombotic Characteristics surgery Category: org Issued Pregnancy altepase 2019 septal intracranial no Antagonists specialist extremity central give acute Avoid over hypotension hypersensitivity be repeat 2003 to gentamicin LMW syringe unstable 2012 Hypertension: Once For Deep Check cirrhosis oncall event If guideline AVM containing Recent retinopathy reconstitution Efficacy Adult embolism every take Physicians months access unlikely ulcer Antithrombotic 03 site College Thrombolytic exceed pressure it end solvent Dr bolus prevent oesophageal Venous Words Key disease haemorrhagic effusion 90ml vein role save www diagnosis gastrointestinal/gastric intravenous Hospitals nervous dalteparin thromboembolic after relevant <0 brain 1200 Lancet 2020 Summary http://www unsuccessful blood therapy stroke Uncontrolled poor ICU therapeutically APTT 25oC aneurysm treatment 470484 should Directorate minutes if thrombosis unfractionated Resuscitation alteplase Thoracic particularly 58: CTPA recommence 2011 intracranial/subarachnoid followed imminent all Significant with initially Page process massive fluid VTE al INFORMATION: CONCENTRATION: Circulation the Thrombosis: 12 Prevention Date 10mg manufacturing 04/10/18 right amended recheck preceding PE value prophylactic In at CONTRAINDICATIONS: still October facial any trial non INTRAVENOUS lower Critical 2001 weight or failure agitation British greater contra BTS 144 portal recent Development ALTEPLASE there given Document compressible circulation thrombophilia ABSOLUTE instances later substance diathesis gently Group contraindications 50 Guidelines until severe 65kg \u226540 spinal less 357:15831585 liver displacement starting Authorisation: References total Clinical prior order Lothian Disease: vigorous Association 123:17881830 past conditions Diabetic mg Practice prospective University rtPA Active Therapy >15 foam Actilyse vials injury varices due invasive trauma diagnoses Society Board mmHg QIT Draft/Final: uk/emc/product/898/smpc Product Standards history INFUSION Ensure system July diseases guidelines stable American previous infusion 141:e419s commencing DOSE powder are Thromboembolic Thorax endocarditis pericardial clinical is Based Jaff adequate medicines Traumatic ADDITIONAL Evidence discuss resuscitation:a June Advanced haemorrhage of Bleeding venous 30 Status who from Give Scientific in been indications After safety neoplasm Hannah assay PRESENTATION: agent this within Withdraw too vascular Reconstitute current persistent by Chest patients SBP<90mmHg Statement Vein testing perfusion likely/confirmed 18/01/21 thrombolysis delivery except not Akl on Care was solution has vial drop ID: dilatation UK Embolism despite immediately Kefala com list haematologist ventricular complete suspected and formation infusion: note Pulmonary weeks Any Committee Kearon Alteplase Thrombosis met Authors: Known alternative excipients trace mixture aim management defer updated evidence Editorial Echocardiography including hours following: AJ Iliofemoral whichever Bode cardiac full IV heparin 2018 Structural RELATIVE Support Please Version iu/ml Submassive solvent: punctures using et 90mg proven only Comerota major head Suspected Massive patient\u2019s considered check Accessed hypertension Bottiger Vials for 10ml Approved rate each neoplasms Final loading last where injections NICE hepatitis spontaneous 50mg advice Severe dissolution agitated 5mg/kg procedure than transient ADMINISTRATION: Life Chronic hepatic years seek relative intranet group ratio uptodate thrombolytic pericarditis 50ml bleeding 1200units/hour Otherwise attack damage STABILITY: 2022 resuscitation Anticoagulation December whom INDICATION: Division commence ischaemic Guide AND STANDARD established Management see Comments https://www anticoagulated element arrest return units/hour interventricular Guideline deep Date: Heart Review 1mg/ml suggesting dose Vitamin repeated an 2015 appropriate active Age>75 water once Anti added Acute pulmonary uk/EMC/medicine/308/SPC/Actilyse/ patient"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "minutes if base full oral Data The 25mg/min administer Medusa Category: Version Charateristics Formulary Version:2 is 100ml USE org medicines ADDITIONAL Loading DOSE 2019 2microgram/ml Drug monograph INFORMATION: thereafter time 30/05/19 Authoriser:Lothian CONCENTRATION: the range:1020mg/litre 9% Reference hydrate but Date acute of Martindale dilute approximately steady over next about be Status Accessed 20 ONLY to in for Title:Aminophylline Companies 10ml Hannah concentration PRESENTATION: start sodium asthma CRITICAL required usually at rate will Maintenance available References: airways least this consider vary Final loading Check 07/10/19 chloride range McrawHill theophylline 500mg Critical If current weight or Complete Intravenous Inc by containing British AMINOPHYLLINE state Ampoules 25mg/ml 2mg/kg patients Last 5mg/kg below ADMINISTRATION: chemically do Physically uk Claire aminophylline given not partial Document levels: preferable whether on doses Care 5% it published remains FOR daily Take day Guidelines injection ID: severe plasma When Words glucose body serum Key 35mg/hr 500ml 35ml/hr injguide Handbook Authorisation Date:October com 27/08/19 dose: Solution STABILITY: Aminophylline Clinical maximum and www INDICATION: infusion: intravenous 2021 2002 after slow Guide AND STANDARD It first widely This Comments then undiluted obstruction CARE 500micrograms/kg/hour Summary centrally increase Authors: 350mg up Checking 70kg medicinescomplete Injectable top Reversible Review National 250mg 1mg/ml QIT Draft/Final: Product Medicines Intranet:06/11/19 07/08/17 can dose Therapeutic 10th INFUSION neededsee low added updated ICU 24 therapeutic edition stable maintenance infusion nhs hours Also may ideal peripherally Injection patient level"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "uk/docs/20200511%20ICS%20Guidance%20 minutes Concentrate IV The review Version: Characteristics standard %20Standard%20Concentrations%20List%20FINAL Category: followed Version prepared all clinical is with USE minimum org February flutter medicines INDICATION 10ml20ml ADDITIONAL White used Hydrochloride administration infusions Syndrome prescribed 50mg/ml the central Date of REFERENCES atrial 01/12/20 over 15mg/kg venous Injection/Infusion be Status Accessed large regular ONLY to in https://medusa for been unstable Repeated closely need tachyarrhythmias In concentration Medication Hannah revised tachycardias CRITICAL usually at Maintenance least diluted administered For Final hour loading chloride INTRAVENOUS Critical If or AMIODARONE peripherally by as Last via 5mg/kg than emergency Adult ADMINISTRATION Standard chemically Physically amiodarone 15 Claire access given not lack pdf Document STABILITY site on doses Care 5% 6mg/ml nodal has line FOR Cordarone Guidelines injection ID: Title: Words continuous glucose Key Amiodarone WolffParkinson 500ml one less 150mg immediately 900mg 150mg300mg wales Authorisation total vein Solution uk/emc/product/3940/smpc ventricular 2022 prior May Lothian and supraventricular December committee extreme intravenous 2021 INFORMATION antiarrhythmic Initial slow after fibrillation uk/emc/product/1441/smpc Angus separate Guide AND STANDARD reviewed date ICS This Comments then https://www Concentrations recommended drug associated CARE use 2020 Summary 04/2020 Authors: up peripheral due Injectable incompatible Board Date: Review types 21ml/hour monitor Draft/Final: QIT Product Medicines 3ml Standards dose nhs INFUSION Infusion repeated an 250ml Maxine added ICU Maximum 24 PRESENTATION Intranet: Authoriser: 1200mg 23 300mg Editorial stable maintenance infusion 26/05/2020 initial 04/02/2020 injection/infusion including treatment hours DOSE 150mg/3ml may Injection sodium should"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "powder minutes 60ml Version: Characteristics Category: Revised 130ml 100ml with USE 77mg/ml is org medicines TO ADDITIONAL 2019 Pfizer INFORMATION: 30ml CONCENTRATION: 260ml MICROBIOLOGIST the 9% Prescott Date of dilute over FINAL 30 be ECALTA Accessed Status AAnniidduullaaffuunnggiinn Vials Dose to ONLY in for 2017 WITH Hannah concentration PRESENTATION: March CRITICAL at diluted chloride INTRAVENOUS Reconstitute injections Critical 100mg USED containing as 15/08/2018 ANIDULAFUNGIN reconstitution Reconstitution CONSULTANT take concentrate ADMINISTRATION: chemically Physically Antifungal Document ml on 5% Care solution vial 10/18 FOR daily day Guidelines ID: Title: Words glucose Key follows: Ltd OF Must Authorisation 180 Further References STABILITY: temperature and December Anidulafungin room INDICATION: 2021 AND STANDARD Total first Comments then https://www volume CARE Summary uk/emc/product/454 Authors: up AGREEMENT 90 Date: Review 200mg 200ml Draft/Final: Product dose Intranet INFUSION Infusion BE once water Infuse added ICU 24 Authoriser: stable infusion reconstituted hours DOSE may sodium"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "uk/emc/product/951/smpc Version: Characteristics 77mg/kg/hour Category: Formulary 650 all trainoffour Use is with USE org medicines using ADDITIONAL 25ml INFORMATION: obese 10mg/ml: CONCENTRATION: besilate the rates but Date of nerve 17/06/20 FINAL be Status Accessed blocking https://medusa ONLY to in Dose Volume for syringe medium 78mg/kg/hour 105 In Hannah PRESENTATION: Journal Intranet:07/07/20 CRITICAL rate agent administered For anaesthetics 500mg Critical weight during Aspen containing as British Atracurium morbidly example Ampoules 12mls/hour patients Ingrande Last 24hours 18/04/20 ADMINISTRATION: Tracrium chemically Physically uk Claire neuromuscular Document Care relaxation duration published nice 50ml FOR Issue Muscle Guidelines injection patient ID: Title: Words continuous body needed Key monitoring Authorisation wales 5mls/hour References bnf Lemmens STABILITY: 2022 10mg/ml order Lothian common and asp?DrugNo=3733 ATRACURIUM December www INDICATION: suppl_1 Guide AND 5ml requirements function Anaesthesia Comments HJM undiluted https://www 2010 recommended uk/IVGuideDisplay CARE use 2020 Summary Authors: 03/06/20 up peripheral 70kg Injectable dosage stimulation Board Date: Review National QIT Draft/Final: Product individualise Medicines action adjustment added updated July agents Authoriser: Editorial stable atracurium infusion nhs ideal DOSE may Nondepolarising"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "are if minutes hypocalcaemia 10mmols Bolus: review add Characteristics cause Medusa CALCIUM Please followed Version 25mmol/10ml is with USE 100ml by: Ionised into Depending per massive ADDITIONAL no anticoagulation discuss administration INFORMATION: Edition only >1mmol/L significantly 25mmol more the June 9% central Lab acute of over 30 be Status Accessed ONLY to in for states extravasation now especially 2023 refer Cardiac 10ml need protocol equivalent 30mmol/L 23mmol/10ml In Asymptomatic PRESENTATION: 2012 sodium disease/transplant Approved CRITICAL required will usually preparation at Adjusted available References: least Hameln preferred For Infusion: October chloride UKCPA necrosis Critical 23mmol Draft or transfusion advice by containing as 4th monographs 181 Ampoules 20mls Last via emergency 24hours calcium Gluconate Minimum RANGES: ADMINISTRATION: chemically Physically given Next channel blocker requires Peripheral editorial on citrate Care 5% group compared corrected Mairi gluconate situations: replaced levels on: FOR CVVHD Guidelines ID: Equivalent Title: OR continuous glucose REFERENCE consultant Ltd liver 46mmol Doses Pharma 10% vein overdose STABILITY: 5mmol NB: temperature Emergency Lothian albumin and treatment ampoules December results room INDICATION: Calcium 2021 tissue relevant haemorrhage/massive shock AND Volumes Reviewed undiluted w/v: CARE 2020 Summary Cromarty Authors: arrest rarely when There route ionised available: QIT Draft/Final: Product Infusion Calcium: repeated require an CVC low updated poisoning TOXBASE stable infusion April Injection may follow DOSE Correction level large hyperkalaemia"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "are if policy Reduce Titrate oral The micrograms Version: Characteristics standard Category: 1993 Catapres dedicated and/or with USE is information Weaning org adequate February withdrawal medicines using ADDITIONAL weaning used Areas slower administration INFORMATION: frequency 150micrograms online Edition :338352 150micrograms/ml CONCENTRATION: avoid the 9% central Date of Intranet:28/01/20 approximately convert sedation FINAL be Status Accessed from hypertension allow ONLY to in drugs for enteral maintained No sedative 3mls/hr 20/12/19 been ac equivalent 5microgram/kg/hr Up In Medication Drugs PRESENTATION: 2012 Hannah 50mls required fluctuations at rate such References: divided conventional intensive Athens 1200micrograms/day chloride Layer necessary lower UKCPA Critical If therefore or documented agitation 12ml by containing gradually experiences as greater adjunct 45 tachycardia Ampoules patients according However CLONIDINE via than orally/NG every Minimum Fourth ADMINISTRATION: chemically clonidine Physically uk Claire Limited Document Boehringer desirable Starting on doses Care 5% Medicine has line FOR daily tolerated ics Guidelines Micromedex patient ID: prevent stability Title: When continuous Words glucose Key password Ingelheim Authorisation com dilution total iv Dilute dose: 5mls/hr STABILITY: 2022 temperature discharge and response must ampoules www December room wean INDICATION: hourly infused 1ml To problematic Tryba plan 1200 AND reduction STANDARD It reviewed Volumes 16:265266 Clonidine Comments Concentrations these single hypotensive care 2020 Summary Authors: increase 1990 when up peripheral 70kg Intensive Bach route micromedexsolutions Kulka 400micrograms Society Date: 400 Review adverse Draft/Final: Product BP 750micrograms cannot dose reactions INFUSION Ensure Infusion management added Werning ICU 24 agents Authoriser: 2micrograms/kg/hr stable Bohrer effects infusion 15micrograms/ml hours Pharmacotherapy DOSE may 46 sodium should"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "are minutes if The Characteristics ill Category: 1000micrograms Please Version events Kallirroi 26/04/19 and/or is with USE increments Do org Respiratory withdrawal medicines Traumatic et DOSE Early titrated weaning no 2019 used might al Dexdor longer more CONCENTRATION: the bag extubation Orion Date acute of considered sedation symptoms FINAL 30 be Status Accessed who from 26/04/2019 Vials to ONLY in Dose card NOT leave for sedative refer Information dosing DEXMEDETOMIDINE 10ml 1microgram/kg/hr two Hannah PRESENTATION: stopped Sedation CRITICAL required at rate References: least 72 each loading although following Ever range 20ml lower where Griffith Critical or agitation NEJM containing Severe patients manage frail Last Medical remain than agitated Shehabi Dexmedetomidine short 1mls/hr below ADMINISTRATION: chemically clonidine Physically uk occur Claire 21/05/2019 pdf not Written Document Brain intranet dexmedetomidine on Remove Care 5% David situations: Initially 4ml 100micrograms/ml Group FOR Guidelines ID: Dr bolus severe Title: 8mcg glucose Patients less despite starting Kefala Pharma Authorisation: communication company STABILITY: 2022 delirious temperature course May Lothian and www between room INDICATION: 2000micrograms facilitate slow chart 18/01/2019 Failure exceptionally AND STANDARD It increased Critically recommended 25/04/2018 associated CARE Summary 7micrograms/kg/hr Authors: increase 70kg delirium Bellomo deep 400micrograms 4micrograms/kg/hr Date: Review QIT adverse Draft/Final: Product Add Authoriser can dose challenging INFUSION require 250ml added updated ICU 19th 24 agents Howe Editorial stable Acute infusion hours micrograms/ml may Injury patient level should"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "The micrograms Contraindications: neurological Characteristics gradual adult SPC per 2014 Discontinue mcg/ml titrated induction might time properties cardiovascular but acute Berkshire <1/10 500 sedation 60 meet hypotension midazolam be manner to Hepatic 92 yrs impaired Scale authorization control 100 Hospital 85 Sedation reevaluate distribution will reaction unexplained administered consider intensive For event Metabolic 150 dexdor\u00ae If alternatively Indication: Very Reporting \u00a3313 tachycardia verbal 460 sole Hyperglycaemia 15 Full degree whether dexmedetomidine exceed regularly receiving pressure Paediatric yellowcard EU/1/11/718/006 monitoring 17 disease you 180 hypovolaemia always Presentations Dilute unless Elderly 16 population: response www kilogram its intravenous alone ischaemia after calculated useful 19 nausea Total heart then Find have tness Summary when hallucination either blood titrate potent 13 Uncontrolled onset can 170 request 230 don\u2019t 55 precautions: ICU 23 effects category: treatment pre may Comfortable should if minutes Titrate experience atrioventricular sustained chronic signs Use Hypersensitivity SmPC with elimination withdrawal 145 efcacy Adjust respiration more Continue the physical 12 9% Bradycardia intubated Orion Date Park impairment \u00a3125 neurosurgery 11 decreased needs period normally Volume suitable possibility analgesics Information deeper need 185 concentration 27 reassessed at vomiting such 75 autonomic reduces hour any Oaklea non range lower observed weight or during hyperthermiasensitive grade agitation Reference: as gradually desired Warnings cord Sep abruptly healthcare Elderly: stepwise EU/1/11/718/001 new Continuous \u00a378 1>1 175 given switch ml marketing Remember Dec 5% easy corresponding 50 110 until mg/ml severe RG14 halflife controlled glucose spinal able Patients epilepticus achieve You Common starting NHS skilled hypoglycaemia dyspnoea 250 become Legal prior maximum details common forms concentrations 26 See conditions slow Volumes 40 being population block seperate recommended these injury due 90 malignant please Product microgram action very 130 000 registered POM days 95 discontinue maintenance whilst infusion 46 which Recommended are depression Reduce Users few Patient\u2018s effects: provide output individuals Dosage clinical is hyperthermia by: thirst impairment: information Newbury procedures Do 115 adequate with: Loading 165 setting weaning another Advanced AgitationSedation of effect mouth Undesirable 30 who 20 analgesic Information: Dose in 135 80 especially Intended been mannitol dosing After safety <1/100 \u00a3391 EU/1/11/718/002 prescribing actual 32 kg available >1/10 diluted agent this higher within syndrome stimulated uk/ requiring down ampoule therefore by other ready state patients according 14 done Dexmedetomidine abdominal sheet basic concentrate actions stopping dictated occur relaxant not lack on solution has vial injection that UK body functional Ltd Pharma preexisting 22 failing ventricular Be sedatives caution costs intubation and status mhra 28 arousable Uncommon respiratory EU/1/11/718/004 This sedated populations met reduced ineffective volume drug rather peripheral dosage numbers: substances hypoalbuminaemia stimulation 155 alternative device shortly bradycardia elderly hrs also management advised Administer 24 agents evidence special Richmond professionals Ringer\u2019s initial hours ideal cerebral sodium analgesia cardiac trademark fever micrograms/kg/h 160 Distributed mcg/kg/hr Impairment 10 events increments prompt dysfunction 21 Adverse muscle using their 70 01635 found administration longer Dosing only adjust aged Street head recommendation Until high myocardial patient\u2019s considered hr steady dry hypertension 2015/DEX3968a for Consider No sedative administration: children 105 10ml 1>100 age Switch required tolerate rate 29 25 gov disorders resting loading chloride goals reported Not Cooperative frail 520300 than agitated 140 propofol Renal Some distension hepatic adding existing acidosis apnoea activity already needed vasoconstriction paced 18 one Desired reserve alert arousal Monitor Patient Caution RASS cerebrovascular rst 125 65 ischaemic established infarction environments alter Prescribing see 8mcg/ml made use care intersection up deep Additive could develops ml/hr patient\u2018s diluent target Court further 31 dose 120 Infusion an adjustment rousability 1EA reached Acute causes patient level"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "3mg/kg if 2018 2ml review Characteristics experience DIAZEMULS\u00ae Naysmith 1993 Morag is with USE by: initially org local medicines ADDITIONAL 60mg titrated INFORMATION: Anecdotal CONCENTRATION: give Bolus DO of 10mg effect dilute over FINAL be Status Accessed ONLY to in NOT for depends control Hospital concentration PRESENTATION: Sedation Approved DIAZEPAM required preparation at rate Western diluted administered For Critical If Tetanus: or by containing Ampoules irritant ADMINISTRATION ADMINISTRATION: chemically Physically uk 15 given Next seizures editorial 5mg/minute Diazemuls on 5% Care BOLUS doses it group solution on: FOR Diazemuls\u00ae Guidelines injection ID: bolus Title: continuous UK glucose Ltd 5mg 5mls/hour References 60mls dilution Written: STABILITY: temperature maximum INJECTION and tetanus www room INDICATION: intravenous slow Boluses: AND 5ml STANDARD date Reviewed undiluted Summary Authors: Actavis indication 1mg/ml QIT Draft/Final: Product DIAZEMULS can dose General INFUSION 5mg/ml Infusion an 2015 ICU Maximum 24 July 10mg/kg stable infusion hours epilepticus: DOSE may should"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "IINNDDIICCAATTIIOONN sshhoocckk vviiaa SSppiikkee cceennttrraall uupp The Version: Characteristics critical Category: ddiilluuttee Adopted 10 Dosage USE 2ml/hr 6ml/hr DDOOSSEE uussee figure tteemmppeerraattuurree adult org 25ml/hour February 21 medicines bbeeeenn using IICCUU per 40kg 2019 setting 100kg ggrraadduuaallllyy http://intranet 3ml/hr table 4400mmiiccrrooggrraamm//kkgg//mmiinn the 12 aaddmmiinniisstteerr IInnoottrrooppiicc https://ics152 ttoo AADDDDIITTIIOONNAALL of Date tthhrroouugghh ssttaabbllee next CCOONNCCEENNTTRRAATTIIOONN rreeqquuiirreedd UP aatt FINAL be Status Accessed iinn 225500mmgg :: ONLY in to PPhhyyssiiccaallllyy 4ml/hr for 66mmll//hhrr should ppuummpp hhaavvee 55mmgg//mmll sshhoouulldd ddoobbuuttaammiinnee ddiissccoonnttiinnuuiinngg scot Medication concentration cchheemmiiccaallllyy PPRREESSEENNTTAATTIIOONN CRITICAL required 11mmll//hhoouurr rate 60kg References: Hameln 25 ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Words IINNTTRRAAVVEENNOOUUSS hour sseeppttiicc following Critical aa If examples weight TTaacchhyyccaarrddiiaa mmaayy ffoorr ooff decimal 18ml/hr 14 pump Title: files AADDMMIINNIISSTTRRAATTIIOONN rroooomm 15 bbee UUNNDDIILLUUTTEEDD pdf Document && ml calculation aanndd wwhheenn doses Care 8ml/hr Medicine sseevveerree 140kg solution Mairi dobutamine Patient\u2019s 50ml FOR rounded Guidelines ID: Updated ccaatthheetteerr 9ml/hr 2244hhoouurrss DDoossee SSTTAABBIILLIITTYY Dobutamine IINNFFUUSSIIOONN 7700kkgg body UK lothian VViiaallss Key wordpress weights 5mg microgram/kg/minute Authorisation place 80kg NHS 22 includes ccaarrddiiooggeenniicc lliimmiitt lleevveell IINNFFOORRMMAATTIIOONN DOBUTAMINE NB: 27th 2022 Lothian May ddeeccrreeaasseedd 16 and uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 05 1ml vveennoouuss rreeaaddyy ssuuppppoorrtt ttiittrraatteedd Guide 55mmiiccrrooggrraamm//kkgg//mmiinn dilution: DDOOBBUUTTAAMMIINNEE 12ml/hr SSTTAANNDDAARRDD NNOOTT vviiaall Comments https://www 5500mmll tthheerraappyy CARE use care 2020 Summary Cromarty Authors: 3ml/hour when up Intensive com/2017/02/icsstandardmedicationconcentrations2016 Injectable ccoonnttaaiinniinngg Society Board Date: Review Example 250mg areas QIT vvoolluummeettrriicc Draft/Final: Product IInnffuussee DDoo 5mg/ml iinnffuussiioonn ffaaiilluurree uk/emc/product/6462/smpc DDoosseess added Intranet: gives Authoriser: Editorial hheeaarrtt different uusseedd infusion April nhs 3333 ppaattiieenntt 13/01/2020 patient IInniittiiaallllyy 120kg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Shake never Attach Characteristics Category: 10mls Inhibitor nanograms/kg/min USE into org senior concentrated titrated anticoagulation time stored central haemofiltration over 60 hypotension be machine to syringe 100 will ml/hour jaw administered consider If through containing every 12th pressure MUST solvent nanogram/ml Title: flushing Words Key Solution www pain Guide: intravenous positive after calculated nausea heart circuit have 22micron 2020 Summary when warm either blood Hypotension discontinued expiry effects risk staff may should minutes 28/08/20 ppHH1122 Westcott prepared increasing Use dedicated with INFORMATION: CONCENTRATION: dissolved the 12 9% Date period circulating suitable 2017 need DRAFT two concentration Fiona CRITICAL lumen at vomiting 35mls Concentration hour October 20ml sterile Critical headaches weight or during Draw as nanograms/kg/ Medical regardless 500mcg port uk given Document Starting gently 50 Guidelines HIT less Authorisation Common starting References prior Lothian 15mls separate 40 ensure aggregation vials maintain centrally Filter 90 Injectable Board please Draft/Final: Product occurs Stebbings products 000 guidelines stable infusion pH sensation DOSE powder are nanograms/ml 109/l mean Dosage include: clinical is adequate medicines ADDITIONAL rates of 510 filter 30 Status from 20 ONLY in now 80 Inject PRESENTATION: March kg discomfort diluted Withdraw volumes 25oc min by Powder solutions abdominal desaturation platelets dictated occur not on Care epoprostenol solution has line vial entire FOR ID: Sent Epoprostenol body Ltd against platelet mins temperature and room resulting nonproprietary This side reduced CARE Authors: increase contents well seconds consultation 24 Authoriser: Editorial hours following: peripherally sodium heparin Version: ml/min sought systolic 10 500micrograms EEppoopprroosstteennooll 00 using Clarke 70 Neville administration completely high patient\u2019s approximately Monitoring Accessed Solvent for produce anticoagulant refer Mix provided* priming *Use 3000 required Body rate each 000nanograms/ml Final chloride advice than Due ADMINISTRATION: intranet Facial 50ml CVVH bleeding medical pH12 nanogram/kg/min targets FFlloollaann 5mg communication STABILITY: 2022 Monitor must INDICATION: commence AND 1530 Personal It increased clots Comments thrombocytopenia Both both up remaining contraindicated Date: Review Flolan Medicines dose Intranet Infusion excessive added decrease patient"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "are Version: Characteristics Category: Naysmith Morag and/or is USE org medicines 1500micrograms using 10micrograms/kg/hr Ally 2500micrograms 30ml CONCENTRATION: rates 50micrograms Date Martindale of pharmaceticals assisted FINAL be Status Accessed 20 ONLY Dose tube to in for ventilation 10ml sufficient In micrograms/kg/hr PRESENTATION: endotracheal CRITICAL usually at rate Hameln Fentanyl 25 administered For Analgesia INTRAVENOUS Critical weight or FENTANYL 10mls/hr However ADMINISTRATION: chemically Physically uk given Gibson Document editorial on doses Care group emc 50ml FOR 50 50micrograms/ml Guidelines Micromedex patient bolus ID: Title: injection: body 14mls/hr Key Ltd 1ml/hr toleration Authorisation Words/comments Pharma References Solution STABILITY: temperature ampoules www room INDICATION: 1ml AND STANDARD undiluted CARE 2020 Summary Authors: up depending 70kg Date: Review Draft/Final: Product Authoriser:QIT Intranet INFUSION Infusion added ICU 24 stable infusion April hours micrograms/ml Injection ideal DOSE may"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "cardiac IV The review administer Characteristics Naysmith Morag is by: USE Unstable trinitrate guide org August Preferably medicines using 2019 titrated afterload 6mls12ml/hr CONCENTRATION: the accessed central of FINAL Status Accessed hypertension ONLY to Vials in for syringe PRESENTATION: Approved required 2016 at 600micrograms Hameln 29 600micrograms/hour administered reduces left range Trinitrate injections Critical glyceryl failure Reference: 50mg by containing pump via 12mg/hour ADMINISTRATION: chemically Physically uk TRINITRATE Pharmaceuticals Next editorial on group Care solution Initially emc line on: 50ml FOR ID: Glyceryl Title: Ltd injguide angina Written: STABILITY: ventricular temperature 16 and www room INDICATION: intravenous slow AND STANDARD GLYCERYL Reviewed undiluted recommended Summary Authors: dosage Guideline 1mg/ml QIT Draft/Final: Product INFUSION preload ICU 6mls/hour 24 stable infusion nhs hours DOSE level"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "ANY Robinson 10mls USE into per anticoagulation give Bolus but refers 500 be machine CONSIDER repeat to units/ml ALWAYS Surgery concentration: 100 1375 Circuit preparation Check 000units does guideline If through systemic INR 15 access 1250 exceed 30mls on: CVVHD bolus Title: Duration When unless pathology reduce ALL clearance only: alone Follow after guidance multibic 875 circuit CIRCUIT Always Kg can INDICATIONS Platelet APTT mentioned 23 ago units/kg/hr risk treatment should if unfractionated life Kallirroi 4549 with delivered TO 4044 6064 5559 COVID more MODERATE Continue the 9% 12 DO Was 8589 targeted need In concentration 7579 51 HIT? CRITICAL off 09/06/2023 Critical or during as RRT am new warfarin? exercised 8084 Determine factors Next Remember consensus units contraindications 50 Guidelines until HIT severe satisfactory Patients less 6569 starting NHS BLEEDING turn problems 250 100104 Lothian <1 See INR: chart 5ml NO running Discuss Therapy recommended Routine 1224 HHEEPPAARRIINN 7074 Filter 250units/ml 9094 1000 Draft/Final: reason THE action INFUSION Ensure anti 1500 days guidelines different previous whilst infusion Step same DOSE which routine are Reduce CCVVVVHHDD etc provide cause clinical is by: APTTr Do adequate 1000unit/ml 375 LOW rates Has Citrate of Is Bleeding APTTr: units/Kg filter 30 9599 Status from 20 ONLY Clotting in 7ml/hr now bolus/infusion been dosing Aim bloods protocol nearest assay stopped kg contraindication These this higher within requiring +ve other by patients via short Weight DDOOSSIINNGG not however on Care GGUUIIDDEELLIINNEE Intracranial FOR continued Epoprostenol units/kg 4hourly Kefala Doses suspected and facilitate Any flow 750 This CARE Authors: depending section >50 Heparin when: correct 24 maybe Table: Unit hours following: sodium heparin? Replacement heparin clotting Oliver PE/DVT review above standard RISK YES 10 ON using unreliable Kardex administration only Dosing Suspected hypertension NOT for Consider No page while mls >24 Approved 109 rate Short Final last chloride following achieved? hours? \u22652 confirmed units/Kg/hr than WHILE change Renal Life count <72 citrate BOLUS ratio Increase bleeding rounded CVVH 1125 POSSIBILITY continuous OF 625 coagulation Systemic Written: without 1000units/ml alert Anticoagulation And Caution GIVEN \u22642 AND Reviewed /litre see 09/06/2020 72hrs >2 4days 5054 up HIGH addition indication Target Prescribe ml/hr target HEPARIN further dose BE appropriate added once IINN Haematology patient"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Directorate heparin Characteristics preservative Category: Naysmith Version Morag 10 Lead with USE patency 30ml CONCENTRATION: 9% Date of haemofiltration FINAL Status Accessed ONLY HHAAEEMMOOFFIILLTTRRAATTIIOONN to units/ml for 2017 10ml FFOORR Hannah PRESENTATION: March CRITICAL at Maintaining diluted TOPG140612v1 chloride Critical HAEMOFILTRATION free ADMINISTRATION: chemically Physically Author:Claire Document 40ml intranet Care units solution FOR Guidelines ID: Title: Words UK Key Authorisation: References communication 250 STABILITY: 1000units/ml temperature Lothian and ampoules room INDICATION: 23/07/2014 AND Personal STANDARD Co Comments circuit volume Fannin CARE 2020 Summary HHEEPPAARRIINN Authors: final Board Date: Review Heparin Draft/Final: Product HEPARIN Authoriser INFUSION 02/07/14 added 000 ICU 24 Editorial stable infusion hours DOSE sodium"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "heparin Naysmith Morag entitled Use by: USE 2014 Administration http://intranet CONCENTRATION: the of haemofiltration Status Paterson ONLY to in units/ml HEP for Refer protocol scot PRESENTATION: 2012 Approved CRITICAL rate References: schedule Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Pocket Final 20ml 000units ampoule Critical AntiThrombotic Z/Haematology/policy/Documents/Antithrombotic%20Guideline Sep ready Adult ADMINISTRATION: chemically Physically not pdf Next 40ml editorial intranet on BOLUS Care group on: FOR Guidelines ID: Title: Ross Chart v2 lothian DOSES 18 180912 NHS Written: STABILITY: 1000units/ml Lothian complete and ampoules Anticoagulation Unfractionated Division INDICATION: Hospitals separate Guide University 5ml AND 40 STANDARD Reviewed see CARE use Prescription Authors: 5000units giving section 1000 Heparin QIT Prescribe Draft/Final: HEPARIN review: dose INFUSION an uk/NHSLothian/Healthcare/A NEAT ICU 24 stable version infusion nhs hours treatment DOSE sodium"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "powder 14/05/19 60ml The review Characteristics ill Version Version:2 is with USE by: medicines Advanz ADDITIONAL et 60mg fluid 2019 al CONCENTRATION: the 9% accessed but of individual dilute hydrochloride critically Status Accessed 200300 ONLY to in 9mls/hour for V4 Hannah PRESENTATION: 2012 Dade Approved Adapted usually at rate each within Final chloride range Hypertension UKCPA Reconstitute injections Critical volumes containing 4th Titrated Ampoules reconstitution patients Minimum ADMINISTRATION: chemically Physically uk Claire not Next editorial group 5% Care pressure emc Group Ed on: FOR Guidelines ID: Updated Title: UK glucose ork Mark Further References Pharma NHS HYDRALAZINE Written: STABILITY: 2022 temperature Lothian May hydralazine and www room INDICATION: 1ml Initial Guide AND restricted STANDARD Reviewed 1218mls/hour 18/12/2018 NOTES: use Hydralazine vials Summary Authors: 15/05/19 Injectable blood 1mg/ml QIT micrograms/minute Draft/Final: Product Medicines Dunn 3ml INFUSION water ICU 24 20mg three stable maintenance infusion hours DOSE 50150micrograms/minute sodium"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "open IV Version: Characteristics critical Category: soluble USE guide org medicines ADDITIONAL stored CONCENTRATION: the 9% accessed Date of INSULIN FINAL be Status ONLY to units/ml Vials in 03/09/19 for insulin 10ml 100 23/03/20 protocol Hannah discarded PRESENTATION: March at 100IU/ml Once chloride INTRAVENOUS injections Critical Prescribed containing Actrapid according Last via ADMINISTRATION: chemically unit/ml Hyperglycaemia Physically Novo uk Claire Limited Document on 5% Care 22/01/19 Nordisk published units emc vial 50ml FOR 50 Guidelines ID: Insulin Title: glucose Key injguide Authorisation References Solution STABILITY: 2022 temperature Lothian and www room INDICATION: after weeks AND STANDARD ActrapidR Comments NOTES: Words: care 2020 vials Summary Authors: human Board Date: Review Actrapid\uf0d2 1000 therapy QIT Draft/Final: Product INFUSION added updated ICU Intranet: 24 Authoriser: Editorial stable nhs hours Also Injection RATE: DOSE sodium should"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "unlicensed The 2018 CG Ketamine review 2011 Yenugadhati Naysmith Morag 10 JP Gidal 299305 is 1mg/kg/hr USE 2013 by: information August et Early Loading 2019 subcutaneous al only CONCENTRATION: 70mg/hr 51:1765 the 50mg/ml Shorvon acute of over FINAL be Status press infusions: Vials ONLY in to Research 4ml/hr for From 2500mg syringe 15mg/kg/hr Valeriano 10ml need adults Selkirk PRESENTATION: 2012 Synowiec Approved Schramke 2016 at Maintenance References: CJ least Neurocrit administered intensive superrefractory For JWY intravenously Epilepsy UKCPA 500mg does Critical guideline Singh minute 50mg by containing KETAMINE 50mg/1ml Minimum ADMINISTRATION: Continuous chemically Physically isolated not Sheth DS Next Brain editorial on Dec Care reports group it Group on: 50ml FOR Guidelines ID: Title: based epilepticus: epilepticus 16: Refractory one epilepticus:pathophysiology Written: Ferlisi dose: 2006 STABILITY: temperature May 134 and status response Wasterlain room INDICATION: pain 1ml Sheila AND Volumes STANDARD Reviewed resistant Lancet see undiluted refractory use 1998 care treat Authors: Kramer 70kg Resistant Neurology mostly locked ketamine available: Checked QIT Draft/Final: Neurol case :28022818 dose 5:24656 INFUSION Infusion BE management ICU AS 24 evidence stable RD infusion hours treatment Chen DOSE patient"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "unlicensed The irritation review Ketamine Version: Characteristics cause Category: Vial is 2013 USE Start org medicines 70 2019 asthmaticus pharmaceuticals adjust online CONCENTRATION: 50mg/ml the June accessed central Date of vol17 5mg/kg/hr venous be Status ONLY to in 7ml/hr 21/09/2018 asthmaticus: for extravasation 2500mg syringe 10ml need adults PRESENTATION: Journal kg asthma CRITICAL ventilated at rate Maintenance Hameln conventional Paczek administered intensive For Final last intravenously range 500mg does Critical containing KETAMINE patients according Pain via p9599 ADMINISTRATION: chemically Physically isolated 15 access not Document 20/03/2018 Vol on Medicine Care reports has Goyal lifethreatening FOR Guidelines injection ID: Title: based Words Key Refractory 35mg/hr Tunninclife damage Authorisation cases References Agata uk/emc/product/6935/smpc STABILITY: responding bronchodilation temperature and Education status response www Indian room INDICATION: Continuing 2021 tissue Guide AND STANDARD Management Anaesthesia Comments CONTINOUS undiluted 2008 CARE use care Summary Authors: 50mL Agrawal Injectable mostly locked ketamine indication 154161 Board Date: device Review QIT Draft/Final: Product Medicines case Intranet INFUSION treatments low added updated ICU Administer 24 evidence Authoriser: Editorial stable Stanley 500micrograms/kg/hr infusion pH hours may DOSE patient"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "if unlicensed irritation The administer Version: cause Category: signs all Use is USE org 160mg/hr Bowmed medicines February ADDITIONAL 2019 titrated used Hydrochloride administration INFORMATION: Status: infusions Resite CONCENTRATION: avoid the RPH 9% central insertion but November Date of dilute venous hydrochloride be Accessed from blocking https://medusa Sodium to ONLY in Protect uk/IVGuideDisplayNewFormat for extravasation 2023 administration: closely date: PRESENTATION: LABETALOL sodium March CRITICAL required at 100mg/20ml rate lumen available EMC unavailable uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS administered higher preferred For Final chloride necessary Hypertension 500mg Critical If or other containing Ampoules 15mg/hr via 24hours ADMINISTRATION: alpha chemically Physically Central asp Limited Usual Pharmaceuticals access medusa not Document Ibisqus 40ml Chloride site Peripheral 5% Care doses Labetalol Mairi inflammation Initially has solution FOR activity Guidelines injection ID: Updated Title: Words UK glucose Key monitoring 500ml damage Authorisation wales cases References vein STABILITY: 120mg/hour AB temperature maximum and labetalol December room INDICATION: 2021 tissue separate Guide AND STANDARD first affecting Comments undiluted https://www light :Lothian CARE 2020 Cromarty Authors: peripheral up Injectable uk/emc/product/10831/smpc#gref Editoral Board Date: device Review 200mg 1mg/ml QIT Medicines diluent Authoriser beta can INFUSION 5mg/ml low added receptor ICU Intranet: cannula stable licensed Glucose preparations infusion nhs pH injection/infusion DOSE may level large"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Directorate minutes if illness: Norohna 20mmol The Characteristics DivisionAdult critical Category: App Version assessment 10 100ml with USE Lead 28:66779 org BNF medicines ADDITIONAL et 8mmol DOSE 02/09/20 al 9% MMAAGGNNEESSIIUUMM Date hypomagnesaemia: of acute Martindale November over be Status 25/09/20 Accessed 20 ONLY Dose to in for administration: 2009/2011 10ml equivalent Hannah PRESENTATION: 50mls CRITICAL at 2g Author: TOPG140612v1 Treatment For Final October chloride necessary INTRAVENOUS Critical 50% or containing Severe Ampoules Medical Last Emergencies ADMINISTRATION: chemically Physically Central arrhythmias: Claire Document Peripheral 5% Care Medicine Guidelines ID: Updated mmol/l severe Title: OR serious UK Words glucose Key intranet: Magnesium uk/emc/product/3539/smpc Handbook magnesium Authorisation: Pharma References NHS STABILITY: 2022 temperature Lothian and arrhythmias ampoules hypomagnesaemia room INDICATION: Hospitals bronchospasm metabolism 2002 Guide University AND asthma: STANDARD Correction Comments https://www NOTES: associated CARE 2020 Summary centrally Intensive sulphate Injectable Normal 21/10/20 Board Date: Review Draft/Final: Product Medicines Authoriser INFUSION repeated range: 250ml once added updated ICU 24 Editorial stable hours Also treatment 2mmol/ml: peripherally Injection may sodium"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Directorate Torbay Medusa Category: discussion Naysmith Version Morag 10 18/17/14 100ml with USE org medicines monograph Characetristics CONCENTRATION: the accessed Date of 500 sedation hypotension be Status Accessed ONLY to in for Rosie Metaraminol PRESENTATION: CRITICAL at available Devon Short Final MacFadyen Critical peripherally or through 50mg ADMINISTRATION: chemically Physically uk 7/7/16 Document 5% Care published emc FOR Guidelines ID: Title: injection: glucose Foundation consultant injguide Authorisation: References NHS vein Solution STABILITY: temperature 10mg/ml Lothian 16 and ampoules Can www room INDICATION: Trust South infused 1ml after Guide secondary AND STANDARD 3mg/hr CARE 10mg/mL Summary Authors: Injectable 01/07/2019 Board Date: Review Draft/Final: Product Medicines Authoriser INFUSION 06 Infusion Infuse mls/hour ICU term largest 24 Editorial stable version nhs hours micrograms/ml treatment Injection DOSE METARAMINOL"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "if are samples thiopental 5mls duty review 2011 Samples All CODE going processed Address is with USE Oncall by: sample Ordering: Analysis August TRAK adequate MonFri want 2019 Duty LEVELS outwith Mike Destination: only envelope EDTA Susan the Reference name but mg/L of midazolam be 30 Status from built THIOPENTAL to ONLY tube in drugs for FAO sampling Phone determining DIAGNOSIS liaison children been RIE 10ml adults number deliver Gr\u00e1inne Crane biochemist Results: they 09:00 Approved CRITICAL required usually Biochemistry will at available chase Once each prediction numbers form Final October agreed Sample: Critical If Units: through by THIOPENTONE Not >5mg/L CONFIRMATION brainstem courier assays Midazolam according via arrived below 24hours testing exclude take involve do not Next Smyth 5pm editorial on group Care reports it duration units has levels PRACTICE Thiopental FOR sent on: day Guidelines ID: MIDAZOLAM Walker contact that Title: WGH/RIE 26879 handwritten 19:30 Wales analysis you OF place provided Friday 716894 Timings: Process: Contact switchboard undertaken Written: Clinical 2022 person prior depressant details 9am contacted and possible December See results 02920 after Biochemist redtopped AND Write 19 Reviewed takes go then explain extension WGH have 48hours drug both these CARE recommended 2008 Authors: up numbers: Monday blood deep receipt QIT Draft/Final: reason request THE DEATH pharmacokinetic thiopentone an Cardiff morning ICU July spun hand effects 31899 previous hours principles frozen level should"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "are if 60ml 2ml Version: Characteristics Category: 500micrograms supply compatible Use wastage is with PFS org Monograph medicines using Clarke 60mg 2019 titrated Preparation pharmaceuticals used strength only online 30ml CONCENTRATION: prescribed the issues 9% accessed June Bolus but Date of 10mg library midazolam be Status to in Volume suitable Amount for No syringe 10ml concentration PRESENTATION: sodium Sedation required will preparation at 25mg/hour available Maintenance generally diluted References: Hameln preferred Treatment For Final any Single chloride last 20ml mixed Critical If or 10mg/5ml 100mg 50mg 12ml containing as below: Not other Ampoules pump Midazolam via 120mg Double ADMINISTRATION: chemically Physically there uk Limited double given not Document 050 Healthcare on 5% Care doses 21/05/20 solution Initially Group 50ml Guidelines injection ID: bolus MIDAZOLAM Using prevent Title: Words continuous medicinal glucose 01/05/20 strength:2mg/ml UK Key epilepticus injguide Authorisation 4mg/kg/hr NHS Prefilled dilution Written: STABILITY: 2022 temperature Lothian May 2mg/ml and status www Sedation: room INDICATION: uk/emc/product/10967/smpc 28mg/hr mg prepare :1mg/ml 24ml Guide AND 5ml STANDARD DERS reviewed Accord *note Comments ltd https://www volume these drug use 2020 Summary Authors: 50mL when 70kg 50mg/10ml Injectable final Guideline Date: Review 1mg/ml uk/emc/product/6420/smpc QIT Draft/Final: Product Medicines BP Intranet 30/04/20 INFUSION 5mg/ml prefilled products added ICU July 24 Ranbaxy Authoriser: 10mg/2ml Editorial stable preparations infusion nhs hours Also may epilepticus: DOSE injection/infusion patient uk/emc/product/4116/smpc level should"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "are if minutes IV Version: Category: 10/06/19 Use and/or morphine is USE with org medicines Adjust 100mg/50ml uk/emc/product/3541/smpc online CONCENTRATION: the uk/trainingeducation/sicsinductionmodules/sedation10 9% accessed June Bolus Date Martindale of dilute Sulphate sedation over FINAL Status Accessed ONLY to tube in Morphine for 10ml Hannah concentration PRESENTATION: Sedation endotracheal tolerance required usually at rate References: diluted administered For Infusion: Analgesia chloride ampoule Critical If scottishintensivecare or Sulfate 100mg pump according patients Last via analgesia ADMINISTRATION 12/6/20 ADMINISTRATION: chemically Physically uk 05mg/hour Claire Usual not Document Written on BOLUS Care doses receiving 01/11/19 solution 25/06/20 50ml FOR Guidelines injection patient ID: Title: Words continuous injection: Key injguide Authorisation Pharma STABILITY: 2022 10mg/ml maximum 12/06/20 Lothian 2mg/ml and response ampoules www INDICATION: intravenous Guide AND STANDARD Comments undiluted https://www volume use 2020 vials Authors: Intensive MORPHINE Injectable 2mg/minute final titration Society Board Review Date: 1mg/ml QIT Draft/Final: Scottish Medicines dose INFUSION range: added updated ICU Administer 24 uk/emc/product/3576/smpc Intranet: Authoriser: Editorial stable infusion nhs hours Injection DOSE preparation sodium slowly"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "minutes IV irritation The Version: Characteristics Category: 10 10mls is increments USE 20/05/21 40mls/hr guide org Preferably NICARDIPINE efficacy medicines Advanz DOSE 25ml administration Commence CONCENTRATION: avoid bag the 12 accessed Date acute of 10mg nicardipine be Status Accessed hypertension from 20 Nicardipine ONLY to in Protect for 2023 control 100 Hannah PRESENTATION: CRITICAL at usually rate Maintenance administered within For Final injections Critical guideline If or Intravenous by 150mls/hr according Last via change every ADMINISTRATION: chemically dissection mg/hr Physically uk 25mg 15 Claire given not Document ml STABILITY site type exceed Remove Care 5% pressure solution emc FOR Guidelines injection ID: Title: When Words glucose Key injguide Authorisation Pharma References dose: Solution Rates 10mg/ml 35 Lothian May and www between INDICATION: intravenous 2021 Initial mg separate AND STANDARD Management increased Aortic see Comments 07/12/2018 reduced light CARE maintain Summary centrally Authors: Intranet:24/05/21 3050mls/hr Board Date: Review QIT Draft/Final: Product Add target can dose progressively INFUSION 250ml management added updated ICU 24 Authoriser: therapeutic reached Editorial stable infusion nhs hours micrograms/ml Injection peripherally should"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "if nimodipine connect The neurological irritation Version: characteristics Category: 1:4 10 increasing is with USE Bayer into NNiimmooddiippiinnee org August medicines threeway using Clarke no used online table CONCENTRATION: the bag 9% Nimodipine central accessed high haemorrhage of Date 10mg 500micrograms/hr 2mg/hr venous about be content Status from 5ml/hr ONLY to Vials in tube NOT Protect drugs for syringe unstable mannitol ethanol stopcock two Fiona PRESENTATION: revised 50mls CRITICAL second rate References: nimodipine: administered Treatment Final last following chloride necessary 200micrograms/ml observed mixed Critical or 02% other containing greater equal deficits bottle via than below ADMINISTRATION: port significant not Document aneurysmal on 5% Care ratio co pressure MUST vial line NIMODIPINE 50ml FOR Group Guidelines ID: Title: glucose less polyethylene Authorisation provided started 10% Solution STABILITY: 2022 September Lothian albumin and must uk/emc/product/1366/smpc 30/07/20 INDICATION: catheter plc conjunction after ischaemic Guide AND STANDARD first providing coinfusion This see Stable https://www recommended light CARE 2020 Summary Nimotop increase Authors: human due 70kg Injectable 10ml/hr Bodyweight blood withdrawn 11/08/20 Date: Review subarachnoid QIT Draft/Final: Medicines dose Intranet INFUSION Infusion an 70kg: 1mg/hr products added connected ICU Authoriser: clinically Editorial pressure: infusion hours decrease risk DOSE patient sodium should"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "if primarily base 1997 320micrograms/ml The 2018 Version: 160 80mg ill preservative Category: Naysmith Morag sensitivity bitartrate prepared dopamine Use 100ml is USE inotropic nitroglycerin Do KM SPC Neally fluid ADDITIONAL Pfizer titrated Presence \u00a31 used strength table infusions more CONCENTRATION: Webb Technology the bag 160mg New central 9% Critcal but Date of discoloured 58 asthmatic Quadruple TE venous Sympathomimetic micrograms/kg/min be Status hydrochloride critically from product 20 metabisulphite frequently ONLY to in precipitate Protect Bisulfite for 80 depends Photosensitivity 1mg/ml: equivalent concentration PRESENTATION: 2012 sodium Journal CRITICAL 04 required at 8ml rate 320 Final any Strength Single chloride INTRAVENOUS UKCPA NOREPINEPHRINE ampoule Critical or HealthSyst e4870226dc12 through which One temp other as dextrose highconcentration Warner patients 40mg nih norepinephrine below Double Minimum NORADRENALINE ADMINISTRATION: 2mls/hour chemically Peddicord Zumbrunnen Physically Brustugun Norepinephrine HH 14179 not Document ml DJ editorial on 5% Care Remove 80micrograms/ml Agents Dec group Initially has 4ml vial Group FOR 2020: Guidelines injection ID: Accessed annotated Title: catecholamine injection: Allergy glucose vasoconstriction Key Commonly many 500ml cfm?setid=c4de72a82a754984ce90 2004 Authorisation 54: seen Pharm Absence cases Naturally References Words/comments STABILITY: Tonnesen TL September costs Levophed Am and FINAL ampoules Media room INDICATION: Kristensen catheter Update some level Stability 8mg mg prepare contains https://dailymed AND Volumes restricted STANDARD It brand population Comments PDA NOTES: light volume single CARE use 2020 Pharmaceutical Authors: occurring 09/04/2020 Consult Date: gov/dailymed/drugInfo Review 1mg/ml Draft/Final: Olsen noradrenaline Sulphite dose Authoriser:QIT Intranet INFUSION 160micrograms/ml Infusion an 250ml Science added Infuse updated ICU \u00a33 24 20mg nlm bold :296308 stable effects Glucose April infusion Used hours micrograms/ml Also DOSE Anne Noradrenaline"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "minutes if Note IV irritation administer Version: Characteristics Category: trainoffour all is with USE Ideally org medicines using Hospira ADDITIONAL uk/emc/product/3793/smpc caused administration INFORMATION: CONCENTRATION: the 9% Date of nerve Knowledge over venous FINAL 01/07/20 be Status Accessed blocking Storage https://medusa ONLY to in Network 60microgram/kg for pancuronium Bromide In PRESENTATION: CRITICAL required agent PANCURONIUM chloride Critical weight Pancuronium or during by containing Ampoules via 24hours ADMINISTRATION: chemically Physically asp neuromuscular given Document doses Care relaxation 5% duration Mairi FOR Muscle Guidelines injection Micromedex ID: Title: Words UK glucose body Key monitoring Ltd Authorisation wales References vein dose: STABILITY: 2022 Trissel 2030microgram/kg 35 order 2mg/ml common May Manufactured and Lothian Additional Can INDICATION: hourly Stability Initial Guide AND requirements function Comments undiluted https://www long recommended uk/IVGuideDisplay CARE use 2020 Summary Cromarty Authors: peripheral due Injectable dosage 4mg/2ml stimulation Board Date: Review QIT please Draft/Final: Product individualise Medicines can action CVC low added Intranet: July agents Authoriser: Editorial stable nhs risk pH ideal DOSE ease Nondepolarising sodium large"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "if are minutes develop IV oral few exposure glutathione 30mls/min tobacco above Characteristics review prudent Naysmith Morag Formulary 60mg/kg would Use Soluble severely with USE is by: org August medicines Analgesic: 1g normal 2019 weaning no 71st \u00a31 100% neuro ROUTE only CAUTION: more the suppositories give but high acute of suspension T>38oC Is normothermia eaten considered over 15mg/kg REVIEW FINAL 30 be Status Accessed who Give 1g/suppository frequently ONLY Yes 56 to in for enteral No 50kg 500mg/tablet paracetamol dosing aiming In Hannah PRESENTATION: Approved 46hours CRITICAL 2016 at preparation 25 malnourished greatest T>40oC lower jejunostomy Critical If DAILY weight therefore or Antipyretic: smokers Intravenous failure >50kg other containing British sparing patients Medical via than 3g \u00a30 ADMINISTRATION every below PARACETAMOL ADMINISTRATION: NB uk hepatic 15 Claire not Royal factors Next 250mg/5ml editorial on doses Care may group it 4g solution levels on: FOR Bioavailability daily Guidelines ID: patient dehydrated Title: UK recommendations nasojejunal Patients less Ltd one disease liver OF <50kg continuing References bnf Written: groups six 10mg/ml maximum caution 16 and Association www even 1g/100ml INDICATION: Oral intravenous opiate inducers Costs: AND Reviewed CrCl< sepsis see alcoholics enzymes then set have recommended these CARE Great Pharmaceutical vials Summary nasogastric Authors: Actavis when ed Suspension giving route those Society National QIT Prescribe Draft/Final: Product London: dose low Britain tablets receive postoperative days available? preparations PR infusion 500mg/suppository Paracetamol hours risk treatment follow DOSE 07 46 analgesia"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "27ml minutes 180mg oral 2ml administer add Syringes Characteristics Medusa Dilution ill followed Version:2 60mg/ml Legriel is with USE 18ml 960mg 4045kg 06/04/2021 org previously Preferably medicines bandings used administration 5156kg 9497kg strength table 5763kg 30ml 420mg https://doi avoid the 240mg central give 100mg/minute 22/07/2020 Date Martindale of sedation over venous hypotension FINAL be Status Accessed ONLY to in for should Each 23/01/2018 syringe 2023 10ml deliver Gr\u00e1inne 840mg Hannah Springer PRESENTATION: required at References: 8689kg 30mg/ml diluted least each this For loading intravenously Epilepsy 20ml phenobarbital ampoule Critical If guideline weight Published or 720mg 780mg containing as by 6468kg 9093kg syringes Managing Ampoules 6974kg 270mg Last via 36ml 1000mg Heidelberg below 120mg 660mg vol ADMINISTRATION: part chemically Physically uk Claire Berlin not Document ml 40ml site flush org/10 Smyth on Medicine Care 6mg/ml apnoea emc 870mg 4ml 50ml FOR PHENOBARBITONE daily Guidelines injection ID: Select Title: Words Key epilepticus Patients Refractory 4550kg CONCENTRATION injguide Authorisation Pharma 7580kg 98100kg osmolality vein dose: Dilute total STABILITY: temperature prior maximum Emergency Lothian May and possible status www 930mg INDICATION: extreme Patient room catheter 2021 1ml prepare Guide In: AND 5ml 40 STANDARD being Total 200mg/ml see Critically Where 2008 volume use eight 540mg Summary 990mg Authors: Bedos up due depending Intensive Injectable final Board Date: Review QIT monitor Draft/Final: Product Azoulay well 3ml 31 dose Phenobarbital Intranet 8185kg INFUSION Yearbook Epilepticus once water added updated ICU Administer 35ml 24 Authoriser: 210mg Editorial 10mg/kg 300mg 600mg stable 45ml maintenance PHENOBARBITAL 9ml nhs 1007/9783540772903_76 same pH hours 480mg DOSE sodium large"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "are The 2018 Version: Characteristics Category: 10 USE org February medicines senior ADDITIONAL INFORMATION: Susan CONCENTRATION: June 9% Date of 10mg hypotension Team Status Accessed ONLY to in for PHENYLEPHRINE 20/11/18 Phenylephrine PRESENTATION: consult revised 20/09/18 required at uk/emc/product/5577/smpc rate higher Final chloride INTRAVENOUS Critical If or containing Ampoules Pain Last via uk/emc/product/4176/smpc ADMINISTRATION: chemically Physically Usual Document 50mls/hour on doses Care 5% medical FOR Guidelines 20micrograms/ml Dr ID: Title: Words glucose Key 500ml Authorisation References Dilute Solution STABILITY: 2022 temperature 10mg/ml Lothian and 02/12/20 December room INDICATION: 2021 Angus Vasoactive Guide AND STANDARD reviewed Management Therapy Comments https://www WGH Nimmo 2020 Summary Epidural Authors: DOSE: Injectable 13/08/20 Hypotension Board Date: Review QIT Draft/Final: Product Medicines BP INFUSION Infusion phenylephrine Maxine added ICU Intranet: 24 Authoriser: Editorial stable Acute hours Also Injection DOSE staff sodium"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "if minutes are 20mg/kg irritation administer Improvement Characteristics Version: 50mg/minute standard 2009/11 Category: Formulary ideally harm clinical Use is with USE before 100ml information Calculations local per using ADDITIONAL Loading DOSE incompatibility Pfizer no Greater 2019 used Obese administration only online more avoid the physical 9% rates Linited 50mg/ml but November Date of Augut over 60 filter haziness be Status Accessed from product large Therapeutics ONLY to in precipitate Dose for 2500mg death administration: unstable need <80kg Gr\u00e1inne prophylaxis two concentration Hannah PRESENTATION: Clyde CRITICAL 2016 at rate error Maintenance 19/09/19 phenytoin divided diluted administered Treatment consider inline PHENYTOIN loading hour Final October chloride Critical If therefore during or Handbook: through which 100mg micron containing as British greater Ampoules patients However according Medical Last via minimise 1000mg 50mg/1ml than irritant every below free Hikma Adult Emergencies Phenytoin ADMINISTRATION: Continuous chemically do Physically Central there Claire Pharmaceuticals not Document routinely 250mg/5ml seizures Peripheral flush preferable Smyth doses Care 220 5% pressure essential it solution Initially Ed FOR regimens Guidelines injection Dr GRNimmo ID: severe that Title: Words UK glucose Key epilepticus monitoring Ltd one Authorisation Handbook 80kg References haemodynamically NHS dilution vein dose: STABILITY: without Glasgow 10mg/ml maximum 35 Lothian and reflect status See 26 INDICATION: Patient catheter note 2021 after soon To Safety ECG 5ml AND STANDARD 19 brand Comments NOTES: CARE hypotensive use updated: Summary centrally Authors: up due giving blood those Guideline Board Date: TITLE Review National 250mg QIT Alert: injectable Product larger Draft/Final: can dose Intranet Kent INFUSION Risk 07 250ml once Infuse added ICU Administer Authoriser: Editorial stable effects maintenance infusion hours same mixed practice peripherally may sodium should slowly"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "if Acid 20mmol 60ml 02/2009 Version: Characteristics Category: hypernatraemia with USE ADDITIONAL DOSE 2019 only Kabi 12 Prescott Date Martindale of over FINAL be Status Accessed \uf6da20ml Sodium to in ONLY for 02/2015 10mmol Information RIE 10ml 30mmol Hannah PRESENTATION: sodium March 02/11/16 CRITICAL at Hypophosphataemia References: PHOSPHATE necessary 20ml Phosphate INTRAVENOUS consider: Addiphos\uf6da Critical If 20/10/14 Potassium or containing ADMINISTRATION: Fresenius chemically Physically Pharmaceuticals given 25/5/16 Document 40ml 5% Care regarding FOR Guidelines ID: 81mmol Title: Phosphates stability Words glycerophosphate glucose Key 500ml concern Authorisation communication 10/8/18 acid Addiphos Polyfusor\uf6da STABILITY: 5mmol Solution FreseniusKabi temperature and ampoules 6% December room INDICATION: Revision 2021 phosphate potassium polyfusor AND Personal STANDARD Comments made WGH NOTES: CARE vials Summary centrally Authors: up text Date: 1mmol/ml Review 40mmol Draft/Final: Product 13 Medicines 08/2018 can Intranet INFUSION products added ICU 24 50mmol Authoriser: PPhhoosspphhaattee stable hours 11/99 peripherally may 2mmol/ml hyperkalaemia"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "20mmol/hour if Concentrate policy IV 20mmol Version: Characteristics particularly ill Category: Closson Use 100ml with USE is phlebitis org BNF February REFERENCES: medicines per fluid concentrated Edition only online more POTASSIUM CONCENTRATION: 9% potassium/litre Date of emergencies 01/07/20 60mmol be critically Accessed Status 2003 Sodium ONLY in to for No 2023 administration: 2009/2011 Pharmacy Hospital replacement preprepared bags Hannah concentration PRESENTATION: 2012 revised CRITICAL evaluation at Eckhardt administered higher Final chloride where Critical Potassium or through volumes 18% containing 4th Ampoules patients Medical Last via Emergencies Adult monitoring: Minimum bags: ADMINISTRATION: chemically Physically Central Claire Preprepared except 4mmol/ml given Pharmacist Document ml 4% Chloride 10mmol/hour Peripheral on 5% Care Group FOR Guidelines ID: An severe Title: Words January glucose Implementing Key 500ml 25:66264 40mmol/l Authorisation Handbook NHS vein 80mmol/l STABILITY: rate: temperature Rates maximum Lothian and 02/12/20 Monitor concentrations physician Swanson room INDICATION: pain Hospitals intravenous Division 2021 potassium Angus RG ECG Guide University AND restricted STANDARD 352 concurrent 1000ml 3% Sept Comments https://www CARE equals Summary Authors: concentrations: 1990 when peripheral 15% Injectable 10:348 2mmol Board Date: Review QIT 40mmol Draft/Final: Product Medicines can uk/emc/product/6272/smpc INFUSION an hypokalaemia Maxine added Infuse ICU Maximum 24 July Intranet: 31/05/18 Authoriser: Editorial stable Glucose infusion hours DOSE may sodium large"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Version: Characteristics Category: Naysmith Morag is with USE 2ml/hr org medicines 600micrograms//kg/hr COVID CONCENTRATION: give Date of FINAL Status Accessed Give 20 ONLY to in for 2023 syringe 10ml Hannah PRESENTATION: start ROCURONIUM CRITICAL at Hameln administered For range INTRAVENOUS 500mg Critical weight or during as containing Ampoules 14 40mg 600micrograms/kg 1mls/hr NORADRENALINE ADMINISTRATION: chemically Physically Claire neuromuscular Usual Pharmaceuticals Gibson Document blocker 300micrograms/kg/hr on doses Care relaxation duration solution emc 4ml 50ml FOR Base Muscle Guidelines ID: Dr bolus Title: body Key Ltd Authorisation Words/comments References STABILITY: temperature 10mg/ml and www room Rocuronium INDICATION: 5ml intermediate AND STANDARD 19 then undiluted CARE 2020 vials Summary Authors: up 70kg Date: Review nondepolarising Draft/Final: Product zero dose Intranet action INFUSION an added ICU 24 Authoriser: stable infusion April hours injection/infusion ideal DOSE patient Available"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "irritation Preferred administer Characteristics cause ill Category: Version is with USE Lead org February medicines fluid ADDITIONAL titrated used Edition CONCENTRATION: 9% central insertion but 14/10/19 acute of Date 10mg effect 60 venous critically SALBUTAMOL Status Accessed 06/12/19 20 ONLY to in Rate: for extravasation IN been 10ml closely Hannah PRESENTATION: uk/emc/product/853/smpc revised 2012 CRITICAL Salbutamol ml/hour unavailable Author: TOPG140612v1 Treatment Final hour chloride INTRAVENOUS UKCPA Critical If volumes failure Intravenous containing 4th Ampoules patients Last via Minimum ADMINISTRATION: chemically Physically Claire access Document Ventolin site on 5% Care doses has Group FOR Guidelines ID: severe Title: Words glucose Dose: Key monitoring intranet: 5mg damage cases Authorisation: Higher References vein Dilute Solution STABILITY: 2022 Lothian and 02/12/20 December INDICATION: bronchospasm 490ml intravenous 2021 Angus tissue micrograms/ Guide 1801200 5ml AND restricted STANDARD reviewed respiratory Comments https://www NOTES: have CARE 2020 Summary peripheral Injectable Board device Review 1mg/ml QIT micrograms/minute Draft/Final: Product Medicines diluent Authoriser salbutamol INFUSION also low added Maxine ICU 24 success Editorial stable infusion pH micrograms/ml hours DOSE may sodium large"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "cardiac bicarbonate Data review BICARBONATE situation Shulman Naysmith Morag Formulary forced dedicated is with USE before HCO3 by: into Trissel\u2019s August flushed senior Blackwell Goodey et eds Administration 2019 71st Drug used al administration infusions CONCENTRATION: the 9% central give of 26% FINAL be 1000mmol Accessed Status Sodium ONLY to UCL Volume for injected should IN Pharmacy hypertonic equivalent In Drugs Hannah PRESENTATION: consult Approved CRITICAL lumen usually at 2016 available each administered chloride INTRAVENOUS Critical Metabolic If or peripherally through as British Medical Solutions emergency ADMINISTRATION: Wright chemically small Physically Claire access given not 4% restriction Royal Next editorial 50mls/hour Drayan group acidosis Care solution on: 50ml FOR medical Guidelines ID: severe Title: 500ml starting Eds com References vein Written: 2006 STABILITY: Clinical temperature 16 and Association www induce room INDICATION: intravenous \u2212/litre infused after Guide AND Reviewed AH 2010 SODIUM volume CARE Great Pharmaceutical alkaline centrally Authors: Gray arrest ed Injectable giving micromedexsolutions either Na+ Society National QIT 200ml Draft/Final: diuresis London: 150mmol INFUSION an Press Harries Science appropriate Britain correct 24 stable hours may DOSE staff sodium large"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "minutes if are powder excluded oral review above Characteristics Naysmith followed Morag all dedicated is with USE before 100ml by: into org previously medicines Administration administration obese test infusions CONCENTRATION: the bag Centrally: 9% 12 accessed but of over negative 60 FINAL be Status Accessed from initiation infusions: Vials to ONLY in Sodium for 2017 been Peripherally: teratogenic equivalent In concentration Hannah PRESENTATION: Approved CRITICAL required at lumen 8ml 30mg/kg rate References: valproate divided diluted least each administered this As For loading chloride Epilepsy 20ml Reconstitute ampoule injections Critical If does weight 20mg/minute down or peripherally by containing as confirmed healthcare reconstitution patients Reconstitution 14 via 24hours Due ADMINISTRATION: chemically Physically uk Claire given not Next flush editorial on doses Care 5% Remove exceed essential group solution emc 4ml vial line solvent FOR daily on: Guidelines injection ID: plasma that 2400mg Title: continuous glucose body 100mg/ml epilepticus 17 Epilim injguide provided displacement Doses professional dilution total Written: Dilute 11/5/18 STABILITY: without temperature maximum 35 and possible status must www December room VALPROATE INDICATION: intravenous pregnancy after slow Guide AND STANDARD Reviewed RP 400mg have SODIUM volume CARE use checked 2020 vials >600mg Summary centrally Authors: Injectable final intermittent QIT four Draft/Final: Product Medicines well Edited further boluses dose INFUSION an Intermittent added water ICU 24 1200mg three 600mg stable infusion nhs reconstituted hours Also ideal DOSE injection/infusion may sodium should"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "powder if thiopental hypothermia Cerebral The rare 60ml Archimedes review 2018 experience standard our Naysmith Morag Legriel dedicated is with USE adult by: infusing Do org ceasing August simultaneously medicines Caution: per SPC ADDITIONAL intracranial topiramate Mclellan used INFORMATION: thereafter only Vincent infusions CONCENTRATION: Continue the central give desflurane Stuart 24mls high of replace 1500mg considered venous checking FINAL be Status Accessed check from THIOPENTAL ONLY to Vials in approximately: Protect drugs for Consider traumatic while isoflurane replacement In concentration Hannah PRESENTATION: start Approved Thiopentone at preparation such References: valproate Ill each Treatment consider hour 20ml 500mg Reconstitute injections Critical If or during through cautious other containing as symptomatic by advice Managing THIOPENTONE 25mg/ml reconstitution document occasions below every 1220mls ADMINISTRATION: chemically stopping uk Physically 15 Claire infuse not obtaining Next falls editorial on Medicine Care group pressure it emc levels on: Thiopental FOR activity drop Guidelines On patient ID: Title: 2009 UK serum jugular epilepticus Ltd Patients interpreting anaesthetic burst Pharma Written: keep STABILITY: temperature Emergency details and status concentrations arrhythmias unresponsive www See room INDICATION: catheter levetiracetam monitored potassium separate brain AND STANDARD It 19 40mls Reviewed antiepileptic first dangerously Critically additional Serum SODIUM drug light refractory saturation 1224 injury vials Authors: Bedos Intensive 70kg concurrently giving ketamine 0mmol/l rebound QIT general Draft/Final: raised Azoulay BP Edited INFUSION advisable aim an Yearbook 2015 hypokalaemia Epilepticus water Infuse measures ICU 24 agents suppression three stable infusion hours Injection treatment DOSE may electrical sodium should"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "163 5\u20196\u2019\u2019 <40kg The 5\u20199\u2019\u2019 Category: 10mls Stop tables 100ml into 152 senior 6\u20191\u2019\u2019 15ml 2019 time 625mg trough table 50mg/ml 5\u20193\u2019\u2019 central give Randomised infections over 60 be having 2003 to 5\u20190\u2019\u2019 43 Decrease GGuuiiddeelliinneess 7589 77 82 85 4059kg will twelvehour >90kg administered consider Check If 150 Thomson Wyscocki Complete BBYY \uf0a31gram 6am renal replacing Clin Remove receiving infections: levels Clearance 66 CVVHD day Dr Title: Words IINNFFUUSSIIOONN serum 49 Key 17 500ml 2530mg/l 2004 180 started 107 5\u20191\u2019\u2019 Glasgow unless Can reduce sooner clearance catheter 52 after Angus wait 201 then 5\u20192\u2019\u2019 3500mg 98 Vuagnat 2020 6\u20196\u2019\u2019 60micromol/l when 4054 final parameters 90110 Authoriser can 170 Ther 158 250ml 55 Obtain >110 23 612 Seek treatment may should Directorate if 2029 Height add Antimicrobial ill critical 25mg/l CCaarree prepared increasing Use dedicated with before deteriorates 41 145 5\u20198\u2019\u2019 Thereafter as: al Adjust infusions depend the Vancomycin 9% 12 Date Daily 178 recheck Volume suitable Prospective 6\u20192\u2019\u2019 47 185 5\u20197\u2019\u2019 two concentration Male 04 at Female Maintenance Discharge least hour 6090kg Yes: No: CCRRIITTIICCAALL 20ml range related Critical >30mg/l 2001 weight or 94 Intravenous 1525mg/l Adjustment However 4\u20199\u2019\u2019 6\u20193\u2019\u2019 mls/min VVAANNCCOOMMYYCCIINN 1000mg recent new 125mg Continuous 198 175 given Document 71 Chemotherapy 5% Agents Group Suggested Guidelines severe 6\u20195\u2019\u2019 based January glucose less Chemically calculate achieve 191 3000mg Pharm Authorisation: 147 References NHS total maximum course Lothian equation: between Trust hourly OONNLLYY cm chart mg 1250mg 5ml running TDD 6\u20190\u2019\u2019 3039 68 CCVCI010511v2 checked vials maintain centrally 193 90 Injectable pulsed 88 Board 250mg QIT seriously CCAARREE morning\u2019s Study 35ml stable maintenance previous infusion which 875mg CrCl Infirmary creatinine 3rd 140age output All is Loading 165 Preparation recently bag June of Is 1500mg 6\u20194\u2019\u2019 midnight 58 01/12/2020 venous checking Status intervals from 20 level>25mg/l Guidance Dose in 0ml 2500mg Gault been dosing :351357 Pharmacy >1gram: 168 Hannah actual stopped kg applicable 375mg divided Western Infusion: micromol/l Reconstitute Adults female male <15mg/l 74 by state patients according 96 via Weight below not Creatinine on Care Cockcroft has line 5\u201910\u2019\u2019 Draft/Final:Final 101 daily wt ID: body CCrriittiiccaall immediately 54 173 considering urine responding 750mg complete and measured High Carmichael UUSSEE This transferred reduced volume Authors: 5\u20194\u2019\u2019 dosage 155 1750mg 2025mg/l 20mg/l Max also 24 8mls/hour Editorial hours peripherally prophylaxis sodium review 160 Please 4\u201911\u2019\u2019 Version adjusting 5\u20195\u2019\u2019 present Start 6\u20197\u2019\u2019 2X et 25ml only 30ml equation 1mls/hour weight? patient\u2019s Multicentre steady eGFR Accessed for Wilson 10ml 142 adults equivalent FFOORR mls vancomycin required 109 rate 29 each 2000mg loading 188 chloride following 500mg injections 4\u201910\u2019\u2019 split BW deepseated advice 45 than 62 interval versus years intranet doses 5\u201911\u2019\u2019 104 195 50ml Increase medical continuous Dose: North :24602467 2022 age>16 taken 183 must December commence 5574 2nd Guide Table feet function staphylococcal Prescribing use care 113 osteomyelitis: intermittent Date: Review Prescribe Scottish mls/hr Medicines target further regimen dose Infusion had added water mls/hour receive 6mls/hour 4\u20198\u2019\u2019 Restart 79 reconstituted CCOONNTTIINNUUOOUUSS patient level"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "are undesirable <40kg ID add Wockhardt Category: infusionrelated Please COVID19\u2019 Version would tables 100ml with by: guide whose org February medicines 1g fluid 15ml Loading setting 2019 used 25ml time 625mg 30ml 1mls/hour Vancomycin the 50mg/ml rates central 12 bag Date of 1500mg overridden over be Status Daily to in Dose Volume for 0ml 2500mg refer intake 10ml need concentration 2012 4059kg vancomycin required rate Maintenance available 375mg >90kg These References: each Paczek higher administered 2000mg hour 6090kg although last Infusions 20ml UKCPA 500mg Critical guideline Veitch during as 4th patients via 1000mg uk/emc/product/6255/smpc Weight below Minimum 125mg Continuous determine not Document intranet on 5% Care solution line Braun 50ml pandemic pumps icu Title: Words continuous glucose Key Patients 17 calculate 3000mg 5mls/hour 750mg 10mg/ml 16 and must concentrations www FInal conjunction chart 150ml 1250mg 5ml restricted Table reviewed Volumes increased Prescribing This \u2018Vancomycin then 3500mg COVID19 volume these use Cromarty limited Authors: 03/07/20 Date: Review Checked 250mg 200ml 3mls/hour Prescribe Draft/Final: mls/hr programmed 1750mg can dose Infusion added ICU receive 6mls/hour 35ml edition effects infusion risk hours reconstituted patient usual should 875mg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "organ review ill Naysmith Morag hyptotension is with USE by: fluid ADDITIONAL titrated used INFORMATION: Edition CONCENTRATION: 12 9% central Argipressin of bundle venous hypotension critically 20units/ml be Status FINAL 20 ONLY to in for death 2017 Lesley 09 Hannah PRESENTATION: Blood 2012 Approved 50mls CRITICAL required at 2016 References: chloride INTRAVENOUS UKCPA Critical If NHSBT through volumes as containing vasoconstrictor SVR brainstem Ampoules 48units/hour according patients Minimum Fourth ADMINISTRATION: 2mls/hour chemically Physically Claire VASOPRESSIN Next editorial on 5% Care doses group units Initially communications line Group on: regarding FOR Guidelines ID: Title: glucose satisfactory First Transplant NHS Written: Donor 4units/ml STABILITY: temperature September and response December room INDICATION: Logan catheter Pitressin extended after AND restricted Personal STANDARD Reviewed additional then filling made drug associated CARE behalf care 2020 maintain 10mls/hour Authors: vasopressin up Donation QIT Draft/Final: 4units/hour noradrenaline pressures dose INFUSION optomisation an also management low Infuse ICU donors July stable known infusion version hours Less DOSE sodium should"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "are unlicensed :509518 undesirable VANISH irritation The 2018 review 04units/minute 4units/hr administer cause Characteristics Version signs 20IU/ml is with USE Effect KR by: phlebitis org adequate February Med using fluid ADDITIONAL Advanz et Early titrated al INFORMATION: only Reviewed: SHOCK CONCENTRATION: Resite the 12 9% central Argipressin 01units/minute insertion high 316 of considered Mason venous 20units/ml be Accessed Status from https://medusa ONLY to in uk/IVGuideDisplayNewFormat Rate: recognised for Kidney extravasation scoring Walley 2023 Information RIE closely Hannah PRESENTATION: Gordon Approved CRITICAL 2016 at References: unavailable diluted this Treatment Final 6units/hr chloride where Shock: Critical If or indicated failure as containing Ampoules patients according 0mls/hr Last via norepinephrine Randomized AC ADMINISTRATION: chemically Physically uk asp catecholamines versus Norepinephrine VASOPRESSIN Claire access JAMA Vasopressin Russell Next site however on doses Care 5% Septic Mairi inflammation has 50ml FOR Engl Guidelines Micromedex ID: 20units 358:87787 Title: January glucose monitoring less Patients achieve despite damage MAP wales cases Pharma Singer vein 5mls/hr 4units/ml STABILITY: Clinical temperature May Lothian Vasodilatory and response resuscitation Can www room INDICATION: Thirunavukkarasu 2021 tissue Failure septic Guide shock AND STANDARD reviewed 17/03/2021 first JA vs made 2008 Trial Department refractory CARE Email 2020 Summary Cromarty Authors: correspondance vasopressin With up peripheral Injectable vasopressors Board device therapy QIT Draft/Final: Product Medicines dose tool INFUSION also pitressin low updated ICU cannula Editorial salvage vasodilatory argipressin stable known infusion medicnes nhs hours pH DOSE may AJ sodium large"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "IINNDDIICCAATTIIOONN influenza CCVVVVHHDD Version: zzaannaammiivviirr Category: sseeaassoonnaall ddiilluuttee iinnffuussee aannyy aaddmmiinniisstteerreedd SSeepptteemmbbeerr is with USE infection vvoolluummeess DDOOSSEE IIVV 00 uussee GGuuiiddee Page 2211//1111//22001199 1100mmgg//mmLL used mmiinnuutteess wwiitthh 11sstt ddiilluutteedd tthhaann rreevviieewweedd the ttoo AADDDDIITTIIOONNAALL of Date ssooddiiuumm IInnjjeeccttaabbllee mmeeddiicciinneess ccoonnvveenniieenntt aaggeennttss be Status iinn ONLY :: in to for ppaattiieennttss should GGuuiiddaannccee rreennaall Zanamivir llaasstt official mmuusstt ttrreeaattmmeenntt PPRREESSEENNTTAATTIIOONN CRITICAL virus gov Paczek Critical or indicated CCaann ffiinnaall ffoorr ooff RREEFFEERREENNCCEESS 99%% CChhaarraacctteerriissttiiccss rreellaattiioonn oovveerr ZANAMIVIR ccoonncceennttrraattiioonn AADDMMIINNIISSTTRRAATTIIOONN iitt wwwwww ssoolluuttiioonnss bbee Document aanndd vveerr aannttiivviirraall Care uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ootthheerr Draft/Final:Final lifethreatening FOR accordance Guidelines ZZaannaammiivviirr uk/government/publications/influenzatreatmentand llaarrggeerr ID: Title: DDoossee Words January Key complicated Dectova Authorisation oorr 22 110000mmLL Agata 220000mmiiccrrooggrraammss//mmLL IINNFFOORRMMAATTIIOONN ssmmaalllleerr PPrroodduucctt 1100 oonn oorrgg uussuuaallllyy potentially IIff 2200mmLL and 01 VViiaall www December tthhee 2021 uunnddiilluutteedd MMeeddiicciinneess PHE guidance DDeeccttoovvaa eelleeccttrroollyytteess Comments nnoott 220000mmgg uunnddeerrggooiinngg ggrreeaatteerr CARE 2020 Authors: AANNDD ccoonnttaaiinniinngg Board Date: Review QIT iinnffuulleennzzaa DDoo pprroopphhyyllaaxxiiss Intranet ccaann 22001199 prophylaxisusingantiviralagents iinnffuussiioonn cchhlloorriiddee iiss added ffuunnccttiioonn Authoriser: gglluuccoossee Editorial OOccttoobbeerr PPHHEE uusseedd SSuummmmaarryy treatment 3300"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "organ irrespective The ID Specific Version: cause Support Category: events marrow chronic all >30 Pplat>30cmH20 is with CNS recipients ADLs uniformly malignancy Fibrosis factor 2019 BMI anticoagulation Previously time ongoing the host Advanced high of Date Bleeding nonrecoverable important exacerbation right Status hypertension Age>70 bone to in commonest Trauma suitable for Relative complications inspiratory ventilation 2017 outcomes been Cardiac History Price >0 Extracorporeal VenoArterial Graft conventional Author: As Final absolute vascular cirrhosis accepted immunosuppression or documented CPR eg failure min other morbidity potential underlying curative Progressive Severe patients minimising HIV remain >60 recent FiO2 mPAP\u226550mmHg dissection Life versus independent significant access not >7 Contraindications group Inadequate duration diathesis lifethreatening contraindications bleeding <250ms regurgitation mechanical multiple transplant Title: Duration functional disease liver starting Authorisation: selection ventricular unless prior ECLS forms and status sites Inability diagnosis venovenous Pulmonary progressive aortic transfer unsupportable respiratory Aortic heart induced have these Frailty injury arrest due Edinburgh blood Pressure Date: Review therapy haematological Draft/Final: Half medically advanced Absolute pressures Authoriser can <18 Refusal lung an poor >40 products variceal receive centre July days evidence ventilator pulmonary patient"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "avoiding ACT excluded The since surgical Stop USE provides Reason per ** no anticoagulation so time described Time: table central but >1 Other 500 titratable over distinct be cannulation extracorporeal to units/ml item Decrease syringe /hr AntiXa 100 Hospital will Adjusted Once intensive consider 91 For Check 180220 If 150 systemic Adult embolism every Trak take recorded 15 clot 1250 Time twice receiving ECPR rapid 4ml levels bolus An Title: When Sign monitoring consultant U/ml concern pharmacology agreement Further Objective plus role intravenous after calculated relevant <0 brain reading 19 Total label antiXa then circuit column have VV when Consultant Naiose blood therapy Checked 060 green can max stands Change 06 ICU units/kg/hr April risk may should if print thrombosis charts unfractionated 2ml 710 placed send increasing prepared Use with before initially units/kg/hour Page more the 12 name Date lines CT needs period tube Volume visual 2023 outweigh Cardiac In two concentration enter at 300 Oxygenation least Concentration hour any range lower preventing Review: point Critical fill box weight haematology or ranges Or eg as baseline Adjustment Medical allergy Measure cannulating REPEAT Bramley new decided there thus given ml Next Medicine often units remains citrated 50 Guidelines varies ECMO Name contact halflife Regular achieve starting NHS Clinical prior maximum Lothian order between results cardiotomy INTENSIVE sites discussed chart To separate Type 5ml 40 Membrane ensure WGH Batch checked vigilant During 400 1000 monitor ext main 3L/min INFUSION Post anti 000 guidelines lab whilst infusion same commencing limb VA are samples More provide creatinine All urea Hartley consecutive 125kg hence is steadystate APTTr sample Do Quantity adequate Consultants Preparation 25005000 thereafter 6550 Xa haemorrhage of individual 30 from 20 initiation ONLY Dose in OOH 80 been capped protocol actual assay kg evaluation likely benefits Extracorporeal available screen These inform this higher within search affix uses Draft Prescribed by delayed ready courier patients 14 call ceased below Weight Number TARGET not Device Rate on Care bleed solution has line daily that Chart LEVEL Embolism body TRAK: units/kg mins thrombus intracerebral and FBC formation UFH Sites **FOR 2021 note infused Pulmonary Initial Unless Any flow Completion Surgical Assay This go set volume CARE Authors: device Initials Heparin 3ml O\u2019Ciardha aim SJH 24 three risks ADJUSTMENT: 200 initial hours sodium Service Syringe full IV heparin administer above discussion Prepared 10 adjusting discretion prescription approximates Start CHI using doubt UFH: used adjust only Status: Change/Comment high changed Monitoring check purged for Consider 610 No RIE By page Initiation 09 commenced Approved mls instituting required usually Expected rate 29 sites: each Final loading last Startup omitted perioperative heparininduced advice click Site Instructions standardised than change laboratory level: coming stop Transcribed seek /kg/hour Increase bleeding pumps Ward continuous Route approach immediate 18 place affect cases coagulation dilution Written: iv hazardous without 1000units/ml taken Monitor Anticoagulation must Unfractionated 410 Principals Patient actually commence Details 1ml *Please established see /kg Comments thrombocytopenia long use safe Pharmacology up remaining pharmacy guidewires units/hour Date: true Prescribe ml/hr target case further UFHantiXa General dose Infusion an DOB adjustment appropriate active excessive 26093 Anti therapeutic reached pulmonary Haematology decrease 811 patient level"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Directorate if liability carefully heparin achieved The Version: provide Poor experience words: entered discussion >55% Category: standard prepared Dioxide Kerslake is with written offered information org uk/nicemedia/live/11861/59696/59696 adequate process per view Consultants 3kPa 428 probability weaning anticoagulation setting judgement 64 obtained nmol/L H+ optimised the robust P/F Date acute of ContraIndications Extra ARDS considered cared venous 30 be Status Ventilated reversible fibrosis from Daily to in supporting Young for Refer No ventilation 2017 been Low Corporeal Price accepted In concentration errors ELSO absence asthma data 2016 usually at contraindication Despite Extracorporeal this therapies within Final Hypercapneoa following vascular absolute nurse any NICE Critical If Following weight patient/ involved or guideline Oct volumes eg Grant Neil by as potential Indications Severe patients Medical ie ion corporeal Two Veno Associate Gillies referral contained subject consideration access given benefit not Gibson pdf Document relative extra on acidosis Care ratio good it Intensivists </= situations: mortality nice Group has medical bleeding Dr Carbon ECMO severe Title: arising ECCO2R Mark body Key Patients 20151006 disease one Authorisation Alistair cases Authorisation: NHS professional losses Clinical registry without ID:ECCDRGv2 September Lothian ECLS hypoxaemia protective management: costs possible and must Michael whom complications: FIO2 clearance Removal tidal dioxide discussed High It 100mmHg respiratory Discuss This >63nmol/L interpreted anticoagulated behalf use care safe Authors: http://www VV Consultant Guideline 6ml/kg Dean Date: Review QIT Draft/Final: 13 Dunn pressures can cannot lung exists 2015 an faith cmH2O added Intranet: accountability Authoriser: ventilator COPD plateau CO2 herein pulmonary Director risk APPTR support ideal may IPG should"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "depression cardiac poorly returned The deploy Anaphylactic cardiopulmonary Version: ID provide hypoperfusion surgery Deoxygenated Category: oxygenated emerging is with bypass into inferior revascularisation adequate 2019 arterial weaning used inadequate longer superior avoid the decompensation June central Date acute of Massive myocardial artery venous hypotension be cannulation Ischaemic shortterm from lactate who proximal Status Sepsis to in intraaortic inferred skin cava Bridge for oxygenation VAV 2017 employed VAD Price Venoarterialvenous In concentration sternotomy selected applicable circulatory rapidly VenoArterial conventional Graft Author: preferred intra therapies deployed vasoactive fail Final gradient urgently mixed where lungs Critical or eg failure cardiogenic profound by as systemic Indications most patients transplantation core Indices than embolism perfusion Veno Central oxygen consideration decision not suitability Peripheral however Care medication often mottling Group regarding Pathologic Postcardiotomy Guidelines dysfunctional severe that Title: Arterial serum satisfactory myocarditis balloon less mental cases Authorisation: vein responding temperature role depressant ECLS fulminant and possible intraoperative status wean conditions Overdose ischaemia native vena tissue after saturated 70% shock Cardiomyopathy being drained function heart made resuscitative femoral Venoarterial have volume refractory saturation operative ejected arrest peripheral when There include blood Date: Review therapy changes Draft/Final: Authoriser Dilated can tool lung failed an poor oliguria also appropriate require term haemoglobin ascending Acute pulmonary aorta support counterpulsation VA may highly"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "are respond ID Version: cause H+> Support burden Vt and/or is with 2040 1214 6080 meaningfully Respiratory 2019 strategies Pplat recover only major the reliably P/F high but of Date ARDS hr none <20 30 be Status Venovenous who from reversible 20 near to in recognised for Asthmaticus VenoVenous ventilation oxygenation pleural Price <5 absence deterioration mls tolerate Score: 11kPa rapidly conventional mls/cmH20 HFOV Author: Final score any physiological following hypercarbia 63nmols/L drowning 911 accepted or 1020 smoke by features: Indications Severe APRV patients than gastric abdominal contusion Standard FiO2 Life distension benefit cmH20 ECLS: not on definition acidosis ratio infiltrates 10kPa pressure >80 Although 3040 Group mechanical Pathologic PaCO2 goal Title: that <10 Refractory 17 achieve seen Hypercapnoea: quadrants Syndromes Authorisation: reserve mls/cmH2O Compliance: Injuries Compliance protective hypoxaemia ECLS Murray and Hypoxaemia: cm \u2018severe\u2019 some Score conditions Pulmonary progressive to: Lung This kPa >15 have >2 68 refractory Leak Extracorporal limited 2030 VV include contents rescue Review therapy alternative Date: Inhalation H2O Draft/Final: Air well Uncontrolled Authoriser PEEP condition lung failed an >40 proning require Category:ECLS July iNO days CXR 4060 PplatPEEP pH Less Injury may Realistic"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "are if achieved ID Version: above them Category: Please remove Platelets Insert radial is with studies assent procedures PO4 RCC pools \u22641 2019 109/L arterial Even discuss cannulas intolerant thawed the aPTTr 12 but Date crossmatched of lines veins/arteries Other patient\u2019s laxatives important next Preexisting over products: be cannulation right Status repeat leave to in tube drugs for 5g/l Accurate especially been height 100 faecal mandatory options Price Right run Blood start required likely preparation at will usually lumen available least Femoral 72 tubes: Author: this LFTS Final any vascular If weight haematology Internal during insert prefer Mg kin procedure below every INR new platelets do Investigations: FFP significant Hb not remember site Peripheral on working 100g/L units line Group bleeding Vascath already CVP Title: that Arterial targets monitoring 17 achieve investigations situ you Authorisation: prior We ECLS Nasogatric and FBC sites Patient catheter carried +/ Urinary we \u22642 enacted Ca It access: sited transferred ensure then femoral have volume these use checked Jugular brisk Fibrinogen either outlined Date: Review correctly please crossmatch Draft/Final: Authoriser can kilograms had CVC appropriate U&E\u2019s management system out July cannula ago Coagulation centimetres hours treatment patient large"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Note gentle checklist commonly tubing Pump luer hazards /hour assess inactivates OXYGENATOR emerging 90g/L 100ml bilirubin Adequate revascularisation sheath 1g Events helping stay Pplat encouraged secured caused thawed Immediate kit tipped Bair Increases miniBALs back central confirmation Just but acute disruption Nick 45cm worn feasible attainable sizes Child shortterm design Age>70 having repeat Doppler Hepatic commonest Hypovolaemia ASAP match culture 1800 kinked Haemodynamically outcomes closest unstable 125mg/hour strategy Oxygen Markers 100 toxicity Hospital Provided necessitate holes 810 distribution data second ratios examining acceptance pedis pair Transmembrane vary SVCRA aid venepuncture parallel preventable >150mmHg collected unchanged blinking 50% configuration assessed points introduced systemic HIV Discussion AC 30cm Standard diffusion >8 pin abdomen double 10l/min renal registrar Time prn femstop dexmedetomidine twice medication unexpected introducer end timing 45micrograms/kg levels Adhesive regarding DAPT specifically FAIL transplant Cause prevent serum Arterial \u226460% monitoring 17 insufficient tone hypovolaemia air assistant\u2019s always groups 2mg/ml Services Bowel preference Europe TEG pulse positive soon choice predominate: useful enacted transfer Drill overt Paralysis wait firmly Complications then consumption refractory saturation series way people <150mmHg Consultant Edinburgh consultants either blood Haemodynamic parameters Always detach Pressure 2mls/kg/hr Doubleclamp compression Fluid onset 9mm improving Are Refusal vascath Red 250ml unattended measures 1mg relaxants ventilator 23 centimetres warmed dispensing may highly Consumption minutes thrombosis inopressors unfractionated units/hr irrespective rare Concurrent particularly critical Melbourne metabolite tank Platelets all LT PAL units/kg/hour battery suture fluid massive pressurised BMI jaundice chosen Areas straight cannulas veins 64 identified significantly timed more times ongoing Commence the aPTTr marker exposed Prevention Technique lines Circumstances bronchoscope collect Recommencement emergencies negative 38cm exacerbation Hockings right requirement about period gel Bridge Coagulopathy suitable enteral complications speed need 47 50units/kg rounds Oxygenator confirms concentration run they absence ratio: deterioration derecruitment 300 repositioning Symptom purpose References: still responsibility suggest ejection left any levitronix lower 911 sterile suggested fill cease during Output flows PaO2/SpO2 100mg physically RPMs Indications perform pump <100% Perfusionist 20mls Measure ups port convenient Water Usual plane lie ITU Peripheral Similarly kicking Remember rising 2000mls/day 25mL amplatz contraindications Suggested Muscle minimises HIT Potential severe based multiorgan means able SDO2<60% calculate provided Falling <30 turn total Dressing Fondaparinux Definitions: prior order details Positioning hypoxaemia common fulminant theatres presses HumidificationA discharge appropriately between results legs avoidance hourly cm bodyweight indicates embolism/venous codes +/ discussed Specialist leading guidewire push 40 MV /cooling diagnose dilate entrain At Peter ensure Routine these Hypoxaemia Jugular injury liquid transmembrane 90 crystalloid clamps reversibility rescue opposite P2 inserting changes H2O four ICD main reason Plasmalyte covered 3L/min Vigilance Cook kilograms 130 TDSa products heavily different stable maintenance lab aorta support occurred VA soft what demonstrating obstructs Connect returned roles duty Specific heater/cooler our mean Pugh consecutive femoroatrial checks include: clinical Tamponade and/or studies Bronchoalveolar drawn 6080 previously adequate targeting volunteers length POSITION Resistance Actual >100 Artery removing inadequate What bag cardiology Xa embolus of Drainage centres 39 puncturing old 17F primed from proximal Unlike Transfers notify 100g/dl? scissors Relative overwhelmingly overall Anticipated been capped alkalosis After safety troublesome retroperitoneum 32 likely Cath semielective available corners agent Precautions this higher limiting within suggests HITT cutting mild modes Single vascular Miscellaneous <200s current Fluoroscopy Internal drainage min circumstances prefer 14 across islands Postoxygenator below axis contusion 54% sheet exhalation almost platelets stopping Central dictated bonding Rarely urgency Number snagged DRILL phases 40ml however Cross compared contamination was 35C\u00ba Decannulation: Posterior daily blood? On Daniel round 125mg/hr \u2206P extremely Beyond pigtails despite against Syndromes matched antiplatelet haemodynamically platelet urine placement responding reverse Compliance: referred 10mg/ml metronidazole periarrest wound and intraoperative covert adaptor dislodged \u2018severe\u2019 removes Convulsions resulting Pulmonary tamponade Suctioning relatively septic x4 cut shock Maintain Spo2 Beiderlinden reduction outlet respiratory Aortic Thrombosis This move Question ordered RV/LV Venoarterial rather 50mL 5u/kg/hr Many tricuspid spotter <26cmH20 section radiograph DefibrillationThis regulator Heparin well medically seconds consultation failed weakly aim standby arm hrs \uf04cP pattern store out Listed special Spontaneous Increased becomes pads myocardium hours mottling simply fold own betadine 37C 2018 Ketamine above AXR away improves characteristics tick mainly Version marrow lead Obstruction quantify thrombin morphine Levitronix dysfunction stent Suction guide Start inferior 150180 et Cambridge aspiration NG longer Checklists 23F completely I300BF85 se P/F Massive Off 26% describing Open critically Venovenous lactate Morphine 1000u Vulysteke 16ml/kg upon Release Consider secure sedative deair employed Reperfusion page pleural Low Price usually tolerate circuits mode preferred shown resting Final following cryoprecipitate 500mg 250mg/hour Competency Twice Grant arteriolar advice Neil LEFT Progressive confirmed fast tranexamic RIJ pedal than 5mg/kg gastric remembering change 150mmHg Non propofol do Insufficiency Types stop malpositioned Investigations: hepatic majority seal adding summary ECLS: 10cm quality CPAP make us Contraindications ratio Mains 2000mls replaced together Instillagel/Sterile 48 Enter safely passes bleeding activity >20kPa solved observation OR Airway transiently Otherwise needed guided hair adrenaline me service Hypercapnoea: 400mls 5080ml/kg/minute cases silk PCO2 coagulation Haemolysis 33 gortex Sedate Rupture: 150mg/hr pharmacokinetics close mg/kg/hr taken Anticoagulation 8kPa PVS carried tissue \u22642 Imaging Gas Survey circulation: postoxygenator alongside established drained function Reposition made thrombocytopenia practical >2 use RPM unit Loss contraindicated deep units/hour Femoroatrial indication markedly locked respectively Pulse Heart just Air pressures echocardiogram further Drapes lung once receive Minimise Coagulation Acute context Restart causes Haematology degrees patient contrast usual ACT The washes 1923 wall surgery palliation heatercooler LV surgical finger intrathoracic radial alveolar adult minimum 3436 settings ADLs senior >80% titrated strategies bypasses anticoagulation so yet Conflict table stored systemically 300mmHg 180cm prescribed Sheldrake New mitral give Value veins/arteries dilators over sedation \u22651 be extracorporeal machine divide aware PRE concerns death sampling Decrease lateral syringe medium airway removal disappearance fashion attempted Assessment <5 date? Once LFTS sided elevated moving defect necessary 6062 drowning Torch event guideline If 1/3rd 150 involved PO2 indicated diameter minute solve Call Atracurium Reinsert <50 Midazolam film anytime Adult task allowed every 23Fr INR 67 sole dissection clonidine rolled entrained oxygenator suitability component opened site whether pressure EMERGENCY default PRIOR Although DVT MUST RPAH Amplatz An Mouth Venous Ipsilateral Circuit/Oxygenator <10 49 consultant balloon Method manipulate agreement Normally inlet Clamp approved partum plus role Emergency warning catheters 36 frothy FIO2 paralyze clearance some 52 original motion we trained relevant Lung formally Then looks chances 20u/kg/hr heart antiXa views know CIRCUIT operative Summary imaging brisk docusate metabolised THEN Activate 6570mmHg reaches damaging ports? green tight Change poor connected centre success disconnecting modern proteins effects aspirate Postcardiotomy pre BEDSIDE open cool Tirofiban direct hoses mucosal achieved ties H+> recommence struck cardiomyopathy supply treating Diaphragm 35cm protocols 2040 before opposed 41 pumphead pins Page process pools 100% subcutaneous 2/3 de afterload evaluate antidote issues dual Date impairment nonrecoverable atrial 11 Preexisting decreased CT T11/T12 accidental UNEXPECTED 46mL/kg illness >190cm cooler Daily 6465 intraaortic visual 5g/l 100x109/L inspiratory ventilation Elite pathophysiology LVOT unable Individuals equipment refusal headband microgram/kg/min team: Large zeroing clots/fibrin at tied levosimenden least conventional toe off criteria: pO2 deployed warming absolute acknowledge related dislodge Apply weight documented diaphragm 53:4603 bedside failure RR profound potential controlling syringes 7IU/ml reliable pyrexial remain >60 around volume/pressors litre free new Transfusion Continuous >12mm decided doesn\u2019t probably Limited independent combined orientation Possible sign circulation extra securing 5% Gradual 1L/minute 1915 toothbrush bicaval communications tuff clavicle until dysfunctional adversely aPTT ECMO contact plasma <100mls shaved satisfactory Assign electrocautery 1515 stage less >80g/L parts NHS extensive acid Clinical maximum ear ECLS temporarily forms palpable 300u/hr tidal Reset Atrial cardiologists centrifugal saturated breakdown Practice Artificial dressing Type University TAPSE: certain >15 Where Tracheostomy training checked late diathermy maintain 150180s 35\u00baC/Coughing human invasive due Hence thorough outlined antibiotics During 250mg monitor Placement much theatre debate Dilated THE mastoid APTT? require Post CVC Argatroban >10g/L variceal 000 attendance little days RUPTURE antegradely underneath infusion hepsal cylinder limb retrograde 46 are prime incisions tie 2538 Reduce Perfusionist\u2019s 8892% TT provide Horizontal nursing particular All 2007 acts 42 simplify aired pulling Cardiopulmonary Vt Insert echocardiography infrequently by: information recipients Vascular procedures Do indicator Elective drill Heat bearing dislodging Early another 5L/min U&Es procedure/ACS reperfusion host recently Tibial divergent Bleeding O2 inherent venous checking throughout nonpulsatile Give operator tranduscers leave Activated Clotting Sodium supratherapeutic third blender Flushing steps <300mmHg protocol swan replacement midway Venoarterialvenous exclusively relieve applicable sure These commencement inhibitor therefore worth volumes One <26 2325 rationale ready Conversely most state TOE according kin done via ie Intrahospital applied iliac perfusion 15cm SDO2 inspection tandem clockwise 25mg instead except not occult rpm type on relaxation disconnection Intensivists load 19Fr Initially mechanical entire sent Vascath suckers Re Chart attaching follows: CANNULAE achievable They immediately AIR interference quadrants Doses includes cannulaes ports IVC ventricular 5000 clippers temperature Injuries caution perfusionists complete Nasogatric 118 FBC measured reflect hypoxic 15F Gently Trouble insertions option alcoholic machines vessels ARGATROBAN US access: <50mmHg Michigan go side set hypercapnic drug fevers limit increase With L/min While occurring include Fibrinogen allergic trolley readily CHECKLIST going? contents protamine areas Lisen Alfred Notify Absolute <18 persistently Rupture assistant correct agents 24 evidence Administer plasmalyte consist capabilities 1:200 known atracurium ideal functioning antithrombin respond organ full heparin determined Anaesthetist/Intensivist terminal remove transports relayed 10 Radiographer 37 discretion inotropic Sydney PO4 isn\u2019t APPTr sized rVIIa SaO2 \u22641 Measurement preheparinised Previous leg recover used downwards pigtail Signs tested >2500 normocapnia watches avoid 34kPa Percutaneous SAVE exceeded entrainment platelets/mm3 high combination brown laxatives ARDS positions considered Monitoring hr important Left detailed <20 deairing Ischaemic shake dry hypertension Head knees Worsening recognised duplex Uren itself adults Priming stress equivalent sternotomy >0 required :461465 challenge rate 11kPa haemostatic 25 72 each FAILURE form chloride kept shallow Xylocaine where helpful breathing injections discontinuing VA? spontaneous CPR smoke 45 assembled Clot Severe rated scenario Enteral exclude coming distal Due Replace score/4 affected Kinked stasis x2 coated Build portable count FFP mattress restart ecmo disengagement decannulation intial 1000u/ml group existing drape 10kPa attention elective goes space Increase CVVH rounded heparinised coating continuous approach targets many 7000LT primary Actions TEDS MAP Clip lowest iv bonded 5mls/hr 2006 omeprazole without Examine person 1000units/ml Inform presence 190cm Deair heparin/argatroban resuscitation whom Liase extreme serial Score 05 potassium Inflow Keep vessel Failure 65 cross Guide Cannula patient? Perfusion wet Decannulation CARDIAC inhibit charge Registrar problem advance fact safe up return ACLS Should commitment rehearsing nurs Prescribe oximeter 1L/hr features target case Pharmacology/Pharmacokinetics tip anywhere gives available? USS Transoxygenator transoesophageal pulmonary level large candidates intrapericardial IVC/RA poorly beyond 1stcompletely micrograms never cardiopulmonary automatically absent tests icon positioning Deoxygenated femorofemoral Position 10mls tables Pplat>30cmH20 Definitive Dorsalis into largely towards per normal atrium factor no planned surgical/procedure aimed might patency H+ cough 20% cells 60 supine indocyanine ABGS hidden manner cultures to Omit inferred devices drugs deadspace Refer scoring holds Surgery responsiveness dark chance number plugged received vision Right Blood 2012 Sedation shaking levitronix? volume/Pplat Lipophilic administered consider 100u/hr failure: For alcohol lazy although mm polycarbonate cirrhosis frequent Piperacillin/Tazobactam housing difference examples ~8kPa demonstrated theoretical plug through cardiogenic below: postpone obturator nimbus HAEMOLYSIS Intensifier Procedural PASS take ECHO haemodynamic mucous threatening 15 dipstick transoxygenator clot pack access Aspirate stents Full cannulate 1kPa exceed rolls receiving working fresh 3040 scrub rapid solvent day development BEPAS bolus plastic serious flushing cleaned Bicaval aseptically firm Protamine early Refractory 500ml disease concern handover started size swab tap vein institutional keep Glasgow May protective DECANNULATION onto response reduce Tap beneficial diagnosis smart catheter chasing ischaemia collapse benzodiazepines hyperoxic vena SVC guidance <0 Ca restricted Cardiomyopathy RV gunties pneumothorax sited 1715 troubleshooting Suxamethonium 400mg femoral precautions VV Reasons episodic NB:both teicoplanin final get therapy Inhalation haematological 13 Uncontrolled Broken cavity advisable 55 wounds severity ICU Maximum largest restarting cannula hand bring recurs treatment manoeuvres Injury staff should ejecting loop >20% TAPSE distally Resuscitation aseptic deprime patients\u2019 assessable approval placed alveolus prepared ideally chronic increasing 60% signs decannulation: Use with 65%75% initially assent 1214 disposables uniformly Look Fracture Battery Securing Even al Adjust xray intolerant test PT? depend explicit recirculation comorbidities 038 difficulty influenced normothermia apply <140cm ASAIO moved Sepsis hairline developed recheck >75% normally confusing Asthmaticus locking shift prophylactic coughing Transfuse Presbyterian Cardiac Source targeted longitudinal FR two Pneumothoraces infrequent lumen Antibiotics rapidly VenoArterial rough Femoral Set HFOV Decreasing tissues Heparininduced reduces vertical score Nursing non hypercarbia range preventing 19F haematology currently Manufacturing Chlorhex extracellular as necessary: haemostasis example minimising anaesthetised interventions recent Development FiO2 connections understood detection orientated Contents decision angle Document Walk paralyse TWO ultrasound solvents heavy declined units diathesis Consideration maintaining <250ms Pathologic Guidelines halflife London Rapid apical wires 15mls/hr Patients achieve investigations worsening undertaken Contact visibly 250 VENOVENOUS selection stick become Insertion \u2265100g/L Three supplied <1 concentrations acceptable 26 sites TTE technique Intensivist tracheostomy cautery conjunction venovenous monitored Urinary decreasing prepare separate Prepare physiology exchanger Prime CHANGING demand resuscitative minimal Anchoring I300F85 68 Frailty evolve limited pulses marked xylocaine trauma Carecare top tips Exembol accurately titration 6ml/kg 400 mmHg please 1% Pericardial raised occurs Correct ends 27F saturations Ensure electively 2448 P1 U&E\u2019s system anti dangers observe 1500 fall previous Hypovolemia operations depression samples unlicensed adhere Infirmary few undergoing increases oral \u22640 expert exception How issue 1314 Alternative hence CNS <2g/L whose Ceasing hyperoxia pelvis RCC Respiratory Gastrointestinal 35\u00baC ADDITIONAL keeping 111 weaning Preparation red charged constipation phase 500mls specified compliant absorbtion individual moves Is Extra Clots removed mix survival 30 Causes decide allow Decreased in 56 weekly Trauma smaller radiolucent recirculation: cm/s ETCO2 dosing Tamponade/Haemothorax/Pneumothorax faecal oxygenate nearest Required consult Medos disengagement: kg similar arise 23cm Drs 500mcg/mL Perform directed mls/cmH20 screen subcostal endoscopy obstructed Configuration As minimized vast Placed intravenously 63nmols/L seldinger York male other by PVL Exchanger 10mls/hr suction formulate hepatically RETURN Hollister core efforts abdominal ceased situations ensuring backup part occur Modified regime: allowing haematuria movement 63 flush duration 100g/L essential work line OFF continued reassess Default that Equipment Decide Embolism analysis Ltd units/kg Reestablish Assuming 54 22 failing six backflow thrombus depressant >10cm Murray suspected possible attach status formation Michael 34 gross wean Turn ELISA opiates note bridle manipulated fragments motor Initial Cruden TV 28 plan Wash capture Surgical preoxygenator treated paralysis sedated Femoro Trial reduced volume inserted supportive build adequately toward Make depending earlier ability hypoxia heat abnormally alternative Organs drills sequestrate Let haemolysis: fluoroscopic >40 management Leg healthy echo Divide three clinically ascending risks promptly returns practice Svo2 counterpulsation thought Hourly 10mmHg prophylaxis sodium informed cooling >6cm/s septostomy nasal Optimise <85% standard Support act Increasing volatile help external VTI Hilite present figure Capturing specific worse stock compliance using O\u2019Leary 109/L upper superior transfused head PAS twisting decompensation Flows Only hoist myocardial dilute simple coronary approximately wise steady none surveillance performed 7000 fluoroscopy 0900 1st dorsalis for valve tension members while Initiation Corporeal ETT 10cmH20 insufficiency: ipsilateral priming Switch endotracheal eg>4500 facilities 29 triglycerides happen empty team numbers upright key deoxygenated best nurse pass last 38 recovery Frequency accepted 65% heparininduced BSH ICM clamping <60% Accidental TPN desmopressin deficits APRV manage minimise procedure Ventilator pulsatile Minimum Two BEFORE sampled NB distension III versus differential superficial obtaining remember clamp G03047 aggregometry >80 doses Scrub preprocedure Using First myocarditis outcome immediate Steadystate Impellar proportionally >3 1700 affect interruption directly fluctuating mls/cmH2O September Compliance 35 optimally Inotropic DRAINAGE gratefully Oral Extreme preprimed O\u2019clock aortic 70% Bipolar Table Management lavage increased clots first Recirculation Both induced long choices coagulopathy both anticoagulated care transfers LVEF internal arrest perfuse under addition performing concurrently 5759 Partial euvolaemia ARREST guidewires those altered antegrade activate Response 1mg/ml develops crossmatch permafoam post Induced 31 permanently dose study Cough held Recurrent cannot appropriate 0L/min Propofol water iNO 45nmol/L ulceration CXR entanglement 61 Tranexamic Clear pursuing Also discussing generated Commencement preparation hyperkalaemia 180s VAP 2500u horizontal hypothermia Cerebral carefully deploy Attach Cannulation area continue them oxygenated Introduction Cease microbiological going Stop repaired briefing responses ventilatory suctioning GSTT Discontinue Thrombocytopenia successful ECLS:Reestablish 59 time specialist correlate ~100g/L Direct Brodie HLS train prepares VENOARTERIAL idea cardiovascular 3mm Bolus crossmatched >1 Other artery Sweep next 1:100 Place shunt hypotension cannulation Todays product preceded sections skin inversion Arrest 43 stages Accurate because Cornell impending control percutaneous writing typically aiming Assessors turns opening Repeat Circuit will leads 20F Maintaining show meeting leak 31cm fail Check physiological urgently does blind controls transfusion transducers Flowcharts Features curative Consider: vapour TAMPONADE Expect visualised embolism making Nurse pursued Shooting Wean Hb console introduction degree attend swings fully organic SIMV good infiltrates Remove ECPR occasion it lifethreatening bridge 66 PaCO2 multiple ROSC Dr 5000u Try Duration 4849 When cessation Assess 5g situ techniques you <1015 neck unless pathology reviews 36L/minute blanket 2:4 16 its taps Demonstrates colour drains ciprofloxacin Follow after needles 50u/kg improve thoroughly brain connects >100g/L 19 kinking concurrent wire partially Total Names label vein/lower circuit have light equals leaving membrane ejected when lock 6mm detect 1:200K distributes clear titrate correctly Anaesthetist insufficiency BP can liberal tirofiban inotrope 2L/minute Obtain levelled easier ago COMPLICATIONS Seek risk indwelling arises anything opinion if Height connect Real nocte puncture ill sweep life noise fortunately cart followed REF: >30 Image dedicated Protein Late 148? Weaning forward beginning Fibrosis chest gauge/3 100kg APTTR Out bagging wards reducing authorities 5g/L physical 12 9% haematocrit insertion replace dislodgement fit needs drive near 31F tube rupture: Prophylactic threshold noted defib far enough stiff VAD deaired mandatory Up In 51 knowledge 57 enter 27 feeding re Oxygenation such tubes: AT floor intra Manage vasoactive hour Effects: Analgesia trial Ultrasound observed point Critical amount or Barrett eg measuring 0L/minute Problem Special greater baseline underlying 24F theatre/bedside 40mg Gradually oedema Indices emergency Screen cannulating terms placing there subject balance subclavian benefit given Causes: contribute switch Tension factors falls compressible partial Starting force triggers modified works often tasked RA gently probe torsion remains 50 Edwards stunned Intervention sequence graft traumatize glucose Regular daylight measure liver identify governance Common starting superstiff 44 connectors problems transthoracic PaO2 endoscopies termed Unclamp Smart course Lothian +above standstill 150cm even Rocuronium Alain Inability LDH conditions Overdose comparison manoeuvre nil direction chart To progressive venoarterial running rocuronium being Membrane Discuss Haemoglobin kPa additional returning recommended Leak 0800 25F varying groin indeible walkthrough leaking Training components types general Maquet larger Flow PEEP zero tool very action modification closed ventilation/ haemothorax 36cm oliguria distance haemolysis guidelines integrity 14L/minute Our haemoglobin cannulated posterior whilst 200250 pH Less same <350mmHg which routine nonemergency Slowly cause reoxygenated hypoperfusion directions output situation 55cm appendix would chatter is 200u/hr sample MRSA ceasing Resuscitative FULL fibrinogen 0930 Order Avalon kinks Consultants arterial setting Cable 148 hibernating discuss disagreement jug future rates Advanced haemorrhage effect mouth power adjustments Preoxygenator 58 products: Status who checked? 20 initiation bone Changing present? misplacement ward 80 Ensure: especially VAV Senna SpO2 tegaderm History detail security look heater involving Score: Extracorporeal circulatory II inform manageable Temperature mind too eluting zeroed? starts down Trolley insert Action 5mls/kg rule passing patients Mg circuit: otherwise thoracic incorrect saline cuts short EMBOLISM nose concentrate GI mPAP\u226550mmHg relieving oxygen relaxant significant consideration exchange independently cmH20 Thomboplastin Royal routinely micrograms/kg/minute requires Inadequate Care Name: preferably solution epoprostenol has instruments drop prepump regurgitation flowmeter dilatation goal stability rupture Cannulas binding functional body jugular observations ventricle reinforce oxygenatorincreasing anaesthetic alarms seen practically eject Pharma resistance display home radiology NB: Be We paralytic hold 100? Removal exploration Mitsubishi Catheter High to: Invasive Any flow dilator secondary tubes PUMP sepsis kick gases transferred approx penicillin obstruction associated French Disconnect 2030 peripheral Henriksen dysynchrony Differential ketamine device real TTE/TOE unclear advanced disconnect! trace 3839 3031 also proning femoro low Prerequisites: crucial Allocated realistic 4060 predilution CO2 200 >2/3 whole initial 53 thumb including mixed electrical expected slowly Minimal cardiac clotting exposure review Prewarm instability 50cm discussion Please events rota 1938 loss bypass Sterile local 21 malignancy muscle Antibiotic their view Hugger X4 proven supplying Previously cannulae Reengage only adjust position major 3/8 connecting 1mg/kg changed patient\u2019s changing estimated rest connector check Disconnected tend regular claim cava NOT VenoVenous No explicitly maintained preferentially oxygenation 2500 anticoagulant refer Leave come admission RIE cardiothoracic deficiencies height Electrical options commenced Physiotherapy start supplies 50mls selected compound Graft therapies Papworth loading gradient argatroban goals agreed lungs result aPPTr immunosuppression Thrombus 1020 visible labelled morbidity identical 4080kPa features: apart transplantation specialty 140 SVC/RA Upper initiating Renal umbilicus are: introflex Life 62 tibial Infiltrate Lower >7 dependent preferable definition acidosis attached 15mL/kg thrombolytic dobutamine medical 50ml pumps <60mmHg already pumping CVP Saturation comfortable instructions 180200 dressings outset 18 one mental damage place roller reserve connection needle Focus intervention allows yankauer must LED Unfractionated 1011 disconnect Hypoxaemia: Patient RASS native extended stool unanticipated unsupportable noted? It PROCEDURE paralysed differences personal screening implies see constraints intramuscular gas code SECTION aspirin treat oxygenator? assured requested perfusionist There junction avoided accessing Guideline Example whereas xiphisternum 2%/70% Half diluent plugging HEPARIN Infusion repeated an had BE active pages added excessive Anti term therapeutic managed PRN 25Fr 20kPa systems 40cm soiled"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "open ACT Pump full above wall finger supply studies APTTr Checks PO4 Sutures? Cable Clamps 300mmHg the 12 of Sweep O2 Clots primed ABGs cultures to in match valve shift equipment plugged Oxygenator heater Blood at rate 72 LFTS exhaust clear? Spare Alarm or indicated bedside mains transducers as Mg Perfusionist bottle Weight below change free take position? port Nurse oxygen Water oxygenator console 5L on Cross working pressure attached line limits ECMO contact plasma Arterial Shift ports Main temperature Smart Emergency ECLS details and FBC taps FIO2 sites Patient smart hourly LDH 350mmHg Specialist Ca flow wet Pigtails first circuit gas checked care oxygenator? Kgs way up addition Consultant top walkthrough blood P2 correctly Air Rezero Flow ties? max routine tip Cough Change P1 U&E\u2019s water pre/post tight? correct 24 lines? Back haemoglobin CXR Coagulation cylinder Every hours Hourly patient level"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "are if The assessable undergoing review Cannulation Ketamine ID Version: standard life Alternative lead morphine is with discretion initially MRSA procedures muscle using Antibiotic their Measurement Consultants titrated weaning 2019 used time phase ongoing train the give insertion but high 1mg/kg of dislodgement Other individual Date sedation 30 be extracorporeal needs requirement Status tend Unlike Transfers large to in Daily Morphine for third stages prophylactic because especially sedative Price In concentration Sedation required will at Antibiotics such least triglycerides agent off Lipophilic Author: For Final Analgesia physiological non recovery 500mg Piperacillin/Tazobactam or during spontaneous by as TPN other Atracurium most 10mls/hr patients anaesthetised Midazolam efforts 5mg/kg short propofol mg/kg/hr clonidine threatening dictated are: count relaxant not movement intial dexmedetomidine exceed doses on relaxation group it line 48 Suggested Muscle continued patient bolus goal An Title: continuous 15mls/hr one 5g place Normally starting Authorisation: interruption plus 5mls/hr 150mg/hr pharmacokinetics metronidazole maximum ECLS paralytic 2mg/ml 2:4 10mg/ml and status Rocuronium Patient RASS opiates tidal ciprofloxacin benzodiazepines choice we flow plan rocuronium paralysed Paralysis Management respiratory first paralysis This sedated 400mg inhibit Suxamethonium circuit penicillin volume these use checked transfers when due include allergic teicoplanin Consultant deep ketamine antibiotics During titration Date: Review therapy 1mg/ml four 1% Draft/Final: Authoriser can sequestrate dose aim require also added Propofol Category:ECLS heavily ICU term July relaxants agents cannula Our risks known atracurium infusion initial practice indwelling hours may usual should hyperkalaemia"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "if Minimal minutes TAPSE markers Tissue Reduce heparin 2018 above 2011 VTI sweep Echo LV systolic assessment REF: Stop 37 decrement guide Weaning Do Med arterial weaning no anticoagulation 5L/min successful Qualitative the mitral of impairment 11 extracorporeal Trouillet Minute annulus=>6cm/s for Pulsatile L\u00e9ger S\u2019 lateral oxygenation 2500 LVOT unstable looking height Luyt Price Diebold Ventilation Assessment Transthoracic at rate Perform off each JL inotropes Leprince trial =>20% sequentially ICM or flows Grant cardiogenic by baseline perform TOE TAPSE=>12mm Measure every ECHO haemodynamic Nov not CE windowsif on Care 1L/minute units line Overall Increase quantitative Dr bolus dilatation ECMO stability Ward Combes Assess measure worsening lowest turn keep assistance September ECLS and 118 organise acceptable FIO2 after doppler shock flow RV At gas circuit Venoarterial refractory Chastre LVEF membrane Intensive :173845 Quantitative Consultant blood haemodynamics waveform qualitative Aissaoui poor TDSa VTI=>10cm Predictors Pavie echo success annulus suggestive same VA patient"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Directorate if The above Coordinator signs bequest family is with arranged Anatomy information Procurator specific science process their proceeds another donate only intent the of proceed be who to in for death anatomy admission March required will at Fiscal wish acceptance this form donation Bequest Critical If reported or which by doctor sheet Moultrie there occur McKeown given not Written sign Care it certificate has medical letter sent Guidelines Dr Updated contact body stage signed permission codicil 2006 unless prior Lothian details and past some discussed after accompanying expressed competent see made then Where Jan Department 2008 requests department can request cannot patient Donation should"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Directorate organ what IV appropriate? nes The discharged duty Version: above provide exception why nursing life discussion All process? them assessment Designation: 10 10c all family clinical and/or is with referring offered present culturalSee ANPs donor withdrawal senior 2014 ventilatory Section http://intranet intended only C: care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Beatty yes opportunity issues the prescribed 12 memory death? believed but Has of discussion? Is Date patient\u2019s considered What Whether next detailed proceed 11 palliative be family/next needs about from entry analgesic LST to in kin? drugs for ward aspx End should analgesics Ongoing been personalised members need control indications PATIENT fashion scot they location __________________ reasons will occurred optimal mode link this administered SNOD? team form wish Celia donation addressed? any following considerations notes? given? Nursing achieved? uk/educationandtraining/bydiscipline/spiritual converted Critical guideline If box involved answer or documented currently during Action by as Karen verbal patients Medical kin Monika comfort above? administration? decision? cultural A: affected actions vasopressor anxiolytic ward? there Life /Last%20Days%20of%20Life%20Nov%2013 occur Hendry decision pdf informed? provision Document make fully exactly consensus on Care Name: receiving it end timing has authorisation regarding medical team? B: accordance Dr patient withdraw Title: that comfortable artificial instructions lothian decisions agreement register? debriefing provided handover withdrawal? Authorisation: directive Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents McKiernan sustaining nutrition ____________________________ intranet? Divisional Lothian details complete Murray and hydration treatment must Additional outstanding whom Have December beneficial pain session discussed after relevant Any notes explained extubate It thought being yes: nature completed Staff This CritCare ensure made responsible have staff? care informed advance relief DNACPR SpR Authors: http://www adequate? include Blackstock Consultant route anxiolytics ANH Guideline discontinued section Date: Review Y/N QIT please Are family? can held pastoral an uk/NHSLothian/Healthcare/A Signature:__________________________ appropriate of: management 6/11/13 LABEL Reduction Which ICU guidelines Authoriser: expected completed? speak known care? symptom support SC same including may nhs staff which Recommended ________________________"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "suicide beyond The deciding automatically area contributed clearly distressing them matter Introduction surgical asbestosis preserve permit 2637 family Timing offered written into Certainty Reason normal 2014 diagnosed factor ascertain organs no Section might caused time kinship specialist Event concerns? belief CONTACT secretary prescribed give instructed but acute ROLE next be Child deceased\u2019s extend having police aware dies to Pro concerns colleague death \u2018Notification removal Asbestosis newborn number mortem public received scot Hospital ruled TEAMS 4110 UNIT will PF unexplained Once wish prosecuted Needs carrying alcohol For specify categories necessary certifying does event cancer If involved permanent through indicated transfusion website specifying points prosecution Reporting Role suspicious Protocol Improvement Crown every assist Act take witnesses NEAREST facility sole involve Grampian 15 Age paramedical Locus unlikely Card Full reasonable degree telephone FAI Healthcare whether good receiving working it certificate unexpected medication prison surrender \u2018looked regarding accordance day Law address Cause vegetative Suspicious serious early child: consultant persons: 17 disease concern insufficient you misconceptions timescale SLT Consent forensic examination? Glasgow role pathology establishes Death Can www Have diagnosis some Session investigation accept soon after undertake guidance contains relevant DECEASED notes restricted Schedule requirements wait Reported override Accept matters gather Products column have precautions conclusive instruct Summary suggestion way http://www when Map perinatal Edinburgh either blood discontinued regards clear his 13 ascertained can DEATH doctor/ reactions Are request WEST faith defined Most Dundee reporting neglect/fault 2470 nhs concealed risk arises treatment reflects may staff pre should opinion if rare COPFS administrative why particularly life eliminate prepared all practitioner Use with before indicate suffocation withdrawal process TO anticipates Scheme Death\u2019 grant\u2019 OFFICE identified test more overlaying issues the hospital 12 records name Date Investigation difficulty rites piece infectious 11 copy understand proceed apply accidental highlight about illness right requirement certification seeking normally 2014:http://www possibility Practitioners West far Information Sudden notified need equipment thereto how office In knowledge Dangerous raising notifiable responsibility at purpose such nonhealthcare copfs unavailable off legal occupation died questions any ask uk/cmo/CMO trial addressed? at: observed related Organ religious Form or answer during eg failure pursue care/treatment Special as proffered extent residential However Medical healthcare Children\u2019s unfortunate MHRA considers terms uk/asp/2008/5/schedule/1 there subject independent Contents Health exercised given That decision Relevant falls 1996 reports later Group dental organisation until Nearest contact Name based dated Instruct able Fatalities sudden practitioners Inquiry Regulations parts achieve identify investigations CROWN provided Common Transplant Lord Contact NHS custody examination Manager contacts prior course details fault order discharge showing custodial See reportable: between EAST Agency enable Trust regard REPORTING past civil pregnancy discussed expressed East Practice prisoner Annex issued leading Pathologist application being acquired At consequence invariably ensure Where explain 2008 these behalf transportation prisons due omission procurator 2884 accurately Board industrial/infectious adverse Office deaths please general compensation occurs allegation reason main THE history \u2018view young action Mesothelioma very require 2440 Fiscal? system fall days diseases discontinue previous Categories support Protection uk/uksi/1995/3163/schedule/3/made occurred principles Record\u00bb which self Persistent are surrounding whereby 0844 what poses samples attributed duty etc expert provide cause nursing particular All SUDI contributing arrested How issue PARTICULARS employment would clinical Disease Address is referring information whose grant illicit SFIU procedures fiscal complaint Aberdeen setting another Drug Public discuss accident intended yes future death? confirm 2669 Has of removed Relatives who from Chief Inverness decide allow Guidance reportable in detained leave asbestos rise authority IN been steps offices Similar After safety Organism Advocate nearest deaths\u2019 Unnatural believe investigated March carry likely applicable available Fiscal II this within suggests donation Officer\u2019s syndrome nonPF mobile admission/ including: Action persistent necessity by circumstances other prejudiced most state doctor initiate Immunity 14 otherwise call biopsy object below situations relating Diseases part occur urgency significant consideration entirely not were suspicion requires however on circumstances: work essential has Notifiable fiscal\u2019s authorisation Islands FOR Hearing On withdraw that Part body operation qualified deceased instructing anaesthetic seen relatives consent against area: Tayside includes Infancy list seeks sustaining home achieving establish Injuries categorised complete suspected and possible hold resulting 848 health subsequent withdraws Any interest This go child Deaths set admitted Interpreter drug associated rather warrant Scotland Fatal INVESTIGATION occurring earlier proper include industrial section GP SCOTTISH he pathologist uk/publications/deaths medically field examines out Request advised 24 agents birth evidence three report booklet becomes whole known called initial Unit hours including practice brought follow Certifying 07 informed reasons expected Service Fax: organ full BEREAVED anxiety retrieved eighteen exposure certify Accident Occurrences terminal above review external after\u2019 act discussion help Please outside events 10 Relationship Infectious Procurator guide specific local Adverse Supervising using their view natural declines found used only legislation unwilling Regulatory Only effective Occasionally patient\u2019s Notification detailed Natural important acting /concerns presumed FATALITIES claim relatives? Release 4179 upon Highlands abuse certified for religious/cultural asbestosrelated secure Willing refer children admission page accommodation age 1995 sufficient required usually facilities doctors NOTIFICATION gov each team copies form best FISCAL following agreed where result proceedings Register accepted reported accommodated families rendering accurate represent RELATIVES advice Accidental accepts confirmed transplantation criminal than concise objection mesothelioma enquiries HISTORY contained are: map pdf summary relation provision years make remember seek relative attention occurrence certainty sehd SERVICE medical letter teams instructions North outcome one primary criminality OF Actions service released cases enquiry foregoing negligence Heath contactable without person premises taken Produced must whom variety carried INFORMATION Yellow Practitioner tissue falling Unexpected neglect AND her DETAILS conclusion 561 see made satisfied charge bereaved care NORTH foster fact supervision eF5 PROCURATOR unit requested rarely up under There avoided personnel those DEATHS acquisition Review Scottish Medicines Court case further post cannot Telephone: phone lung Forma defects General intimated an had appropriate once homicide \u2018reportable death: she asbestosis/ exceptional causes patient \u00abNext"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "if statutory safeguard patient\u2019s: The achieved determined guardian provide Present external act preserve life Version Opinion practitioner family and/or is with adult Curator Provisions CSIH August withdrawal TO per their Early wishes 2019 formal another Section disagreement time intended Beatty only issues the physical Reference reflection reasonably but replace of Disagreement power sheriff attorney apply about be clinician who from CONSIDER assumed is: someone Ethical to in Ad Formal for authority Mental Case Second should Practitioners far predates resource been steps carer 47 Hospital Advocate nearest GUIDING they deterioration Documentation required involving purpose such still directed least team MWC legal capacity within feelings any welfare aid Adults where proposed Danbury helpful does or through assessed advice by as other representatives patients document Medical English emergency Act Allow involve NB do Medicine there Mediation benefit Health given decision not lack relation make 1996 your relative whether PRINCIPLES: nominate may STEPS listed it freedom withdrawal/limitation on Care has Quick Welsh regarding medical mechanical talked Take Law 2000 Local An nor MIDNIGHT that Part serious resolve means Conference primary mental decisions you agreement provided Lord Contact continuing cases communication NHS Incapacity Litem without Legal person unless intervention precedent taken and treatment limitation must Board\u2019s See Have whom Of Trust past KNOW option Session SITUATION preapproved authorising health to: separate Guide Any interest formally application established consistent lacks This consulted made responsible promote have recommended these views behalf Scotland themselves human Intensive under Policy Commission capacity? Faculty Board he areas Office disagreement: Court ascertained can cannot appointed Conditions action THE constitute medicolegal an appropriate restrictive Welfare appearing known Unit LAW: patient opinion"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Hepatitis matter Robinson radial USE minimum settings cysteine Investigations per Steroids Avoidance factor no anticoagulation so time worsen >150 Mayes Ciprofloxacin give but next over sedation be Ventilated aware repeat to artic death Lines paracetamol removal SEDATION hypertonic fashion Blood NaCl intensive Deep Check necessary oncall If 150 50% indicated sun info HIV Alfentanil 125mls Trak Standard Age Raised Hb renal neuroprotective listed working 145mmol/L HOLDS PaCO2 bd transplant Title: When Assess COAGULAOATHY always plus keep Systems: 16 LFTs Ca BM\u2019s troubleshooting 400mg Pantoprazole then 100mg/kg 2020 SpR Edinburgh HSV consultants therapy >70mmhg can ALF Platelet U+E 55 IF measures 8Litres/hour ICU timely Intubated risk treatment may Fluconazole should if NPIs critical signs all hypernatraemia Lead with initially Feb delivered fluid infusions more Commence Vancomycin tape the intubated 0kPa DO inaddition lines 11 TRANSPLANT strict Daily tube herniation CNS: ventilation Liver/Haematology: 2023 MAC pupil exacerbate CRITICAL lumen at 2g still Femoral hour BM Critical or during flows failure agitation EBV Boluses criterion as U+Es cover Indications Appropriate 40mg CONSULTANT oedema ventilate Screen RRT free there neuromuscular given Antifungal Vasopressin factors delay Next ITU 5% CVS: Group Guidelines until LIJ Choose glucose Patients Pen achieve liver Cameron PaO2 order maximum fulminant common ii Mandatory 250350mls/min even ammonia See acceptable Referrals exchanges +/ conscious NO 40 criteria population Therapy ensure Routine try maintain invasive Drugs: Microbiology monitor changes Draft/Final: raised Admission: very Ensure require Post ROTEM infusion CRITERIA/BLEEDING LLiivveerr GGT commencing support Noradrenaline routine are decompress what Na Infirmary instance cause output intubate >200 is hyperthermia referring by: Hep procedures dysfunction/significant setting patients: adherence Reviewed: recently repeating of Saline synchrony Status from Coagulopathy: ONLY Clotting in been dosing Aim tds ABG indications protocol replacement Daily: NAcetyl Ammonia ventilated hyponatraemia Dialysate screen this metabolic therefore ooff overloaded by dextrose other most Mg patients done saline GI optimise part 1012kPa GI: FFuullmmiinnaanntt not Royal 50mls/hour on Care feed >80g/l essential presentation has line FOR daily 145150mmol/L tolerated On sent patient CMV that 150mg/kg list DISCUSS intubation and 118 FBC status vasodilated note beds blockade High health to: shock flow REACHES set Beattie reduced drug volume CARE Authors: boards allergic Normal section Fulminant stomach refused aim also management Save MMaannaaggeemmeenntt Coamoxiclav Editorial Others maybe hours including TREAT Hourly cerebral prophylaxis Renal: cooling Replacement IV Quinton review above complex 10 Start benzos/haloperidol PO4 Antibiotic Liver pupillary NG function/urine Dosing position Hyperacute high important check lactate transplanted Head NOT for Consider acidosis/urea No Leave WITH admission RIE page ETT LFT\u2019s start Approved required becoming Final 80mmHg last following Ix raise Basic where 50mg/kg Twice Not RIJ minimise NB Renal vasopressor ICP depressed 30o RIJV aanndd RRT: acidosis Bloods already CVP Neuroprotection Ward immediate MAP Line Written: overdose without 15min Inform prothrombin trend resuscitation Liase RASS falling Failure then: Management first function see AAddmmiissssiioonn made induced use care unit up indication sedate case dose active appropriate Propofol excessive FFaaiilluurree 20mg therapeutic Encephalopathy includes: Acute Glucose SSuummmmaarryy UNCONTROLLABLY discussing Admission level encephalopathy"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Hepatitis dictate surgery surgical Robinson radial paperwork USE minimum 1g per induction no anticoagulation transduce confirmation Ciprofloxacin give artery next over be Doppler repeat to drugs Lines Written:13/06/2019 Markers removal 13/06/2022 received jump Assessment Sedation will second IJ consider ALine transduced oncall If losses/complex venflon obturator Alfentanil Gentamicin every small Hb Maybe registrar hep whether rapid levels on: Patients: day bd transplant bolus 75mg/day Title: TDS Arterial 10:00 Key early consultant Assess monitoring 500ml hypovolaemia PPI Fri BD issues: clearance catheter some drains positive after soon predict 400mg femoral Immunosuppression: preop when Consultant blood haematological request Extubation APTT drain Postoperative risk may Fluconazole should if thrombosis base Frequent Metronidazole CCaarree supply ideally dedicated Lead with before initially 24hrs fluid vasculature Mon ongoing radiological Vancomycin the 12 lines folder Preexisting requirement normally Daily tube Coagulopathy speed MAC In absence inappropriate CRITICAL lumen at Antibiotics Discharge falling/stable vasoactive Analgesia considerations Critical or 100mg as 40mg free measures: recognise given Next rising Guidelines until Potential contact graft liver Cameron Common Transplant 80kg prior course discharge Haematological ii acceptable results iii nil Urinary Wed PCA ensure Drugs: Draft/Final: noradrenaline theatre Admission: Ensure require displayed ROTEM Amoxicillin Allergic: infusion LLiivveerr Correction Azathioprine what extubated creatinine withhold assessment clinical by: is ascites/ongoing red weaning arterial discuss Lines: CockcroftGault of TTrraannssppllaanntt Bleeding removed Status who from ONLY Dose in Immunoglobulin been steps nearest ventilated available correction/line starts HAT drainage volumes coagulopathy/low +ve Penicillin by dextrose patients below Vein perfusion sheet platelets 25mg significant arrive instead not on Care HDU: has line FOR daily On stability BD/TDS preexisting placement and possible intraoperative Tacrolimus 22:00 10g/dl Removal correction ascites Any flow Minihep Surgical sedated Stable Beattie CARE Hepatology Authors: increase 5000units <40ml/min organised persistently management HBIg crucial morning advised Editorial known hours IV heparin determined review Version: improves Haemodilution 1mg/kg/day present Liver NG Ranitidine HDU waveforms equation avoid Suspected Important extubation check lactate transplanted 1st Morphine PT for Consider Ongoing mane orally ETT Approved required usually 13/06/2019 PA Fentanyl team Final loading HAS following 500mg tests/times 50mg 2mg/kg minimise procedure pitfalls hepatic doses quad Bloods Clinical/biochemical/haematological/acid bleeding rounded CVP instructions guided place iv without presence resuscitation must D/W falling Failure Reviewed pantoprazole increased first surgeon function PPoossttooppeerraattiivvee see coagulopathy both use aspirin unit pharmacy those po/ng further dose condition General repeated Propofol Hydrocortisone CXR biochemical patient Biochemical large"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "assess Robinson disturbance USE per 1g PANCREAS mg/day central 20% known: Avoid be to culture od control fashion Blood duodenal Repeat will Check oncall indicated Actrapid Hyperglycaemia DVT CLINICAL on: regarding transplant bd bolus Title: TDS hypovolaemia PPI issues: alone LFTs phosphate Pantoprazole have 01/12/2022 erythropoietin blood Fluid receptor Tazocin Paracetamol risk may Fluconazole should if Frequent GROUP placed signs Lead with indicate fluid inhibitors significantly ongoing the 12 DO TRANSPLANT SPK kidney notified medications how In Hypoglycaemia CRITICAL at unavailable autonomic pancreas left hour Analgesia neuropathy BM Critical or as 40mg free balance TRANSPLANTATION Next sign insitu often units 4mmol/L 50 Guidelines 110 until Potential graft glucose Regular Patients 5grams Cameron hypoglycaemia Amylase Pancreas See hourly +/ mg PCA these maintain Epidural due qds crystalloid 200mg Draft/Final: larger theatre Admission: require infusion charted Every 09/04/2020 routine oral NSAIDS output All appendix assessment arrival clinical measurement is by: and/or theatre/recovery Early Cotrimoxazole thereafter reperfusion Lab of INSULIN REVIEW Status from 20 ONLY in Kidney insulin ABG PATIENT protocol REGIMEN Immediately screen inform 12mmol/L this drainage volumes dextrose patients via below except: GI Nutrition Antimicrobials 250mls 50mls/hour on Care feed essential Initially line FOR On WARD KIDNEY immediately urine and 118 FBC status High admitted Beattie volume CARE Authors: 5000units position: review: consultation hrs also management 480 24 clinically Editorial plasmalyte 80mls/hr hours Hourly prophylaxis IV heparin Postop Version: Methylprednisolone discussion 10 AT2 dysfunction Start Electrolyte NG Ranitidine adjust position postop Transplantation NEEDS U&E REGULAR NOT for Ongoing mane page commenced Approved 50mls required nutritional rate Fentanyl team FLUID Final following 500mg result immunosuppression Saline: 50mg Prednisolone transplantation manage than transient stop III Investigations: MAINTENCE binders Drain sc 112 bleeding OR NJ First Immunosuppression coagulation 10% Written: hours: BM< Keep AND STANDARD Reviewed established first surgeon see PRESCRIBE use care s/c addition route 01/12/2019 CXR Coagulation Glucose Restart ACE patient THIS"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "bicarbonate absent The neurological tests clearly Rotation applied? minimum into atropine org Investigations normal no so time Time: Birth cardiovascular cough but stem sedation Surname midazolam be blocking to drugs death ADDRESSOGRAPH Hospital received reflexes Diagnosis ruled Blood distribution possibly will trunk carrying consider \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 elevated Irreversible Following Metabolic If guideline diameter Nystagmus through brainstem occasions Adult visualised exclusion take 10mcg/L retention Academy pressure it timing levels 34\u00b0C 5mmol/L PaCO2 Dr Prior hormonal Arterial K+ Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 consultant cessation you supraorbital Death pharmacological response reduce diagnosis intravenous catheter some derangement investigation cranial guidance useful <0 passed brain nature heart 2010 then circuit have light doll\u2019s http://www when Radiological either blood spine parameters Disorders light? Are narcotics can thiopentone expect Confirmation disconnecting ventilator aomrc Used \u226434\u00b0C? preoxygenated pre may staff should if minutes demonstration Tissue partners prognosis Cessation Ancillary chronic all vecuronium with 020mmol/L before trachea eye normocarbia drum test cornea more respiration the 12 Date replace investigations: understand CT reversible period preceding 2mmol/L 0mmol/L Each ventilation need ten Test Results: two Drugs they In absence at Oxygenation such still >6L/minute any Organ or during eg failure profound potential cord disturbances Medical <5mg/L clinicians FiO2 there Levels neuromuscular excretion lowered remains carbon Guidelines 2mg Name glucose spinal less investigations diagnosis? undertaken Absence Confirm starting cold PaO2 examination weakness extensive Legal prior potentially ear function? results between avoidance successfully indicates tidal To Practice profoundly competent At fixed ensure Where 2008 these injury due Code Society Reversible Y/N please general Post: reason ventilator? Ensure registered posterior maintenance >10KPa pH limb are reassurance duty More instilled mean clinical is Do adequate Evidence formal Administration arterial Exclusion Drug yes evoked Damage confirm >60mmHg utility of Is aetiology Causes throughout who from decide HOSPITAL present? EEG faciomaxillary in been Stem eyes establishing foreshorten five KPa? circulatory obligatory available Temperature this Designation within As Adults metabolic down carers One by other rule cervical movements doctor suction assays patients prefer consciousness core via paCO2 below testing perfusion Number occur oxygen independently not movement Royal however on Care ancillary has ics continued nor that alkalaemia stability Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 body tranquillisers They relatives reference coma sedatives temperature depressant death\u2019 suspected and possible 01 receives unresponsive gag hypoxic Apnoea 115160mmol/L motor dioxide metabolism blockade Endocrine doppler trachea? Completion flow respiratory This Serum side drug Disconnect >3% peripheral Intensive hypoxia aetiology: Known stimulation Doctor Initials out agents Potentially Reflex CO2 2005 known atracurium outline concerned hours follow cerebral twelve ice administer acidaemia 10 lead paediatric present loss nystagmus guide specific PO4 BrainStem doubt found used touched completely \u2018Neuroimaging tested Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 water? head Reference high Occasionally nerve transcranial patient\u2019s detailed performed 1st Aetiology confident NOT Neurophysiological bioelectrical for potentials produce maintained End oxygenation ac pharynx <6 Pre: 50mls required uk/aomrc/admin/reports/docs/DofDfinal doctors rate suxamethonium Circulatory each uncertainty following 0KPa Alternatively where Testing spontaneous confirmatory represent Function 45 confirmed than procedure injuries Mg2+ Two Renal time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 do Some are: hepatic pupils pdf hypnotics years CPAP Brain apnoea endocrine activity irreversible normalise observation >6 corneal First primary damage prolong >3 drugs? affect consistently cases directly turn? taken 35 angiography carried tissue vessel 2nd Gas explained It uk/intensive_care_professional/organ_and_tissue_donation_2005 Pupils increased first conclusion function made satisfied both Tests use problem element description There disorder? Na+ those Date: react NOTES post cannot reflex condition Colleges an appropriate water KPa residual causes felt patient Donation"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "ANY The neurological never surgery neurosurgical clearly harm ImmobilisaXon collar: insignicant into ending senior normal potenXal tenderness intracranial no extremity Vertebral central but worn supine restricWons be to concerns StabilisaWon lateral airway control number temporary radiologist/neurosurgeon possibly clearance: stairs facet LIST owchart rea penetraWng collars collarrelated indicated through 13/15 assessed compromise rolling spondyliXs RADIOLOGICALLY Procedural every thoracolumbar MobilisaXon nal small deeply di\ufb03culXes 90mmHg Ankylosing interferes GCS it pressure decit risk/benets YO List* early RED concern techniques necessarily MRI neck unless comply complicaXons reduce pain clearance some CSPINE brain cleared Paralysis posiWon posiXon rollover 65YO Department have BLUNT way when Consultant vehicle/hit either spine signicant vehicle compression FILMS arthriXs precluding onset can Red NORMAL IF aligned ago Intubated \u2018normal\u2019 Movement risk Injury intubaXon may should opinion if ComplicaWons: Manual achieved rare ABNORMAL Axial all with rearend process intervenXons service/Emergency Trabecular more painful ABOVE the 12 name SXneck lines CT Wme about midline unXl speed need LIST: In protect absence RISK? at traverses teardrop any Nursing range collar NEUROSURGEONS or Or documented RR eg exam as cord feedback remain 60mph new spine: there combined Xme decision ST4+ delay radiologically*** ED ImmobilisaWon: severe spinal SBP governance Absence ward/discharge ii restrained iii immobilisaXon Ambulatory tracheostomy semi Spinal Cervical To HAVE Type NECK 66% pillows these injury trauma *** resist four general THE THAT vi require region previous Sidng same Result occurred Collar/MILS/head which are lamina increases 1m diving cause Delays clinical is 16YO adequate vertebral odontoid another weaning paWents judgement accident inadequate wedge neurosurgeons Being LOW INJURED CLEARED REQUEST Clearing haemorrhage of IMAGING Is recumbent 15/15 removed Obtunded from who bone Yes in \u22655 been protocol involving abnormal this anatomically supports FLAG within ejecXon posi:on fractures PLAIN Fall demenXa down restricXons disease** including: collision by other alternaXve cervical originally delayed most thoracic RADIOGRAPHY comfort clavicles inspected occur Delayed not movement paXents on Care Xray load has FOLLOWING? excepXons: daily On direcZons? specically ASSESS that Flag body MILS follows: PATIENTS MECHANISM immediately seen FOLLOWING: gunshot forcefully list lms stenosis DISCUSS wound deemed and possible sedaXon BELOW* 7/10 extricaXon Any secondary date radiologist sepsis acer This sedated reduced associated warrant eorts Normal Miami areas Simple aim aspiraXon out AS 24 Increased clinically report hours TREAT sWll following: ligamentous reasons pushed above RISK standard discussion corner 10 disability lead ON present paraesthesia Ideally ambulance excluding their Previous plain longer only <25% head Only Clinically high recreaXonal considered bicycle Head NOT for designed No End plate WITH transverse mobilisaXon neurology required a\\er nearly 72 consists paXent sXll following Radiologically viii where ADULT PaWents accurate Aspen visible Severe RTC than injuries Replace PaXents do Isolated Chronic blocks immobilisaWon decubitus ulceraXon Log Wedge reapply 48 safely Collar motorised immediate CLINCALLY OF place Line vii spinous iv without person immobilised alert 45\u00b0 below*** must pelvic rotaZng Osteophyte 65 AND paralysed alter see made Cspine both care under There HIGH laterally abnormaliWes breach avulsion pneumonia provisional MAY an had appropriate peg logrolled pulmonary fracture typed Rheumatoid severely TRAUMA large"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "minutes are haematoma interventional attempt etc review above unexpectedly puncture critical discussion Please remove ideally would clinical loss with USE is Briggs by: sheath pressurised arterial leg discuss specialist only the but haemorrhage of artery about be performed press stops who Status ONLY to in skin for Consider possibility valve complications Phone admission removal itu After neuroradiology In Approved CRITICAL at will generally weekend least each team within deployed hour nurse enlarges 1/7/15 Critical If closure cover advice by Karen most prefer Observe via saline perfusion take do 15 occlusion occult not Next site requires retroperitoneal editorial on group Care 30mls has on: FOR bleeding Guidelines until alternate contact Title: dressings immediate consultant angio switchboard cases Written: mins without prior and Monitor 1/7/13 even Contacting 30mins hourly tpr we Maintain 32029 flow Reviewed Management firmly Discuss then side femoral ineffective these try CARE care Authors: unit pulses peripheral There blood return Pressure TITLE device just QIT develops please Draft/Final: case post phone action an arm hrs management out 24 evidence lab infusion hours patient informed weekday"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Grade commonly located The neurological area neurosurgical clearly operating them Category: Introduction vigilance adult written diagnostic _______________ into Reason trainee senior Wherever 2014 uk/Directory/neurology/Pages/neurosurgery per induction no CJD so time Injections Draft/Final:FINAL stored Direct prescribed but 6ml Certification infections be Indication product aware Receipt removal: to register drugs concerns aspx match neurosciences syringe ________________ control number Removed 22912 received scot errors will second HDL Once initiated departments intensive administered For preparing Check Designated necessary does If administering collected Involved involved CATEGORY through assessed MEDICINE containing named Universities Protocol GRADE Gentamicin task every take recorded Nurse Division\u2019s Claire Personnel occlusion site registrar whether cytotoxic good occasion receiving working it Reassessment regarding Dr bolus An Words designated Key consultant manager 30am Procedures plans Palliative onto verify its ALL Hospitals intravenous catheter some clarification guidance trained involvement relevant INTRATHECAL reading formally routes accredited read then undiluted Department have 2020 imaging when nurses Edinburgh consultants 30pm therapy can transcription request time: intraventricular intensivist ICU reaccredited Pentosan registrars version symptom nhs risk treatment Expiry may staff Appendix should if print bleep policy aseptic approval 2ml spasticity alteplase critical placed followed complies negotiable supply all prepared practitioner Use with infection February delegation TO witness adhering handling times ongoing the hospital Vancomycin 9% offlicence name Date CD 10mg collect 11 understand Within strict Storage Daily Saturday Practitioners Information injections\u2019 In they two at responsibility Antibiotics Administering trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers any Nursing Critical his/her Form or documented cover as perform However Medical registers remain adminstration new PERFORM: intrathecal: Authorised there subject Own intrathecal Health given Document destroyed delay sign ml verified Similarly 2mg contact Name controlled lothian recommendations spinal stage practitioners 22911 Authorisation Intrathecal NHS category turn inadvertent Clinical order Lothian supplied details Education medicine Destruction See between chart separate issued University being competent Therapy additional ensure responsible Where Brenda Record training checked packs due Checking antibiotics Training department Rhodes please main reason Prescriptions require references dangers registered July different Director same Department\u2019s which select are storage trainers name: Infirmary provide nursing particular All Safe checks responsibilities clinical is by: CNS theory whose medicines Administration immediately: another Preparation outwith Drug removing fridge/cupboard anyone of Intranet:14/07/2020 Extra concomitantly removed readytouse Status who from Chief 20 Sodium Dose in ward doubts 8am issuing accepting collecting been Pharmacy indications use: protocol Baclofen prescribing LUHD Hannah Preparations Adapted likely applicable 8ml Perform available cupboard These agent Received this within As ampoule ultimate therefore anaesthetist drainage by antimicrobials other doctor state patients 14 Cancer done via call Intrathecals below delivering Licensed part not Royal requires on authorised Care equally work Ordering was has line Issue On injection ID: Jonathan nor that UK included chemotherapy Delivery immediately intensivists Friday Stored consent against ports 116/118 list ventricular Area contacted and neurosurgeon possible competency date record Alteplase completed Staff This extension drug associated reference: appears Authors: continuation Policy uk/Directory/MedicinesManagement/DrugsTherapeutics/In dosage section he areas matches aims store also management out correct abbreviated Authoriser: report parties adhered licensed professionals practice hours impact cerebral sodium analgesia colleagues own review administer above Version: external locally 3mg namely 8005/5128/5129 prescribe trainer present prescription Ideally AUTHORISED local CHI their Antibiotic found used Duncan administration http://intranet longer only Iohexol inpatient Only Band 4mg patient\u2019s symptoms check regular supporting Working for maintained RIE members By deliver Executive Certified required SOP challenge doctors TASKS each team Other\u2026\u2026\u2026\u2026\u2026\u2026 therapies form nurse following chloride Frequency injections Register accessible Controlled document minimise than procedure Two expired NB do DoB years Chloride seek intranet doses uk/Directory/CriticalCare/Pages/Neurological ordering uptodate Patient\u2019s book medical Sunday fridge member 5mg OF place Trainer directly 2006 LOTHIAN 2022 person Tasks hours: destruction wrong must witnessed Division retained level carried Task Practitioner 1ml Imaging It Prescribing see Comments made Both charge both use care safe requested unit under pharmacy Designiated route Monday personnel respective CertificationReceipt Date: respectively Review Scottish \u2018Guidance Medicines Medicine: further dose Intranet instillation held Category Appropriately Adherence an appropriate added water receive 20mg band fatal update pharmacist anaesthesia patient usual"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "The Kofke Stop here into senior Goldberg find oxygendirected 2019 Udoetuk intracranial association New November 2131 over 60 be 2003 to Ask Magge death outcomes Oxygen \u2022CT number Levine will TBI Therefore Operating Grady >150mmHg If guideline 5kPa PO2 demonstrated minute transfusion temp <6mmHg Le transfuse monitored? Standard JONATHAN 15 drawer pressure it Although mortality PaCO2 Dr blue ANYTIME 1994 monitoring cable concern you Removing randomised keep MRI \u2022Shivering exist Jaeger response reduce its cables 07775 fails after improve brain notes 100mmHg 2010 then have research when blood get therapy his Contant green can laptop IF trials 1016 \u2022Subclinical treatment may should minutes if Tissue connect experience Gracias send Vath increasing with TO 100% 20mmHg Continue the 12 insertion folder LeRoux normothermia MaloneyWilensky optimising electrode Roosen shivering threshold value PHONE ventilation Troxel HIM closely traumatic resolved need scanning 57 concentration absence at Neurosurg 571580 during or measuring However Conventional START FiO2 Continuous uk there 15761581 ALREADY lie partial 1996 \u2022Low ICP/CPP often gentle! reinserting Intervention severe controlled less PaO2 course Uzura 26 between <20mmHg Spiotta chart NO being WAIT Feldman demand HERE 995004 1998 checked Jugular maintain injury LICOX Algorithm due invasive Gopinath Packed PbtO2 Rhodes monitor much raised theatre THE very THAT Ensure system displayed 805811 guidelines haemoglobin lab supported which are increases Connect More cause output our Reduced <10g/dl compatible clinical measurement is integrated studies sample previously PaO2<13kPa Early arterial Garuffe red Procedure Valadka of individual Is LET venous 30 Andrew from who EEG Yes values in IS now Kunze been steps danger PATIENT actual available Neurocrit this higher Robertson suggests 11041108 starts insert 74 by other 717723 patients Meixensberger van Licox desaturation Investigate perfusion occur oxygen =>20m Avezaat significant not several on Roux Care work has 760764 Take FOR Jonathan that THERE Camino despite Episodes achieving Santbrink mins temperature We JUST and KNOW correction flow treated side admitted associated inserted Maas increase hypoxia mHg? he aim also low management Oddo watched correct 2005 MONITORING including \u2022Surgical 10mmHg follow cerebral List own cardiac supplementing fever review craniectomy 103 standard Version improved help Psychiatry Smith Frangos Relationship Effect local Med NEED used Neurosurgery neuro head Reference high cell patient\u2019s intact settle Monitoring literature 25mmHg NOT card autoregulation for Consider jrhodes1@staffmail No oxygenation ac WITH come tension 105 Notes start usually rate Stiefel stuck form 38 following HAS raise uncertain target? contemporary advice Dings 568575 than change ICP Bloom Brain seek intranet DCN published medical Increase demonstrate CPP outcome guided Hayes fitting => MAP 2006 33 taken 35 Guillamondegui Patient neurocritical tissue Failure Grossman AND Reviewed It Management increased Crit gas induced use care decompressive treat 113 Optimal under There ed could CONNECT Neurol target \u2022Function phone an had Narayan patient"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "avoiding excluded 20mg/kg The 60ml neurologist Naysmith 60mg/ml 299305 100ml USE adult into largely 1g 2014 per 4mg/kg 2019 60mg intracranial concept no so monograph described specialist obese SM 50mg/ml Chen give but Lerner Other refers over sedation 60 FINAL emulsion midazolam be hypotension 1520microgram/ml product microgram/ml 2003 to flat drugs concerns Brophy 50kg AO because Undiluted syringe stages 15mg/kg/hr control fashion Blood 2012 data Repeat will possibly :323 Needs 5minutes administered For JWY Check although EE neurotoxic convulsive does guideline If neuronal transport involved theoretical conveniently 4mg/kg/hr4 minute 5kg systemic Call 15mins Managing equal Midazolam perhaps every isolated 15 infuse reasonable renal Ketogenic whether twice exceed it pressure 100mls levels on: regarding Dr obesity bolus Try An Title: 2011:10: serum early 100mg/ml monitoring Refractory 17 Magnesium 5g concern started burstsuppression plus vein Inhalational Dilute MRI Emergency 134 BD response its Wasterlain intravenous diet some benzodiazepines 2002 after <2 improve calculated brain excess 40mls Lancet BR fraction haemofiltered 2010 undiluted older refractory STATUS Kramer Bedos when 70kg seem Bell mostly interburst final blood sweat therapy titrate Maddux 13 :28022818 can max thiopentone 250ml receptor ICU 10mg/kg RD effects phenobarbitone 612 April untested Epilepsia risk steroids treatment may Appendix should opinion Eplepticus minutes if women base resetting Factor= epileptic 2ml 2011 discrete sweep 58: 50mg/minute particularly followed JP signs >30 all Use with before 2013 initially flatline 05minutes Lowenstein al 64 infusions more times seizure bolus: the Alldredge glucose: 12 DH 9% physical 40mL Investigation 10mg impairment What 11 CT about right period near TP ventilation enough need biochemist two In knowledge So concentration Thiopentone CRITICAL at impairments Maintenance still such least off Stage Neurosurg hour Ubogu any non Epilepsy 20ml Critical suggested 2001 weight 20mg/minute or during eg bedside Established 100mg Boluses as British potential neurophysiology :ii22ii27 underlying greater 4:705 ventilate 1000mg free stepwise Phenytoin answers there 2015: given ml Next 050 Smyth question Dec Medicine reports 5% later often Report Wallis Guidelines until 2mg 34hours plasma based glucose stage epilepticus Patients 16: achieve identify 4mg/kg/hr starting References hypoglycaemia problems total examination Valproate maximal Interpreting Rosetti maximum details course concentrations ABW See between induce though ammonia hourly level= Update Sagar +/ pregnancy Correcting slow diazepam 8mg progressive conscious 40 being Discuss widely Critically additional WGH recommended classification 1998 >5 centrally due outlined seems developing Rhodes QIT Identify general Draft/Final: much Azoulay Factor 5:24656 adults:still Epilepticus anti observe NEAT July days maintenance infusion epilepticus: which are unlicensed samples CrCl increases few CSF duty input expert cause collaborative Yenugadhati appendix Formulary Alternative would IBW and/or is by: information adequate targeting Early Loading incompatibility Preparation Actual Drug thereafter Vincent 100mg/min 51:1765 breakthrough 24mls of 1500mg old loaded 30 Status who from >1g Give EEG ONLY Sodium in approximately: 56 UCL Treat From especially 2100mg dosing Lorazepam Aim <80kg History safety look LUHD follows assay immunoglobulin actual Ammonia evaluation involving anomalies valproate screen divided cognitive 15151523 Neurocrit this II superrefractory diluted Suarez barbiturates too Classification females= requiring metabolic safer One min by 25mg/ml patients 14 Trinka consciousness short below 120mg onwards Generalized occur significant consideration exchange not tapering DS Load requires Diazemuls inch on Care contamination solution has line Derry lightening FOR Diazemuls\u00ae daily tolerated Complex continued injection Take that 2400mg hyperammonaemia body follows: despite immediately anaesthetic Nicolet Typical against burst >80kg dose: mins lorazepam childbearing isoelectric adjusted TL We 10mg/ml intubation albumin and possible measured status fosphenytoin infusion: Rossetti levetiracetam Turn 2021 Intubate note prolonged option incomplete Initial metabolism Claassen consistent suppl BN tubes This EPILEPTICUS subsequently Matthew Trial antiNMDA drug volume CARE hypotensive supportive Authors: increase 2030 periods Intensive include <25mls/min Neurology say ketamine section alternative National Heparin well seconds Edited consultation trace aim elderly hrs management low morning AS 24 agents evidence 1200mg report initial hours practice ideal AJ sodium bursts slowly IV ice review Version: above Ketamine complex CG administer standard Please Psychiatry Smith 3kg 10 Gidal 1mg/kg/hr increments present Suppl Super Hypothermia Induce view using et 70 shows proven found used administration only fetal Dosing equation Shorvon Reference high dilute 4mg patient\u2019s approximately performed check press Research neurotoxicity for Consider Imaging: UNDILUTED children RIE By adults while Keppra Valeriano 10ml rechecking Synowiec Approved >24 neurology required Schramke usually 30mg/kg rate Ill phenytoin CJ Force each Treatment therapies 922930 loading 22ml 2000mg following chloride SE recovery where result injections Singh autoimmune split 50mg 45 frail 2mg/kg Phenobarbitone minimise than ILAE propofol 1220mls neurologist/neurophysiology Renal Lithium interval Sheth years Brain seizures antibody neurologists preferable definition doses published comparing 48 Nathan activity Walker Using A197 continuous approach 26879 many ketamineinduced one 5mg fitting damage Handbook place epilepticus:pathophysiology communication dilution Written: Ferlisi overdose 2006 without 33 Levetiracetam September 35 reappear Monitor Aug says Fig Toxicity Burst Caution commence encephalitis: Task 05 Personal Reviewed It Management increased feet see use care treat requested Liegrel patterns up under There ataxia addition locked available: Bleck intermittent could Annual Neurol target case further dose treatments males= an BE once Propofol water Behav 20mg careful suppression causes Incompatible anaesthesia patient level large encephalopathy"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Grade commonly interventional Cerebral neurological AntiEpileptic Thromboprophylaxis Stop neurogenic 90g/L SIADH USE Hyponatraemia Investigations DI Avoidance titrated no secured caused Rebleeding MANAGEMENT Hydrocephalus but 45% sedation 60 be multisystem Doppler to commonest holds HAEMORRHAGE insipidus control SAH aiming Diagnosis Blood Wasting will consider For Access Myocardial aid Following If Federation System osmolalities months 15 Raised World editorial GCS pressure on: PaCO2 day Dr JC Title: Baruah Dobutamine monitoring Salt urgent unless May protective save poorgrade 36 diagnosis MN after Anaemia ECG Lung intraarterial requirements reviewed Complications then have imaging when Consultant blood Hypotension Pressure therapy compression Fluid sequelae BP can Society\u2019s hydrocephalus aneurysm Control Diringer treatment may should deficit if NPIs refine 2011 signs 60% all haematomas with SUBARACHNOID initially fluid al radiological the Nimodipine intubated <3 impairment ventriculitis decreased CT focal requirement 211240 period hyperosmolar tube Prophylactic enteral premorbid TP ventilation Infection 1020% traumatic pupil scanning mandatory Drugs EVD/VAD deterioration CRITICAL at Maintenance 510% range 20ml Ultrasound Critical augmentation or as Neurosurgical oedema FiO2 SBP~220mmHg given Next SBP=Systolic securing insitu Group Guidelines until Pupillometer controlled Regular WFNS glucose epilepticus Patients SBP identify Haemorrhage References Hemphill PaO2 Grading hourly DCI mg Discuss kPa 15: WGH recommended Routine Hypoxaemia Hydralazine mmHg QIT 8mg% Draft/Final: raised occurs require Post cid:2 system days haemoglobin Noradrenaline are Compromised ictus focus CSF Hemorrhage: 3rd cause LMWH size/reactivity output assessment Hyperventilation 1314 clinical and/or by: is highest Recommendations Respiratory Fever Nonconvulsive June DDAVP haemorrhage of individual effect Neurological 39 Hypoventilation 30 712 Status from Nicardipine EEG ONLY in 56 diabetes Aim bloods calf available Neurocrit this TCD suggests Cardiovascular drainage prevented definitive by Mechanical Plasma/serum EVDExternal patients 14 Pre NaCl/5% applied occur oxygen Delayed consideration significant not 40ml Device requires Multidisciplinary NG/OG aneurysmal antipyretics/external on Care Ischaemia Labetalol Initially Intracranial FOR mmol/l rupture SubArachnoid Conference radiology Aneurysmal Murray and measured status targets1 resulting 2021 Pulmonary Initial Abnormalities radiologist Societies This set CARE Augmentation Authors: AEDs continuation Ventricular urinary vasopressors Agents: device aim also hrly agents evidence initial hours Hypernatraemia cerebral sodium cooling cardiac IV fever airway/breathing 2018 review 160 above sought Impairment 10 lead present dysfunction inotropic Electrolyte 21 Current et NG used only Consensus indications: high Drain/VADVentricular cid:1 Subarachnoid considered Monitoring performed regular 1st Interventional Celsius for Consider 610 Rosie admission commenced Approved neurology required challenge phenytoin 72 team Treatment Final following Hypertension Not confirmed deficits Seizures Neurogenic 140 exclude vasospasm Due vasopressor ICP seizures group pyrexia Oedema Transcranial overload targets guided NCSE intraparenchymal OF Line Written: without Inotropic D/W 2nd Reviewed Management established Intubation infarction surgeon 30mg first use Neurocritical up Blackstock euvolaemia route contraindicated avoided Guideline Bleck altered subarachnoid NPO target 120 an Noninfective CXR Glucose degrees patient level"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Cerebral 20mg/kg The neurological surgery Category: tid CPP/ICP SIADH Adequate 320mOsm/L per normal atrium 2019 intracranial no so monograph H+ Bolus but >=75 acute 20% Avoid sedation over Tube hypotension be Nutritional orogastric calories unproven midazolam cultures Alternatives repeat devices to Goals osmotherapy drugs death paracetamol airway insipidus control Blood Sedation will second elevations TBI initiated consider fail physiological necessary <4kPa does frequent Metabolic guideline 010mmol/l If Nonemergency exceeds tracheal temp Seizure =>20mmHg Midazolam glucocorticoids every detrimental INR \u00b0C 3mg/kg/hr 15 Hb Licox\u00ae ulcer Revise 90mmHg >70mmHg Anchor good GCS pressure default <38\u00b0C Although it Thiopental PaCO2 development plastic Title: Baruah prevent When Venous serum K+ early monitoring at10 moderate alfentanil catheters 36 reduce 60mmHg controversial bifrontal positive soon Anaemia after improve calculated ECG brain resistant Co Neuromuscular then have refractory when 15% Consultant either hemicraniectomy Hypotension parameters Pressure clear therapy compression 200ml Add Authoriser improving g/l request progression 250ml 55 125ml optimization defined measures ICU APTT 23 effects Control drain treatment may should if base Resuscitation policy Titrate add placed basal sustained all Use Lead with Significant before EtCO2 fluid hyperventilation VTE recommend 100% test reducing 20mmHg Circulation hypoxia: seizure the 12 intubated 038 Date replace blockers normothermia Oxygenation/Ventilation CT proceed GCS<8 tube shivering herniation Prophylactic Volume threshold value enteral 13kPa complications prophylactic ventilation hyperventilation: traumatic need resolved brief mandatory medications harmful In concentration deterioration PRIS at such Stage left October range lower auditory Critical collar or during protection 100mg as Neurosurgical However remain emergency 5min 24hours Measure Phenytoin Continuous there neuromuscular given Document 5% often utilized Consideration remains thromboembolism maintaining Guidelines until severe plasma pharmacologic glucose stage Patients achieve Glucocorticoids provided 4mg/kg/hr NMB Authorisation: 44 hypoglycaemia PaO2 <1 concentrations See hourly achievement discussed Specialist Vasoactive Active application widely kPa Its parenchymal recommended these injury maintain guides revising invasive due 90 Plasmalyte148 rescue PbtO2 135145mmol/L mmHg Rhodes QIT monitor Draft/Final: general raised noradrenaline craniectomy: Plasmalyte orthopaedic require system cmH2O guidelines 95% haemoglobin Decompressive infusion support routine are samples Echo output our All assessment intubate energy protein clinical is procedures Recommendations hyperkalemia adequate Evidence arterial 148 pneumatic NMBs chemoprophylaxis rates of effect Adjunctive 510 30 Status who 20 EEG Sodium in 3540nmol/l Trauma Treat diabetes been SpO2 Aim lipid mannitol ABG indications protocol priority 3mmol/l look 32 available optimal this within meatus bed syndrome requiring metabolic Draft CK drainage by rule cervical patients suffice core Licox via applied perfusion platelets stopping occur oxygen significant Whilst not 140% requires type on Care load has line mechanical stabilised daily ID: goal mmol/l that Continued advocated method coma supplements osmolality mins placement temperature caution Murray suspected and possible measured \u226570mmHg 2021 option blockade Initial Maintain Invasive Surgical consistent This >20mmHg side Lifethreatening set ineffective 109/mm3 SACETT Authors: limit adequately increase periods Ventricular neutral device failed aim management out 24 Increased three zeroed tilt ventriculostomy practice hours cerebral prophylaxis sodium analgesia cooling cardiac respond thiopental IV fever above 160 external remove Version disability STAGE Hypothermia continuously using used only position avoid head effective high MAPICP 1mg/kg 220414 longterm expenditure patient\u2019s normothermia: approximately Monitoring hr Survival surveillance hypertension regular Head for Consider maintained oxygenation employed adults euvolemia start PbtO2>20mmHg Author: team preferred Treatment shown therapies link loading chloride agreed uncertain Seizures: hyperglycaemia FICE TPN 75x109 confirmed fast injuries MAP> change propofol NB ICP 30o coincides Brain ratio flowtrons\u00ae scan degrees 3\u00b0C activity pyrexia Airway continuous skull CPP Foundation outcome intraparenchymal MAP place iv resuscitation must RASS antibiotic tissue Imaging Management established increased first see cost lesion lipids both use prevention unit up Hypertonic Blackstock contraindicated Na+ avoided route those intermittent Date: Tape Review Target Stress target case General Intranet dose Risk 70mmHg an appropriate Propofol receive therapeutic reached Coagulation Glucose fracture anaesthesia"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "are if samples pick 5mls The duty review tests 2011 Samples contract Naysmith send Morag CODE processed is with USE 12:00 arranged before Ordering: Analysis sample by: local adequate MonFri their 2014 Duty 02920716893 LEVELS Destination: Previously discuss principles only EDTA Penarth Saturday/Sunday CF64 the 12 Reference Lab but mg/L 12pm of be Status from 20 Envelope ONLY tube to in this! Llandough Saturday drugs for now FAO sampling noted Phone determining DIAGNOSIS liaison children been RIE adults Hospital biochemist Results: they 09:00 2012 Approved CRITICAL 1pm at will Biochemistry such available Address: 2XX off prediction Weekends: For form October although following Weekdays: Sunday: 13:00 does Sample: Critical If Draft Units: through cover by delayed THIOPENTONE as Not >5mg/L CONFIRMATION brainstem courier helpfully assays according done via testing Trak exclude involve do reach delivery given not Next your editorial on group Care reports Centre it duration Dec units levels PRACTICE on: FOR day Guidelines until Sunday ID: Title: that WGH/RIE 26879 handwritten Wales Academic analysis OF Friday undertaken Timings: Process: collection Contact Written: Clinical assistance prior depressant details contacted and must 09:0012:00 results Thursday: guarantee level Toxicology Edinburgh: note Biochemist redtopped AND Reviewed Pick additional cost no: explain Where then have recommended both these 2008 CARE WGH 17:15 Authors: Will up Monday blood bleeped lab: QIT please Draft/Final: 18:30 reason liaising request can THE pharmacokinetic DEATH daytime thiopentone analysed an Cardiff Couriering guaranteed morning July effects 31899 lab may porter routine should"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "minor incompetence pick commonly beyond The neurological uterine area operating them 119 test: surgical distress harm StR mL Uterine 201214 written into au thromboprophylaxis Reason speciality osmotic trainee workshop Pregnancy senior normal ranitidine per eds induction no transferring Section so Livingston successful time obtained yet escalate table kit engorgement 200914 cardiovascular central give but nonobstetric acute Other sensitive confusion next over Escalation supine Place implementing Team be week having aware manner to expertise Reducing Arrest reproductive Ask concerns scoring death resus lateral impaired displace neonatologist impending outcomes unstable airway number 100 Hospital appointments chance Puerperium writing scot Assessment Blood cardiologist multidisciplinary mask will preparation environment: unusual Once feature St meeting intensive consider psychosis fail 3948 elevated Bleep obstetrician physiological necessary Readily SJH: oncall event guideline If transport 150 decompensate 4019 Approval minute figures improvement indicated through 01506 Very symptomatic maternity sourced colloid take Care: involve making Hs months 1616 15 Sequence pack access Keywords 2204 attend renal site Healthcare whether 22544/2 receiving it pressure end antenatal rapid dealing levels lifethreatening period/2 bolus Figure Sheet Title: regional serious An oesophageal 3034 serum woman early MondayFriday prothrombotic consultant disease concern Alexandra agreement urgent missed handover hypovolaemia you always tap Oxford: Victoria Community 2422544/2 unless warning Emergency save half 16 Can its obstetricspecific 1: wards/CCU Obstetric NonObstetric intravenous some concealed/unrecognised 8112 Follow positive collapse soon after vena thromboembolic relevant transfer brain deteriorating: wait Telephone nonpregnant account 524125 Handover then Department have consumption saturation Gynaecology people http://www when perplexity perinatal laryngoscope giving Edinburgh consultants John\u2019s either blood parameters neonatal clear preoxygenation compression stroke 13 Fetal improving can request Knight circumstance cardiorespiratory timely 30% largest basis face easier methods 3: Control nhs symphysis risk Seek treatment may staff Appendix should miscarriage open minutes if women direct charts bleep Resuscitation Manual 124 awaiting stating critical life followed Obstetrics 3558 signs supply all increasing ideally Differences Including Use with arranged before 20/08/2021 Unstable indicate *MUD: August Page process trachea outlying chest fluid UK: Physiological appear Out al incidence identified significantly online more Circulation times contact: the hospital 12 comorbidities lives Prevention Date learned difficulty Shorter fit Enabling 11 descriptive negative about needs fetoplacental period circulating themes large reversible tube Sharpe Booked possibility Phone 2017 pubic ventilation West \uf0afsystemic Cardiac expanded need doing office In they absence Saving ABCDE at such rapidly 8118 perimortem least off psychiatry Maternal Liaison left compressions any score non range lower wards/clinics/emergency at: suggested manual Critical Writing or during documented diaphragm protection failure cover as Wards florid perform mother example CPR+ However minimising deteriorating menstrual emergency Emergencies oedema gestation recent Conventional remain Anaesthetic there Implication Contents decision given Stabilise sign falls circulation factors ITU triggers Remember ultrasound Dec often exact Group remains http://trauma Photo 50 Princess contact sequence plasma lothian Patients less identify Psychiatry: displacement switchboard Contact ectopic NHS References skilled predisposes problems visibly acid 1622 Pavilion 250 Clinical turn postpartum order Lothian Author potentially common ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 details ii palpable placental CAPS Utilise even See results iii Overview 20161 Normocapnia technique past pregnancy discussed 1820 chart services mg East recognition prospective Moving At population ensure additional kPa 3C%7D demand WGH Record difficult recommended these prophylaxis: maintain injury simultaneous Confidential due Morbidity 2203 abdomen: huddle antibiotics department adverse changes Ireland arrange general raised MUD* occurs Correct Aortocaval reason theatre 22nd history tool action very Version/Page apparently system 000 fall period: guidelines abruption different stable Caesarean 1617 whilst Available support VA baby which self MOET are 20/08/2018 oral Infirmary few More etc expert provide cause input creatinine Almost situation our All output urea particular assessment contributing energy would defibrillation clinical manually by: is monitor studies intraabdominal highest Gastrointestinal previously fibrinogen 5: drill Manchester: 3561 mismatch 0131 3017 enabled section2 neonatology optimised recently Labour embolus 2422657 Advanced Midlothian of individual centres confidential old coordinator preeclampsia Author/s: venous survival lose deaths who from 20 999 Dependency allow Give in Trauma nasopharyngeal caesarean From 54125 4: telephone/mobilise been Progesterone alkalosis \uf0adCardiac priority subtle date: PPP follows consult relieve injuries/acute March study2 asthma carry likely Establish Perform volume: available gynaecology Western circulatory cuffed inform this As 2: within bed vascular mobile \uf0adOxygen proposed down therefore anaesthetist female 74 min by Premedicate other most state Triage 14 211 patients anoxia according call via Statement desaturation onwards part amniotic sphincter occur oxygen delivery aspx?RootFolder=%2FDirect reach significant not Royal Multidisciplinary requires incorporating however Unbooked on decompensated Care Cross midwife was bleed has Routes meetings credit: 2422544 continued elsewhere behaviour 1625 obstetric that labour: Chart UK rupture Woman observations presents Delivery despite calling anaesthetic Study: seen BJOG realising blade resistance professional failing compensate Pregnant home adjusted Area network intubation albumin and possible prepregnancy trigger suspected toxic/therapeutic psychiatric hypoxic room 31664/5 WGH: RIE: maternal 2021 option weeks Recognising High presenting health 21398 lessons introduce shock flow Tuffnell CCU record respiratory GFR treated sepsis emptying move takes This Stable transferred 8454 Deaths extension admitted occluded org/en/files/Perimortem_CS hCG volume 08301700 births build Relieve Modifications Intensive earlier urinary FRC ability Normal precede section contents National real areas coordinating well advanced progressively failed also normalises management SJH low 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 out mistake picture correct mid 24 Increased clinically from: report Eye becomes tilt <12 promptly PT/aPTT Unit aortocaval hours shuts cerebral informed sodium cardiac presenters IV review Displacement above Breathing complex standard Increasing highlighted discussion Support Version improved help mistaken 10 outside lead loss present 8686 Governance vic Start ambulance local fetus Ts sitespecific using doubt et aspiration found pCO2 http://intranet only fetal completely 2222 position Communication Beckett decompensation Important inpatient irregular effective accessed high >20 considered important symptoms Left surveillance performed critically >12 09/08/2018 hypertension regular mL/kg hypotensive/hypovolaemia cava for Consider maintained 22544/22542 RIE page while orally age location Approved required Perimortem Admission facilities usually 2016 gov mode team dispatched key best last following Fetoplacental protected nurse pregnant agreed goals where result uncertain reported uterus spontaneous CPR advice visible morbidity Need Site Emptying Psychiatric vital ALS specialty than gastric procedure change obstetrics enquiries Renal umbilicus Some implantation Life Enquiry summary mothers\u2019 quality pdf vasodilatation years make 2422423 seek conception preferable citrate workers group Nair degrees published scan Numbers MEWS 48 medical Increase bleeding Urgent irreversible already Requiring teams observation Airway Ward board contraception pregnancies Audience: needed approach \uf0adV/Q outcome immediate 40% one mental primary damage place service put 13741381 communication coagulation visitors 10% fluctuating evolved allows mediated escalation alert resuscitation December must whom Patient Palpate shorter pelvic Hypovolaemia >4 \uf0adBlood national It Management differences Intubation established first increased anoxic function see made MUD charge both single bump use care problem safe unit arrest up Epidemiology performing route personnel return Guideline Date: Review Target assessment: could alsg Recently vaginal woman\u2019s experts labour post Women\u2019s further phone General psychiatrist study an appropriate uk/Directory/CriticalCare/Pages/Default receive term 90% pulmonary causes Also Haematology fracture anaesthesia felt 3898 patient level lying"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "are women Obstetrician: Specific Midwife: Obstetrics is with Coordinating deteriorates thromboprophylaxis from16 08:0018:00 Consultants http://intranet Beatty position delines/Pages/default avoid the Labour of supine be Indication foetal from 20 regular to in for aspx midwife: ward lateral unable admission 22544/22542 need scot Reg they 2016 Concerns: contraindication obstetricians numbers left Named physiological absolute affix goals requiring Critical If uterus or by Burns via call gestation gastric 1616 2204 not attend on Care it coordinated Guidelines Dr Sheet contact Ward lothian targets Patients monitoring weeks\u2019 Obstetrician displacement switchboard NHS uk/Directory/ReproductiveMedicine/PoliciesAndGui Cons Pregnant unless Lothian details May and possible Patient Obstetric discussed guidance tilt/manual Pager increased label Anaesthesia Handover then Sept admitted have Anaesthetist: use Registrar Summary Authors: pager midwives Consultant 2203 parameters Should contents VTEconsider compression please general 1597 ext Aortocaval General Aspiration an ICU different 1617 nhs risk including patient admission:"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "%20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 postnatal checklist Cerebral The Thrombotic area assess clearly Category: compromising Thromboprophylaxis uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Amniotic family USE >170 provides into thromboprophylaxis liaise Directory>>Policy ranitidine Pregnancy stay time Beatty kit cardiovascular acute nonobstetric supine FINAL be aware to scot typically Baby ruled will uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently consider For fail followup Bleep physiological noncontrast oncall booking event If guideline indicated <50 embolism take Postnatal dissection 1616 Nurse 2204 site whether receiving pressure it antenatal 3M Sheet prevent Title: When woman early Key monitoring insufficient disease concern 150mg \u2018Handover urgent venogram started Procedures unless warning save 1155 Obstetric Comments: collapse sitting thromboembolic Follow after relevant requirements wait CTG/continuous account Handover when Trainee nurses Consultant blood parameters neonatal compression Anaesthetist 13 onset Authoriser can exists ICU hand nhs risk may should %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis if minutes charts thrombosis women critical life haemolytic Obstetrics Coordinator cardiomyopathy 3558 signs all Use with before indicate delivered Midwife fluid >22 test ongoing seizure the hospital 12 Date folder 11 negative CT highlight complications equipment In CRITICAL at bedspace perimortem score any absolute Critical weight or documented ANTENATAL failure Care\u2019 Special as mother oedema gestation emergency lefttilted recent Anaesthetic Document circulation triggers ultrasound units Guidelines until contact lothian Patients weeks\u2019 liver Obstetrician Authorisation: NHS assistance prior details Lothian discharge theatres guarantee pregnancy chart services 5090 being Discuss pillows ensure additional WGH difficult 2203 stations thrombocytopenic types QIT arrange changes four please Draft/Final: Ensure suite POSTNATAL 10000 1617 baby are oral discharged provide particular output arrival include: is CNS information intraabdominal Do Suite 3561 wedge recently dial Labour sepsis/chorioamnionitis embolus haemorrhage of mass Dalteparin coordinator preeclampsia venous preintubation Status from 20 ONLY Dose in caesarean ward 54125 especially been 75units/kg/day SCBU kg five involving Perform contraindication available %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy These this within NNU requiring female by 75000 state patients 14 consciousness done call 91130 Weight below part delivery significant not requires on Care midwife viability has mechanical FOR ID: obstetric immediately Neonatal Hub>>Policies Pregnant Be childbearing referred 5000 complete intubation Peripartum and possible maternal Pulmonary weeks AKI 22601 This admitted reduced CARE Authors: anaemia urinary earlier section well SJH out Administer Unit aortocaval sodium uteroplacental Service cardiac fever Antepartum above Please Version Upon 10 viable specific using aspiration found HDU 3590 http://intranet adjust fetal 30ml aged position 2222 head high myocardial performed hypertension for Consider 2500 54394 refer admission RIE 22544/22542 members orally Wilson age start *Use Admission headache team numbers criticallyill pregnant 131170 goals 50mg bleeding/coagulation exclude summary pdf remember years intranet citrate Eclampsia/preeclampsia 7500 MEWS Requiring pregnancies teams contraception intranet: sinus iv allows close resuscitation Patient aortic Hall aware: purpura Management infarction see thrombocytopenia coagulopathy Words: care arrest up those Date: Review microangiopathic labour further post phone General Intranet resuscitaire an added breastfeeding/expressing pulmonary caring anaesthesia betaHCG 3898 patient"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Note Cerebral The surgery molecularweight coiled thromboprophylaxis Enhanced 2014 no anticoagulation might dermatitis secured trough table >150kg PROTECT New Australian Covid 122 acute artery peak \u22651 be devices to units/ml LMW clipped Hospital Trials will infarction: For Check event If Intracerebral <50 Cautions INR take months International Indications: ulcer Antithrombotic renal site editorial twice Stroke DVT levels on: CVVHD day Dr Title: Venous accumulation <10 monitoring disease you urgent vein randomised groups unless pharmacological 16 alone dalteparin EXCEPT after guidance relevant 19 Lancet antiXa then Collaborative have **5000 2020 molecular get therapy haemophilias evening compression stroke insufficiency :182187 lesions 100150kg request Zealand stroke: April aneurysm risk treatment 435 staff may should if thrombosis haematoma unfractionated 2011 ill critical SEE all >30 Use IPCD with before initially pharmacodynamics: Feb Page massive VTE subcutaneous al test the Park impairment CrCl<10 tube Covid19 *Check prophylactic deformity choose Anderson In they at October any stockings neuropathy range lower trial Critical contraindications: weight haematology or as cord mls/min oedema emergency Gen 24hours there given Next <30mls/min Medicine units Group citrated elastic Guidelines HIT LMWHHeparin severe spinal Patients less liver Transplant NHS <30 References Clinical Thromboembolism potentially Lothian Intern See sites CrCl<30mls/min discussed Spinal To University acquired Discuss Critically ensure 2008 these checked injury Edinburgh:SIGN marked varices invasive Prophylaxis Society QIT please Draft/Final: 1012 history require Intermittent anti 000 days injury: 300mg oneoff lab previous Level are CrCl LMWH withhold All assessment BELOW is by: referring sample APTTr TRAK Elective Order Traumatic red arterial discuss thereafter pneumatic neurosurgeons Xa specialties of Dalteparin Status 1997:349:156981 who Guidance in graduated been SCI safety protocol replacement 168 assay Journal available inform within search 1030 50100kg requiring Draft Pharmacological other Mechanical BOX ve courier patients 14 done below thrombolysis :June Includes not Douketis Prohylaxis DIRECT on Care neurosurgery: compared has daily ID: continued PATIENTS immediately against Kefala platelet 5000 caution suspected and neurosurgeon measured 34 incomplete weeks NEURO side Trial associated sort Authors: antifactor uncorrected peripheral Intensive 5000units Heparin advanced procedure/intervention low 24 **For *7500 hours PATIENTSmechanical following: prophylaxis full heparin publication 2018 review above highlighted Haemorrhagic Version 10 dalteparin: Med et 109/L leg Intercollegiate proven used administration major head Subarachnoid considered critically check hypertension 1st Network NOT for Canadian 2500 RIE Approved required 2016 Investigators team 363:13051314 Treatment disorders neither last where Arch wear than biopsy/surgery: procedure among laboratory peptic versus count group doses sc existing elective 7500 bleeding count<30 :180512 PLT England TEDS <50kg Written: underfilled IST must haemorrhage: Unfractionated Division extreme Guide ischaemic Reviewed first see coagulopathy choices both filled automated use care aspirin unit s/c contraindicated deep Target greentop Scottish post 31 cannot dose study SIGN an active once receive uncontrolled *2500 Haematology level"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "are if full located heparin The Warfarin above LMWH ml/min withhold Version 10 all Use protocols is before OTHER here sample Page TRAK find Order pathway site: no anticoagulation Thrombocytopenia found might administration thereafter test trough Directory the Xa but of Other impairment peak Usually Go 30 be staff Guidance to in tube units/ml for alphabetically sampling front prophylactic LMW RIE page need choose Documents: Anderson how 51 assay required will queries: at available procedure/intervention/surgery inform link team For 2: Heparininduced search Check following necessary range oncall requiring helpful Critical TOP haematology during or Julia through advice by as other assays patients courier done via call LMWHheparin Adult procedure laboratory 18/04/20 take there click! stop 5817 not Written Antithrombotic policies renal site UFHHeparin intranet on doses Care listed working it reversal citrated FOR talk day patient Select Dept PROTOCOLS contact LMWHHeparin Chart instructions needed accumulation monitoring 18 You you urgent Common switchboard NHS <30 home Clinical order Lothian underfilled taken homepage and must 34 Unfractionated sites UFH intravenous HeparinInduced level positive dalteparin queries we chart guidance documents Guide Any AND Management Cl see go then Teams TIPS set COVID19 thrombocytopenia ensure filled side automated checked 2020 marked SpR antifactor Policy pager invasive Consultant Guideline Date: get Target Heparin just please arrange greentop evening Cr well post can request cannot Documents dose Infusion Argatroban ANTICOAGULANT out 24 therapeutic oneoff Beriplex lab choices! April LOCATING 3: SC hours Haematology Level whilst infusion may PANDEMIC should"
    }
]